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Abstracts 
This thesis is comprised of an introductory chapter, followed by four chapters outlining 
the research undertaken by the author throughout the duration of study. 
 
Chapter 1 provides an introduction to homogeneous gold(I) catalysis, focusing on the 
selective hydrofunctionalisation of 1,3-disubstituted allenes and in particular axial-to-
point chirality transfer. 
 
Chapter 2 describes the development of the first gold-catalysed intermolecular 
hydroalkoxylation of 1,3-disubstituted allenes to occur with excellent chirality transfer. 
The substrate scope and limitations of the reaction were investigated. A wide range of 
allenes and alcohols were shown to be suited to the reaction, with excellent chirality 
transfer achieved through prevention of the competing allene racemisation. 
 
Chapter 3 outlines the successful development of gold-catalysed hydroarylations of 
1,3-disubstituted allenes. Excellent chirality transfer for the hydroarylation of allenes 
was achieved for the first time and the scope was extended to nucleophiles previously 
reported to be unsuited to the hydrofunctionalisation of 1,3-disubstituted allenes.  
 
Chapter 4 presents the first dual gold and photoredox catalysed aryl-aryl cross coupling 
which occurs through C-H activation. This work also constitutes the first gold-catalysed 
C(sp2)-H activation reaction which does not require stoichiometric oxidant.  
 
Chapter 5 details the development of a metal-, light- and photocatalyst free Minisci-
type alkylation procedure which is suitable for the late-stage C-H functionalisation of 
N-heteroarene and 1,4-quinone moieties, and uses cheap and readily available 
carboxylic acids.  
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Chapter 1: Introduction 
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1.1 A brief introduction to gold 
1.1.1 Metallic gold and its uses 
Gold is probably one of the most well-known and obsessed over elements in the 
periodic table, with almost everyone having heard of it. It is one of relatively few 
elements found in its elemental form and has been used for centuries as currency, as 
well as in artwork and jewellery. These uses depend on gold’s inert nature which is 
possibly best demonstrated by the many ancient gold artefacts which have long 
outlived the civilisations which created them. This inert nature also means that 
metallic gold is non-toxic and causes no allergic reaction in our bodies, allowing its 
extensive use in dentistry.1 Also drawing on these properties, gold nanoparticles have 
been shown to have biomedical applications in both drug delivery and imaging.2-5 It is 
perhaps this apparent non-reactivity that led chemists to previously overlook gold as a 
catalyst.1 However, interest in the area has picked up since the turn of the millennium, 
and the field of homogenous gold catalysis is now being heavily investigated.1, 6-11 
Gold’s unique reactivity and selectivity is quickly establishing it as an important 
contributor to the field of metal catalysis as a whole. 
 
1.1.2 Electronic properties of gold 
Gold’s reactivity, as with any element, is governed by its atomic structure. However, 
gold’s electronic properties offer some particularly unusual and interesting 
characteristics due to the relativistic effect.10 This effect can dictate how atoms bind 
and react and so is important for understanding gold’s reactivity.12 The relativistic 
effect comes into play in heavier atoms when the speed of the electrons in the s and p 
orbitals is close enough to the speed of light that their mass becomes significant.  As 
the effective mass of these electrons increases, the radius of the s and p orbitals 
decreases and this reduction in radius provides more shielding of the d and f orbitals. 
In gold’s valence orbitals, this translates to a shift in orbital energies with the 6s orbital 
being lowered in energy and the 5d orbital increasing in energy. The spin-orbital 
coupling also causes a splitting of the 5d orbitals (Error! Reference source not 
found..10 
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Figure 1.1: Hypothetical change in orbital energies before and after considering the 
relativistic effect12 
 
Since gold has a valence electron configuration of 5d106s1, the stabilising of the 6s 
orbital gives gold a high ionization potential and high electron affinity. This makes gold 
one of the most electronegative metals in the periodic table.12 Also, because the 6s 
orbital is stabilised and the 5d orbital destabilised, the orbitals are closer in energy, 
leading to s-d hybridisation. This gives gold some covalent bonding character and also 
gold’s famously alluring colour, all due to the relativistic effect.12, 13 
 
When bound, gold predominantly exists in Au(I) and Au(III) oxidation states.12 Au(III) 
species are commonly found as 4-coordinate 16-electron species, similar to Pt(II) 
complexes. However, Au(I) complexes, more unusually for transition metals, are 
generally linear, 2-coordinate 14-electron complexes.12 This gives rise to catalytically 
active LAu(I)+ species with a diffuse bonding orbital which can act as a soft Lewis acid. 
LAu(I)+ species are particularly good at coordinating to and so activating carbon-carbon 
multiple bonds such as alkynes, alkenes and allenes. The π-electrons of the multiple 
carbon-carbon bonds are in diffuse orbitals and are therefore readily coordinated by 
the soft Lewis acid LAu(I)+ species. For this reason the Au(I) catalysts are often said to 
be carbophilic and are referred to as π-acids.7 Au(III) catalysts, while also able to 
activate multiple carbon-carbon bonds,  tend to be more oxophilic than Au(I) and will 
coordinate more readily to harder groups. Au(I) catalysts are therefore more 
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commonly employed for activating carbon-carbon multiple bonds due to their better 
selectivity.  
 
Another consideration to take from the electronic structure of gold, which has an 
effect on its action as a catalyst, is the full and diffuse 5d orbital. Since the 5d electrons 
in this diffuse orbital incur less electron-electron repulsion, they are more tightly held, 
which leads to oxidative addition being disfavoured.10, 12 This resistance to oxidation 
means Au(I) catalysts can be exposed to oxygen, allowing air and moisture stable 
catalysts to be developed.10 It should be noted that although gold is resistant to 
oxidation under air, the redox cycle can be easily accessed using more powerful 
oxidants. In recent years a range of cross-coupling reactions exploiting the Au(I)/Au(III) 
redox cycle of gold have been developed.14 This area has been greatly expanded 
through the use of photoredox catalysis15 and is discussed in more detail in Chapter 4. 
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1.2 Introduction to gold catalysis 
The field of gold catalysis, despite only having been heavily investigated since the turn 
of the millennium, is now very broad and great progress has been made in both 
heterogeneous16 and homogeneous catalysis.1 Heterogeneous catalysis has received a 
large amount of attention due to its potential application to industrial processes.17, 18 
However, a much richer range of transformations can be achieved through 
homogeneous gold catalysis.1 Since the field of homogeneous catalysis is so expansive, 
the following introduction gives only a taste of the types of reactions which can be 
carried out. Concentrating on carbon-carbon multiple bond activation, this 
introduction to homogeneous gold catalysis will first give some examples of gold-
catalysed reactions with alkynes and then focus on gold catalysis with allenes, which is 
the main subject of the Chapters 2 and 3 of this thesis. C-H activation using gold 
catalysis represents another important field which is relevant to this thesis and is 
introduced as part of Chapter 4.  
 
1.2.1 Homogeneous gold catalysis with alkynes 
One of the first gold(I)-catalysed reactions, reported by Teles et al., was the addition of 
alcohols to terminal alkynes (1.1).19 PPh3AuMe, in the presence of MeSO3H, was used 
to catalyse the hydroalkoxylation of alkynes and the major product formed (1.2) was 
the result of double addition to alkyne 1.1 (Scheme 1.1).  
 
 
Scheme 1.1: Early example of addition of alcohol to alkynes19 
 
Some more modern reaction conditions can be found in a review by Goodwin et al.20 
along with a discussion of the regioselectivity issues with non-terminal alkynes and 
reactions with water as the nucleophile.  
 
  6 
 
The hydroalkoxylation of alkynes generally proceed via the mechanism shown in 
Scheme 1.2. The gold catalyst first coordinates to the C-C bond of alkyne 1.4 then the 
nucleophile attacks anti to the gold (1.I) and finally product 1.5 is obtained by 
protodeauration of intermediate 1.II (Scheme 1.2). 
 
 
Scheme 1.2: General mechanism for C-C bond activation and nucleophilic attack 
 
Since the initial work by Teles et al. (Scheme 1.2), a range of different nucleophiles 
have been added to alkynes via this general mechanism (Scheme 1.2).1 The most 
heavily investigated of these hydrofunctionalisations include hydroamination and 
hydroarylation.1  An example of the latter is shown below (Scheme 1.3) with double 
addition of the indole being obtained as the product (1.8). Pleasingly, pyrroles were 
also used successfully as nucleophiles under Echavarren’s conditions (Scheme 1.3).21  
 
 
Scheme 1.3: Hydroarylation of alkynes21 
 
Single addition can now also be achieved in some cases, as discussed in detail by 
Hashmi in his recent report22 and the intramolecular hydroarylation variation of this 
reaction was also successfully reported by Echavarren21 and others.1   
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Intramolecular hydrofunctionalisations with heteroatoms can also be performed to 
give heterocyclic products.23-25 The high yielding example in Scheme 1.4 proceeds with 
low catalyst loading through a 5-endo cyclisation and dehydration to give the 
substituted furan and Boc or tosyl protected pyrrole products 1.10.  
 
 
Scheme 1.4: Gold(I)-catalysed synthesis of substituted furan and pyrroles23 
 
 
Scheme 1.5: Gold(I)-catalysed [2 + 2] cycloaddition of alkynes and alkenes26 
 
Besides hydrofunctionalisations, cycloadditions of alkynes can also be catalysed by 
gold (Scheme 1.5) proceeding via selective activation of the alkyne (1.11) by Au(I), 
followed by alkene (1.12) attack to give the cyclopropyl gold(I) carbene intermediate 
1.III. Intermediate 1.III is subsequently converted through to the product (1.13) in 
good yield.26 The intramolecular version of this reaction can also be carried out and 
proceeds through a similar intermediate to give often bicyclic products, albeit through 
more complicated mechanisms.27, 28 
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The examples given above highlight some of the main types of reactivity which occur in 
alkynes and give a good indication of the types of reactions which can be achieved 
with allenes as substrates.  
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1.3 Homogeneous gold catalysis with allenes 
1.3.1 Intramolecular gold catalysis with allenes 
Some of the first examples of hydrofunctionalisations of allenes were intramolecular 
heteroatom additions, giving rise to heterocyclic products. In the following selective 
example (Scheme 1.6Scheme), the allene (1.14) is activated by the gold(I) catalyst and 
subsequent nucleophilic attack by the hydroxyl group produces the dihydropyran 
product (1.15), after deprotonation of the oxygen and protodeauration.29  
 
 
Scheme 1.6: Gold(I)-catalysed intramolecular hydroalkoxylation of an allene29 
 
As well as many examples of intramolecular hydroalkoxylations,1, 30, 31 similar 
intramolecular gold-catalysed reactions have been reported with heteroatoms other 
than oxygen, such as nitrogen1, 30, 32 and sulphur.1 Intramolecular hydroarylations 
(Scheme 1.7) have also been reported and as with intramolecular hydroalkoxylations 
(Scheme 1.6), they have been shown to proceed with excellent chirality transfer.30, 33 
 
 
Scheme 1.7: Intramolecular hydroarylations with chirality transfer30 
 
Intramolecular hydrofunctionalisation reactions of types discussed above can give 
products with various ring sizes and can occur through both exo and endo ring 
closures. Being intramolecular, constraints on the ring size help to give some control 
over which position of the allene is attacked and so excellent selectivity can be 
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achieved. In enantioenriched substrates, chirality transfer is also achieved through the 
intramolecular nature of the mechanism. For example, in Scheme 1.6, the hydroxyl 
group can only attack from the upper face of the allene in substrate 1.14, thereby 
favouring the formation of one diastereomer of the product 1.15. Furthermore, 
cyclisation to give the 6-membered ring is much less sterically demanding than 
reaction at the other end of the allene, which would give a strained 4-membered ring. 
This control of the products obtained is lost when we look at intermolecular addition 
of nucleophiles to allenes. However, there are still many examples which show 
excellent selectivity and these examples will be discussed later in Section 1.3.5. Before 
these intermolecular examples are discussed, the following section has been included 
to better explain and define the selectivity issues faced in intermolecular 
hydrofunctionalisations.   
 
1.3.2 Selectivity issues in intermolecular hydrofunctionalisations of allenes 
As discussed, the early examples of selective hydrofunctionalisation of allenes were 
intramolecular. This is perhaps due to the large number of selectivity issues associated 
with the intermolecular variant.  
 
 
Figure 1.2: Selectivity issues in intermolecular allene reactions 
 
Stereoselectivity, chemoselectivity and regioselectivity are all potential issues in both 
allene and alkyne hydrofunctionalisations. The first of these, stereoselectivity, is of 
most relevance in the mono-addition of disubsituted alkynes and non-symmetrical 
allenes, which give products with either E or Z alkenes. The anti-attack of the 
nucleophile to the gold (Scheme 1.2) helps to define this E/Z selectivity in the product, 
but for 1,3-disubstituted allenes, as discussed later (Chapter 2), the face on which the 
nucleophile attacks (Figure 1.2, 1.20) also defines the E/Z selectivity of the product. 
Chemoselectivity is also an issue as single or double addition is possible in both alkynes 
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and allenes. Finally, there is a question of regioselectivity, as either the Markovnikov or 
anti-Markovnikov products could be obtained. In terminal alkynes this equates to the 
nucleophile adding to either the substituted or non-substituted end of the alkyne 
whereas in allenes the nucleophile can add to either carbon a or b (Figure 1.2, 1.18).  
 
There is another kind of regioselectivity in allenes which is not found in alkynes. For 
the purposes of differentiating between the two kinds of regioselectivity, in this thesis 
the selectivity between carbon a and c will be referred to as positional selectivity 
(Figure 1.2, 1.19).  This positional selectivity occurs because the gold catalyst can 
activate either of the two adjacent carbon-carbon double bonds and so the 
nucleophile can attack either carbon a or c (Figure 1.2, 1.19).34 Another form of 
selectivity not found in alkynes, but that is present in enantioenriched 1,3-
disubstituted allenes, is the selective attack at either the upper or lower face of the 
allene (Figure 1.2, 1.20). In order for chirality transfer to take place, the nucleophile 
must preferentially attack either the upper or lower face of the allene.    
  
1.3.3 Intermolecular hydrofunctionalisation of mono-substituted allenes 
Despite the selectivity issues discussed above, there are still many examples of gold-
catalysed hydrothiolations, hydroaminations, hydroalkoxylations and hydroarylations, 
which give only one product. The hydrothiolation example below (Scheme 1.8) shows a 
double addition at the central carbon of allene 1.21 under gold(III)-catalysed 
conditions to give product 1.22 in good yield.  
 
 
Scheme 1.8: Gold(III)-catalysed hydrothiolation of allenes35 
 
Interestingly, the regioselectivity (Figure 1.2, 1.18) of this gold-catalysed 
hydrothiolation (Scheme 1.8) is unlike that reported for similar hydrofunctionalisation 
reactions. When amines, alcohols and aryls are used as nucleophiles, the reaction 
would be expected to occur at the outer carbons of the allene. 
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In the following hydroamination example (Scheme 1.9), a single nucleophile is added 
to the least substituted outer carbon of the allene 1.23. The reaction proceeds under 
gold(III)-catalysed conditions to give product 1.24 in excellent yield.36  
 
 
Scheme 1.9: Gold(III)-catalysed hydroamination of a mono-substituted allenes36 
 
These gold-catalysed hydrothiolations and hydroaminations differ in both 
chemoselectivity and regioselectivity, with a double addition of the nucleophile at the 
central carbon in hydrothiolations (Scheme8) and a single addition to an outer carbon 
in hydroaminations (Scheme 1.9). 
 
The selectivity reported in hydroamination (Scheme 1.9) is also reported for the 
hydroalkoxylation of allene 1.25. The reaction is catalysed by a gold(I) species and 
gives the product 1.26 in good yield (Scheme 1.10).37  
 
 
Scheme 1.10: Gold(I)-catalysed hydroalkoxylation of mono-substituted allenes37 
 
Hydroarylation of similar mono-substituted allene 1.27 with indole 1.28 proceeds in 
excellent yield and again reacts at the terminal carbon of the allene (Scheme 1.11).38 
The latter was found to be the case for all other reported hydroarylations of mono-
substituted allenes using arenes as the nucleophile.39, 40 
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Scheme 1.11: Gold(I)-catalysed hydroarylation of a mono-substituted allene38 
 
As well as the same chemoselectivity and regioselectivity in these hydroamination, 
hydroalkoxylation and hydroarylation reactions with mono-substitued allenes, the 
same positional selectivity is also observed. Interestingly, the examples of 
hydroamination (Scheme 1.9) and hydroalkoxylation reactions (Scheme 1.10) are taken 
from literature reports which show examples of hydrofunctionalisation reactions with 
1,1-disubstituted and 1,1,3-trisubstituted allenes. They report that the positional 
selectivity for the least substituted carbon-carbon bond of the allene is the same for all 
these allene types. However, it was later shown that the positional selectivity can be 
switched in the hydroalkoxylation of 1,1-disubtituted allenes.  
 
1.3.4 Positional selectivity in hydroalkoxylation of 1,1-disubstituted allenes 
Unlike the hydroamination reaction, where positional selectivity for the least 
substituted end of the allene is found in all cases,36, 41, 42 the related hydroalkoxylation 
of allenes is not as straightforward and required further investigation. Among the first 
reports of intermolecular hydroalkoxylation was the following example by Horino et al. 
(Scheme 1.12) where the allyl alcohol 1.30 was preferentially added to the more 
substituted end of allene 1.31.43 
 
 
Scheme 1.12: Early example of hydroalkoxylation at most substituted end of allene43 
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However, other reports at the time, using more general substrates, showed selective 
attack at the least substituted end of the allene to give the primary allylic ether. For 
example, the following conditions reported by Widenhoefer and co-workers37 (Scheme 
1.13) and Yamamoto & co-workers41, 44 (Scheme 1.14) produced good yields and high 
selectivity for a range of substrates. 
 
 
Scheme 1.13: Hydroalkoxylation of 1,1-disubstituted allene – Widenhoefer’s 
conditions37 
 
 
 
 
Scheme 1.14: Hydroalkoxylation of 1,1-disubstituted allene – Yamamoto’s  
conditions41, 44 
 
Shortly after these experimental observations (Scheme 1.13 and Scheme 1.14), Paton 
and Maseras reported their computational investigations on this system.45 Initially, 
they found that their results were in agreement with what was found experimentally. 
Their computational results suggested that coordination of the gold catalyst to the less 
substituted end of the allene is energetically favoured, a result later confirmed by 
variable temperature NMR studies conducted by Widenhoefer.46 However, as Paton 
and Maseras furthered their investigation, they found that nucleophilic attack at the 
more substituted end of the allene to give the tertiary allylic ether product 1.40 
(Scheme 1.15) was in fact kinetically favoured. Experimentally, however, 
Widenhoefer37 (Scheme 1.13) and Yamamoto41, 44 (Scheme 1.14) isolated the primary 
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allylic ether 1.41 as the sole product. Paton and Maseras therefore suggested that the 
primary allylic ether 1.41 (Scheme 1.15), which was found to be the thermodynamic 
product in their studies, was isolated experimentally due to subsequent isomerisation 
of the kinetic product 1.40. Their computational studies suggest that the kinetic 
product 1.40 is formed, and then gold-catalysed attack of a second alcohol molecule 
gives the intermediate 1.IV. This intermediate then loses an alcohol molecule to yield 
the thermodynamic primary allylic ether product 1.41 observed experimentally.  
 
 
 Scheme 1.15: Isomerisation proposed by DFT calculations45  
 
In 2010, the Lee group provided experimental evidence to support this theory by 
successfully developing conditions that suppressed the isomerisation of 1.40 to 1.41 
(Scheme 1.16).47 As a result, the selectivity was successfully switched for the first time 
from the primary (1.41, Scheme 1.15) to the tertiary allylic ether product 1.40 (Scheme 
1.16).  
 
 
Scheme 1.16: Conditions used by the Lee group to give the kinetic product47 
 
The development of these conditions and their use as a means to prevent a secondary, 
undesired gold-catalysed reaction is of great importance to the projects discussed in 
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Chapters 2 and 3. More detail as to development and application of these conditions 
will be given in Chapters 2 and 3. 
 
1.3.5 Chirality transfer in hydrofunctionalisation of allenes 
As well as the other forms of selectivity previously mentioned, there is also the 
possibility for chirality transfer in the hydrofunctionalisation of allenes. Since 
1,3-disubstituted allenes possess axial chirality,48 if the face on which the nucleophile is 
added is controlled, then chirality from enantioenriched allenes can be transferred to 
the product. Since the product has point chirality, this is defined as axial-to-point 
chirality transfer.48 The possibility of chirality transfer makes 1,3-disubstituted allenes 
very interesting substrates for hydrofunctionalisation reactions. However, when 
compared to mono-substituted and 1,1-disubstituted allenes, 1,3-disubstituted allenes 
have been far less studied. This may be due to positional selectivity issues (Figure 1.2), 
as unlike the mono-substituted and 1,1-disubstituted allenes, 1,3-disubstituted allenes 
do not have a more substituted end. Instead, positional selectivity is dependent on R1 
and R2 being sufficiently different to give selective addition at one end of the allene. 
Therefore, to obtain one positional isomer and achieve chirality transfer, the 
nucleophile must selectively attack one of the carbon-carbon bonds of the allene and 
must do so with facial selectivity. Despite these challenges, hydroamination of 1,3-
disubstituted allenes has been achieved for nitrogen containing nucleophiles with 
excellent chirality transfer (Table 1.1).  
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Entry R1 R2 NuH e.e. 
(%) 
1.42 
Conditions 
(mol%) 
yield 
(%) 
e.e. 
(%) 
1.43 
136 Ph Me PhNH2 
(2 eq.) 
94 AuBr3 (10) 
THF, 30 oC 
68 88 
236 (CH2)4CH3 (CH2)4CH3 PhNH2 
(2 eq.) 
99 AuBr3 (10) 
THF, 30 oC 
80 99 
341 (CH2)4CH3 (CH2)4CH3 Morpholine 
(1.2 eq.) 
96 (L1)AuCl/AgOTf 
(10) 
toluene, 80 oC 
74 55 
449 (CH2)2Ph (CH2)2Ph NH2NHCO2Me 
(4 eq.) 
87 (Ph3P)AuNTf2 (6) 
MeNO2, 45 oC 
81 56 
L1 = (Ph2(o-tolyl)P)  
Table 1.1: Chirality transfer in the hydroamination of 1,3-disubstituted allenes 
 
Yamamoto and co-workers first reported two examples of excellent chirality transfer in 
the hydroamination of allenes with aniline (Entries 1-2, Table 1.1)36. The same group 
later reported a similar reaction but this time using morpholine as the nucleophile and 
employing more forcing conditions (Entry 3, Table 1.1).41 Unfortunately, perhaps due 
to the more forcing conditions required, the hydroamination of allenes with 
morpholine gave much poorer chirality transfer. Finally, Toste and co-workers 
reported the use of a hydrazide as a nucleophile, however, the chirality transfer 
achieved is more modest under their conditions (Entry 4, Table 1.1).49 These reports 
demonstrate that chirality transfer in the hydroamination of allenes is indeed possible 
but also shows that there is often substantial erosion of e.e. All of the reports 
described in Table 1.1 suggest that racemisation of the starting material allene is the 
cause for the erosion of e.e. and indeed it has been shown that the allenes are quickly 
racemised under gold-catalysed conditions.41, 44 
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Scheme 1.17: Gold-catalysed 1,3-disubstituted allene racemisaton 
 
The mechanism by which enantioenriched allenes are thought to be racemised under 
gold-catalysed conditions begins with the coordination gold catalyst to the allene (1.V, 
Scheme 1.17). The gold catalyst is then thought to slip to the central carbon of the 
allene bringing the two R-groups into the same plane (1.VI, Scheme 1.17) and so 
allowing for racemisation.  
 
Allene racemisation through this mechanism (Scheme 1.17) presents a major challenge 
to achieving chirality transfer in the hydrofunctionalisation of enantioenriched 1,3-
disubstituted allenes.50 Ingeniously however, Widenhoefer and co-workers took 
advantage of the gold-catalysed racemisation of allenes in their report (Scheme 
1.18).51 Using racemic aryl allenes rather than enantioenriched substrates and a di-
gold chiral catalyst, they report the enantioselective hydroamination of allenes to give 
products with high e.e. Reactions of this type, where the catalyst selectively reacts 
with one enantiomer, would usually have a maximum possible yield of 50%. However, 
since the catalyst also racemises the allene starting material, high yields are obtained 
in this reaction (Scheme 1.18). 
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 Scheme 1.18: Enantioselective hydroamination of racemic 1,3-disubstituted allenes51 
 
Although allene racemisation has posed a challenge, chirality transfer in the 
hydroamination of 1,3-disubstituted allenes has been achieved for some selected 
substrates (Entry 2, Table 1.1). In contrast, allene racemisation is a much bigger 
problem in gold-catalysed hydroalkoxylation of allenes and has prevented progress in 
this field. For example, Yamamoto and co-workers found that even in systems where 
chirality transfer in hydroamination worked well (Entry 1, Table 1.1), hydroalkoxylation 
of the same allene (1.46) yielded only racemic product (Scheme 1.19).41, 44 
 
 
Scheme 1.19: Unsuccessful attempt at chirality transfer in hydroalkoxylation41, 44 
 
Yamamoto and co-workers suggest that allene racemisation is more of an issue in 
hydroalkoxylation reactions than hydroamination reactions because alcohols are less 
nucleophilic than N-nucleophiles. This difference in nucleophilicity makes the 
hydrofunctionalisation slower in hydroalkoxylation reactions, thereby exacerbating the 
problem of competitive gold-catalysed allene racemisation.41 
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Scheme 1.20: Widenhoefer’s chirality transfer in hydroalkoxylation37 
 
Encouragingly, Widenhoefer and co-workers had more success with achieving chirality 
transfer in the hydroalkoxylation of allenes, but published only one example, using 
allene 1.48 (Scheme 1.20). Although chirality transfer does occur, the reaction 
proceeded with substantial erosion of enantiomeric excess (97% e.e. to 79% e.e., 
Scheme 1.20) showing that allene racemisation is a much greater challenge in the 
hydroalkoxylation of allenes than it was found to be in the hydroamination of allenes. 
Similarly, chirality transfer in the hydroarylation of allenes is not nearly as well 
documented, with the only attempt being reported by Che and coworkers and their 
conditions providing almost totally racemic product (Scheme 1.21).52  
 
 
Scheme 1.21: Hydroarylation of enantioenriched allene – Che’s initial conditions52 
 
Che and co-workers were able to overcome the challenge of starting material 
racemisation by instead developing the first chiral digold-catalysed enantioselective 
hydroarylation reaction. Under Che’s conditions, racemic symmetrical diaryl allene 
starting materials were reacted with indoles in up to 90% yield. However, the best 
enantioselectivity accomplished was only 63% e.e.52 (Scheme 1.22) and importantly 
this was achieved using a chiral catalyst rather than chirality transfer from the allene. 
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Scheme 1.22: Enantioselective hydroamination of racemic 1,3-disubstituted allenes52 
 
Prior to the projects detailed in Chapters 2 and 3, the reports discussed in this section 
were the only attempts at chirality transfer in intermolecular gold-catalysed 
hydroalkoxylation and hydroarylation of allenes. Therefore there is clear scope for 
improvement in this area, with the main challenge being the competing racemisation 
of the allene substrate.   
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Chapter 2: Chirality transfer in the gold-
catalysed hydroalkoxylation of allenes 
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2.1 Introduction  
2.1.1 Previous work in the hydroalkoxylation of allenes 
As discussed in Chapter 1, the gold-catalysed hydroalkoxylation of allenes, and 
hydrofunctionalisation of allenes generally, has been extensively investigated. 
However, in hydroalkoxylation reactions, much of the attention has been focused on 
intramolecular reactions to form heterocyclic products.1 Any investigation which has 
been done on intermolecular reactions has focused mainly on 1-substituted and 1,1-
disubstituted allenes.37, 41, 44, 47 However, 1,3-disubstituted allenes (2.1) are of 
particular interest due to the possibility of axial-to-point chirality transfer. This has 
been investigated with some success for hydroamination.36, 41, 42, 44, 49, 51 However, 
chirality transfer in hydroalkoxylation of 1,3-disubstituted allenes has been far less 
successfully investigated, with only two attempts being published. The first attempt 
was by Yamamoto and co-workers who reported totally racemic product (Scheme 
2.1).41, 44  
 
 
Scheme 2.1: Unsuccessful attempt at chirality transfer in hydroalkoxylation41, 44 
 
Another, more promising result, was reported by Widenhoefer and co-workers who 
showed some chirality transfer but with substantial erosion of e.e. (Scheme 2.2).37  
 
 
Scheme 2.2: A more successful attempt at chirality transfer in hydroalkoxylation37 
 
In both cases, racemisation of the starting material allene was cited as the reason for 
the lack of, or poor, chirality transfer. This remains an unsolved problem and a clear 
  24 
 
limitation in this field. One possible solution to this challenge would be to develop 
conditions in which the gold catalyst is reactive enough to catalyse the 
hydroalkoxylation reaction but not the unwanted allene racemisation. The Lee group 
have experience in the field of selective gold catalysis and have shown many examples 
of how conditions can be adapted to drive one gold-catalysed reaction over another.  
 
2.1.2 The Lee group’s work in selective gold catalysis 
Previous work in the Lee group has demonstrated that several experimental conditions 
can be altered to give excellent selectivity in gold-catalysed reactions. Discussed below 
are some examples where the product obtained was controlled by adapted conditions 
to retard a secondary, unwanted and often gold-catalysed reaction. 
 
In the following example, the Lee group successfully prevented the gold-catalysed 
isomerisation of the desired tertiary alkylic ether product (2.5) in their investigations 
on gold-catalysed reactions with cyclopropenes (Scheme 2.3).53  
 
 
Scheme 2.3: Selective gold(I)-catalysed alcohol additions to cyclopropenes giving tert-
allylic ether53 
 
It was found that the kinetic product of the gold-catalysed addition of alcohols to 
cyclopropenes (2.4) is readily isomerised to the primary allylic ether 2.6 under gold-
catalysed conditions. However, this isomerisation can be prevented by increasing the 
equivalents of alcohol in the reaction. In order to investigate this further, the Lee 
group resubjected the tertiary allylic ether product 2.5 to the reaction conditions with 
no alcohol present. It was found that the tertiary allylic ether product 2.5 is quickly 
isomerised to the primary allylic ether 2.6. However, if the tertiary allylic ether 2.5 is 
resubjected to the reaction conditions with 5 equivalents of alcohol present, no 
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isomerisation to 2.6 takes place. This result confirms that the excess alcohol is 
preventing isomerisation, likely by coordinating to the gold catalyst and dampening its 
reactivity.53  
 
Later work showed the use of molecular sieves to achieve chirality transfer in gold(I)-
catalysed direct allylic etherifications of unactivated alcohols (Scheme 2.4).54 
 
 
Scheme 2.4: Chirality transfer in direct allylic etherification using mol. sieves54 
 
With the assistance of computational experiments, the Lee and Macgregor groups 
were able to suggest that the molecular sieves likely facilitate chirality transfer by 
disrupting the aggregation of alcohol molecules. The involvement of only one alcohol 
molecule allows efficient delivery of the alcohol nucleophile to one face of the alkene 
through a chair-like 6-membered transition state (Scheme 2.5). In contrast, when no 
molecular sieves are used, aggregation of alcohol molecules allows for attack at either 
face of the alkene (Scheme 2.5). Since attack of the nucleophile can occur on either 
face of the alkene, when aggregation of alcohol molecules is allowed, racemic product 
is obtained.   
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Scheme 2.5: Proposed mechanism for loss of chirality transfer without mol. sieves54 
 
Most closely related to this project, and previously discussed in Chapter 1, is the allene 
hydroalkoxylation work reported in 2010 by the Lee group.47 In this report, the Lee 
group successfully developed conditions which allowed for selective formation of the 
kinetic product from the hydroalkoxylation of 1,1-disubstituted allenes (2.10, Scheme 
2.6). Computational studies45 had suggested that the tertiary allylic ether product 2.10 
was indeed the kinetic product of the reaction. However, in previous experimental 
reports, only the primary allylic ether 2.11 was ever isolated.37, 41, 44 This was thought 
to be due to the subsequent gold-catalysed isomerisation of 2.10 to the 
thermodynamic product 2.11. Nevertheless, the Lee group successfully developed 
conditions that suppressed this isomerisation, allowing isolation of the tertiary allylic 
ether 2.10 in up to 86% yield for a range of substrates (Scheme 2.6).  
 
 
Scheme 2.6: Conditions used by the Lee group to give the kinetic product47 
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The conditions used in Scheme 2.6 were designed specifically to slow down the 
reactivity of the gold catalyst, thereby preventing the secondary isomerisation. Upon 
comparison with previously reported conditions37, 41, 44 in which the isomerisation to 
the thermodynamic product 2.11 occurs, there appears to be three main differences. 
These differences are the higher number of equivalences of alcohol, lower 
temperature and the use of the coordinating solvent DMF. DMF and excess of alcohol 
are thought to reduce the activity of the active cationic gold catalyst (IPr)Au+ through 
reversible coordination.55 At the lower temperature of 0 oC, the resulting less active 
catalytic conditions are enough to catalyse the hydroalkoxylation of the allene 2.9 
giving product 2.10, but not active enough to catalyse the unwanted isomerisation to 
the thermodynamic product 2.11.  
 
The development of these different conditions to prevent a secondary gold-catalysed 
reaction is of great importance to the aim of this project. With the knowledge gained 
during the projects discussed in this section, we hoped to develop conditions to 
selectively allow for chirality transfer in hydroalkoxylation of 1,3-disubstituted allenes 
by supressing the racemisation of the allenes. 
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2.2 Project aims 
The aim of this project is to develop the first hydroalkoxylation of 1,3-disubstituted 
allenes with efficient chirality transfer (Scheme 2.7).  
 
 
Scheme 2.7: Is efficient chirality transfer in the hydoalkoxylation of 1,3-disustituted 
allenes possible? 
 
The main challenge is the competing gold-catalysed racemisation of the allene starting 
material 2.1. Drawing upon the Lee group’s experience in selective gold catalysis, we 
hope to achieve this by adapting the conditions described in Section 2.1.2 to allow the 
gold-catalysed hydroalkoxylation reaction to occur without the unwanted gold-
catalysed allene racemisation.  
 
Upon developing conditions for good chirality transfer, we aim to investigate the 
substrate and nucleophile scope of the reaction. By investigating the substrate scope 
we hope to better understand the prerequisites for achieving good chirality transfer as 
well as positional selectivity, and to better understand the mechanism of the reaction. 
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2.3 Results and Discussion 
2.3.1 Optimisation of the hydroalkoxylation reaction  
The initial approach used by the Lee group to supress allene racemisation and 
therefore facilitate chirality transfer was to add molecular sieves to the reaction 
(Scheme 2.8). This approach was inspired by previous work on gold-catalysed allylic 
etherification, where molecular sieves were crucial for efficient chirality transfer.54 
Allene 2.1b and alcohol 2.2b were adopted for these trial reactions to allow a direct 
comparison with previously published results by Widenhoefer.37 
 
 
Scheme 2.8: Trial conditions with molecular sievesϖ 
 
The results obtained under these conditions were promising, providing a higher degree 
of chirality transfer to the product (2.3bb, 97:3 e.r.) than that reported by 
Widenhoefer (2.3bb, 90:10 e.r., Scheme 2.2).37 However, the yield was only 30% and 
attempts at optimisation by increasing the time, temperature and catalyst loading did 
not significantly improve the yield without a decrease in chirality transfer. 
 
The second approach investigated made use of conditions previously reported in the 
Lee group (Scheme 2.6).47 Since these conditions successfully catalysed the 
hydroalkoxylation of 1,1-disubstituted allenes while supressing unwanted 
isomerisation of the product, it was hypothesised that the conditions may also allow 
for the hydroalkoxylation of 1,3-disubstituted allenes while supressing racemisation of 
the starting material. 
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Scheme 2.9: Trial with previously reported conditionsϖ 
 
Pleasingly, excellent chirality transfer and a much more respectable yield of 65% were 
observed using these conditions (Scheme 2.9). To investigate whether these conditions 
were indeed giving better chirality transfer by preventing the racemisation of the 
allene substrate, control reactions were carried out. These control reactions compared 
the new conditions (Scheme 2.9) with those reported by Widenhoefer37 (Scheme 2.2). 
First, the product 2.3bb was resubjected to the reaction conditions and it was found 
that under both conditions the product 2.3bb showed no or very little erosion of e.r., 
suggesting that this is not the major cause of e.r. erosion in the gold-catalysed 
hydroalkoxylation reaction. Control reactions with the allene 2.1b were also carried 
out, which showed that the allene 2.1b completely racemised under both conditions. 
However, these initial control reactions were done with no alcohol present, which 
does not accurately reflect the reaction conditions in which excess alcohol is always 
present.  The control reactions were therefore repeated in the presence of tBuOH 
(2.2c) to give a more accurate representation of the reaction conditions (Scheme 2.10). 
Since tBuOH (2.2c) is sterically hindered, it reacts very slowly with allene 2.1b, allowing 
the racemisation to monitored. 
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Scheme 2.10: Racemisation of allene control reactionsϖ 
 
The control reactions clearly show that the allene 2.1b racemises faster under 
Widenhoefer’s conditions and that allene racemisation is indeed the reason for the 
erosion of e.r. in the product.  
 
Next, investigations were carried out to determine whether the solvent, temperature, 
equivalents of alcohol or a combination of these factors was causing the difference in 
the rate of allene racemisation. First, in order to investigate the effect of solvent, 
allene 2.1b was subjected to the reaction conditions in the presence of tBuOH and with 
toluene as the solvent rather than DMF (Scheme 2.11). 
 
 
Scheme 2.11: Investigation into the effect of solvent on allene racemisationϖ 
 
After two hours, the resulting enantiomeric ratios were within error of each other, 
suggesting that the solvent is not the most crucial change. The temperature was then 
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investigated by carrying out the same control reaction at room temperature rather 
than 0 oC (Scheme 2.12).  
 
 
Scheme 2.12: Investigation into the effect of temperature on allene racemisationϖ 
 
This control reaction showed that increasing the temperature to room temperature 
from 0 oC caused a substantial drop in e.r. after two hours (0 oC, 97.5:2.5 e.r. vs. r.t., 
81:19 e.r., Scheme 2.12).  
 
With these two results in mind, the gold-catalysed hydroalkoxylation reaction with 
allene 2.1b was carried out with toluene as solvent and at 0 oC (Entry 2, Table 2.1). It 
was found that when compared to the original conditions (Entry 1, Table 2.1) the 
change in solvent had a very small effect on the e.r. of the product and increased the 
yield. Next, the effect of alcohol concentration was investigated (Entries 3-5, Table 
2.1). Decreasing the equivalents of alcohol to 4 equiv. had no effect on the e.r. of 
product 2.3bb but any further drop in equivalents of alcohol gave a decrease in 
chirality transfer (Entries 4-5, Table 2.1). 
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Entry Solvent BnOH equiv. e.r.[a] Yield (%) 
1 DMF 10 98:2 65 
2 Toluene 10 97:3 81 
3 Toluene 4 97:3 85 
4 Toluene 2 96:4 78 
5 Toluene 1.1 93:7 74 
[a] Determined by CSP-HPLC. 
Table 2.1: Effect of solvent and alcohol equiv. on the hydroalkoxylation of 2.1bϖ 
 
The new conditions optimised for allene 2.1b (Entry 3, Table 2.1), which gave excellent 
chirality transfer and yield with lower alcohol concentration, were then ready to be 
used as optimised conditions for the substrate scope. However, it was soon discovered 
that these conditions (Entry 3, Table 2.1) were very substrate specific, only giving good 
e.r. for product 2.3bb. The original conditions (Entry 1, Table 2.1) consistently gave 
better chirality transfer or yield in all other allenes subjected to these conditions (Table 
2.2 vs. Table 2.3) and were therefore more general.  
 
 
Entry Allene Alcohol Product Yield[a] e.r.[b] 
1ϖ[c]  BnOH 
2.2b 
 61% 87:13 
 
2  BnOH 
2.2b 
 70% 
 
78:22  
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Table 2.2: Substrates trialled with conditions optimised for 2.1b in toluene 
 
Table 2.3: Substrates under original conditions (DMF) for comparison with Table 2.2 
 
It was therefore concluded that these original conditions (Table 2.3) should be taken 
forward as optimised conditions for the full substrate scope. However, before 
3  BnOH 
2.2b 
 79%[d] 
7:1 pos. 
78:22 
4  MeOH 
2.2e 
 63% 
 
97:3 
 
[a] Isolated yields, >20:1 E:Z and positional selectivity by 1H NMR unless otherwise stated. 2.2e 
was used when the product using 2.2b was not separable by CSP-HPLC, CSP-GC or chiral shift 
reagents. [b] Determined by CSP-HPLC [c] 2 equiv. alcohol [d] Combined yield. 
 
Entry Allene Alcohol Product Yield[a] e.r.[b] 
1ϖ  BnOH 
2.2b 
 45% 95:5 
 
2  BnOH 
2.2b 
 79% 
 
90:10  
3  BnOH 
2.2b 
 94%[c] 
9:1 pos. 
81:19 
4  MeOH 
2.2e 
 92% 
 
97:3 
 
[a] Isolated yields, >20:1 E:Z and positional selectivity by 1H NMR unless otherwise stated. 2.2e 
was used when the product using 2.2b was not separable by CSP-HPLC, CSP-GC or chiral shift 
reagents. [b] Determined by CSP-HPLC [c] Combined yield. 
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discussing the allene scope, a brief summary of how the enantioenriched allene 
substrates studied in this project were prepared has been included. 
 
2.3.2 Substrate synthesis 
Perhaps the most commonly used synthetic route for the preparation of 
enantioenriched allenes starts with a commercially available enantioenriched 
propargylic alcohol. This starting point was used extensively during this project to give 
a range of allenes through the methods discussed below. However, the synthesis of 
enantioenriched 1,3-disubstituted allenes has been heavily investigated and a range of 
enantioenriched allenes can be made via a variety of strategies.56 Racemic versions of 
each of the substrates were also made in order to determine the e.r. of the allene and 
products of the hydroalkoxylation. Unless otherwise stated this was achieved under 
the same conditions by starting with racemic starting material. 
 
The majority of the allene substrates used in this project were made from (R)-1-butyn-
3-ol 2.12 and the allenes which were first used as substrates were all made by 
conversion of (R)-1-butyn-3-ol to allenol 2.15 and subsequent protection giving 
substrates 2.1b – 2.1f (Scheme 2.13).37 
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Scheme 2.13: Synthesis of protected allenol substrates 2.1b-2.1f 
 
Starting from (R)-1-octyn-3-ol 2.16 rather than (R)-1-butyn-3-ol 2.12 provided allene 
2.1g in good yield (Scheme 2.14) using the same conditions shown above (Scheme 
2.13).  
 
 
Scheme 2.14: Synthesis of substrate 2.1gϖ 
 
In order to test the effect of moving the functionality one CH2 farther from the allene, 
substrate 2.1i was prepared by conversion of (R)-1-butyn-3-ol to the ester containing 
allene 2.1h57 (also used as a substrate) followed by  reduction with LiAlH4 to allenol 
2.1757 and subsequent benzylation (Scheme 2.15).42 
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Scheme 2.15: Synthesis of substrates 2.1g and 2.1h 
 
Next we targeted an allene with a different heteroatom in the β-position. It was 
thought that an unprotected amine or amine with a single protecting group would be 
likely to undergo gold-catalysed intramolecular hydroamination under our 
conditions,58, 59 so a fully protected amine seemed like a more viable option. For ease 
of synthesis and to avoid this potential side reaction, the phthalimide protecting group 
was used. Allene 2.1j was readily synthesised from the allenol 2.15 via the Mitsunobu 
reaction (Scheme 2.16).60  
 
 
Scheme 2.16: Synthesis of substrate 2.1j 
 
Under the same conditions, allenol 2.17 (Scheme 2.15) was also reacted with 
phthalimide to give allene 2.1k in a more pleasing 96% yield. 
 
Allene 2.1l was synthesised by nucleophilic substitution of the mesylated allenol 2.18 
with diethyl malonate (Scheme 2.17). It was chosen as a substrate in order to study the 
effect of not having a heteroatom at the andpositions.  
 
  38 
 
Scheme 2.17: Synthesis of substrate 2.1k 
 
The ester substrate 2.1h was converted to the Weinreb amide,61 giving substrate 2.1m. 
This was initially done with the intention of converting through to the ketone 2.1n 
(Scheme 2.18). However, although the ketone product 2.1n seemed to have formed, it 
could not be isolated, possibly due to isomerisation of the allene into conjugation with 
the ketone. 
 
 
Scheme 2.18: Synthesis of substrate 2.1m 
 
Substrate 2.1a, which was used by Yamamoto in his aforementioned paper on 
hydroalkoxylation44 was prepared from (R)-1-butyn-3-ol 2.12, by a Sonogashira 
coupling62 with iodobenzene and then conversion to the allene with 2-
nitrobenzenesulfonylhydrazide (NBSH) (Scheme 2.19).63 
 
 
Scheme 2.19: Synthesis of substrate 2.1a 
 
Another route to enantioenriched 1,3-disubstituted allenes is through a Crabbé 
homologation. The dialkyl substituted allene 2.1o was made in this way from 4-phenyl-
1-butyne 2.20 (Scheme 2.20).64ϖ 
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Scheme 2.20: Synthesis of substrate 2.1oϖ 
 
The CF3 containing allene 2.1p or similar CF3 containing substrates proved difficult to 
prepare. However, after several failed investigations, both racemic and 
enantioenriched allene 2.1p were successfully prepared through a similar method to 
2.1o albeit in a low yield (Scheme 2.21). 
 
 
Scheme 2.21: Synthesis of substrate 2.1p 
 
The final substrate discussed is the symmetrical alkyl-substituted allene 2.1q which 
was synthesised through methylation of the propargylic alcohol 2.16 followed by 
copper-mediated SN2’ substitution (Scheme 2.22).65 
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Scheme 2.22: Synthesis of substrate 2.1q 
 
Unfortunately, allene 2.1q could only be synthesised in approximately 85:15 e.r. which 
was determined by 1H NMR using chiral shift reagents Eu(hfc)3 and Ag(FOD).66 This 
method of e.r. determination proved to be problematic due to solubility issues with 
Ag(FOD) and is therefore only reported as an estimation. Since allene 2.1q is very non-
polar, other more commonly used methods of e.r. determination (CSP-HPLC and CSP-
GC) were unsuited to this substrate. 
 
Using the strategies described above, a range of enantioenriched allenes were 
conveniently synthesised for use as substrates in the gold(I)-catalysed 
hydroalkoxylation reaction. 
 
2.3.3 Allene scope 
With optimised conditions and access to a range of substrates we looked to probe the 
scope of the gold-catalysed hydroalkoxylation reaction. In particular, we were 
interested in probing how much we could reduce and adapt the functionality in the 
allene substrate 2.1 whilst still achieving good selectivity and chirality transfer.  
 
Entry Allene Alcohol Product Yield[a] e.r. 
1ϖ  BnOH 
2.2b 
 65% 
 
98:2[b] 
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2ϖ  BnOH 
2.2b 
 45% 95:5[b] 
 
3ϖ 
 
 BnOH 
2.2b 
 70% 
 
93:7[c] 
4ϖ  MeOH 
2.2e 
 78% 
 
94:6[c] 
5ϖ  MeOH 
2.2e 
 94% 
 
87:13[d] 
6ϖ  MeOH 
2.2e 
 91% 97:3[b] 
7  BnOH 
2.2b 
 79% 
 
90:10 [b] 
8  BnOH 
2.2b 
 81% 
 
97:3[b] 
9[e]  BnOH 
2.2b 
 94%[f] 
9:1 
pos. 
81:19[b] 
10  MeOH 
2.2e 
 92% 
 
97:3[b] 
 
11  PMBOH 
2.2f 
 71% 
 
95:5[b] 
12  BnOH 
2.2b 
 58% 
 
91:9[b] 
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Table 2.4: Allene substrate scope 
 
Initially, the OBz substituent 2.1b used in our optimisation reactions was replaced with 
other protected alcohol groups, and to our delight it was found that removing the 
carbonyl (Entry 2, Table 2.4) or Ph (Entries 3-4, Table 2.4) does not significantly affect 
the degree of chirality transfer to the product (2.3cb-2.3eb, >93:7 e.r., Entries 2-4, 
Table 2.4). In order to investigate the minimum amount of functionality required to 
achieve good positional selectivity, the ether allene 2.1f was investigated (Entry 5, 
Table 2.4). This result shows that with only an ether O the hydroalkoxylation reaction 
proceeds with perfect positional selectivity, albeit with a slightly lower degree of 
13  BnOH 
2.2b 
 86% 
 
90:10[b] 
14ϖ  BnOH 
2.2b 
Mainly 2.1r and a complex mixture of 
products 
 
15  BnOH 
2.2b 
 79%[f] 
10:1 
pos. 
Racemic 
16ϖ  BnOH 
2.2b 
 71% [f] 
1:0.7 
pos. 
- 
17  BnOH 
2.2b 
 82% 
 
69:31[b] 
[a] Isolated yields, >20:1 E:Z and positional selectivity by 1H NMR unless otherwise stated. 2.2e 
was used when the product obtained using 2.2b was not separable by CSP-HPLC, CSP-GC or 
chiral shift reagents. [b] Determined by CSP-HPLC [c] Determined by 1H NMR using chiral shift 
reagent (R)-(-)-1-(9-anthryl)-2,2,2-trifluoroethanol [d] Determined by CSP-GC. [e] When 
(IPr)AuNTf2 was used as catalyst instead, positional selectivity improves to >20:1; 82:18 er. [f] 
Combined yield. [g] Estimated by 1H NMR using chiral shift reagent Eu(hfc)3 and Ag(FOD), e.r. 
could not be definitively determined by any method attempted. 
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chirality transfer (2.3fe, 87:13 e.r., Entry 5, Table 2.4). Pleasingly, swapping the Me 
group with a longer alkyl chain results in high yield and excellent chirality transfer 
(2.3ge, 91%, 97:3 e.r., Entry 6, Table 2.4). To our delight, moving the OBz group one 
CH2 further from the allene gave only slightly reduced chirality transfer and retained 
>20:1 positional selectivity (2.3bb 98:2 Entry 1 vs. 2.3ib 90:10 e.r. Entry 7, Table 2.4). 
 
Expanding the scope to an entirely different inductively withdrawing functional group 
in the form of phthalimide containing allene 2.1j proceeded very smoothly to give 
product 2.3jb (81%, 97:3 e.r., Entry 8, Table 2.4). Interestingly, as before (2.3bb vs. 
2.3ib) when the functionality was placed one CH2 further from the allene, there is a 
drop in the enantiomeric ratio of the product (2.3jb 97:3 Entry 8 vs. 2.3kb 81:19 e.r. 
Entry 9, Table 2.4). In this example, in addition to a more substantial drop in e.r., the 
positional selectivity also dropped, with a 9:1 ratio of positional isomers being 
obtained. It should be noted however, that when the silver free catalyst (IPr)AuNTf2 is 
used instead of the standard mixture of (IPr)AuCl and AgOTf, the positional selectivity 
is successfully restored to >20:1 (2.3kb, 82:18 e.r.). The ester allene 2.1h was also 
investigated and gratifyingly gave the expected products 2.3he and 2.3hf in excellent 
yield and e.r. for both alcohols trialled (2.3he 92% 97:3 e.r. and 2.3hf 72% 95:5, Entries 
10-11, Table 2.4). Satisfyingly, the Weinreb amide containing substrate 2.1m reacted 
well under our conditions albeit with a slight drop in yield (2.3mb, 58%, 91:9 e.r., Entry 
12, Table 2.4). To our delight, allene 2.1l with no heteroatoms in the β or γ position 
relative to the allene reacted selectivity giving one positional isomer and retaining 
good e.r. despite the functionality being far removed from the allene (2.3lb, 86%, 
90:10 e.r., Entry 13, Table 2.4). Unfortunately, having the ester directly conjugated to 
the allene (2.1r) is detrimental to the reaction, presumably due to the allene being less 
electron-rich (Entry 14, Table 2.4). 
 
The previous examples demonstrate good positional selectivity and enantiomeric 
ratios with a wide range of functionalised allenes (Entries 1-13, Table 2.4). Interestingly 
however, with unfunctionalised allenes the reaction does not proceed with the same 
degree of selectivity. Aryl substituted allene 2.1a, originally investigated by 
Yamamoto44, gave a good 10:1 ratio of positional isomers. However, as reported with 
Yamamoto’s conditions, no chirality transfer was obtained (2.3ab, 79%, racemic, Entry 
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15, Table 2.4). This is likely due to the faster allene racemisation outcompeting the 
hydroalkoxylation for this substrate (see Section 2.3.5), as the aryl substituent can 
stabilise the intermediate of the allene racemisation (1.VI, Scheme 1.17).41 In order to 
determine whether positional selectivity could be controlled by steric differentiation, 
the dialkyl 1,3-substituted allene 2.1o was subjected to our conditions. Interestingly, 
this gave an inseparable mixture of positional isomers (2.3ob, 71%, 1:0.7 pos., Entry 
16, Table 2.4), showing that some inductively withdrawing functionality is needed to 
give good positional selectivity (see Section 2.3.5). Although this limits the scope of the 
hydroalkoxylation to functionalised allenes, this is not necessarily a major drawback as 
functional group containing substrates and products are much more useful for further 
synthesis. 
 
The symmetrical dialkyl substrate 2.1q (85:15 e.r., see Section 2.3.2) was of particular 
interest as positional selectivity is not an issue and if chirality transfer was to occur it 
would show that it is facilitated by steric interactions alone. Interestingly, some 
moderate chirality transfer did occur (2.3qb, 82%, 69:31 e.r., Entry 17, Table 2.4). 
However, the estimated e.r. of the starting material (see Section 2.3.2) and some loss 
of chirality transfer led us to refrain from drawing any major conclusions from this 
result.  
 
The absolute configuration was determined for products 2.3bb and 2.3hf (see 
experimental Section 2.5.5 for details) and the absolute configuration of all other 
products was inferred by analogy. 
 
2.3.4 Nucleophile scope  
 
Entry Alcohol Product Yield[a] e.r. 
1   65% 98:2[b] 
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2   81% >95:5[c] 
3 
 
  68% 
 
98:2[b] 
4   62% 98:2[c] 
5   60% 97:3[b] 
6   37% 99:1[b] 
7   88% 97:3[b] 
8   78% 81:19[b] 
9   51% 97:3[b] 
10   30% 94:6[b] 
11   60% 98:2[b] 
12 
 
 66% 99:1[b] 
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13   64% 99:1[b] 
14 
 
 79% 91:9[c][d] 
15  - No reaction  
[a] Isolated yields, >20:1 E:Z and positional selectivity by 1H NMR analysis unless otherwise 
stated. [b] Determined by CSP-HPLC [c] Determined by 1H NMR using chiral shift reagent (R)-(-
)-1-(9-anthryl)-2,2,2-trifluoroethanol. [d] Determined on the THP deprotected product. 
Table 2.5: Alcohol nucleophile scopeϖ 
 
The alcohol nucleophile scope was investigated using allene substrate 2.1b (Table 2.5) 
and gave perfect positional selectivity throughout the scope. Pleasingly, the reaction 
was shown to work well with a range of other primary alcohols, giving the desired 
allylic ethers in good yields and excellent e.r. (2.3be, 2.3bg, 2.3bh, >62%, >95:5 e.r., 
Entries 2-4, Table 2.5). To our delight, primary alkyl alcohols with pendent electron 
withdrawing Cl (2.2c) and CF3 (2.2i) groups, also react smoothly and gave products 
with high e.r. albeit with a lower yield for alcohol 2.2i (2.3bc, 70%, 97.3 e.r. and 2.3bi, 
37%, 99:1 e.r.,  Entries 5-6, Table 2.5). The more sterically hindered secondary alcohol 
iPrOH 2.2a reacts well to give the desired product in good yield and e.r. (2.3ba, 88%, 
97:3 e.r., Entry 7, Table 2.5) and homochiral secondary alcohols 2.2j and 2.2k also 
proceed with good e.r. and d.r., (2.3bj, 78%, 81:19 e.r. and 2.3bk, 51%, 97:3 e.r., 
Entries 8-9, Table 2.5). The extremely bulky tertiary alcohol tBuOH 2.2d reacts 
sluggishly under our conditions but with good chirality transfer (30%, 96:4 e.r., Entry 
10, Table 2.5). Gratifyingly, this difference in reactivity allows for chemoselective 
reaction of diol 2.2l at the less hindered primary end (2.3bl, 60%, 98:2 e.r., Entry 11, 
Table 2.5). Other potentially sensitive functional groups such as a pendent alkene 
(2.2m), furan (2.2n) or acetals (2.2o) are also tolerated well (2.3bm, 2.3bn, 2.3bo, 
>64%, >91:9 e.r., Entries 12-14, Table 2.5). However, the less nucleophilic phenol 
(2.2p) is not a viable nucleophile in this reaction (Entry 15, Table 2.5). 
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2.3.5 Investigation into selectivity 
The allene scope revealed a great deal about why the hydroalkoxylation of 
enantioenriched allenes occurs with excellent selectivity. Firstly, the positional 
selectivity is lost when the substituents on the allene are electronically similar (2.3ob, 
71%, 1:0.7 pos., Entry 16, Table 2.4). This is thought to be because the inductively 
withdrawing functional group is drawing electron density away from the carbon-
carbon bond of the allene closest to it (π2, Figure 2.1)  and thereby promoting reaction 
at the more remote and electron-rich carbon-carbon bond (π1, Figure 2.1). 
 
 
Figure 2.1: Positional selectivity through inductively withdrawing group 
 
Another possible mechanism that could explain the positional selectivity observed 
involves the gold catalyst chelating to the functional group of the allene and so being 
directed towards activation of one half of the allene over the other. This mechanism 
would also explain the chirality transfer observed as the interaction would direct the 
gold to one face of the allene and through anti attack of the alcohol give the 
configuration observed (Scheme 2.23). 
 
 
Scheme 2.23: Alternative selectivity through gold chelation (disproved) 
 
This mechanism depends entirely on the functional group being capable of chelating 
the gold catalyst to confer the selectivity observed. The symmetrical dialkyl allene 2.1q 
was chosen as part of the scope as it has no functionality which is capable of chelating 
the gold catalyst. Although this substrate did suggest that some chirality transfer 
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occurred without the possibility of chelation (2.3qb, 82%, 69:31 e.r., Entry 17, Table 
2.4), the result was not convincing. To investigate this further, the CF3 containing 
allene 2.1p was subjected to our conditions (Scheme 2.24). This substrate has a CF3 
group which is inductively withdrawing but does not have any functionality capable of 
chelating the gold catalyst. 
 
 
Scheme 2.24: Gold-catalysed hydroalkoxylation of allene 2.1p 
 
The perfect positional selectivity and chirality transfer observed for this substrate 
(2.1p) demonstrates conclusively that only an inductively withdrawing group on one 
substituent of the allene is required for excellent selectivity. Based on this result, the 
following mechanism is proposed for this reaction (Scheme 2.25). 
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Scheme 2.25: Proposed mechanism of selective hydroalkoxylation of allenes 
 
It is thought that the gold catalyst can coordinate to either face of the allene  and 
these intermediates (2.I and 2.I’’, Scheme 2.25) are rapidly interconverting.67 The gold 
catalyst prefers to activate the more electron-rich half of the allene, which is the π-
bond that is furthest from the inductively withdrawing group (see Figure 2.1). Since the 
face to which the gold catalyst binds is in equilibrium, in accordance with the Curtin-
Hammett principle the energy barrier of the next step of the mechanism defines which 
product is observed. The attack of the alcohol nucleophile is preferred at the less 
hindered face of the allene and so, through this lower energy pathway, the observed 
product (R, E)-2.3 is obtained after protodeauration. The product formed through 
attack at the lower face (S, Z)-2.3’’ is never detected in our reactions.  
 
With this mechanism in mind, it follows that any loss of chirality transfer is likely due to 
allene racemisation (Scheme 2.26).  
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Scheme 2.26: Gold-catalysed 1,3-disubstituted allene racemisation 
 
Looking back at the allene scope (Table 2.4), it can be seen that substrates which have 
more inductively withdrawing groups gave better chirality transfer. For example, the 
protected allenols which have inductively withdrawing carbonyls or benzyl groups 
(2.3bb-2.3eb, >93:7 e.r., Entries 1-4, Table 2.4) outperformed the less inductively 
withdrawing ether allene (2.3fe, 87:13 e.r., Entry 5, Table 2.4). Also, moving the 
inductively withdrawing group one CH2 farther from the allene and so lowering its 
affect causes a drop in chirality transfer (2.3bb 98:2 Entry 1 vs. 2.3ib 90:10 e.r. Entry 7 
and 2.3jb 97:3 Entry 8 vs. 2.3kb 81:19 e.r., Entry 9, Table 2.4). Due to this trend of 
allenes with more inductively withdrawing character in one substituent outperforming 
those with less inductively withdrawing substituents, it was proposed that the 
inductively withdrawing groups destabilise the transition state of the allene 
racemisation mechanism (Scheme 2.26). This is thought to slow down the 
racemisation, thereby allowing better chirality transfer for allenes with more 
inductively withdrawing substituents. This would also explain why there is a drop in 
chirality transfer in the hydroalkoxylation of dialkyl allene 2.1q which does not have an 
inductively withdrawing group (2.3qb, 82%, 69:31 e.r., Entry 17, Table 2.4).  
 
Allene 2.1a which produced totally racemic product under our conditions (2.3ab, 79%, 
racemic, Entry 15, Table 2.4) is likely quickly racemised by the gold catalyst, since 
having a phenyl group directly bound to the allene will stabilise the intermediate of the 
allene racemisation mechanism.  
 
From this investigation, we have been able to show that having an inductively 
withdrawing group close to the allene ensures excellent positional selectivity by 
drawing electron density away from one half of the allene. The inductively 
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withdrawing substituent is also thought to prevent allene racemisation which, based 
on our proposed mechanism, is the only reason for loss of chirality transfer in the 
hydroalkoxylation of enantioenriched allenes.  
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2.4 Conclusions  
The first gold(I)-catalysed hydroalkoxylation of enantioenriched 1,3-disubstituted 
allenes with excellent positional selectivity and chirality transfer for a range of 
substrates has been developed. This was achieved by developing conditions which 
allow the hydroalkoxylation reaction to occur whilst preventing the gold-catalysed 
racemisation of starting material allenes. During optimisation of the reaction it was 
found that the solvent, equivalents of alcohol and temperature can all be used to 
dampen the activity of the gold catalyst. These changes to the conditions were key in 
achieving excellent chirality transfer by supressing allene racemisation.  
 
An extensive allene scope study showed that a range of substrates with one 
inductively withdrawing substituent proceed with perfect positional selectivity and 
excellent chirality transfer. This is thought to be due to the inductively withdrawing 
group pulling electron density away from one half of the allene and so causing 
selective reaction at the other, more electron-rich position of the allene. The 
withdrawing group also destabilises the intermediate of the allene racemisation 
mechanism, thereby slowing down the racemisation of these allenes and allowing for 
excellent chirality transfer. The allene scope study shows that a range of inductively 
withdrawing functional groups can be tolerated including groups with O, N or CF3 in 
the β position, an ester or an amide. Pleasingly, when the functionality is stripped back 
to an ether group or the functional group is moved an extra CH2 farther from the 
allene, the excellent positional selectivity is retained and there is only a slight drop in 
chirality transfer.  
 
The alcohol nucleophile scope demonstrates that the reaction is tolerant to a range of 
primary, secondary and tertiary alcohols as well as alcohols with potentially sensitive 
functional groups. The yield was shown to drop with tertiary alcohols and primary 
alcohols with pendent electron withdrawing groups, but to our delight the chirality 
transfer was excellent for all the alcohol nucleophiles investigated.  
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2.5 Experimental  
2.5.1 General considerations 
1H NMR spectra was recorded on Bruker AV 300 and AV 400 spectrometers at 300 and 
400 MHz respectively and referenced to residual solvent. 13C NMR spectra were 
recorded using the same spectrometers at 75 and 100 MHz respectively. Chemical shift 
data are quoted in parts per million (ppm) and are referenced to tetramethylsilane 
(TMS) or to residual solvent peaks (CDCl3 at δH 7.26). J values are given in Hz and s, d, 
dd, dt, ddt, dtd, t, td, tt, q, qd, qt, p and m abbreviations correspond to singlet, 
doublet, doublet of doublet, doublet of triplet, doublet of doublet of triplet, doublet of 
triplet of doublet, triplet, triplet of doublet, triplet of triplet, quartet, quartet of 
doublet, quartet of triplet, quintet and multiplet respectively. Mass spectra were 
obtained at the EPSRC National Mass Spectrometry Service Centre in Swansea. 
Infrared spectra were obtained on Perkin-Elmer Spectrum 100 FT-IR Universal ATR 
Sampling Accessory, deposited neat or as a chloroform solution to a diamond/ZnSe 
plate. Flash column chromatography was carried out using Matrix silica gel 60 from 
Fisher Chemicals or Silicagel 60A from Fluorochem and TLC was performed using 
Merck silica gel 60 F254 pre-coated sheets and visualised by UV (254 nm) or stained by 
the use of aqueous acidic KMnO4 or aqueous acidic ceric ammonium molybdate as 
appropriate. Chemicals were purchased from Sigma-Aldrich, Acros, Apollo Scientific, 
Fisher, Fluorochem and Manchester Organics chemical companies and used without 
further purification unless otherwise stated. THF, DCM and DMF were dried using an 
MBRAUN SPS-800 solvent purification system. Diethyl ether was purified by distilling 
over CaH2. High performance liquid chromatography (HPLC) was carried out on Agilent 
Technologies 1120 Compact LC. Gas chromatography was carried out on a Shimadzu 
GC2014 with FID. 
 
The gold(I)-catalysed  reactions were carried out in screw cap 1 dram vials partially 
immersed in a bath of IPA cooled by a huber TC45E-F immersion chiller unless 
otherwise indicated. No special precautions to exclude air or moisture were taken 
unless otherwise indicated. 
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2.5.2 Preparation of allene precursors 
Allenol 2.15(ϖ) – precursor for allenes 2.1b – 2.1f, 2.1j and 2.1l 
 
Scheme 2.27: Synthetic route to allenol 2.15 
2-(((R)-But-3-yn-2-yl)oxy)tetrahydro-2H-pyran (2.13) (ϖ) 68 
 
To (R)-1-butyn-3-ol 2.12 (3.50 g, 50.0 mmol, 1 equiv., 97% e.e.) and 3,4-dihydro-2H-
pyran (5.50 mL, 60.0 mmol, 1.2 equiv.) in DCM (38 mL) at 0 ᵒC was added TsOH (129 
mg, 1.50 mol%).  The solution was stirred for 2 hours at 0 ᵒC. The reaction was diluted 
with DCM and quenched with a saturated solution of NaHCO3, separated and then 
extracted with Et2O. The combined organic layers were dried over MgSO4 and 
concentrated.  The mixture was purified by column chromatography (eluent: 20:1 to 
15:1 petrol 40-60 oC/Et2O) to yield product 2.13 as a colourless oil (6.95 g, 45.5 mmol, 
91%) in a 1:0.3 mixture of diastereomers. 
 
RF 0.64 (15:1 petrol 40-60 oC/Et2O); νmax/cm-1 3291 (C≡C-H), 2940, 2870 (C-H), 1162 (C-
O-C); 1H NMR (300 MHz, CDCl3) δ 4.93 (1H, t, J = 3.6 Hz, OCHO, major), 4.76 (1H', t, J = 
3.3 Hz, OCHO, minor), 4.54 (1H, qd, J = 6.7, 2.1 Hz, CH3CH, major), 4.45 (1H', qd, J = 6.8, 
2.1 Hz, CH3CH, minor), 4.03-3.93 (1H', m, OCHCH2CH2, minor), 3.86-3.76 (1H, m, 
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OCHCH2CH2, major), 3.57-3.47 (1H + 1H', m, OCHCH2CH2, major + minor), 2.41 (1H', d, J 
= 2.2 Hz, C≡CH, minor), 2.35 (1H, d, J = 2.0 Hz, C≡CH, major), 1.81-1.76 (1H + 1H', m, 
alkyl H’s, major + minor), 1.76-1.64 (1H + 1H', m, alkyl H’s, major + minor), 1.64-1.49 
(4H + 4H', m, alkyl H’s, major + minor), 1.46 (3H, d, J = 6.7 Hz, CH3CH, major), 1.43 (3H', 
d, J = 6.7 Hz, CH3CH, minor); 13C NMR (75.5 MHz, CDCl3) δ 97.3 (CH, minor), 96.1 (CH, 
major), 84.8 (C, minor), 83.8 (C, major), 72.6 (CH, major), 72.0 (CH, minor), 62.7 (CH, 
major), 62.4 (CH2, minor), 62.3 (CH2, major), 60.7 (CH, minor), 30.7 (CH2, minor), 30.6 
(CH2, major), 25.6 (CH2, major), 25.5 (CH2, minor), 22.2 (CH3, major), 21.9 (CH3, minor), 
19.6 (CH2, major), 19.2 (CH2, minor). 
 
(4R)-4-((Tetrahydro-2H-pyran-2-yl)oxy)pent-2-yn-1-ol (2.14) (ϖ)68 
 
n-BuLi (17.5 mL, 2.5 M in hexanes, 43.8 mmol, 1.4 equiv.) was added dropwise (over 20 
mins) to a solution of 2.13 (4.79 g, 31.3 mmol, 1.0 equiv.) in THF (105 mL) at -78 ᵒC 
under Ar.  Allowed to warm to room temperature and paraformaldehyde (1.89 g, 62.6 
mmol, 2.0 equiv.) was added.  The reaction was stirred for a further 2 hours.  The 
reaction was diluted with Et2O and quenched with a saturated solution of NH4Cl and 
extracted with Et2O.  The combined organic layers were dried over MgSO4 and 
concentrated. The mixture was purified by column chromatography (eluent: 3:1 to 2:1 
petrol 40-60 oC/EtOAc) to yield product 2.14 as a colourless oil as a 1:0.3 mixture of 
diastereomers (3.38 g, 18.3 mmol, 76%). 
 
RF 0.36 (3:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3416 (br, OH), 2938, 2868 (C-H), 1114 (C-
O-C); 1H NMR (300 MHz, CDCl3) δ 4.92 (1H, t, J = 3.0 Hz, OCHO, major), 4.76 (1H', t, J = 
3.1 Hz, minor), 4.57 (1H, qt, J = 6.7, 1.6 Hz, CHCH3, major), 4.49 (1H', qt, J = 6.6, 1.7 Hz, 
CHCH3, minor),  4.29 (2H', d, J = 1.6 Hz, HOCH2, minor), 4.27 (2H, d, J = 1.7 Hz, HOCH2, 
major), 4.02-3.93 (1H', m, OCH2CH2, minor), 3.85-3.67 (1H, m, OCH2CH2, major), 3.57-
3.47 (1H + 1H', m, OCH2CH2, major + minor), 2.38 (br. 1H + 1H', m, OH, major + minor), 
1.90-1.79 (1H + 1H', m, alkyl H’s, major + minor), 1.77-1.65 (1H + 1H', m, alkyl H’s, 
major + minor), 1.65-1.48 (4H + 4H', m, alkyl H’s, major + minor), 1.45 (3H, d, J = 6.7 Hz, 
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CH3, major), 1.42 (3H', d, J = 6.6 Hz, CH3, minor); 13C NMR (75.5 MHz, CDCl3) δ 97.3 (CH, 
minor), 95.9 (CH, major), 86.5 (C, minor), 85.5 (C, major), 83.1 (C, major), 82.4 (C, 
minor), 62.7 (CH, minor), 62.6 (CH2, major), 62.5 (CH2, minor), 60.9 (CH, major + 
minor), 51.2 (CH2, minor), 51.1 (CH2, major), 30.7 (CH2, minor), 30.6 (CH2, major), 25.53 
(CH2, major), 25.46 (CH2, minor), 22.2 (CH3, major), 21.9 (CH3, minor), 19.5 (CH2, 
major), 19.3 (CH2, minor). 
 
(S)-Penta-2,3-dien-ol (2.15) (ϖ)68 
 
A solution of 2.14 (3.38 g, 18.3 mmol, 1.0 equiv.) in Et2O (18 mL) was added to a 
solution of LiAlH4 (1.26 g, 33.2 mmol, 1.8 equiv.) in Et2O (30 mL) at 0 ᵒC.  The reaction 
was slowly warmed to room temperature and stirred for 18 hours.  The reaction was 
then cooled to 0 ᵒC and quenched by dropwise addition of 1M NaOH solution.  The 
white suspension was filtered through celite® and washed with Et2O and then 
concentrated. The mixture was purified by column chromatography (eluent: 5:1 to 2:1 
pentane/Et2O) to give product (S)-2.15 as a colourless oil (1.39 g, 16.6 mmol, 49%). 
 
RF 0.30 (2:1 petrol 40-60 oC/Et2O); νmax/cm-1 3378 (br, OH), 2938 (C-H), 1967 (C=C=C); 
1H NMR (300 MHz, CDCl3) δ 5.334-5.19 (2H, m, allene H), 4.10 (2H, dd, J = 5.5, 3.2 Hz, 
OCH2), 1.69 (3H, dd, J = 6.6, 3.6 Hz, CH3); 13C NMR (75 MHz, CDCl3) δ 203.9 (C), 91.4 
(CH), 88.9 (CH), 60.8 (CH2), 14.4 (CH3). 
 
Allenol 2.17 – precursor for allene 2.1i and 2.1k 
 
See later for experimental details for allene 2.1h 
Scheme 2.28: Synthetic route to allenol 2.17 
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(R)-Hexa-3,4-dien-1-ol (2.17)57      
 
(R)-Ethyl hexa-3,4-dienoate 2.1h (491 mg, 3.50 mmol, 1.0 equiv.) in dry THF (8 mL) was 
added dropwise to stirring solution of lithium aluminium hydride (266 mg, 7.00 mmol, 
2.0 equiv.) in THF (4 mL) at 0 °C and under argon. THF (4 mL) was added and the 
reaction mixture was stirred at room temperature for 1 h. 1 M NaOH solution was 
added dropwise until the solution turned viscous and then to a clear solution with 
white precipitate. The reaction mixture was passed through a Celite® plug and 
concentrated. The mixture was purified by column chromatography (eluent: 10:1 then 
6:1 hexane/EtOAc) to yield product 2.17 as a pale yellow oil (235 mg, 2.40 mmol, 69%).  
  
RF 0.35 (7:1 pentane/Et2O); νmax/cm-1 3324 (br, OH), 2926 (C-H), 1965 (C=C=C); 1H NMR 
(300 MHz, CDCl3) δ 5.03-5.22 (2H, m, allene H), 3.73 (2H, t, OCH2), 2.28 (2H, dtd, CH2), 
1.70 (3H, dd, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 205.5 (C), 86.6 (CH), 86.2 (CH), 62.0 
(CH2), 32.2 (CH2), 14.5 (CH3); [𝛼]𝐷
20℃ = -33.6 (c = 0.66 in CHCl3) [lit.57 [𝛼]𝐷
20 ℃ = -93.2 (c = 
1.0 in MeOH)]. 
 
Alcohol 2.19 – precursor for allene 2.1a 
 
Scheme 2.29: Synthetic route to alcohol 2.19 
 
(R)-4-Phenylbut-3-yn-2-ol (2.19)69 
 
To a solution of iodobenzene (0.49 mL, 4.40 mmol, 1.1 equiv.) in diisopropylamine 
(5.30 mL, 38.0 mmol, 9.5 equiv.) was added bis(triphenylphosphine)palladium(II) 
dichloride (210 mg, 0.30 mmol, 0.70 mol%) and copper(I) iodide (195 mg, 1.03 mmol, 
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1.4 mol%). To the resultant mixture was added but-3-yn-2-ol 2.12 (283 mg, 4.0 mmol, 
1.0 equiv.) dropwise at 0 oC. The mixture was allowed to warm to room temperature 
and the reaction mixture stirred for 2 h and then concentrated. The concentrated 
reaction mixture was loaded directly onto a silica gel column and purified by column 
chromatography (eluent: DCM) to yield product 2.19 as an orange oil (549 mg, 3.92 
mmol, 98%).   
 
RF 0.45 (DCM); νmax/cm-1 3321 (br, OH), 2981 (C-H), 1598, 1489 (C-C Ar); 1H NMR (300 
MHz, CDCl3) δ 7.50-7.31 (5H, m, Ar-H), 4.80 (1H, qd, OCH), 2.04 (1H, br d, J = 4.9 Hz, 
OH), 1.59 (3H, d, J = 6.6 Hz, CH3); 13C NMR (75 MHz, CDCl3) δ 131.7 (CH), 128.4 (CH), 
128.3 (CH), 122.6 (C), 90.9 (C), 84.0 (C), 58.9 (CH), 24.4 (CH3); [𝛼]𝐷
20 ℃ = +27.2 (c = 1.03 
in CHCl3) [lit. [𝛼]𝐷
25 ℃ = +37 (c = 0.8 in CHCl3)]. 
 
Alkyne 2.22 – precursor for enantioenriched allene 2.1p 
 
Scheme 2.30: Synthetic route to 2.22 
 
(S)-2-(Pyrrolidin-1-ylmethyl)-1-((S)-1,1,1-trifluoro-7-phenylhept-4-yn-3-yl)pyrrolidine 
(2.22)  
 
  59 
 
Following a general procedure by Periasamy et al.70 CuBr (187 mg, 20 mol%), (S)-(+)-1-
(2-pyrrolidinylmethyl)pyrrolidine (1.00 g, 6.50 mmol, 1.0 equiv.) and dry toluene (13 
ml) were added to a flask. 3,3,3-Trifluoropropanal (0.56 mL, 6.50 mmol, 1.0 equiv.), 4 Å 
molecular sieves (4.5 g) and 4-phenyl-1-butyne 2.20 (1.00 ml, 7.10 mmol, 1.1 equiv.) 
were added to the flask and stirred under N2 at r.t. for 42 hours.  The molecular sieves 
were removed via filtration and washed with Et2O. The crude product was purified by 
graduated column chromatography using basic alumina (eluent 50:1 to 10:1 
hexane/EtOAc) to yield product 2.22 as a yellow oil (55.0 mg, 0.17 mmol, 2.7%). 
 
RF 0.39 (25:1 hexane/EtOAc neutral alumina plate); νmax/cm-1 2960, 2787 (C-H), 1454, 
(C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.09-7.25 (5H, m, Ar-H), 4.20 (1H, t, J = 7.4 Hz, 
NCHCH2), 2.74 (2H, t, J = 7.3 Hz, ≡CCH2), 2.61-2.72 (2H, m, alkyl-H), 2.17-2.50 (11H, m, 
alkyl-H), 1.37-1.84 (8H, m, alkyl-H); 13C NMR (100.6 MHz, CDCl3) δ 140.6 (C), 128.4 (CH), 
128.3 (CH), 126.2 (CH), 125.8 (q, J = 277.3 Hz, CF3), 85.2 (C), 61.7 (C), 59.4 (CH), 54.8 
(CH2) 47.0 (CH2), 46.9 (q, J = 4.1 Hz, CHCH2CF3), 39.8 (q, J = 27.2 Hz, CH2CF3), 35.2 (CH2), 
30.3 (CH2), 23.5 (CH2), 22.9 (CH2), 20.5 (CH2);  19F NMR (282 MHz, CDCl3) δ -64.09 (t, J = 
10.7 Hz); Found (FTMS p NSI+) [M + H]+ 379.2353 C22H30F3N2 requires 379.2356. 
 
Alkyne 2.23 – precursor for racemic allene 2.1p 
 
Scheme 2.31: Synthetic route to 2.23 
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1-(1,1,1-Trifluoro-7-phenylhept-4-yn-3-yl)pyrrolidine (2.23)  
 
Following a general procedure by Periasamy et al.70 CuBr (226 mg, 20 mol%), 
pyrrolidine (0.74 ml, 8.90 mmol, 1.0 equiv.) and dry toluene (14 ml) were added to a 
flask. 3,3,3-Trifluoropropanal (1.00 g, 8.90 mmol, 1.0 equiv.), 4 Å molecular sieves (4.5 
g) and 4-phenyl-1-butyne 2.20 (1.38 ml, 9.80 mmol, 1.1 equiv.) were added to the flask 
and stirred under Ar at r.t. for 36 hours.  The molecular sieves were removed via 
filtration and washed with Et2O. The crude product was purified by column 
chromatography (eluent 30:1 then 10:1 hexane/EtOAc) to yield product 2.23 as a 
yellow oil (498 mg, 1.70 mmol, 19%). 
 
RF 0.68 (10:1 hexane/EtOAc); νmax/cm-1 2961 (C-H), 1496, 1455 (C-C Ar); 1H NMR (300 
MHz, CDCl3) δ 7.09-7.26 (5H, m, Ar-H), 3.78 (1H, t, J = 5.8 Hz, NCHCH2), 2.75 (2H, t, J = 
7.4 Hz, ≡CCH2), 2.26-2.53 (8H, m, alkyl-H), 1.59-1.71 (4H, m, alkyl-H); 13C NMR (75.5 
MHz, CDCl3) δ 140.6 (C), 128.5 (CH), 128.3 (CH), 126.2 (CH), 125.8 (q, J = 277.4 Hz, CF3), 
85.6 (C), 76.1 (C), 48.8 (CH2), 48.0 (q, J = 3.6 Hz, CHCH2CF3), 39.7 (q, J = 27.3 Hz, 
CH2CF3), 35.1 (CH2), 23.4 (CH2), 20.6 (CH2); 19F NMR (282 MHz, CDCl3) δ -64.07 (t, J = 
10.4 Hz); Found (FTMS p NSI+) [M + H]+ 296.1620, C17H21F3N requires 296.1621. 
 
Ether 2.24 – precursor for allene 2.1q 
 
Scheme 2.32: Synthetic route to 2.24 
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(R)-3-Methoxyoct-1-yne (2.24)71 
 
Freshly ground KOH pellets (1.14 g, 20.4 mmol, 3.4 equiv.) and iodomethane (0.75 mL, 
12.0 mmol, 2 equiv.) were added to a stirring solution of (R)-1-octyn-3-ol 2.16 (757 mg, 
6.00 mmol, 1 equiv.) in DMSO (12 mL) and stirred for 1 h. A saturated solution of 
NaHCO3 (40 mL) and tBuOMe (60 mL) were added and the layers were separated. The 
organic layer was washed with a saturated solution of NaHCO3 (30 mL) and water (30 
mL) and the combined aqueous layers were extracted with tBuOMe (2 x 40 mL), the 
combined organic layers were dried over MgSO4 and concentrated. The mixture was 
purified by column chromatography (eluent: 45:1 hexane/EtOAc) to yield product 2.24 
as a thin colourless oil (745 mg, 5.33 mmol, 89%).   
 
RF 0.57 (40:1 hexane:EtOAc); νmax/cm-1 3309 (alkyne C-H), 2930 (C-H), 2360 (alkyne C-
C), 1097 (C-O-C); 1H NMR (300 MHz, CDCl3) δ 3.96 (1H, td, J = 6.5, 2.0 Hz, ≡CH), 3.44 
(3H, s, OMe), 2.46 (1H, d, J = 2.1 Hz, OCH), 1.81 – 1.64 (2H, m, CH2), 1.59 – 1.41 (2H, m, 
CH2), 1.41 – 1.26 (4H, m, CH2), 0.92 (3H, t, J = 6.9 Hz, CH3); 13C NMR (75 MHz, CDCl3) δ 
82.8 (C), 73.6 (CH), 71.1 (CH), 56.4 (CH3), 35.5 (CH2), 31.5 (CH2), 24.8 (CH2), 22.5 (CH2), 
14.0 (CH3). 
 
2.5.3 Preparation of allenes  
 (S)-Penta-2,3-dien-1-yl benzoate (2.1b)(ϖ), 68, 72  
 
To a solution of 2.15 (252 mg, 3.00 mmol, 1.0 equiv.) in DCM (12 mL) was added BzCl 
(697 µl, 6.00 mmol, 2.0 equiv.), pyridine (1.70 mL, 21.0 mmol, 7.0 equiv.) and 4-
(dimethylamino)pyridine (73.3 mg, 0.60 mmol, 0.2 equiv.) at 0 ᵒC.  The solution was 
stirred for 6 hours.  The reaction was quenched with 6N HCl and extracted with Et2O.  
The combined organic layers were washed with brine, dried over MgSO4 and 
concentrated.  The mixture was purified by column chromatography (eluent: 20:1 
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petrol 40-60 oC/Et2O) to give product (S)-2.1b as a yellow oil (529 mg, 2.82 mmol, 94%, 
99:1 e.r.).  
 
RF 0.68 (15:1 petrol 40-60 oC/Et2O); νmax/cm-1 2948 (C-H), 1970 (C=C=C), 1716 (C=O), 
1601, 1584, 1491,1451 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 8.09-8.03 (2H, m, Ar-H), 
7.59-7.53 (1H, m, Ar-H), 7.47-7.41 (2H, m, Ar-H), 5.40-5.30 (1H, m, allene H), 5.30-5.21 
(1H, m, allene H), 4.80 (2H, dd, J = 6.7, 2.4 Hz, CHCH2O), 1.69 (3H, dd, J = 7.0, 3.2 Hz, 
CHCH3); 13C NMR (75.5 MHz, CDCl3) δ 206.4 (C), 166.5 (C), 133.0 (CH), 130.4 (C), 129.8 
(CH), 128.4 (CH), 87.9 (CH), 86.5 (CH), 63.4 (CH2), 14.0 (CH3); [𝛼]𝐷
22 ℃  = +33.6 (c = 1.07 
in CHCl3); CSP-GC (β-Dex, 120 ᵒC, 35 cm s-1) (R)-2.1b 73.5 min and (S)-2.1b 74.4 min.  
 
(S)-((Penta-2,3-dien-1-yloxy)methyl)benzene (2.1c)(ϖ), 72 
 
Compound 2.15 (252 mg, 3.00 mmol, 1.0 equiv.) was added dropwise to a solution of 
NaH (60% in oil, 180 mg, 4.00 mmol, 1.5 equiv.) in THF (3.0 mL) at r.t. followed by 
addition of BnCl (518 µl, 4.50 mmol, 1.5 equiv.).  The reaction was then stirred at 50 ᵒC 
for 18 hours.  The reaction was quenched with water and extracted with Et2O.  The 
organic layer was dried over MgSO4 and concentrated.  The mixture was purified by 
column chromatography (eluent: 100:1 petrol 40-60 oC/EtOAc) to yield product (S)-
2.1c as a yellow oil (216 mg, 1.23 mmol, 41%, 99:1 e.r.).   
 
RF 0.45 (80:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3029, 2924, 2855 (C-H), 1966 (C=C=C), 
1495, 1453, 1410 (C-C Ar), 1093 (C-O-C); 1H NMR (300 MHz, CDCl3) δ 7.39-7.27 (5H, m, 
Ar-H), 5.28-5.13 (2H, m, allene-H), 4.54 (2H, s, OCH2Ph), 4.05 (2H, dd, J = 6.4, 2.6 Hz, 
CHCH2O), 1.69 (3H, dd, J = 6.7, 3.5 Hz, CH3); 13C NMR (75.5 MHz, CDCl3) δ 206.0 (C), 
138.4 (C), 128.5 (CH), 128.0 (CH), 127.7 (CH), 87.9 (CH), 86.7 (CH), 71.8 (CH2), 68.6 
(CH2), 14.3 (CH3); [𝛼]𝐷
21 ℃ = +31.9 (c = 1.06 in CHCl3); CSP-GC (β-Dex, 110 ᵒC, 35 cm s-1) 
(R)-2.1c 65.5 min and (S)-2.1c 66.1 min. 
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(S)-Penta-2,3-dien-1-yl pivalate (2.1d)(ϖ), 72 
 
Compound 2.15 (252 mg, 3.00 mmol, 1.0 equiv.) was added dropwise to a solution of 
NaH (60% in oil, 240 mg, 4.50 mmol, 1.5 equiv.) in THF (3.0 mL) at room temperature 
followed by dropwise addition of PivCl (554 µL, 6.00, 2 equiv.).  The reaction was then 
stirred at 50 ᵒC for 3 days.  The reaction was quenched with water and extracted with 
Et2O.  The organic layer was dried over MgSO4 and concentrated.  The mixture was 
purified by column chromatography (eluent: 25:1 petrol 40-60 oC /Et2O) to yield 
product 2.1d as a yellow oil (280 mg, 1.66 mmol, 55%, 99:1 e.r. (This allene could not 
be separated by CSP-GC or HPLC. E.r. assumed by analogy to other allenes formed by 
esterification of allenol 2.15)). 
 
RF 0.39 (25:1 petrol 40-60 oC/Et2O); νmax/cm-1 2972 (C-H), 1971 (C=C=C), 1730 (C=O), 
1032 (C-O-C); 1H NMR (300 MHz, CDCl3) δ 5.28-5.14 (2H, m, allene-H), 4.53 (2H, dd, J = 
6.1, 3.0 Hz, CH2O), 1.67 (3H, dd, J = 6.7, 3.5 Hz, CH3), 1.20 (9H, s, tBu); 13C NMR (75.5 
MHz, CDCl3) δ 205.9 (C), 178.4 (C), 87.9 (CH), 86.8 (CH), 62.4 (CH2), 38.9 (C), 27.3 (CH3), 
14.1 (CH3); Found (GC/MS EI+) [M]+ 168.1152, C10H16O2 requires 168.1150. [𝛼]𝐷
21 ℃ = 
+21.4 (c = 1.12 in CHCl3). 
 
(S)-Penta-2,3-dien-1-yl acetate (2.1e) (ϖ), 72 
 
Compound 2.15 (252 mg, 3.00 mmol, 1.0 equiv.) was added dropwise to a solution of 
NaH (60% in oil, 240 mg, 6.00 mmol, 2 equiv.) in THF (3.0 mL) at r.t. followed by 
dropwise addition of AcCl (427 mL, 6.00, 2 equiv.).  The reaction was then stirred at 50 
ᵒC for 18 hours.  The reaction was quenched with water and extracted with Et2O.  The 
organic layer was dried over MgSO4 and concentrated.  The mixture was purified by 
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column chromatography (eluent: 20:1 to 10:1 petrol 40-60 oC/Et2O) to yield product 
2.1e as a yellow oil (267 mg, 2.13 mmol, 71%, 99:1 e.r.). 
RF 0.33 (10:1 petrol 40-60 oC/Et2O); νmax/cm-1 2949 (C-H), 1970 (C=C=C), 1738 (C=O), 
1022 (C-O-C); 1H NMR (300 MHz, CDCl3) δ 5.30-5.15 (2H, m, allene H), 4.57-4.52 (2H, 
m, OCH2), 2.06 (3H, s, O=CCH3), 1.71-1.56 (3H, m, CHCH3); 13C NMR (75.5 MHz, CDCl3) δ 
206.3 (C), 170.9 (C), 87.7 (CH), 86.4 (CH), 63.0 (CH2), 21.1 (CH3), 14.0 (CH3); Found 
(GC/MS EI+) [M]+ 126.0682, C7H10O2 requires 126.0681; [𝛼]𝐷
21 ℃ = +45.5 (c = 1.10 in 
CHCl3); CSP-GC (β-Dex, 100 ᵒC, 35 cm s-1) (R)-2.1e 5.7 min and (S)-2.1e 5.8 min.  
 
(R)-Ethyl hexa-3,4-dienoate (2.1h)57 
 
(R)-But-3-yn-2-ol (1.23 g, 17.5 mmol, 1 equiv. 97% e.e.) and triethyl orthoacetate (10.9 
mL, 59.5 mmol, 3.4 equiv.) were added to an oven dried, argon flushed round-bottom 
flask equipped with a Dean-Stark trap and heated to 170 °C (oil bath). Propionic acid 
(0.22 mL, 3.00 mmol, 0.17 equiv.) was added and the reaction mixture stirred at 170 
°C. After 2.5 h, additional propionic acid (0.16 mL, 2.10 mmol, 0.21 equiv.) was added 
and the reaction mixture was stirred for a further 2.5 h under these conditions. After 
cooling to room temperature the reaction mixture was concentrated, passed through a 
silica plug with 10:1 hexane:EtOAc and concentrated again. The mixture was purified 
by column chromatography (eluent: 15:1 then 12:1 hexane/Et2O) to yield product 2.1h 
as a pale yellow oil (1.95 g, 13.8 mmol, 79%, 99:1 e.r.). 
 
RF 0.61 (10:1 hexane/Et2O); νmax/cm-1 2981 (C-H), 1967 (C=C=C), 1734 (C=O); 1H NMR 
(300 MHz, CDCl3) δ 5.31-5.09 (2H, m, allene H), 4.19 (2H, q, J = 7.1 Hz, OCH2), 3.04 (2H, 
dd, CH2), 1.69 (3H, dd, =CHCH3), 1.30 (3H, t, J = 7.1 Hz, CH2CH3); 13C NMR (75 MHz, 
CDCl3) δ 205.8 (C), 171.7 (C), 86.8 (CH), 83.5 (CH), 60.7 (CH2), 34.9 (CH2), 14.2 (CH3), 
14.1 (CH3); [𝛼]𝐷
21 ℃  = -27.0 (c = 1.11 in CHCl3); CSP-GC (β-Dex, 90 ᵒC, 35 cm s-1) (R)-2.1h 
11.6 min and (S)-2.1h 11.9 min.  
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(R)-Hexa-3,4-dien-1-yl benzoate (2.1i)37 
 
To a solution of benzoyl chloride (2.94 mL, 23.1 mmol, 3.0 equiv.) in DCM (15 mL), 
pyridine (6.19 mL, 77.0 mmol, 10 equiv.), and 4-(dimethylamino)pyridine (281 mg, 2.31 
mmol, 0.3 equiv.) were added sequentially to a solution of (R)-hexa-3,4-dien-1-ol 2.17 
(745 mg, 7.70 mmol, 1.0 equiv.) in DCM (30 mL) at 0 °C. After stirring for 6 h at 0 °C the 
reaction was quenched by addition of 6 M HCl solution, the layers were separated, and 
the aqueous layer was extracted with Et2O (3 × 40 mL). The combined organic extracts 
were washed with brine, dried over MgSO4 and concentrated.  The mixture was 
purified by column chromatography (eluent: 15:1 hexane/Et2O) to yield product 2.1i as 
a thin colourless oil (1.41 g, 7.01 mmol, 91%, 99:1 e.r.).   
 
RF 0.40 (14:1 hexane/Et2O); νmax/cm-1 2953 (C-H), 1967 (C=C=C), 1716 (C=O), 1602, 
1584, 1451 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 8.14-8.03 (2H, m, Ar-H), 7.65-7.41 (3H, 
m, Ar-H), 5.25-5.03 (2H, m, allene H), 4.42 (2H, t, OCH2), 2.48 (2H, dtd, CH2), 1.66 (3H, 
dd, CHCH3); 13C NMR (75 MHz, CDCl3)  δ 205.5 (C), 166.6 (C), 132.9 (CH), 130.4 (C), 
129.6 (CH), 128.3 (CH), 86.5 (CH), 86.1 (CH), 64.1 (CH2), 28.4 (CH2), 14.4 (CH3); Found 
(FTMS p NSI+) [M + Na]+ 225.0884, C13H14O2Na requires 225.0886; [𝛼]𝐷
21 ℃ = -23.1 (c = 
1.04 in CHCl3); CSP-GC (β-Dex, 115 ᵒC, 35 cm s-1) (R)-2.1i 145.8 min and (S)-2.1i 148.2 
min.  
 
(S)-2-(Penta-2,3-dien-1-yl)isoindoline-1,3-dione (2.1j)60 
 
Allenol 2.15 (50.5 mg, 0.60 mmol, 1 equiv.), phthalimide (132 mg, 0.90 mmol, 1.5 
equiv.) and PPh3 (236 mg, 0.90 mmol, 1.5 equiv.) in THF (4.8 mL) were stirred at 0 °C. 
Diisopropyl azodicarboxylate (DIAD) (0.18 mL, 0.90 mmol, 1.5 equiv.) was added 
dropwise and the reaction mixture was stirred for a further 1 h at 0 °C and then 
concentrated. The concentrated reaction mixture was loaded directly onto a silica gel 
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column and purified by column chromatography (eluent: 12:1 hexane/EtOAc) to yield 
product 2.1j as an oily white paste (63.0 mg, 0.29 mmol, 49%, 99:1 e.r.).   
 
RF 0.41 (9:1 hexane/EtOAc); νmax/cm-1 2927 (C-H), 1968 (C=C=C), 1710 (C=O), 1612, 
1466 (C-C Ar);  1H NMR (300 MHz, CDCl3) δ 7.93-7.80 (2H, m, Phth), 7.79-7.66 (2H, m, 
Phth), 5.25-5.10 (2H, m, allene H), 4.28 (2H, dd, CH2), 1.58 (3H, dd, J = 7.6, 3.0 Hz, CH3); 
13C NMR (75 MHz, CDCl3) δ 204.8 (C), 167.8 (C), 133.9 (CH), 132.2 (C), 123.2 (CH), 89.0 
(C), 86.1 (C), 36.8 (CH2), 13.9 (CH3); Found (FTMS p NSI+) [M + H]+ 214.0864, C13H12NO2 
requires 214.0863; [𝛼]𝐷
19 ℃ = +38.9 (c = 0.98 in CHCl3); CSP-HPLC (Chiralcel OD-H, 
98.2:1.8 hexane:IPA, 1 mL min-1) (R)-2.1j 9.0 min and (S)-2.1j 9.6 min. 
 
 (R)-2-(Hexa-3,4-dien-1-yl)isoindoline-1,3-dione (2.1k)60 
 
Prepared in the same manner as 2.1j from (R)-hexa-3,4-dien-1-ol 2.17 (87.4 mg, 0.90 
mmol). The mixture was purified by column chromatography (eluent: 12:1 
hexane/EtOAc) to give product 2.1k as an oily white paste (196 mg, 0.86 mmol, 96%, 
99:1 e.r. (This allene could not be separated by CSP-GC or HPLC. E.r. assumed by 
analogy to other allenes synthesised from allenol 2.17 (2.1i) and by the Mitsunobu 
reaction described (2.1j)).  
 
RF 0.41 (9:1 hexane/EtOAc); νmax/cm-1 2947 (C-H), 1961 (C=C=C), 1707 (C=O);  1H NMR 
(300 MHz, CDCl3) δ 7.95-7.81 (2H, m, Phth), 7.80-7.67 (2H, m, Phth), 5.05 (2H, m, 
allene H), 3.80 (2H, t, NCH2), 2.39 (2H, dtd, CH2), 1.53 (3H, dd, J = 6.6, 3.6 Hz, CH3); 13C 
NMR (75 MHz, CDCl3) δ 205.6 (C), 168.3 (C), 133.9 (CH), 132.2 (C), 123.2 (CH), 86.5 
(CH), 86.3 (CH), 37.5 (CH2), 27.9 (CH2), 14.3 (CH3); Found (TOF MS) [M+H]+ 228.1030, 
C14H14NO2 requires 228.1024 [𝛼]𝐷
21 ℃  =  -28.9 (c = 1.04 in CHCl3). 
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(S)-Diethyl 2-(penta-2,3-dien-1-yl)malonate (2.1l)73 
 
To a stirring solution of allenol 2.15 (210 mg, 2.50 mmol, 1 equiv.) and triethylamine 
(0.54 mL, 3.88 mmol, 1.55 equiv.) in DCM (14 mL) at -25 °C mesyl chloride (0.23 mL, 
3.00 mmol, 1.2 equiv.) was added dropwise over 20 minutes. The reaction mixture was 
warmed slowly to 0 °C and stirred for 2 ½ h. Chilled DCM (40 mL) was added and the 
reaction mixture washed with chilled water (30 mL), 2M HCl solution (2 x 35 mL) and a 
saturated solution of NaHCO3 (30 mL) then dried over MgSO4 and concentrated to give 
the crude mesylated allenol 2.18 which was used without further purification. 
Diethyl malonate (0.50 mL, 3.13 mmol, 1.25 equiv.) was added to a stirring solution of 
NaH (60% dispersion in oil) (125 mg, 3.13 mmol, 1.25 equiv.) in THF (30 mL) at room 
temperature room temperature. After 30 minutes, all of the crude mesylated allenol 
2.18 and tetrabutylammonium iodide (92.0 mg, 0.25 mmol, 0.1 equiv.) in THF (20 mL) 
was added and the reaction mixture was diluted with THF (10 mL) and stirred for 40 h 
at 50 °C. Diethyl ether (50 mL) was added and the solution washed with water (2 x 30 
mL). The combined aqueous layers were extracted with the diethyl ether (40 mL) and 
the combined organic layers were dried over MgSO4 and concentrated. The mixture 
was purified by column chromatography (eluent: 36:1 hexane/EtOAc) to yield product 
2.1l as a colourless oil (202 mg, 0.90 mmol, 36%, 99:1 e.r.).   
 
RF 0.46 (15:1 pentane/Et2O); νmax/cm-1 2983 (C-H), 1730 (C=O); 1H NMR (300 MHz, 
CDCl3) δ 5.31-4.98 (2H, m, allene H), 4.30-4.13 (4H, m, OCH2), 3.49 (1H, t, J = 7.5 Hz, 
CHCH2), 2.65-2.53 (2H, m, CH2), 1.65 (3H, dd, J = 9.6, 3.7 Hz, CHCH3), 1.30 (6H, t, J = 7.1 
Hz, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 204.89 (C), 169.0 (C), 87.5 (CH), 87.0 (CH), 61.4 
(CH2), 51.6 (CH), 27.9 (CH2), 14.3 (CH3), 14.1 (CH3); [𝛼]𝐷
21 ℃ = +34.1 (c = 0.94 in CHCl3);  
CSP-HPLC (Chiralpak IA, 99.2:0.8 hexane:IPA, 1 mL min-1) (R)-2.1l 6.9 min and (S)-2.1l 
7.2 min. 
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(R)-N-Methoxy-N-methylhexa-3,4-dienamide (2.1m)61 
 
2M isopropylmagnesium chloride in THF (5.25 mL, 10.5 mmol, 3 equiv.) was added 
dropwise over 30 minutes to a stirring solution of ester 2.1h (491 mg, 3.50 mmol, 1 
equiv.) and N,O-dimethylhydroxylamine hydrochloride (527 mg, 5.43 mmol, 1.55 
equiv.) in THF (7 mL) at – 20 °C. The reaction mixture was warmed slowly to – 10 °C 
and stirred for a further 30 minutes. 1 M HCl solution (35 mL) was added and the 
organic layer separated off. The aqueous layer was extracted with EtOAc (3 x 50 mL) 
and the combined organic layers dried over Na2SO4 and concentrated.  The mixture 
was purified by column chromatography (eluent: 4:1 hexane/EtOAc) to yield product 
2.1m as an orange oil (286 mg, 1.86 mmol, 53%, 99:1 e.r.).   
 
RF 0.36 (3:1 hexane/EtOAc); νmax/cm-1 2939 (C-H), 1659 (C=O);  1H NMR (300 MHz, 
CDCl3) δ 5.39 – 5.22 (1H, m, allene H), 5.22 – 5.09 (1H, m, allene H), 3.72 (3H, s, OCH3), 
3.21 (3H, s, NCH3), 3.20 – 3.14 (1H, m, CH2), 1.68 (3H, dd, J = 7.0, 3.2 Hz, CH3); 13C NMR 
(75 MHz, CDCl3) δ 205.8 (C), 172.4 (C), 86.4 (HC), 84.1 (HC), 61.3 (CH3), 33.0 (CH2), 32.3 
(CH3), 14.2 (CH3); Found (FTMS p NSI+) [M + H]+ 156.1016, C8H14NO2 requires 
156.1019; [α]D = -30.8 (c = 1.04 in CHCl3);  CSP-GC (β-Dex, 100 ᵒC, 35 cm s-1) (R)-2.1m 
39.8 min and (S)-2.1m 40.4 min.  
 
 (S)-Buta-1,2-dien-1-ylbenzene (2.1a)74 
 
Diethyl azodicarboxylate (DEAD) (0.70 mL, 4.42 mmol, 1.3 equiv.) was added to a 
solution of PPh3 (1.15 g, 4.42 mmol, 1.3 equiv.) in THF (13 mL) at -15 °C. After 10 min, a 
solution of (R)-4-phenylbut-3-yn-2-ol 2.19 (497 mg, 3.40 mmol, 1 equiv.) in THF (10 mL) 
was added to the yellow reaction mixture, followed 10 min later by a solution of 2-
nitrobenzenesulfonylhydrazide (NBSH) (1.04 g, 4.76 mmol, 1.4 equiv.) in THF (13 mL). 
The resulting suspension was held at -15 °C for 1 h, warmed to room temperature and 
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left to stand overnight and then concentrated.  The concentrated reaction mixture was 
loaded directly onto a silica gel column and purified by column chromatography 
(eluent: hexane) to yield product 2.1a as an orange oil (168 mg, 1.29 mmol, 38%, 99:1 
e.r.).   
 
RF 0.74 (hexane); νmax/cm-1 3028, 2982, 2920 (C-H), 1946 (C=C=C), 1598, 1496, 1463 (C-
C Ar); 1H NMR (300 MHz, CDCl3) δ 7.40-7.15 (5H, m, Ar-H), 6.13 (1H, dq, J = 6.4, 3.2 Hz, 
allene H), 5.57 (1H, p, J = 7.0 Hz, allene CH), 1.82 (3H, dd, J = 7.1, 3.2 Hz, CH3); 13C NMR 
(75 MHz, CDCl3) δ 206.0 (C), 135.1 (C), 128.5 (CH), 126.6 (CH), 94.0 (CH), 89.6 (CH), 14.1 
(CH3); [𝛼]𝐷
21℃ = -32.7 (c = 0.98 in CHCl3) [lit.75 [𝛼]𝐷
20 ℃ = -238 (c = 1.33 in acetone)]; CSP-
GC (β-Dex, 93 ᵒC, 35 cm s-1) (R)-2.1a 20.4 min and (S)-2.1a 20.8 min.  
 
(R)-(7,7,7-Trifluoro-4l5-hepta-3,4-dien-1-yl)benzene (2.1p)  
 
Following a general procedure by Periasamy et al.70 compound 2.22 (93.0 mg, 0.30 
mmol, 1.0 equiv.), dry dioxane (1.2 ml) and CuI (29.2 mg, 0.15 mmol, 0.5 equiv.) was 
added to a flask and refluxed for 20 hours.  The crude product was purified by column 
chromatography (eluent: petrol 40-60 oC) to yield product 2.1p as a yellow oil (7.0 mg, 
0.03 mmol, 10%, 95:5 e.r).  
 
RF 0.45 (hexane); νmax/cm-1 3028, 2927, 2858 (C-H), 1969 (C=C=C), 1496, 1454 (C-C Ar); 
1H NMR (300 MHz, CDCl3) δ 7.18-7.28 (2H, m, Ar-H), 7.05-7.17 (3H, m, Ar-H), 5.13-5.28 
(1H, m, Allene-H), 4.89-5.05 (1H, m, Allene-H), 2.49-2.77 (4H, m, alkyl-H), 2.16-2.37 
(2H, m, alkyl-H); 13C NMR (75.5 MHz, CDCl3) δ 207.0 (C), 141.4 (C), 128.5 (CH), 128.3 
(CH), 126.0 (CH), 125.9 (q, J = 276.9 Hz, CF3), 91.8 (CH), 80.9 (q, J = 4.3 Hz, CHCH2CF3), 
35.0 (CH2), 34.5 (q, J = 29.7 Hz, CH2CF3), 29.9 (CH2); 19F NMR (282 MHz, CDCl3) δ -66.93 
(t, J = 10.8 Hz); Found (TOF MS ASAP+) [M + H]+ 227.1049, C13H14F3 requires 227.1048; 
[𝛼]𝐷
21℃ = -12.0 (c = 0.5 in CHCl3); CSP-GC (β-Dex, 135 ᵒC, 35 cm s-1) (R)-2.1p 12.5 min 
and (S)-2.1p 12.8 min. 
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(7,7,7-Trifluoro-4l5-hepta-3,4-dien-1-yl)benzene (2.1p)70 
 
Following a general procedure by Periasamy et al.70 ZnI2 (265 mg, 0.83 mmol, 0.5 
equiv.) and NaI (136 mg, 0.91 mmol, 0.55 equiv.) were added to a flask and dried by 
heating under vacuum. The flask was flushed with argon and a solution of compound 
2.23 (488 mg, 1.70 mmol, 1 equiv.) in toluene (8 mL) was added. The solution was 
refluxed for 2 hours, allowed to cool to r.t. and passed through a silica plug with Et2O.  
The crude product was purified by column chromatography (eluent: petrol 40-60 oC) to 
yield product 2.1p as a colourless oil (45 mg, 0.20 mmol, 12%). See above for 
characterisation. 
 
(S)-Trideca-6,7-diene (2.1q)65   
 
A solution of copper(I) bromide (912 mg, 6.36 mmol, 1.2 equiv.) and triethyl phosphite 
(2.18 mL, 12.7 mmol, 1.2 equiv.) in diethyl ether (6.4 mL) was added to diethyl ether 
(30 mL) at -40 °C. 2 M pentylmagnesium bromide in diethyl ether (3.18 mL, 6.36 mmol, 
1.2 equiv.) was added dropwise giving a yellow precipitate and the reaction mixture 
was stirred at -30 °C for 30 min then cooled to -60 °C before dropwise addition of 3-
methoxyoct-1-yne 2.24 (745 mg, 5.30 mmol, 1.0 equiv.) in diethyl ether (9 mL). The 
reaction mixture was stirred at -40 °C for 90 minutes and then allowed to warm to 5 °C 
over a further 90 minutes. The solution was washed with aqueous solution (1 part 
aqueous ammonia 4 parts sat. aqueous ammonium chloride) (50 mL). The aqueous 
layer was extracted with diethyl ether (2 x 50ml) and the combined organic layers were 
washed with aqueous solution (3 x 50 mL), dried over MgSO4 and carefully 
concentrated. The mixture was purified by column chromatography (eluent: pentane) 
to yield product 2.1q as a thin colourless oil (507 mg, 2.81 mmol, 53%, 85:15 e.r.).   
 
RF 0.91 (pentane); νmax/cm-1  2957, 2924, 2872, 2855 (C-H), 1962 (C=C=C);  1H NMR 
(300 MHz, CDCl3) δ 5.09 (2H, dt, J = 9.7, 5.3 Hz, allene H), 2.07 – 1.95 (4H, m, CH2), 1.52 
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– 1.24 (12H, m, CH2), 1.05 – 0.85 (6H, m, CH3); 13C NMR (75 MHz, CDCl3) δ 203.9 (C), 
90.9 (CH), 31.6 (CH2), 29.5 (CH2), 29.0 (CH2), 22.6 (CH2), 14.1 (CH3); [α]D = +69.2 (c = 
0.014 in CHCl3); e.r. could not be accurately determined due to solubility issues but 
was estimated by 1H NMR with AgFOD and Eu(hfc)3 as chiral shift reagents.66 
 
2.5.4 Gold-catalysed hydroalkoxylation reactions 
General procedure 
Allene 2.1 (0.14 mmol, 1.0 equiv.), alcohol nucleophile 2.2 (1.40 mmol, 10 equiv.) and 
DMF (0.14 mL) were added to a vial and stirred at 0 ᵒC.  IPrAuCl (8.7 mg, 10 mol%) was 
added followed by AgOTf (3.6 mg, 10 mol%).  The reaction was stirred at 0 ᵒC for 24 h.  
The crude product was then passed through two silica plugs and washed with Et2O.  
The solution was washed with water and brine and the organic layer was dried over 
MgSO4, then concentrated.  The crude mixture was purified by column 
chromatography to yield product 2.3. 
 
(S,E)-Ethyl 5-methoxyhex-3-enoate (2.3he) 
 
General procedure followed and crude purified by column chromatography (eluent 
10:1 hexane/EtOAc) to yield product 2.3he as a colourless oil (23.9 mg, 0.13 mmol, 
92%, 97:3 e.r.). 
 
RF 0.22 (10:1 hexane/EtOAc); νmax/cm-1 2978, 2932, 2820 (C-H), 1735 (C=O);  1H NMR 
(300 MHz, CDCl3) δ 5.77 (1H, dtd, J = 15.3, 6.9, 0.6 Hz, =CHCH2), 5.49 (1H, ddt, J = 15.5, 
7.6, 1.4 Hz, =CHCHO), 4.18 (2H, q, J = 7.1 Hz, OCH2), 3.75 (1H, p, J = 6.6 Hz, CHO), 3.29 
(3H, s, OCH3), 3.11 (2H, d, J = 6.9 Hz, CH2), 1.29 (3H, t, J = 7.1 Hz, CH2CH3), 1.29 (3H, d, J 
= 6.4 Hz, OCHCH3); 13C NMR (75 MHz, CDCl3) δ 171.6 (C), 135.7 (CH), 124.3 (CH), 77.5 
(CH), 60.7 (CH2), 55.9 (CH3), 37.7 (CH2), 21.1 (CH3), 14.2 (CH3); Found (FTMS p NSI+) [M 
+ NH4]+ 190.1436, C9H20O3N 190.1436; [α]D = -26.0 (c = 1.00 in CHCl3); CSP-HPLC 
(Chiralpak IC, 99.3:0.7 hexane:IPA, 1 mL min-1) (R)-2.3he 13.0 min and (S)-2.3he 15.0 
min. 
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(S,E)-Ethyl 5-((4-methoxybenzyl)oxy)hex-3-enoate (2.3hf) 
 
General procedure followed and crude purified by column chromatography (eluent 9:1 
hexane/EtOAc) to yield product 2.3hf as a colourless oil (27.7 mg, 0.10 mmol, 71%, 
95:5 e.r.). 
 
RF 0.31 (9:1 hexane/EtOAc) νmax/cm-1 2976 (C-H), 1732 (C=O), 1578, 1512, 1464 (C-C 
Ar); 1H NMR (300 MHz, CDCl3) δ 7.36 – 7.23 (2H, m, Ar-H), 6.96 – 6.84 (2H, m, Ar-H), 
5.78 (1H, dtd, J = 15.4, 6.9, 0.6 Hz, =CHCH2), 5.56 (1H, ddt, J = 15.5, 7.6, 1.3 Hz, =CHCH), 
4.52 (1H, d, J = 11.5 Hz, ArOCHH), 4.35 (1H, d, J = 11.5 Hz, ArOCHH), 4.19 (2H, q, J = 7.1 
Hz, CH2CH3), 3.95 (1H, p, J = 7.1 Hz, OCH), 3.83 (3H, s, OCH3), 3.13 (2H, dt, J = 6.8, 1.6 
Hz, CH2CH), 1.30 (3H, t, J = 7.1 Hz, CH2CH3), 1.29 (3H, d, J = 6.4 Hz, CHCH3); 13C NMR (75 
MHz, CDCl3) δ 171.6 (C), 159.1 (C), 136.0 (CH), 130.8 (C), 129.3 (CH), 124.3 (CH), 113.8 
(CH), 74.9 (CH), 69.5 (CH2), 60.7 (CH2), 55.3 (CH3), 37.7 (CH2), 21.5 (CH3), 14.2 (CH3); 
[α]D = -34.4 (c = 0.99 in CHCl3); CSP-HPLC (Chiralpak IC, 95:5 hexane:IPA, 1 mL min-1) 
(R)-2.3hf 9.7 min and (S)-2.3hf 10.4 min. 
 
(S, E)-5-(Benzyloxy)hex-3-en-1-yl benzoate (2.3ib) 
 
General procedure followed and crude purified by column chromatography (eluent 7:1 
hexane/Et2O) to yield product 2.3ib as a colourless oil (36.3 mg, 0.11 mmol, 79%, 90:10 
e.r.). 
 
RF 0.17 (8:1 hexane:Et2O); νmax/cm-1 2972, 2861 (C-H), 1716 (C=O), 1602, 1584, 1494, 
1452 (C-C Ar);  1H NMR (300 MHz, CDCl3) δ 8.03-8.11 (2H, m, Ar-H), 7.53-7.62 (1H, m, 
Ar-H), 7.18-7.52 (2H, m, Ar-H), 7.23-7.39 (5H, m, Ar-H), 5.72 (1H, dt, J = 16.0, 6.5 Hz, 
CH2HC=), 5.60 (1H, dd, J = 16.0, 8.0 Hz, OCHHC=), 4.56 (1H, d, J = 12.0 Hz, PhCH2O), 
4.43 (2H, t, J = 6.5, BzOCH2), 4.38 (1H, d, J = 12.0 Hz, PhCH2O), 3.87-4.02 (1H, m, OCH), 
2.59 (2H, q, J = 6.5 Hz, CH2), 1.30 (3H, d, J = 6.4 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 
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166.53 (C), 138.8 (C), 135.1 (CH), 132.9 (CH), 130.3 (C), 129.6 (CH), 128.4 (CH), 128.3 
(CH), 128.0 (CH), 127.6 (CH), 127.4 (CH), 75.6 (CH), 69.8 (CH2), 64.0 (CH2), 31.8 (CH2), 
21.7 (CH3); Found (FTMS p NSI+) [M + NH4]+ 328.1910, C20H26O3N requires 328.1907; 
[α]D = -19.1 (c = 0.84 in CHCl3); CSP-HPLC (Chiralpak IA, 99.5:0.5 hexane:IPA, 1 mL min-
1) (R)-2.3ib 10.9 min and (S)-2.3ib 11.4 min.  
 
(R,E)-2-(4-(Benzyloxy)pent-2-en-1-yl)isoindoline-1,3-dione (2.3jb) 
 
General procedure followed and crude purified by column chromatography (eluent 9:1 
hexane/EtOAc) to yield product 2.3jb as a colourless oil (39.2 mg, 0.11 mmol, 81%, 
97:3 e.r.). 
RF 0.41 (6:1 hexane/EtOAc); νmax/cm-1 2973, 2863 (C-H), 1709 (C=O), 1614, 1467, 1453 
(C-C Ar);  1H NMR (300 MHz, CDCl3) δ 7.96 – 7.83 (2H, m, Phth-H), 7.82 – 7.68 (2H, m, 
Phth-H), 7.44 – 7.20 (5H, m, Ar-H), 5.83 – 5.62 (2H, m, alkene H), 4.55 (1H, d, J = 11.9 
Hz, PhOCH2), 4.38 (1H, d, J = 11.9 Hz, PhOCH2), 4.36 – 4.30 (2H, m, NCH2), 3.96 (1H, p, J 
= 6.3 Hz, OCH), 1.29 (3H, d, J = 6.4 Hz, CH3); 13C NMR (75 MHz, CDCl3) δ 167.9 (C), 138.6 
(C), 135.7 (CH), 134.0 (CH), 132.1 (C), 128.3  (CH), 127.7  (CH), 127.4 (CH), 125.2 (CH), 
123.3 (CH), 74.9 (CH), 70.1  (CH2), 39.0 (CH2), 21.4 (CH3); Found (FTMS p NSI+) [M + 
NH4]+ 346.2743, C22H36O2N requires 346.2741; [α]D = -24.0 (c = 1.00 in CHCl3);  CSP-
HPLC (Chiralpak IC, 98.3:1.7 hexane:IPA, 1 mL min-1) (R)-2.3jb 20.5 min and (S)-2.3jb 
22.1 min. 
 
(S,E)-2-(5-(Benzyloxy)hex-3-en-1-yl)isoindoline-1,3-dione (2.3kb) 
 
General procedure followed and crude purified by column chromatography (eluent 9:1 
hexane/EtOAc) to yield an inseparable mixture of products 2.3kb and 2.3kb’ as a 
colourless oil (46.5 mg, 0.13 mmol, 94%, 81:19 e.r., 9:1 positional isomers). 
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RF 0.25 (9:1 hexane/EtOAc); νmax/cm-1 2928 (C-H), 1708 (C=O), 1615, 1465, 1495, 1467 
(C-C Ar);  1H NMR (300 MHz, CDCl3) δ 7.99 – 7.75 (2H, m, Phth-H), 7.75 – 7.55 (2H, m, 
Phth-H), 7.42 – 7.15 (5H, m, Ar-H), 5.64 (1H, dt, J = 15.4, 7.0 Hz, CH2HC=), 5.45 (1H, dd, 
J = 15.4, 7.7 Hz, OCHHC=), 4.41 (1H, d, J = 11.9 Hz, PhOCHH), 4.26 (1H, d, J = 11.9 Hz, 
PhOCHH), 3.97 – 3.68 (3H, m, OCH + NCH2), 2.60 – 2.42 (2H, m, CH2), 1.18 (3H, d, J = 
6.4 Hz, CH3); 13C NMR (75 MHz, CDCl3) δ 168.3 (C), 138.8 (C), 135.4 (CH), 133.9 (CH), 
132.0 (C), 128.4 (CH), 128.3 (CH), 127.6 (CH), 127.3 (CH), 123.2 (CH), 75.4 (CH), 69.7 
(CH2), 37.4 (CH2), 31.4 (CH2), 21.5 (CH3); [α]D = -21.9 (c = 1.28 in CHCl3); Found (FTMS p 
NSI+) [M + NH4]+ 353.1857, C21H25N2O3 requires 353.1860; CSP-HPLC (Chiralpak IC, 
98.3:1.7 hexane:IPA, 1 mL min-1) (R)-2.3kb 14.7 min and (S)-2.3kb 16.7 min. 
 
(R,E)-Diethyl 2-(4-(benzyloxy)pent-2-en-1-yl)malonate (2.3lb) 
 
General procedure followed and crude purified by column chromatography (eluent 
12:1 hexane/EtOAc) to yield product 2.3lb as a colourless oil (42.5 mg, 0.12 mmol, 
86%, 90:10 e.r.). 
 
RF 0.24 (10:1 hexane:EtOAc); νmax/cm-1 2980, 2931 (C-H), 1730 (C=O), 1496, 1454 (C-C 
Ar);  1H NMR (300 MHz, CDCl3) δ 7.53 – 7.19 (5H, m, Ar-H), 5.64 (1H, dt, J = 15.4, 6.4 Hz, 
=CHCH2), 5.54 (1H, dd, J = 15.5, 7.2 Hz, =CHCH), 4.55 (1H, d, J = 11.9 Hz, OCH2), 4.36 
(1H, d, J = 11.9 Hz, OCH2), 4.22 (4H, m, OCH2CH3), 3.90 (1H, app. p, J = 6.4 Hz, OCH), 
3.46 (1H, t, J = 7.5 Hz, CHCH2), 2.69 (2H, t, J = 6.9 Hz, =CHCH2), 1.35 – 1.23 (9H, m, 
CH2CH3 + CHCH3); 13C NMR (75 MHz, CDCl3) δ 168.9 (C), 138.8 (C), 135.2 (CH), 128.3 
(CH), 128.0 (CH), 127.7 (CH), 127.4 (CH), 75.3 (CH), 69.7 (CH2), 61.4 (CH2) , 52.0 (CH), 
31.4 (CH2), 21.6 (CH3), 14.1 (CH3); Found (FTMS p NSI+) [M + NH4]+ 352.2122, 
C19H30O5N requires 352.2118; [α]D = +29.1 (c = 1.17 in CHCl3); CSP-HPLC (Chiralpak IC, 
98:2 hexane:IPA, 1 mL min-1) (R)-2.3lb 13.1 min and (S)-2.3lb 14.3 min. 
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(S,E)-5-(Benzyloxy)-N-methoxy-N-methylhex-3-enamide (2.3mb) 
 
General procedure followed and crude purified by column chromatography (eluent 4:1 
then 3:1 hexane/EtOAc) to yield product 2.3mb as a colourless oil (21.6 mg, 0.08 
mmol, 58%, 91:9 e.r.). 
 
νmax/cm-1 2971, 2932, 2865 (C-H), 1660 (C=O), 1495, 1453 (C-C Ar);  1H NMR (300 MHz, 
CDCl3) δ 7.51 – 7.13 (5H, m, Ar-H), 5.85 (1H, dt, J = 15.0, 6.8 Hz, CH2HC=), 5.57 (1H, ddt, 
J = 15.5, 7.7, 1.4 Hz, OCHHC=), 4.59 (1H, d, J = 11.9 Hz, PhOCHH), 4.42 (1H, d, J = 11.9 
Hz, PhOCHH), 3.98 (1H, p, J = 6.8 Hz, OCH), 3.73 (3H, s, OCH3), 3.28 (2H, d, J = 6.7 Hz, 
CH2), 3.23 (3H, s, NCH3), 1.32 (1H, d, J = 6.4 Hz, OCHCH3); 13C NMR (75 MHz, CDCl3) δ 
172.4 (C), 138.8 (C), 135.5 (CH), 128.3 (CH), 127.7 (CH), 127.4 (CH), 125.3 (CH), 75.4 
(CH), 69.8 (CH2), 61.3 (CH3), 35.6 (CH2), 32.3 (CH3), 21.5 (CH3); Found (FTMS p NSI+) [M 
+ NH4]+ 264.1592, C15H22O3N requires 264.1594; [α]D = -34.7 (c = 1.21 in CHCl3);  CSP-
HPLC (Chiralpak IC, 95:5 hexane:IPA, 1 mL min-1) (R)-2.3mb 25.7 min and (S)-2.3mb 
30.9 min. 
 
(E)-(3-(Benzyloxy)but-1-en-1-yl)benzene (2.3ab) + (E)-(1-(benzyloxy)but-2-en-1-
yl)benzene (2.3ab') 
 
General procedure followed and crude purified by column chromatography (eluent 
20:1 hexane/EtOAc) to yield an inseparable mixture of products 2.3ab and 2.3ab' as a 
colourless oil (26.2 mg, 0.11 mmol, 79%, racemic, 10:1 positional isomers). 
 
RF 0.34 (20:1 hexane/EtOAc); νmax/cm-1 3028, 2972, 2859 (C-H), 1494, 1452 (C-C Ar); 1H 
NMR (300 MHz, CDCl3) δ 7.61 – 7.09 (10H + 10H', m, Ar-H,  major + minor), 6.59 (1H, d, 
J = 16.0 Hz, =CHPh,  major), 6.21 (1H, dd, J = 16.0, 7.7 Hz, =CHCH, major), 5.89 – 5.49 
(2H' m, =CH, minor), 4.83 (1H', d, J = 6.3 Hz, OCH, minor), 4.66 (1H, d, J = 11.9 Hz, 
PhOCHH), 4.48 (1H, d, J = 11.9 Hz, PhOCHH), 4.54 (2H', d, J = 0.9 Hz, OCH2, minor), 4.16 
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(1H, p, J = 6.4 Hz, OCH, major), 1.76 (3H', d, J = 4.9 Hz, Me, minor), 1.43 (3H, d, J = 6.4 
Hz, Me, major); 13C NMR (75 MHz, CDCl3) Major only δ 138.8 (C), 136.7 (C), 131.7 (CH), 
131.4 (CH), 128.6 (CH), 128.4 (CH), 127.7 (CH), 127.4 (CH), 126.5 (CH), 75.9 (OCH), 70.1 
(OCH2), 21.8 (Me); CSP-HPLC (Chiralpak IB, hexane 1 mL min-1) (R)-2.3ab 14.9 min and 
(S)-2.3ab 17.6 min. 
 
(S,E)-(3-(Benzyloxy)-7,7,7-trifluorohept-4-en-1-yl)benzene (2.3pb) 
 
General procedure followed and crude purified by column chromatography (eluent 
80:1 hexane/EtOAc) to yield impure product 2.3pb as a colourless oil (42.2 mg, 0.12 
mmol, 86%, 80% purity by NMR,  95:5 e.r.). 
 
RF 0.47 (50:1 hexane/EtOAc); νmax/cm-1 3029, 2929, 2863 (C-H), 1496, 1454, 1429 (C-C 
Ar);  1H NMR (400 MHz, CDCl3) δ 7.05-7.29 (5H, m, Ar-H), 5.61 (1H, dd, J = 15.6, 7.3 Hz, 
=CHCH), 5.52 (1H, dt, J = 15.6, 6.6 Hz, =CHCH2), 4.50 (1H, d, J = 11.8 Hz, PhOCHH), 4.26 
(1H, d, J = 11.8 Hz, PhOCHH), 3.70 (1H, td, J = 7.3, 5.5 Hz, HCO) 2.72 – 2.87 (2H, m, 
CH2CF3), 2.52 – 2.72 (2H, m, CH2Ph), 1.86 – 1.99 (1H, m, OCHCH2), 1.67 – 1.79 (1H, m, 
OCHCH2) Assigned using COSY 2D NMR; 13C NMR (75.5 MHz, CDCl3) δ 141.8 (C), 138.4 
(CH), 128.44 (CH), 128.41 (CH), 128.36 (CH), 128.3 (q, J = 212.8 Hz, CF3), 127.8 (CH), 
127.6 (CH), 125.8 (CH), 121.0 (q, J = 3.7 Hz, CHCH2CF3), 78.4 (CH), 70.3 (CH2), 37.08 (q, J 
= 29.9 Hz, CH2CF3), 37.0 (CH2), 31.5 (CH2); 19F NMR (282 MHz, CDCl3) δ -66.41 (t, J = 
10.6 Hz); Found (FTMS p NSI+) [M + NH4]+ 352.1884, C20H25F3ON requires 352.1883; 
[𝛼]𝐷
22℃ = -10.0 (c = 0.28 in CHCl3);  CSP-HPLC (Chiralpak IA, hexane, 0.5 ml min-1) (R)-
2.3pb 22.0 min and (S)-2.3pb 24.7 min. 
 
(R, E)-((Tridec-7-en-6-yloxy)methyl)benzene (2.3qb) 
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General procedure followed and crude purified by column chromatography (eluent 
80:1 hexane/EtOAc) to yield product 2.3qb as a colourless oil (33.2 mg, 0.11 mmol, 
82%, 69:31 e.r.). 
 
νmax/cm-1 2955, 2926, 2857 (C-H), 1454 (C-C Ar);  1H NMR (300 MHz, CDCl3) δ 7.53 – 
7.23 (5H, m, Ar-H), 5.65 (1H, dt, J = 15.3, 6.7 Hz, =CHCH2), 5.38 (1H, dd, J = 15.4, 8.3 Hz, 
=CHCH), 4.50 (1H, d, J = 12.0 Hz, OCHH), 4.25 (1H, d, J = 12.0 Hz, OCHH), 3.72 (1H, dt, J 
= 14.6, 6.5 Hz, OCH), 2.13 (2H, q, J = 6.8 Hz, =CHCH2), 1.99 – 1.04 (14H, m, CH2), 1.04 – 
0.87 (6H, m, CH3); 13C NMR (75 MHz, CDCl3) δ 139.2 (C), 134.3 (CH), 130.9 (CH), 128.3 
(CH), 127.8 (CH), 127.3 (CH), 80.3 (CH), 69.6 (CH2), 35.8 (CH2), 32.2 (CH2), 31.8 (CH2), 
31.4 (CH2), 29.0 (CH2), 25.2 (CH2), 22.7 (CH2), 22.5 (CH2), 14.1 (CH3), 14.1 (CH3); Found 
(FTMS p NSI+) [M + NH4]+ 306.2791, C20H36ON  requires 306.2791; [α]D = +14.1 (c = 1.28 
in CHCl3);  CSP-HPLC (Chiralpak IA, hexane, 1 mL min-1) (R)-2.3qb 5.2 min and (S)-2.3qb 
5.6 min. 
 
2.5.5 Determination of Absolute Configuration 
Widenhoefer has previously shown, by comparison of 2.3bb to known compounds, 
that under the conditions shown in Scheme 2.33, the R-enantiomer of 2.3bb is 
formed.68 
 
 
Scheme 2.33: Widenhoefer’s conditions giving (R)-2.3bb 
 
The conditions (Scheme 2.33) were repeated and the product obtained 2.3bb 
produced the following HPLC trace (Figure 2.2). 
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Figure 2.2: HPLC trace of product 2.3bb obtained under Widenhoefer’s conditions.ϖ 
 
Under our conditions the following HPLC trace was obtained (Figure 2.3).  This suggests 
our conditions are also producing the R-enantiomer. 
 
Figure 2.2: HPLC trace of product 2.3bb under our conditions.ϖ 
 
The absolute configuration of 2.3hf was determined by Mosher’s ester analysis using 
1H and 13C NMR.76  
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Scheme 2.33: Synthetic route to Mosher’s esters (S, R)-2.26 and (S, S)-2.26 
 
In the most represented configuration of a Mosher’s ester the CF3 group, the carbonyl 
and the H on the chiral carbon are all in the same plane. For Mosher’s esters (S, R)-2.26 
and (S, S)-2.26, in their most represented configuration, the phenyl group will be in 
close proximity to either the alkene CH or methyl group. Since the phenyl group shields 
the nuclei of whichever group it is closest to, the NMR signal of that group is shifted 
upfield. This means that if alcohol 2.25 is the S-enantiomer (as expected) the Mosher’s 
ester (S, S)-2.26 will have a more upfield methyl group signal than the Mosher’s ester 
(S, R)-2.26 and the Mosher’s ester (S, R)-2.26  will have a more upfield alkene CH signal 
than the Mosher’s ester (S, S)-2.26. This is indeed the case and can be represented as  
 
Δ𝛿SRMe = 𝛿Me(S) – 𝛿Me(R) 
Δ𝛿SRCHalkene = 𝛿CHalkene(S) – 𝛿CHalkene(R) 
 
where if Δ𝛿SRMe < 0 and Δ𝛿SRCHalkene > 0 the alcohol is the S-enantiomer. 
 
Δ𝛿SRMe = 𝛿Me(S) – 𝛿Me(R) 
1H NMR Δ𝛿SRMe = 1.39 – 1.46 = - 0.17 
13C NMR Δ𝛿SRMe = 19.79 – 20.02 = - 0.23 
 
Δ𝛿SRCHalkene = 𝛿CHalkene(S) – 𝛿CHalkene(R) 
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1H NMR Δ𝛿SRCHalkene = 5.77* – 5.69* = + 0.08 
*most downfield point of multiplet 
13C NMR could not be assigned without ambiguity 
 
(S,E)-Ethyl 5-hydroxyhex-3-enoate (2.25)77 
 
2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (120 mg, 0.53 mmol, 1.2 equiv.) was 
added to a stirring solution of PMB ester 2.3hf (123 mg, 0.44 mmol, 1 equiv.) in DCM 
(6 mL) and water (0.3 mL) and stirred for 1 h. A saturated solution of NaHCO3 (20 mL) 
was added and the layers were separated. The aqueous layer was extracted with DCM, 
and the combined organic layers washed with brine, dried over MgSO4 and 
concentrated.  The mixture was purified by column chromatography (eluent: 2:1 
hexane/EtOAc) to yield product 2.25 as a colourless oil (50.6 mg, 0.31 mmol, 71%).  
 
RF 0.23 (2:1 hexane/EtOAc); νmax/cm-1  3412 (OH), 2975 (C-H), 1733 (C=O);  1H NMR 
(300 MHz, CDCl3) δ 5.89 – 5.73 (1H, m, =CHCH2), 5.73 – 5.62 (1H, m, =CHCH), 4.34 (1H, 
p, J = 6.2 Hz, OCH), 4.17 (2H, qd, J = 7.1, 0.9 Hz, OCH2), 3.08 (2H, d, J = 6.6 Hz, CHCH2), 
1.75 (1H, br d, J = 14.7 Hz, OH), 1.35 – 1.23 (6H, m, CH2CH3 + CHCH3); 13C NMR (75 
MHz, CDCl3) δ 171.7 (C), 138.1 (CH), 122.1 (CH), 68.4 (CH), 60.7 (CH2), 37.6 (CH2), 23.1 
(CH3), 14.2 (CH3). 
 
(S,E)-Ethyl 5-(((R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoyl)oxy)hex-3-enoate ((S, 
R)-2.26)78 
 
To a stirring solution of alcohol 2.25 (19.0 mg, 0.12 mmol, 1.0 equiv.) in DCM (3.0 mL) 
(R)-(−)-α-methoxy-α-(trifluoromethyl)phenylacetic acid (84.2 mg, 0.36 mmol, 3.0 
equiv.), dicyclohexylcarbodiimide (74.4 mg, 0.36 mmol, 3.0 equiv.), and 4-
dimethylaminopyridine (44.0 mg, 0.36 mmol, 3.0 equiv.) were added sequentially. The 
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reaction mixture was stirred for 1 hour at room temperature, passed through a silica 
plug (DCM) dried over MgSO4 and concentrated.  The mixture was purified by column 
chromatography (eluent: 14:1 then 10:1 hexane/Et2O) to yield product (S, R)-2.26 as a 
colourless oil (34.2 g, 0.09 mmol, 73%). 
 
RF 0.36 (9:1 hexane/EtOAc); νmax/cm-1 2984 (C-H), 1737 (C=O), 1164 (C-O-C); 1H NMR 
(300 MHz, CDCl3) δ 7.60 – 7.48 (2H, m, Ar-H), 7.48 – 7.36 (3H,  m, Ar-H), 5.89 (1H , dt, J 
= 14.6, 7.0 Hz, =CHCH2), 5.69 – 5.51 (2H, m, =CHCH), 4.17 (2H, q, J = 7.1 Hz, OCH2CH3), 
3.59 (3H, s, OCH3), 3.07 (2H, d, J = 6.9 Hz, OCH), 1.46 (3H, d, J = 6.3 Hz, CHCH3), 1.28 
(3H,  t, J = 7.1 Hz, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 171.0 (C), 165.6 (C), 132.4 (C), 
131.9 (CH), 129.5 (CH), 128.3 (CH), 127.3 (CH), 126.1 (CH), 123.3 (q, CF3), 73.1 (CH), 
60.8 (CH2), 55.4 (CH3), 37.6 (CH2), 20.0 (CH3), 14.1 (CH3). 
 
(S,E)-Ethyl 5-(((S)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoyl)oxy)hex-3-enoate ((S, 
R)-2.26)78 
 
Prepared as above using (S)-(−)-α-methoxy-α-(trifluoromethyl)phenylacetic acid.  
RF 0.36 (9:1 hexane/EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.62 – 7.49 (2H, m, Ar-H), 7.49 
– 7.35 (3H,  m, Ar-H), 5.96 (1H , dt, J = 14.6, 7.0 Hz, =CHCH2), 5.77 – 5.58 (2H, m, 
=CHCH), 4.17 (2H, q, J = 7.1 Hz, OCH2CH3), 3.59 (3H, s, OCH3), 3.10 (2H, d, J = 6.9 Hz, 
OCH), 1.39 (3H, d, J = 6.3 Hz, CHCH3), 1.28 (3H,  t, J = 7.1 Hz, CH2CH3); 13C NMR (75 
MHz, CDCl3) δ 171.0 (C), 165.7 (C), 132.4 (C), 132.0 (CH), 129.5 (CH), 128.4 (CH), 127.3 
(CH), 126.3 (CH), 123.3 (q, CF3), 73.2 (CH), 60.8 (CH2), 55.4 (CH3), 37.6 (CH2), 19.8 (CH3), 
14.1 (CH3). 
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Chapter 3: Chirality transfer in the gold-
catalysed hydroarylation of allenes 
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3.1 Introduction  
3.1.1 Previous work in the hydroarylation of allenes 
After the successful development of conditions which provide excellent chirality 
transfer in the hydroalkoxylation of allenes,72 we looked to expand our methodology 
to other nucleophiles. After searching the literature we found that although there had 
been several reports of successful hydroarylation protocols (see below), general 
conditions allowing the reaction of both indoles and electron-rich arenes had not been 
reported. Most importantly, efficient chirality transfer in the intermolecular 
hydroarylation of allenes had not yet been achieved.  
 
The hydroarylation of allenes was first reported as an intramolecular reaction with 
tethered indoles. Encouragingly, Widenhoefer and co-workers were able to 
demonstrate, that under their conditions, excellent chirality transfer can be achieved 
(Scheme 3.1).30  
 
 
Scheme 3.1: First reported intramolecular hydroarylation with chirality transfer30 
 
Later, tethered electron-rich arenes, thiophenes and benzothiophenes were also 
reported in the intramolecular hydroarylations of allenes, again with excellent chirality 
transfer (Scheme 3.2).33 
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Scheme 3.2: Example of chirality transfer in hydroarylation with electron-rich arene33 
 
The publications mentioned above, report examples with excellent chirality transfer 
using 1,3-disubstituted allenes, which is the same substitution pattern as the 
intermolecular substrates previously studied (Chapter 2).72 However, as previously 
discussed, the intermolecular version of hydrofunctionalisations is more challenging as 
the selectivity derived from the intramolecular nature of these reactions is lost. 
Perhaps for this reason, the intermolecular hydroarylation of allenes with chirality 
transfer has been far less extensively investigated. The racemic intermolecular 
hydroarylation of allenes has been studied, however.  
 
In 2009, Widenhoefer reported the gold-catalysed hydroarylation of a range of allenes 
using indoles as nucleophiles. Although this work included 1,3-disubtituted allenes, no 
attempt at chirality transfer was reported (Scheme 3.3).38 
 
Scheme 3.3: Gold(I)-catalysed hydroarylation of a 1,3-disubstituted allene38 
 
 
Scheme 3.4: Intermolecular hydroarylation of allenes with electron-rich arenes79 
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Other nucleophiles have also been used in gold-catalysed hydroarylations with some 
success (Scheme 3.4). In Gagné and co-workers’ 2009 report,79 as well as in the only 
other similar report found,39 the conditions are specific to only a fairly narrow scope of 
arenes and no other heterocycles. The allene scope reported in both of these 
publications are also limited to only 1-substituted or 1,1-disubstituted allenes. The 
gold-catalysed hydroarylation of 1,3-disubsituted allenes with arenes had not been 
achieved prior to the project described in this chapter.  
 
More recently, Che and co-workers disclosed their work on hydroarylation of allenes 
with indoles, including their initial attempts at achieving chirality transfer with 1,3-
diphenyl-substituted allene 3.1c.52 They reported totally racemic products (Scheme 
3.5), citing gold-catalysed allene substrate racemisation as the reason for the lack of 
chirality transfer observed.  
 
 
Scheme 3.5: Hydroarylation of enantioenriched allene – Che’s initial conditions52 
 
Che and co-workers were able to utilise the gold-catalysed allene substrate 
racemisation to develop the first chiral, digold-catalysed, enantioselective 
hydroarylation reaction via dynamic kinetic resolution (see Section 1.3.5). However, 
the best example of enantiomeric excess achieved was only 63%.52   
 
It was clear from reading the literature that it would be an important advancement in 
the field if conditions could be developed which allowed for chirality transfer in the 
hydroarylation of 1,3-disubstituted allenes. Additionally, it would be particularly 
advantageous if these hydroarylations conditions could also be applied to other 
heterocycles and electron-rich arenes. Following the successful development of 
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conditions which provide excellent chirality transfer in the related hydroalkoxylation of 
allenes (Chapter 2), we felt confident that the aims above could be achieved. 
 
3.1.2 Relevant conclusions from previous work (Chapter 2) 
During the project outlined in Chapter 2 it was shown that the main reason for loss of 
chirality transfer was the gold-catalysed racemisation of the allene starting material 
and that this could be avoided by tuning the conditions to reduce the reactivity of the 
catalyst. It was shown that the temperature, equivalents of nucleophile and solvent all 
contribute to slowing down the catalysts reactivity and helping to prevent allene 
racemisation.  
 
Another important conclusion drawn from the hydroalkoxylation project (Chapter 2) 
was the types of allenes which are best suited to gold-catalysed hydrofunctionalisation 
with chirality transfer; chiefly allenes with inductively withdrawing groups on one 
substituent. Inclusion of an inductively withdrawing group in the allene allows for 
selective attack at one end of the allene. It is thought that the functionality draws 
electron density away from the carbon-carbon bond of the allene closest to it (π2, 
Figure 3.1) and thereby promotes reaction at the more remote and electron-rich 
carbon-carbon bond (π1, Figure 3.1). 
 
 
Figure 3.1: Positional selectivity through inductively withdrawing group 
 
As well as providing good positional selectivity, having an inductively withdrawing 
group on the allene is believed to destabilise the transition state of the allene 
racemisation mechanism (Scheme 3.6). This is thought to slow down the racemisation, 
thereby allowing better chirality transfer for allenes with more inductively withdrawing 
substituents.   
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Scheme 3.6: Gold-catalysed 1,3-disubstituted allene racemisation 
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3.2 Project aims 
The aim of this project is to achieve the first efficient chirality transfer in the 
hydroarylation of 1,3-disubstituted allenes (Scheme 3.7).  
 
 
Scheme 3.7: Is efficient chirality transfer in the hydroarylation of 1,3-disustituted 
allenes possible? 
 
As with the hydroalkoxylation of allenes (Chapter 2), the main challenge is the 
competing gold-catalysed racemisation of the allene starting material 3.1. We planned 
to approach this challenge by adapting the reaction conditions to allow the gold-
catalysed hydroarylation to occur without the unwanted gold-catalysed allene 
racemisation. 
 
Upon developing conditions for good chirality transfer, we hoped to investigate a 
range of 1,3-disubstituted allenes with inductively withdrawing groups on one 
substituent. We also aimed to expand the nucleophile scope as much as possible. 
Firstly, we planned to investigate indoles which have been most heavily studied in 
previous, racemic work52, 80 and secondly, electron-rich arenes and other heterocycles 
since no reports of hydroarylation of these nucleophiles with 1,3-disubstituted allenes 
were known. To accomplish the hydroarylation of 1,3-disubstituted allenes with a 
range of aryls and achieve efficient chirality transfer would be a significant 
improvement to the field of allene hydroarylations. 
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3.3 Results and Discussion 
3.3.1 Optimisation of hydroarylation reaction  
The optimisation of hydroarylation conditions which would allow for chirality transfer 
was carried out with the ester-functionalised allene 3.1d and N-methylindole 3.2c as 
model substrates. The conditions initially used were based on Che’s conditions 
(Scheme 3.5)52 with a lower temperature (10 oC), longer reaction time (1 day) and 
using more convenient silver-free Gagosz catalyst81 (PPh3AuNTf2). These conditions 
(Entry 1, Table 3.1) gave an encouraging 27% yield and good positional selectivity (10:1 
3dc:3dc’).  
 
Entry Conc 
(mol/L) 
Equiv. 
3.2c 
Time 
(days) 
Catalyst 3.3dc: 
3.3dc’[a] 
3.3dc 
e.r.[b] 
NMR 
conv. 
(%)[a] 
Yield 
(%)[c] 
1[d] 0.15 4 1 PPh3AuNTf2 10:1 N.D. N.D. 27 
2[d] 0.40 4 1 PPh3AuNTf2 8:1 N.D. N.D. 39 
3[d] 0.75 4 1 PPh3AuNTf2 7:1 87:13 N.D. 50 
4 1.50 4 1 PPh3AuNTf2 7:1 90:10 N.D. 41 
5 1.50 2 1 PPh3AuNTf2 7:1 91:9 N.D. 37 
6 1.50 4 1 PPh3AuCl/ 
AgBF4 
N.D. N.D. 19 N.D. 
7 1.50 4 1 PPh3AuCl/ 
AgClO4 
N.D. N.D. 19 N.D. 
8 1.50 4 1 (IMes)AuCl/ 
AgNTf2 
5:1 77:23 N.D. 55 
9 1.50 4 1 (CF3C6H4)3PAuCl/ 
AgNTf2 
11:1 93:7 N.D. 60 
10 1.50 4 3 (CF3C6H4)3PAuCl/ 11:1 93:7 N.D. 67 
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AgNTf2 
11 1.50 2 3 (CF3C6H4)3PAuCl/ 
AgNTf2 
10:1 94:6 N.D. 59 
12 0.40 4 3 (CF3C6H4)3PAuCl/ 
AgNTf2 
12:1 90:10 N.D. 55 
[a] Determined by 1H NMR analysis. >20:1 E:Z by 1H NMR analysis. [b] Determined by CSP-
HPLC. [c] Isolated yields. [d] Carried out at 10 oC. N.D. = not determined. 
Table 3.1: Optimisation of the hydroarylation of allene 3.1d with indole 3.2c 
 
After this initial result we looked to increase the yield of the reaction by increasing the 
concentration (Entries 1-3, Table 3.1). Pleasingly, the yield was improved to 50% and 
the product 3dc was obtained in 87:13 e.r. (Entry 3, Table 3.1). The reaction 
temperature was then reduced to 5 oC along with an increase in concentration, 
providing product 3dc in better slightly better e.r. (7:1 3dc:3dc’, 90:10 e.r., 41%, Entry 
4, Table 3.1). Reducing the equivalents of indole was found to be slightly detrimental 
to the yield (37%, Entry 5, Table 3.1) and alternative counterions were found to be 
unfavorable, giving only 19% conversion by 1H NMR analysis (Entries 6 and 7, Table 
3.1). However, varying the ligand on the catalyst had a much more pronounced effect. 
Using the NHC ligand IMes in place of PPh3 improved the yield of the reaction but 
decreased the selectivity substantially (5:1 3dc:3dc’, 77:23 e.r., 55%, Entry 8, Table 
3.1). To our delight, the more active catalyst (CF3C6H4)3PAuCl greatly improved the 
chirality transfer as well as the positional selectivity and yield of the reaction (11:1 
3dc:3dc’, 93:7 e.r., 60%, Entry 9, Table 3.1). Lengthening the reaction time to 3 days 
improved the yield to 67% and gave our optimised conditions for the reaction (Entry 
10, Table 3.1). Finally, it was confirmed that lowering the equivalents of nucleophile 
3.2c or reducing the concentration was detrimental to the yield of the reaction (58% 
and 55% respectively, Entries 11 and 12, Table 3.1). 
 
With our optimised conditions in hand, a range of allenes were prepared in the same 
manner as described in Section 2.3.2 and subjected to the newly optimised gold-
catalysed hydroarylation reaction. Upon commencing the substrate scope we were 
delighted to find that many of the allenes chosen outperformed the original ester 
containing allene 3.1d used in the optimisation study (Section 3.3.2).  
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3.3.2 Allene scope 
 
Entry Allene Major product Yield[a] 3.3:3.3’[b] e.r. [c] 
1  
 
94% 
 
>20:1 97:3 
 
2  
 
81% >20:1 98:2 
 
3 
 
 
 
95% 
 
15:1 97:3 
4  
 
74% 
 
15:1 97:3 
5[d]  
 
58% 
 
8:1 94:6 
6  
 
74% 6:1 85:15 
7  
 
77% 
 
>20:1 98:2 
8  
 
67% 
 
11:1 93:7 
92 
 
9[d]  
 
97% 11:1 76:24 
10  
 
82% 
 
7:1 92:8 
 
11  
 
96% 
 
18:1 87:13 
12[e]  
 
23% 
 
>20:1 N.D. 
13  
 
 
82% 
 
1:3 3.3pc’ 
79:21 
3.3pc 
53:47 
 
14  
 
28% 
 
1.4:1 N.D. 
[a] Yield of isolated products; all >20:1 E:Z. [b] Determined by 1H NMR analysis. [c] Determined 
by CSP-HPLC. [d] Indole 3.2d was used as the product from the reaction of indole 3.2c could 
not be separated by CSP-HPLC. [e] Reaction carried out at r.t. (only trace product observed at 5 
oC). N.D. = not determined. 
Table 3.2: Allene scope of hydroarylation reaction 
 
To our delight, one of the first allenes subjected to the optimised conditions 3.1e 
proceeded with perfect positional selectivity as well as excellent yield and chirality 
transfer (3.3ec, 94%, >20:1, 97:3 e.r., Entry 1, Table 3.2). Pleasingly, replacing the Me 
group in 3.1e with a longer alkyl chain (3.1f) was not detrimental to the reaction, and 
the product was formed in good yield with high selectivity (3.3fc, 81%, >20:1, 98:2 e.r., 
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Entry 2, Table 3.2). Excellent chirality transfer and yield was also obtained for the OBz-
substituted allene 3.1g albeit with slightly lower positional selectivity (3.3gc, 95%, 15:1, 
97:3 e.r., Entry 3, Table 3.2). As with the hydroalkoxylation project (Chapter 2) a range 
of other protected allenols were investigated (Entries 4–6, Table 3.2). Acetyl protected 
allenol 3.1h reacted smoothly to provide the desired product with high e.r. and with 
good positional selectivity (3.3hc, 74%, 15:1, 97:3 e.r., Entry 4, Table 3.2). However, 
some positional selectivity was lost with the pivaloyl-protected allenol 3.1i; Gratifyingly 
though, the e.r. of the product was still high (3.3id, 58%, 8:1, 96:4 e.r., Entry 5, Table 
3.2). Removal of the carbonyl group (3.1j) gave a similar drop in positional selectivity 
but along with a decrease in chirality transfer (3.3jc, 74%, 6:1, 85:15 e.r., Entry 6, Table 
3.2). This is thought to be due to the lower inductive withdrawing ability of the OBn 
group (Entry 6 vs. Entries 3-5; see Section 3.1.2). Much more pleasingly, cyano-
substituted allene 3.1k  performed very well under our conditions giving perfect 
chirality transfer (allene 3.1k, 98:2 e.r.) and positional selectivity (3.3kc, 77%, >20:1, 
98:2 e.r., Entry 7, Table 3.2).  
 
In keeping with the thinking that the inductively withdrawing group helps to prevent 
gold-catalysed allene racemisation and thereby facilitate chirality transfer (Section 
3.1.2), moving the functionality farther from the allene moiety reduced the e.r. of the 
products obtained (Entry 9 vs. Entry 1 and Entry 10 vs. Entry 3). Positional selectivity 
was also lost by moving the inductively withdrawing group farther from the allene (see 
Section 3.1.2). Pleasingly, the products from this investigation were still prepared in 
good yield and reasonably high selectivity (3.3ld, 97%, 11:1, 76:24 e.r., Entry 9 and 
3.3mc, 82%, 7:1, 98:2 e.r., Entry 10, Table 3.2). Again looking at substrates with 
functionality far removed from the allene moiety, allene 3.1n was investigated next. To 
our delight, despite the distant position of the inductively withdrawing group, the 
reaction proceeded well with excellent yield as well as good positional selectivity and 
chirality transfer (3.3nc, 96%, 18:1, 87:13 e.r., Entry 11, Table 3.2).  Interestingly, when 
the ester moiety is in direct conjugation with the allene, the reaction becomes very 
sluggish. Substrate 3.3o gave only traces of product at 5 oC and a poor yield at room 
temperature (3.3oc, 23%, >20:1, Entry 12, Table 3.2). This is thought to be because the 
allene is comparatively electron-poor.  
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The phenyl-substituted allene 3.1p, which was also used as a substrate during the 
hydroalkoxylation project (Chapter 2), was investigated next. Under the 
hydroalkoxylation conditions this allene gave totally racemic product and showed 
preferential reaction at the position farthest from the phenyl group. The racemic 
product obtained in the hydroalkoxylation reaction was thought to be caused by the 
quick racemisation of the allene due to stabilisation of the transition state of the allene 
racemisation (see Section 2.3.5). Surprisingly, under hydroarylation conditions the 
allene was not fully racemised, proceeding with moderate chirality transfer and giving 
the unexpected positional isomer as the major product (3.3pc’, 82%, 1:3, 79:21 e.r., 
Entry 13, Table 3.2). Interestingly, previous racemic studies of hydroarylation with this 
substrate resulted in no positional selectivity (1:1.2).38  
 
Finally, allene 3.1q was subjected to the hydroarylation conditions (3.3qc, 28%, 1.4:1, 
Entry 14, Table 3.2). As expected, since the substituents are electronically similar, the 
positional selectivity is very poor for this substrate, confirming that positional 
selectivity is determined by electronic and not steric factors.  
 
3.3.3 Nucleophile scope 
 
Entry (Het)Ar-H Major product Yield[a] 3.3:3.3’[b] e.r.[c] 
1 
 
 
94% 
 
>20:1 97:3 
 
2 
 
 
89% 
 
>20:1 95:5 
3 
 
 
 
99% >20:1 95:5 
 
95 
 
4 
 
 
32% 
 
18:1 55:45 
5 
 
 
96% 
 
15:1 85:15 
6ǂ 
 
 
90% >20:1 89:11 
7[d] 
 
 
67% 
 
11:1 97:3 
8ǂ 
 
 
84% 
 
>20:1 96:4 
9 
 
 
98% 15:1 82:18 
10 
 
 
92% 
 
>20:1 98:2 
 
11 
 
 
48% 
 
>20:1 82:18 
12 
 
 
58% 
1:1 α/β[e] 
>20:1 
 
N.D. 
13 
 
 
41% 
48%[f] 
>20:1 
 
98:2 
96 
 
14 
 
 
40% 
major[g] 
5:1:1 
α/β/β’[d] 
5:1 N.D. 
15 
 
 
98% >20:1 90:10 
16 
 
 
97% 
 
10:1 57:43 
[a] Combined yield of isolated products; all >20:1 E:Z. [b] Determined by 1H NMR analysis. [c] 
Determined by CSP-HPLC. [d] Allene 3.1g was used as the product from the reaction of allene 
3.2e could not be separated by CSP-HPLC. [e] Ratio of isomers obtained by reaction at different 
positions of the pyrrole. Determined by 1H NMR analysis. [f] 15 mol% catalyst. [g] Yield of the 
major isomer. N.D. = not determined. 
Table 3.3: Nucleophile scope of hydroarylation reaction 
 
The nucleophile scope of the reaction was investigated starting with a range of indoles. 
The N-substitution of the indole was varied first with N-methylindole 3.2c, 
unsubstituted indole 3.2d and N-benzylindole 3.2e all reacting very smoothly (2.3ec-
2.3ee, >89%, >20:1, >95:5 e.r., Entries 1-3, Table 3.3). The Boc protected indole 3.2f 
however, reacted sluggishly, giving a poor yield and almost no chirality transfer (3.3ef, 
32%, 18:1, 55:45 e.r., Entry 4, Table 3.3). This is likely due to the electron withdrawing 
nature of the Boc group making the indole less nucleophilic and thus slowing down the 
rate of the hydroarylation reaction. It is thought that since the hydroarylation reaction 
is slower, the competing allene racemisation can occur, resulting in poor chirality 
transfer to the product 3.3ef.  
 
5-Substituted indoles were investigated next (Entries 5-7, Table 3.3), with Cl- and F-
substituted indoles (3.2g and 3.2h) performing well in the reaction albeit with a slight 
reduction in chirality transfer (3.3eg, 96%, 15:1, 85:15 e.r., Entry 5 and 3.3eh, 90%, 
>20:1, 89:11 e.r., Entry 6, Table 3.3). Interestingly, the more electron-rich MeO-
substituted indole 3.2i82 performed better in terms of chirality transfer (3.3gi, 67%, 
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11:1, 97:3 e.r., Entry 7, Table 3.3). As before, the increased efficiency of chirality 
transfer seen in Entry 7 compared to Entries 5 and 6 is thought to be due to the less 
electron-rich nucleophiles (3.2g and 3.2h) undergoing the hydroarylation reaction 
more slowly and so allowing for competing allene racemisation to occur.  
 
7-Ethyl (3.2j) and 6-Cl (3.2k) reacted smoothly in the reaction, with the more electron-
rich Et-substituted indole 3.2j outperforming Cl-substituted indole 3.2k with regard to 
chirality transfer (3.3ej, 84%, >20:1, 96:4 e.r., Entry 8 vs. 3.3ek, 98%, 15:1, 82:18 e.r., 
Entry 9, Table 3.3). Pleasingly, 1,2-methyl indole 3.2l  provided an excellent yield, 
perfect positional selectivity and excellent chirality transfer (3.3el, 92%, >20:1, 98:2 
e.r., Entry 10, Table 3.3). Perhaps predictably, when the most reactive 3-position of the 
indole is blocked, a drop in yield is observed and the e.r. of the product is lower 
(3.3em, 48%, >20:1, 82:18 e.r., Entry 11, Table 3.3). This is presumably again due to 
slower reacting nucleophiles allowing competing allene racemisation to occur.  
 
Looking to expand the scope of the reaction beyond indoles, we investigated using 
pyrroles as nucleophiles (Entries 12-14, Table 3.3). Gagné previously found N-
methylpyrrole 3.2n to be unreactive under his gold-catalysed hydroarylation 
conditions.79 However, under  our conditions the reaction provided a reasonable yield 
and proceeded with good positional selectivity on the allene (3.3en, 58%, >20:1, Entry 
12, Table 3.3). However, to our surprise, no regioselectivity was observed between 
reaction at the α and  position of the pyrrole (3.3en:3.3en′′ 1:1, Entry 12, Table 3.3).  
In order to overcome this unexpected complication, 1,3,5-trimethylpyrrole 3.3o was 
subjected to the hydroarylation reaction and to our delight reacted very smoothly 
(3.3eo, 41%, >20:1, 98:2 e.r., Entry 13, Table 3.3). The yield could not be improved by 
increasing the reaction time or equivalents of pyrrole but was raised slightly to 48% by  
changing the catalyst loading to 15 mol%. Intrigued by the results obtained for 3.2n 
(Entry 12, Table 3.3) and the success of 3.3o (Entry 13, Table 3.3) a monosubstituted N-
methylpyrrole 3.2p was investigated next. Gratifyingly, the reaction did occur 
preferentially at the α-position of the pyrrole albeit with only moderate selectivity over 
the other two positions (5:1:1, Entry 14, Table 3.3).  
 
98 
 
The final two nucleophiles investigated were electron-rich arenes (Entries 15-16, Table 
3.3) which had not previously been reported in intermolecular gold-catalysed 
hydroarylation of 1,3-disubstituted allenes. Pleasingly however, 1,3,5-
trimethoxybenzene 3.3b reacted smoothly to give 3.3eb in excellent yield, positional 
selectivity and good chirality transfer (3.3eb, 98%, >20:1, 90:10 e.r., Entry 15, Table 
3.3). Unfortunately, although the yield obtained is excellent, removing one methoxy 
group renders the arene (3.3q) not nucleophilic enough for efficient chirality transfer 
to occur (3.3eq, 97%, 10:1, 57:43 e.r., Entry 16, Table 3.3). Disappointingly, other less 
nucleophilic (hetero)aryls such as benzofurans, 2-methylfuran,  2-methoxythiophene, 
methoxybenzene and pentamethylbenzene failed to react under our hydroarylation 
conditions. 
 
The absolute configuration of product 3.3eb was determined by x-ray diffraction 
analysis and the absolute configuration of all other products was inferred by analogy. 
Although there are two independent molecules in the asymmetric unit of the crystal 
and one of those molecules is disordered, it can be calculated that there is 78% R and 
22% S in the crystal and so the absolute stereochemistry can be assigned as R. 
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Figure 3.2: X-ray crystal structure of 3.3eb showing absolute stereochemistry  
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3.3.4 Investigation into the loss of chirality transfer  
In order to better understand why we see reduced chirality transfer for some 
substrates and nucleophiles, a small study was carried out. It is thought that the 
reason for any loss of chirality transfer in the hydroarylation reaction is due to gold-
catalysed allene racemisation. In order to provide evidence for this proposal, the e.r. of 
the allene and the product were measured at different time points over the course of 
the reaction.  
 
Entry Equiv. indole 
3.2c 
Time 
(hours) 
Allene 3.1d  
e.r.[a] 
Product 3.3dc  
e.r.[b] 
NMR conv. 
(%)[c] 
1 0 0.25 55:45 - - 
2 0 1 50:50 - - 
3 4 0 95:5 - - 
4 4 0.25 94:6 - <5% 
5 4 1 93:7 92:8 26% 
6 4 6 90:10 92:8 56% 
7 4 16 87:13 91:9 78% 
8 4 24 83:17 90:10 89% 
[a] Determined by CSP-GC [b] Determined by CSP-HPLC. [c] Determined by 1H NMR analysis 
Table 3.4: Study of the rate of hydroarylation vs. allene racemisation 
 
In the absence of indole 3.2c, allene 3.1d was almost fully racemised after just 15 
minutes and totally racemic within 1 h (Entries 1 and 2, Table 3.4). This shows that 
gold-catalysed allene racemisation is indeed occurring under our conditions and also 
suggests that the nucleophile plays a significant role in slowing down allene 
racemisation (Entries 1 and 2 vs. Entries 3 and 4, Table 3.4). This was also the case in 
the hydroalkoxylation reaction discussed in chapter 2 (see Section 2.3.1) and is thought 
to be due to the nucleophile reversibly coordinating to the gold catalyst and slowing 
down its activity.83, 84 If the properties of the nucleophile affect its ability to coordinate 
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to the catalyst then this could offer an alternative (or perhaps additional) explanation 
as to why less electron-rich nucleophiles perform more poorly in terms of chirality 
transfer.  
 
When indole 3.2c is present in the reaction mixture, the racemisation of allene 3.1d is 
significantly slower than the competing hydroarylation reaction (Entries 3-8, Table 3.4). 
However, it is clear from the data collected that the allene is slowly racemising under 
the reaction conditions and this is causing the e.r. of the product to be reduced over 
time (Entries 3-8, Table 3.4).  This suggests that allene racemisation is indeed causing 
the loss of chirality transfer and that for good chirality transfer to occur, the 
hydroarylation reaction must outcompete the allene racemisation. This explanation is 
in keeping with the observed trend (see Section 3.3.3) that less reactive nucleophiles 
provide poorer chirality transfer.  
 
3.3.5 Proposed mechanism 
The hydroarylation reaction is thought to proceed in a similar manner to the 
hydroalkoxylation reaction previous discussed (Section 2.3.5).  
Scheme 3.8: Proposed mechanism of selective hydroarylation of allenes 
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It is proposed that the gold catalyst can coordinate to either face of the allene, rapidly 
interconverting between the two intermediates (3.I or 3.I’’, Scheme 3.8).67 Since the 
face to which the gold catalyst binds is in equilibrium, in accordance with the Curtin-
Hammett principle, the energy barrier of the next step of the mechanism defines 
which product is observed. It is thought that attack of the nucleophile is preferred at 
the less hindered face of the allene giving selectivity for the observed product (R, E)-
3.3 after protodeauration.  The product formed through attack at the more hindered 
face (S, Z)-3.3’’ is never detected in our reactions. 
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3.4 Conclusions 
The first intermolecular hydroarylation of 1,3-disubstituted allenes that proceeds with 
efficient chirality transfer has been developed. To our delight, the reaction is suited to 
a range of functionalised allenes and tolerates indoles, pyrroles and electron-rich 
arenes providing products in up to 99% yield, >20:1 positional selectivity and 98:2 e.r. 
This development is of significance, as previous attempts at achieving chirality transfer 
in gold-catalysed hydroarylation of allenes gave racemic products.52 Additionally 
pyrroles and electron-rich arenes have not previously been reported as suitable 
nucleophiles for the hydroarylation of 1,3-disubstituted allenes.  
 
Previous attempts at achieving chirality transfer in gold-catalysed hydroarylation of 
allenes were unsuccessful due to gold-catalysed allene racemisation.52 This was 
overcome by developing conditions which allowed the rate of the hydroarylation 
reaction to outcompete the unwanted gold-catalysed allene racemisation. For the 
hydroarylation to occur faster than the allene racemisation the substrates and 
nucleophiles must adhere to certain criteria. Firstly, the enantioenriched allene 
substrates should contain one inductively withdrawing substituent, this feature of the 
allene serves two purposes: helping to slow racemisation through destabilisation of 
the transition state and also ensuring good positional selectivity by electronic 
differentiation of the π bonds of the allene.  
 
During our studies it was found that the nucleophile used must also meet certain 
criteria. When more electron-rich nucleophiles such as N-Me, N-Bn, and unprotected 
indoles were used, the reaction proceeded with excellent chirality transfer. However, 
when less electron-rich and thus slower reacting nucleophiles such as N-Boc-indole 
were used, poor chirality transfer was obtained. This supports the proposal that the 
hydroarylation reaction must outcompete the unwanted gold-catalysed allene 
racemisation for efficient chirality transfer to occur. It should also be noted that more 
electron-rich nucleophiles may perform better in terms of chirality transfer by slowing 
down allene racemisation through stronger reversible coordination to the gold 
catalyst.   
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3.5 Experimental  
3.5.1 General considerations 
1H NMR spectra was recorded on Bruker AV 300 and AV 400 spectrometers at 300 and 
400 MHz respectively and referenced to residual solvent. 13C NMR spectra were 
recorded using the same spectrometers at 75 and 100 MHz respectively. Chemical shift 
data are quoted in parts per million (ppm) and are referenced to tetramethylsilane 
(TMS) or to residual solvent peaks (CDCl3 at δH 7.26). J values are given in Hz and s, d, 
dd, dt, ddt, dtd, t, td, tt, q, qd, qt, p and m abbreviations correspond to singlet, 
doublet, doublet of doublet, doublet of triplet, doublet of doublet of triplet, doublet of 
triplet of doublet, triplet, triplet of doublet, triplet of triplet, quartet, quartet of 
doublet, quartet of triplet, quintet and multiplet respectively. Mass spectra were 
obtained at the EPSRC National Mass Spectrometry Service Centre in Swansea. 
Infrared spectra were obtained on Perkin-Elmer Spectrum 100 FT-IR Universal ATR 
Sampling Accessory, deposited neat or as a chloroform solution to a diamond/ZnSe 
plate. Flash column chromatography was carried out using silica gel 60 from Fisher 
Chemicals or Silicagel 60A from Fluorochem and TLC was performed using Merck silica 
gel 60 F254 pre-coated sheets and visualised by UV (254 nm) or stained by the use of 
aqueous acidic KMnO4 or aqueous acidic ceric ammonium molybdate as appropriate. 
Chemicals were purchased from Sigma-Aldrich, Acros, Apollo Scientific, Fisher, 
Fluorochem and Manchester Organics chemical companies and used without further 
purification unless otherwise stated. THF, DCM and DMF were dried using an MBRAUN 
SPS-800 solvent purification system. Diethyl ether was purified by distilling over CaH2. 
High performance liquid chromatography (HPLC) was carried out on Agilent 
Technologies 1120 Compact LC. Gas chromatography was carried out on a Shimadzu 
GC2014 with FID. 
 
The gold(I)-catalysed  reactions were carried out in screw cap 1 dram vials partially 
immersed in a bath of IPA cooled by a Huber TC45E-F immersion chiller unless 
otherwise indicated. No special precautions to exclude air or moisture were taken 
unless otherwise indicated. 
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3.5.2 Preparation of allenes  
Allenes 3.1d, 3.1e, 3.1g-3.1j, 3.1l-3.1p were synthesised as described in Section 2.5.3 
or purchased (3.1o).  
(S)-Nona-2,3-dien-1-ol, precursor to 3.1f, was synthesised in the same manner as 2.15 
(Section 2.5.2) by Stuart Angiolini. 
Allenol precursor to 3.1k (2.15) was synthesised as described in Section 2.5.2 
 
(S)-2-(Nona-2,3-dien-1-yl)isoindoline-1,3-dione (3.1f)60  
 
(S)-Nona-2,3-dien-1-ol (50.5 mg, 0.60 mmol, 1.0 equiv.), phthalimide (132 mg, 0.90 
mmol, 1.5 equiv.) and PPh3 (236 mg, 0.90 mmol, 1.5 equiv.) in THF (4.8 ml) were stirred 
at 0 °C. Diisopropyl azodicarboxylate (DIAD) (0.18 ml, 0.90 mmol, 1.5 equiv.) was 
added dropwise and the reaction mixture was stirred for a further 1 h at 0 °C and then 
concentrated. The concentrated reaction mixture was loaded directly onto a silica gel 
column and purified by column chromatography (eluent: 15:1 to 12:1 petrol 40-60 
oC/EtOAc) to give product 3.1f as a colourless oil (138 mg, 0.51 mmol, 84%, 98:2 e.r.).  
 
RF 0.32 (12:1 petrol 40-60o C/EtOAc); νmax/cm-1 2927, 2856 (C-H), 1965 (C=C=C), 1711 
(C=O); 1H NMR (300 MHz, CDCl3) δ 7.89-7.79 (2H, m, Phth), 7.75-7.65 (2H, m, Phth), 
5.25-5.13 (2H, m, allene H), 4.27 (2H, app. t, J = 4.3 Hz, CH2N), 1.95-1.80 (2H, m, 
CH2CH), 1.35-1.07 (6H, m, 3CH2), 0.81 (3H, t, J = 6.8 Hz, CH3); 13C NMR (75 MHz, CDCl3) 
δ 203.8 (C), 167.9 (C), 134.01 (CH), 132.4 (C), 123.4 (CH), 94.8 (CH), 86.9 (CH), 36.8 
(CH2), 31.3 (CH2), 28.8 (CH2), 28.6 (CH2), 22.5 (CH2), 14.1 (CH3); Found (TOF MS ASAP+) 
[M + H]+ 270.1495, C17H20NO2 requires 270.1494; CSP-HPLC (Chiralpak IB, 99.5:0.5 
hexane:IPA, 1 ml min-1) (S)-3.1f 9.9 min and (R)-3.1f 10.3 min. 
 
(S)-Hexa-3,4-dienenitrile (3.1k)  
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Following procedure reported by Schaus,85 to a stirred solution of allenol 2.15 (101 mg, 
1.20 mmol, 1.0 equiv.) and triphenylphosphine (629 mg, 2.40 mmol, 2.0 equiv.) in Et2O 
(12 ml) at 0 °C, DIAD (474 µL, 2.40 mmol, 2.0 equiv.) and then acetone cyanohydrin 
(219 µL, 2.40 mmol, 2.0 equiv.) were added dropwise. The reaction mixture was stirred 
at 0 °C for 1 h and then allowed to warm up to room temperature and stirred for a 
further 24 hours. The solvent was removed under vacuum and the concentrated 
reaction mixture was loaded directly onto a silica gel column and purified by column 
chromatography (eluent: 15:1 to 10:1 petrol 40-60 oC/Et2O) to yield product 3.1k as a 
colourless oil (32.3 mg, 0.35 mmol, 29%, 98:2 e.r.).   
 
RF 0.37 (10:1 petrol 40-60 oC/Et2O); νmax/cm-1 3019, 2928, 2857 (C-H), 2253 (CN), 1970 
(C=C=C); 1H NMR (300 MHz, CDCl3) δ 5.45-5.54 (1H, m, allene H), 5.13-4.93 (1H, m, 
allene H), 3.05 (2H, dd, J = 6.1, 3.1 Hz, CH2), 1.71 (3H, dd, J = 7.2, 3.1 Hz, CH3); 13C NMR 
(75 MHz, CDCl3) δ 205.8 (C), 117.8 (C), 90.0 (CH), 81.1 (CH), 18.3 (CH2), 14.0 (CH3); 
[𝛼]𝐷
25 ℃ = +19.4 (c = 2.16 in CHCl3); CSP-GC (β-Dex, 100 ᵒC, 35 cm s-1) (R)-3.1k 6.6 min 
and (S)-3.1k 6.7 min.  
 
(5-Cyclohexylpenta-3,4-dien-1-yl)benzene (3.1q)86  
 
CuBr (226 mg, 20 mol%), pyrrolidine (0.74 ml, 8.9 mmol, 1.0 equiv.) and dry toluene 
(14 ml) were added to a flask.  Distilled cyclohexanecarboxaldehyde (998 mg, 8.9 
mmol, 1.0 equiv.), 4 Å molecular sieves (2 g) and 4-phenyl-1-butyne (1.38 ml, 9.8 
mmol, 1.1 equiv.) were added to the flask and stirred under Ar at 30 ᵒC for 36 hours.  
The molecular sieves were removed via filtration through a Celite® plug and washed 
with Et2O.  The crude product was purified by graduated column chromatography 
(eluent 20:1 petrol 40-60 oC/EtOAc to 10:1 DCM/MeOH - Rf = 0.16 5:1 petrol 40-60 
oC/EtOAc) to yield product 3.8 as an impure yellow oil (2.12 g, 7.2 mmol, 81%), which 
was used directly in the next step. Compound 3.8 (2.07 g, 7.0 mmol, 1.0 equiv.), 
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anhydrous dioxane (22 ml) and CuI (666 mg, 3.5 mmol, 0.5 equiv.) were added to a 
flask and heated to reflux for 18 hours. The reaction mixture was cool and 
concentrated before being loaded directly onto a silica gel column and purified by 
column chromatography (eluent: hexane) to yield product 3.1q as a yellow oil (21.7 
mg, 0.096 mmol 1%). 
 
RF 0.48 (hexane); νmax/cm-1 2920, 2848 (C-H), 1959 (C=C=C), 1495, 1447 (C-C Ar); 1H 
NMR (300 MHz, CDCl3) δ 7.15-7.25 (3H, m, Ar-H), 7.07-7.15 (2H, m, Ar-H), 5.04-5.13 
(1H, m, Allene-H), 4.97-5.04 (1H, m, Allene-H), 2.59-2.70 (2H, m, alkyl-H), 2.17-2.29 
(2H, m, alkyl-H), 1.76-1.91 (1H, m, alkyl-H), 1.49-1.68 (5H, m, alkyl-H), 1.07-1.26 (3H, m, 
alkyl-H), 0.87-1.07 (2H, m, alkyl-H); 13C NMR (75.5 MHz, CDCl3) δ 202.9 (C), 142.1 (C), 
128.7 (CH), 128.4 (CH), 125.9 (CH), 97.7 (CH), 91.3 (CH), 37.4 (CH), 35.7 (CH2), 33.23 
(CH2), 33.20 (CH2), 31.0 (CH2), 26.3 (CH2), 26.21 (CH2), 26.20 (CH2). 
 
3.5.3 Preparation of nucleophiles 
1-Benzyl-1H-indole (3.2e)86 
 
Following a procedure reported by Garvey,87 NaH (60% in oil, 216 mg, 5.4 mmol, 1.08 
equiv.) was added portion wise to indole (586 mg, 5.0 mmol, 1.00 equiv.) in DMF (20 
mL) at 0 oC. The mixture was stirred at r.t for 45 minutes at r.t before cooling to 0 oC. 
BnBr (628 µL, 5.25 mmol, 1.05 equiv.) was added dropwise and the solution warmed to 
r.t and stirred overnight. Water (20 mL) was added and the mixture was extracted with 
EtOAc (3 x 30mL). The combined organic layers were washed with brine, dried over 
MgSO4 and then concentrated. The product was purified by column chromatography 
(eluent: 100:1 to 60:1 petrol 40-60 oC/EtOAc) to yield product 3.2e as a yellow oil (727 
mg, 3.5 mmol, 70%). 
 
RF 0.34 (60:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3056, 3028, 2914 (C-H), 1511, 1484, 
1463, 1453 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.58 (1H, ddd, J = 7.5, 1.5, 0.8 Hz, Ar-
H), 7.25-7.16 (4H, m, Ar-H), 7.13-6.99 (5H, m, Ar-H), 6.48 (1H, dd, J = 3.2, 0.9 Hz, 
NCH=CH), 5.25 (2H, s, CH2); 13C NMR (75 MHz, CDCl3) δ 137.7 (C), 136.4 (C), 128.89 
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(CH), 128.85 (CH), 128.4 (C), 127.7 (CH), 126.9 (CH), 121.8 (CH), 121.1 (CH), 119.7 (CH), 
109.8 (CH), 101.8 (CH), 50.2 (CH2). 
 
1,3-Dimethyl-1H-indole (3.2m)87 
 
NaH (60% in oil, 200 mg, 5.0 mmol, 1.25 equiv.) was added portion wise to 3-
methylindole (525 mg, 4.0 mmol, 1.00 equiv.) in DMF (5 mL) at r.t. The mixture was 
stirred at r.t for 30 minutes at r.t before cooling to 0 oC. MeI (747 µL, 12.0 mmol, 3.00 
equiv.) was added in one portion and the solution warmed to r.t and stirred for 5 
hours. Water (20 mL) was added and the mixture was extracted with EtOAc (3 x 30mL). 
The combined organic layers were washed with brine, dried over Na2SO4 and then 
concentrated. The product was purified by column chromatography (eluent: neat to 
60:1 petrol 40-60 oC/EtOAc) to yield product 3.2m as a yellow oil (291 mg, 2.0 mmol, 
50%). 
 
RF 0.66 (20:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3053, 2915, 2883 (C-H), 1616, 1470 (C-C 
Ar); 1H NMR (300 MHz, CDCl3) δ 7.59 (1H, d, J = 8.3 Hz, Ar-H), 7.32-7.19 (2H, m, Ar-H), 
7.15-7.09 (1H, m, Ar-H), 6.84 (1H, s, NCH=C), 3.75 (3H, s, CH3), 2.35 (3H, s, CH3); 13C 
NMR (75 MHz, CDCl3) δ 137.1 (C), 128.8 (C), 126.6 (CH), 121.5 (CH), 119.1 (CH), 118.6 
(CH), 110.2 (C), 109.1 (CH), 32.6 (CH3), 9.7 (CH3). 
 
2-Benzyl-1-methyl-1H-pyrrole (3.2p)88 
 
Following procedure reported by Mal’kina,89 under Schlenk conditions at -78 oC nBuLi 
(2M in cyclohexane, 2.5 mL, 5.0 mmol, 1 equiv.) was added dropwise to N-
methylpyrrole (311 µL, 5.0 mmol, 1 equiv.) in THF (5 mL). The solution was slowly 
allowed to warm to r.t and stirred overnight. The mixture was cooled to -78 oC and 
cooled BnBr (595 µL, 5.0 mmol, 1 equiv.) in THF (5 mL) was added in one portion. The 
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reaction was slowly warmed to r.t over 1 hour and stirred for a further 5 hours. The 
reaction was quenched with water, separated and the aqueous layer was extracted 
twice with Et2O. After being concentrated the product was purified by column 
chromatography (eluent: neat to 50:1 petrol 40-60 oC/EtOAc) to yield product 3.2p as a 
yellow oil (507 mg, 3.0 mmol, 59%). This was used within one day and despite being 
stored under argon in the freezer turned to a white paste within two weeks.  
 
RF 0.71 (50:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3024, 2899 (C-H), 1604, 1492 (C-C Ar); 
1H NMR (300 MHz, CDCl3) δ 7.33-7.26 (2H, m, Ar-H), 7.24-7.13 (3H, m, Ar-H), 6.58 (1H, 
dd, J = 2.7, 1.9 Hz, pyrrole-H), 6.08 (1H, dd, J = 3.5, 2.7 Hz, pyrrole-H), 5.95-5.87 (1H, m, 
pyrrole-H), 3.95 (2H, s, CH2), 3.43 (3H, s, CH3); 13C NMR (75 MHz, CDCl3) δ 139.5 (C), 
131.4 (C), 128.5 (2xCH), 126.2 (CH), 121.8 (CH), 107.9 (CH), 106.6 (CH), 33.8 (CH3), 32.9 
(CH2). 
 
3.5.4 Preparation of gold catalyst 
(CF3C6H4)3PAuCl (3.9)90 
 
Thioethanol (860 mg, 7.10 mmol, 3.3 equiv.) in MeOH (5 mL) was added dropwise to 
NaAuCl4.2H2O (850 mg, 2.14 mmol, 1.0 equiv.) in water (3.7 mL) and MeOH (1 7mL) at 
0 oC. The reaction was stirred at r.t. until the solution changed from yellow to 
colourless (45 mins). The mixture was cooled to 0 oC and (4-CF3C6H4)3P (1.00 g, 2.14 
mmol, 1 equiv.) in DCM (17mL) and MeOH (11.4 mL) at 0 oC was added slowly. The 
reaction mixture was then warmed to r.t. and stirred overnight. The mixture was 
cooled and concentrated until a white solid precipitated. The precipitate was filtered 
off and washed with pentane before being recrystallised twice from DCM/pentane to 
give the desired product as a white solid 3.9 (1.08 g, 1.54 mmol, 72%).  
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1H NMR (400 MHz, CDCl3) δ 7.83-7.76 (6H, m Ar-H), 7.73-7.63 (6H, m, Ar-H); 13C NMR 
(101 MHz, CDCl3) δ 134.8 (q, J = 33.7 Hz, CCF3), 134.6 (d, J = 14.7 Hz, CHCP), 131.8 (d, J 
= 60.2 Hz, CP), 126.5 (dq, J = 11.8, 3.7 Hz, CHCCF3), 123.1 (q, J = 273.3 Hz, CF3); 19F NMR 
(376 MHz, CDCl3) δ -63.36; 31P NMR (162 MHz, CDCl3) δ 32.98; Found (TOF MS ASAP+) 
[M + NH4]+ 716.0240, C21H16F9PAuClN requires 716.0231. 
 
3.5.5 Gold-catalysed hydroarylation reactions 
General procedure 
Allene 3.1 (0.15 mmol, 1 equiv.), toluene (0.1 mL) and nucleophile 3.2 (0.6 mmol, 4 
equiv.) were added to a 1 dram vial equipped with a small stirrer bar and cooled to 
5 oC. Catalyst (4-CF3C6H4)3PAuCl (0.015 mmol, 10 mol%) followed by AgNTf2 (0.015 
mmol, 10 mol%) were added in quick succession and the reaction was allowed to 
stir at 5 oC for 3 days. The reaction mixture was then loaded directly onto the column 
and purified immediately by column chromatography to give product 3.3. 
Alternatively, the reaction mixture can be stored in the freezer to prevent further 
reaction before purification in the same manner. (Filtration through a short plug of 
silica was found to be insufficient to quench the reaction as the catalyst was found to 
co-elute with the product and any remaining starting material.) 
 
Ethyl (S,E)-5-(1-methyl-1H-indol-3-yl)hex-3-enoate (3.3dc) 
 
General procedure followed and crude purified by column chromatography (eluent: 
20:1 petrol 40-60 oC/EtOAc) to yield product 3.3dc as a colourless oil (27.3 mg, 0.10 
mmol, 67%, 11:1 regioselectivity, 92:8 e.r.).  
 
RF 0.21 (15:1 hexane/EtOAc); νmax/cm-1 2976 (C-H), 1731 (C=O), 1613, 1470 (C-C Ar); 1H 
NMR (300 MHz, CDCl3) δ 7.65 (1H, d, J = 7.9 Hz, indole), 7.30 (1H, d, J = 8.1 Hz, indole), 
7.22 (2H, ddd, J = 8.1, 6.9, 1.0 Hz, indole), 7.10 (1H, ddd, J = 7.9, 6.9, 1.2 Hz, indole), 
6.84 (1H, s, NCH=C), 5.82 (1H, dd, J = 15.4, 6.6 Hz, =CHCH), 5.69 (1H, dt, J = 15.4, 6.6 
Hz, =CHCH2), 4.15 (2H, q, J = 7.1 Hz, CH2CH3), 3.86-3.73 (1H, m, CHCH3), 3.75 (3H, s, 
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NCH3), 3.07 (2H, d, J = 6.6 Hz, CHCH2), 1.48 (3H, d, J = 7.0 Hz, CHCH3), 1.27 (3H, t, J = 7.0 
Hz, CH2CH3); 13C NMR (101 MHz, CDCl3) δ 172.3 (C), 139.4 (CH), 137.5 (CH), 127.3 (CH), 
125.3 (CH), 121.7 (CH), 120.3 (CH), 119.8 (CH), 119.1 (C), 118.7 (CH), 109.3 (CH), 60.6 
(CH2), 38.2 (CH2), 34.0 (CH), 32.7 (CH3), 20.8 (CH3), 14.4 (CH3); Found (FTMS + p NSI) [M 
+ H]+ 272.1640, C17H22NO2 requires 272.1645; [𝛼]𝐷
22 ℃ = -3.8 (c = 0.52 in CHCl3); CSP-
HPLC (Chiralcel OD-H, 99.5:0.5 hexane:IPA, 1 ml min-1) (R)-3.3dc 24.6 min and (S)-3.3dc 
33.0 min. 
 
(R,E)-2-(4-(1-Methyl-1H-indol-3-yl)pent-2-en-1-yl)isoindoline-1,3-dione (3.3ec) 
 
General procedure followed and crude purified by column chromatography (eluent: 
6:1 petrol 40-60 oC/EtOAc) to yield product 3.3ec as a light yellow oil (48.4 mg, 0.14 
mmol, 94%, >20:1 regioselectivity, 97:3 e.r.).  
 
RF 0.30 (5:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2963, 2928 (C-H), 1708 (C=O), 1613, 
1467 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.88-7.80 (2H, m, Phth), 7.74-7.67 (2H, m, 
Phth), 7.57 (1H, d, J = 7.9 Hz, indole), 7.27 (1H, m, indole), 7.19 (1H, ddd, J = 8.2, 6.9, 
1.1 Hz, indole), 7.04 (1H, ddd, J = 7.9, 6.9, 1.1 Hz, indole), 6.80 (1H, s, NCH=C), 6.03 (1H, 
ddt, J = 15.4, 6.6, 1.2 Hz, =CHCH), 5.62 (1H, dtd, J = 15.4, 5.9, 1.3 Hz, =CHCH2), 4.28 (2H, 
d, J = 5.9 Hz, CH2), 3.80-3.69 (1H, m, CHCH3), 3.73 (3H, s, NCH3), 1.42 (3H, d, J = 7.0 Hz, 
CH3CH); 13C NMR (75 MHz, CDCl3) δ 168.1 (C), 139.6 (CH), 137.3 (C), 134.0 (CH), 132.3 
(C), 127.1 (C), 125.5 (CH), 123.3 (CH), 121.7 (CH), 121.6 (CH), 119.6 (CH), 118.69 (CH), 
118.66 (C), 109.3 (CH), 39.7 (CH2), 33.4 (CH), 32.7 (CH3), 20.7 (CH3); Found (FTMS + p 
NSI) [M + H]+ 345.1598, C22H21N2O2 requires 345.1598; [𝛼]𝐷
24 ℃ = -4.1 (c = 2.95 in 
EtOH); CSP-HPLC (Chiralpak IB, 99.2:0.8 hexane:IPA, 1 ml min-1) (R)-3.3ec 22.1 min and 
(S)-3.3ec 23.6 min. 
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(R,E)-2-(4-(1-Methyl-1H-indol-3-yl)nona-2-en-1-yl)isoindoline-1,3-dione (3.3fc) 
 
General procedure followed and crude purified by column chromatography (eluent: 
12:1 to 8:1 petrol 40-60 oC/EtOAc) to yield product 3.3fc as a light yellow oil (48.6 mg, 
0.12 mmol, 81%, >20:1 regioselectivity, 98:2 e.r.).  
 
RF 0.18 (12:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2955, 2928, 2856 (C-H), 1709 (C=O), 
1614, 1467 (C-C Ar); 1H NMR: (300 MHz, CDCl3) δ 7.89-7.79 (2H, m, Phth), 7.74-7.65 
(2H, m, Phth), 7.58 (1H, d, J = 8.1 Hz, indole), 7.27 (1H, d, J =  8.3 Hz, indole), 7.19 (1H, 
app. td, J = 6.9, 1.0 Hz, indole), 7.04 (1H, app. td, J = 7.9, 1.0 Hz, indole), 6.82 (1H, s, 
NCH=C), 5.99 (1H, dd, J = 15.4, 7.7 Hz, =CHCH), 5.62 (1H, dtd, J = 15.4, 6.2 Hz, =CHCH2), 
4.27 (2H, d, J = 6.2 Hz, =CHCH2), 3.74 (3H, s, NCH3), 3.55 (1H, app. q, J = 7.3 Hz, CHCH2), 
1.95-1.63 (2H, m, CHCH2), 1.38-1.12 (6H, m, 3CH2), 0.84 (3H, t, J = 6.8 Hz, CH2CH3); 13C 
NMR (75 MHz, CDCl3) δ 168.1 (C), 139.1 (CH), 137.2 (C), 133.9 (CH), 132.4 (CH), 127.3 
(C), 125.7 (CH), 123.3 (CH), 122.4 (CH), 121.5 (CH), 119.7 (CH), 118.6 (CH), 117.5 (C), 
109.3 (CH), 39.8 (CH2), 39.7 (CH), 35.3 (CH2), 32.7 (CH3), 31.9 (CH2), 27.4 (CH2), 22.7 
(CH2), 14.2 (CH3); Found (TOF MS ASAP+) [M + H]+ 401.2227, C26H29N2O2 requires 
401.2229; [𝛼]𝐷
21 ℃ = -7.4 (c = 4.07 in CHCl3); CSP-HPLC (Chiralpak IA, 95:5 hexane:IPA, 1 
ml min-1) (S)-3.3fc 9.3 min and (R)-3.3fc 10.4 min. 
 
(R,E)-4-(1-Methyl-1H-indol-3-yl)pent-2-en-1-yl benzoate (3.3gc) 
 
General procedure followed and crude purified by column chromatography (eluent: 
20:1 to 15:1 petrol 40-60 oC/EtOAc) to yield product 3.3gc as a light yellow oil (45.3 
mg, 0.14 mmol, 95%, 15:1 regioselectivity, 97:3 e.r.).  
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RF 0.26 (15:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3055, 2962, 2873 (C-H), 1713 (C=O), 
1613, 1471 (C-C Ar); 1H NMR: (300 MHz, CDCl3) δ 8.09 (2H, dd, J = 8.3, 1.4 Hz, Ar-H), 
7.66 (1H, d, J = 7.9 Hz, Ar-H), 7.58 (1H, t, J = 7.4 Hz, Ar-H), 7.46 (2H, t, J = 7.6 Hz, Ar-H), 
7.32 (1H, d, J = 8.3 Hz, Ar-H), 7.25 (1H, t, J = 7.1 Hz, Ar-H), 7.12 (1H, t, J = 7.4 Hz, Ar-H), 
6.87 (1H, s, NCH=C), 6.15 (1H, dd, J = 15.4, 6.6 Hz, =CHCH), 5.84 (1H, dtd, J = 15.4, 6.2, 
1.3 Hz, =CHCH2), 4.84 (2H, d, J = 6.2 Hz, OCH2), 3.85 (1H, app. p, J = 7.2 Hz, CHCH3), 3.77 
(2H, s, NCH3), 1.52 (3H, d, J = 7.0 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 166.1 (C), 
140.4 (CH), 136.9 (C), 132.5 (CH), 130.1 (C), 129.3 (CH), 128.0 (CH), 126.7 (C), 125.0 
(CH), 121.9 (CH), 121.3 (CH), 119.3 (CH), 118.4 (CH), 118.1 (C), 109.0 (CH), 65.3 (CH2), 
33.3 (CH), 32.3 (CH3), 20.2 (CH3); Found (FTMS + p NSI) [M + H]+ 320.1648, C21H21NO2 
requires 320.1645; [𝛼]𝐷
23 ℃ = -2.0 (c = 2.93 in CHCl3); CSP-HPLC (Chiralpak IB, 98:2 
hexane:IPA, 1 ml min-1) (R)-3.3gc 7.4 min and (S)-3.3gc 11.8 min. 
 
(R,E)-4-(1-Methyl-1H-indol-3-yl)pent-2-en-1-yl acetate (3.3hc) 
 
General procedure followed and crude purified by column chromatography (eluent: 
15:1 to 12:1 petrol 40-60 oC/EtOAc) to yield product 3.3hc as a colourless oil (28.5 mg, 
0.11 mmol, 74%, 15:1 regioselectivity, 97:3 e.r.).  
 
RF 0.29 (10:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2929, 2873 (C-H), 1733, (C=O), 1614, 
1471 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.61 (1H, d, J = 7.9 Hz, indole), 7.22 (1H, d, J 
= 8.2 Hz, indole), 7.23 (1H, ddd, J = 8.2, 6.8, 1.1 Hz, indole), 7.10 (1H, ddd, , J = 7.9, 6.8, 
1.2 Hz,  indole), 6.83 (1H, s, NCH=C), 6.03 (1H, ddt, J = 15.4, 6.6, 1.1 Hz, =CHCH), 5.68 
(1H, dtd, J = 15.4, 6.4, 1.3 Hz, =CHCH2), 4.56 (2H, d, J = 6.4 Hz, CH2HC=), 3.91-3.72 (1H, 
m, CHCH3), 3.76 (3H, s, NCH3), 2.06 (3H, s, O=CCH3), 1.48 (3H, d, J = 7.0 Hz, CH3CH); 13C 
NMR (75 MHz, CDCl3) δ 171.0 (C), 140.7 (CH), 137.4 (C), 127.1 (C), 125.4 (CH), 122.3 
(CH), 121.7 (CH), 119.6 (CH), 118.8 (CH), 118.5 (C), 109.4 (CH), 65.3 (CH2), 33.7 (CH), 
32.8 (CH3), 21.2 (CH3), 20.6 (CH3); Found (TOF MS ASAP+) [M + H]+ 258.1494, C16H20NO2 
requires 258.1491; [𝛼]𝐷
23 ℃ = -7.0 (c = 1.43 in EtOH); CSP-HPLC (Chiralpak, 99.6:0.4 
hexane:IPA, 1 ml min-1) (R)-3.3hc 11.5 min and (S)-3.3hc 12.3 min. 
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(R,E)-4-(1H-Indol-3-yl)pent-2-en-1-yl pivalate (3.3id) 
 
General procedure followed and crude purified by column chromatography (eluent: 
15:1 to 12:1 petrol 40-60 oC/EtOAc) to yield product 3.3id as a colourless oil (24.8 mg, 
0.09 mmol, 58%, 8:1 regioselectivity, 94:6 e.r.).  
 
RF 0.21 (12:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3411 (N-H), 2968, 2932, 2872 (C-H), 
1709 (C=O), 1479, 1456 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 8.01 (1H, bs, NH), 7.63 
(1H, d, J = 7.9 Hz, indole), 7.36 (1H, d, J = 8.1 Hz, indole), 7.20 (1H, ddd, J = 8.1, 7.1, 1.1 
Hz, indole), 7.10 (1H, ddd, J = 7.9, 7.1, 0.9 Hz, indole), 6.97 (1H, d, J = 2.2 Hz, NCH=C), 
6.01 (1H, ddt, J = 15.2, 6.8, 1.2 Hz, =CHCH), 5.69 (1H, dtd, J = 15.2, 6.2, 1.1 Hz, =CHCH2), 
4.59 (2H, d, J = 6.2 Hz, CH2HC=), 3.80 (1H, p, J = 6.8 Hz, CHCH3), 1.49 (3H, d, J = 7.0 Hz, 
CH3CH), 1.22 (9H, s, 3CH3); 13C NMR (75 MHz, CDCl3) δ 178.5 (C), 140.0 (CH), 136.7 (C), 
126.8 (C), 122.8 (CH), 122.1 (CH), 120.5 (CH), 120.1 (C), 119.7 (CH), 119.3 (CH), 111.3 
(CH), 65.1 (CH2), 38.9 (C), 33.8 (CH), 27.4 (CH3), 20.5(CH3);  Found (FTMS + p NSI) [M + 
H]+ 286.1803, C18H24NO2 requires 286.1802; [𝛼]𝐷
22 ℃ = -11.9 (c = 1.01 in CHCl3); CSP-
HPLC (Chiralpak IA, 99:1 hexane:IPA, 1 ml min-1) (S)-3.3id 41.8 min and (R)-3.3id 51.7 
min. 
 
(R,E)-3-(5-(Benzyloxy)pent-3-en-2-yl)-1-methyl-1H-indole (3.3jc) 
 
General procedure followed and crude purified by column chromatography (eluent: 
20:1 petrol 40-60 oC/EtOAc) to yield product 3.3jc as a colourless oil (33.9 mg, 0.11 
mmol, 74%, 6:1 regioselectivity, 85:15 e.r.).  
 
RF 0.35 (15:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3027, 2961, 2928, 2852 (C-H), 1614, 
1471 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.66 (1H, d, J = 8.0 Hz, indole), 7.41-7.20 
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(7H, m, indole + Ar-H), 7.16-7.06 (1H, m, indole), 6.85 (1H, s, NCH=C), 6.00 (1H, ddt, J = 
15.4, 6.7, 1.3 Hz, =CHCH), 5.74 (1H, dtd, J = 15.4, 6.2, 1.3 Hz, =CHCH2), 4.52 (2H, s, 
CH2Ph), 4.05 (2H, d, J = 6.2 Hz, =CHCH2), 3.91-3.75 (1H, m, CHCH3), 3.76 (3H, s, NCH3), 
1.51 (3H, d, J = 7.0 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 139.4 (CH), 138.6 (C), 137.4 
(C), 128.5 (CH), 127.9 (CH), 127.6 (CH), 127.2 (C), 125.3 (CH), 124.7 (CH), 121.6 (CH), 
119.7 (CH), 118.9 (C), 118.7 (CH), 109.3 (CH), 72.0 (CH2), 71.0 (CH2), 33.7 (CH), 32.7 
(CH3), 20.8 (CH3); Found (TOF MS ASAP+) [M + H]+ 306.1857, C21H25NO requires 
306.1858; [𝛼]𝐷
24 ℃ = -20.9 (c = 2.68 in CHCl3 CSP-HPLC (Chiralcel OD-H, 99:1 hexane:IPA, 
1 ml min-1) (R)-3.3jc 17.1 min and (S)-3.3jc 21.1 min. 
 
(R,E)-5-(1-Methyl-1H-indol-3-yl)hex-3-enenitrile (3.3kc) 
 
General procedure followed and crude purified by column chromatography (eluent: 
12:1 petrol 40-60 oC/EtOAc) to yield product 3.3kc as a yellow oil (26.0 mg, 0.12 mmol, 
77%, >20:1 regioselectivity, 98:2 e.r.).  
 
RF 0.16 (12:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3018, 2963, 2930, 2873 (C-H), 2250 
(CN), 1613, 1471 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.58 (1H, dt, J = 7.9, 1.0 Hz, 
indole), 7.31 (1H, dt, J = 8.3, 1.0 Hz, indole), 7.28-7.20 (1H, m, indole), 7.11 (1H, ddd, J 
= 7.9, 6.9, 1.2 Hz, indole), 6.85 (1H, s, NCH=C), 6.09 (1H, ddt, J = 15.3, 6.7, 1.6 Hz, 
=CHCH), 5.42 (1H, dtd, J = 15.3, 5.6, 1.4 Hz, =CHCH2), 3.82 (1H, app. p, J = 7.0 Hz, 
CHCH3), 3.76 (3H, s, NCH3), 3.07 (2H, app. dt, J = 5.6, 1.4 Hz, CHCH2), 1.48 (3H, d, J = 7.0 
Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 140.9 (CH), 137.3 (C), 127.0 (C), 125.4 (CH), 
121.8 (CH), 119.5 (CH), 118.9 (CH), 118.00 (C), 117.98 (C), 115.9 (CH), 109.4 (CH), 33.7 
(CH), 32.7 (CH3), 20.6 (CH3), 20.4 (CH2); Found (TOF MS ASAP+) [M + H]+ 225.1391, 
C16H17N2 requires 225.1392; [𝛼]𝐷
22 ℃ = +7.2 (c = 1.66 in CHCl3); CSP-HPLC (Chiralpak IB, 
99:1 hexane:IPA, 1 ml min-1) (S)-3.3kc 24.7 min and (R)-3.3kc 32.3 min. 
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(S,E)-2-(5-(1H-Indol-3-yl)hex-3-en-1-yl)isoindoline-1,3-dione (3.3ld) 
 
General procedure followed and crude purified by column chromatography (eluent: 
10:1 to 5:1 petrol 40-60 oC/EtOAc) to yield product 3.3ld as a light yellow oil (49.8 mg, 
0.14 mmol, 97%, 11:1 regioselectivity, 76:24 e.r.).  
 
RF 0.21 (5:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3413 (N-H), 3019, 2966 (C-H), 1706 
(C=O), 1617, 1456 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.95 (1H, br s, NH), 7.85-7.76 
(2H, m, Phth), 7.73-7.63 (2H, m, Phth), 7.56 (1H, d, J = 7.9 Hz, indole), 7.31 (1H, d, J = 
8.1 Hz, indole), 7.15 (2H, ddd, J = 8.1, 7.1, 1.2 Hz, indole), 7.09-6.97 (1H, m, indole), 
6.85 (1H, d, J = 2.4 Hz, NCH=C), 5.72 (1H, ddt, J = 15.3, 6.9, 1.2 Hz, =CHCH), 5.53 (1H, 
dtd, J = 15.3, 6.9, 1.1 Hz, =CHCH2), 3.75 (2H, t, J = 7.1 Hz, CH2N), 3.66 (1H, m, CHCH3), 
2.42 (2H, q, J = 7.0 Hz, CHCH2), 1.34 (3H, d, J = 7.0 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) 
δ 168.5 (C), 138.5 (CH), 136.6 (C), 133.9 (CH), 132.2 (C), 126.8 (C), 124.3 (CH), 123.2 
(CH), 121.9 (CH), 120.6 (C), 120.2 (CH), 119.6 (CH), 119.2 (CH), 111.2 (CH), 37.9 (CH2), 
33.9 (CH), 31.6 (CH2), 20.8 (CH3); Found (TOF MS ASAP+) [M + H]+ 345.1599, C22H20N2O2 
requires 345.1603; [𝛼]𝐷
21 ℃ = -3.2 (c = 3.71 in CHCl3); CSP-HPLC (Chiralpak IA, 95:5 
hexane:IPA, 1 ml min-1) (S)-3.3ld 51.4 min and (R)-3.3ld 61.9 min. 
 
(S,E)-5-(1-Methyl-1H-indol-3-yl)hex-3-en-1-yl benzoate (3.3mc) 
 
General procedure followed and crude purified by column chromatography (eluent: 
50:1 petrol 40-60 oC/EtOAc) to yield product 3.3mc as a colourless oil (42.3 mg, 0.12 
mmol, 82%, 7:1 regioselectivity, 92:8 e.r.).  
RF 0.24 (30:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3022, 2961, 2929 (C-H), 1714 (C=O), 
1613, 1602, 1470 (C-C Ar); 1H NMR (400 MHz, CDCl3) δ 8.05 (2H, d, J = 7.9 Hz, Ar-H), 
7.65 (1H, d, J = 7.9 Hz, indole), 7.57 (1H, t, J = 7.4 Hz, Ar-H), 7.43 (2H, t, J = 7.8 Hz, Ar-
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H), 7.30 (1H, d, J = 8.2 Hz, indole), 7.23 (1H, m, indole), 7.08 (1H, ddd, J = 7.9, 6.9, 0.9 
Hz, indole), 6.81 (1H, s, NCH=C), 5.86 (1H, dd, J = 15.3, 7.0 Hz, =CHCH), 5.63 (1H, dt, J = 
15.3, 7.3 Hz, =CHCH2), 4.38 (2H, td, J = 6.7, 2.2 Hz, OCH2), 3.84-3.75 (1H, m, CHCH3), 
3.71 (3H, s, NCH3), 2.53 (2H, app. q, J = 6.7 Hz, CHCH2), 1.46 (1H, d, J = 7.0 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3) δ 166.7 (C), 138.4 (CH), 137.4 (C), 132.9 (CH), 130.6 (C), 129.7 
(CH), 128.4 (CH), 127.2 (C), 125.2 (CH), 123.7 (CH), 121.6 (CH), 119.7 (CH), 119.3 (C), 
118.7 (CH), 109.3 (CH), 64.6 (CH2), 34.1 (CH3), 32.7 (CH), 32.1 (CH2), 21.0 (CH3); Found 
(FTMS + p NSI) [M + H]+ 334.1802, C22H24NO2 requires 334.1804; [𝛼]𝐷
21 ℃ = +2.2 (c = 
2.71 in CHCl3); CSP-HPLC (Chiralpak IB, 99.6:0.4 hexane:IPA, 1 ml min-1) (S)-3.3mc 20.6 
min and (R)-3.3mc 62.0 min. 
 
Diethyl (R,E)-2-(4-(1-methyl-1H-indol-3-yl)pent-2-en-1-yl)malonate (3.3nc)  
 
General procedure followed and crude purified by column chromatography (eluent: 
20:1 petrol 40-60 oC/EtOAc) to yield product 3.3nc as a colourless oil (52.1 mg, 0.14 
mmol, 96%, 18:1 regioselectivity, 87:13 e.r.).  
 
RF 0.28 (10:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2962, 2929, 2871 (C-H), 1729 (C=O), 
1614, 1469 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.58 (1H, dt, J = 7.9, 1.0 Hz, indole), 
7.28 (1H, m, indole), 7.20 (1H, ddd, J = 8.2, 6.9, 1.2 Hz, indole), 7.07 (1H, ddd, J = 7.9, 
6.9, 1.2 Hz, indole), 6.79 (1H, s, NCH=C), 5.78 (1H, ddt, J = 15.3, 7.0, 1.2 Hz, =CHCH), 
5.51 (1H, dtd, J = 15.3, 6.9, 1.2 Hz, =CHCH2), 4.15 (4H, m, 2CH2CH3), 3.74 (3H, s, NCH3), 
3.69 (2H, m, CHCH3), 3.39 (1H, t, J = 7.6 Hz, CHCH2), 2.62 (2H, app. t, J = 7.3 Hz, 
=CHCH2), 1.41 (3H, d, J = 7.0 Hz, CHCH3), 1.23 (6H, q, J = 7.7 Hz, 2CH2CH3); 13C NMR (75 
MHz, CDCl3) δ 169.23 (C), 169.19 (C), 138.7 (CH), 137.4 (C), 127.2 (C), 125.2 (CH), 123.8 
(CH), 121.6 (CH), 119.8 (CH), 119.2 (C), 118.7 (CH), 109.3 (CH), 61.4 (CH2), 52.5 (CH), 
34.0 (CH), 32.7 (CH3), 31.9 (CH2), 21.0 (CH3), 14.23 (CH3), 14.19 (CH3);  Found (TOF MS 
ASAP+) [M + H]+ 358.2014, C21H28NO4 requires 358.2014; [𝛼]𝐷
24 ℃ = -4.0 (c = 3.96 in 
CHCl3); CSP-HPLC (Chiralpak IB, 98:2 hexane:IPA, 1 ml min-1) (S)-3.3nc 9.7 min and (R)-
3.3nc 10.5 min. 
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Ethyl (E)-4-(1-methyl-1H-indol-3-yl)pent-2-enoate (3.3oc) 
 
General procedure followed but carried out at r.t and crude purified by column 
chromatography (eluent: 15:1 petrol 40-60 oC/EtOAc) to yield product 3.3oc as a 
colourless oil (8.9 mg, 0.03 mmol, 23%, >20:1 regioselectivity).  
 
RF 0.21 (15:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2973, 2931 (C-H), 1711 (C=O), 1649, 
1471 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.49 (1H, dt, J = 8.0, 1.0 Hz, indole), 7.23 
(1H, d, J = 8.2 Hz, indole), 7.18-7.12 (1H, m, indole), 7.10 (1H, dd, J = 15.6, 6.8 Hz, 
=CHCH), 7.02 (2H, ddd, J = 8.0, 6.9, 1.2 Hz, indole), 6.78 (1H, s, NCH=C), 5.79 (1H, dd, J 
= 15.6, 1.5 Hz, =CHC=O), 4.09 (2H, q, J = 7.1 Hz, OCH2), 3.84 (1H, app. p, J = 7.0 Hz, 
CHCH3), 3.68 (3H, s, NCH3), 1.43 (3H, d, J = 7.0 Hz, CH3), 1.19 (3H, t, J = 7.1 Hz, CH2CH3); 
13C NMR (75 MHz, CDCl3) δ 167.2 (C), 153.1 (CH), 137.3 (C), 127.0 (C), 125.7 (CH), 121.9 
(CH), 119.7 (CH), 119.4 (CH), 119.1 (CH), 116.8 (C), 109.5 (CH), 60.3 (CH2), 33.7 (CH), 
32.8 (CH3), 19.9 (CH3), 14.4 (CH3); Found (FTMS + p NSI) [M + H]+ 258.1489, C16H20NO2 
requires 258.1489. 
 
(E)-1-Methyl-3-(1-phenylbut-2-en-1-yl)-1H-indole (3.3pc’) + (E)-1-Methyl-3-(4-
phenylbut-3-en-2-yl)-1H-indole (3.3pc) 
  
General procedure followed and crude purified by column chromatography (eluent: 
10:1 to 5:1 petrol 40-60 oC/toluene) to yield product 3.3pc’ and 3.3pc as a yellow oil 
(32.1 mg, 0.12 mmol, 82%, 3:1 regioselectivity, 79:21 e.r. 3.3pc’ and 53:47 e.r. 3.3pc).  
νmax/cm-1 3056, 3024, 2915, 2854 (C-H), 1613, 1546, 1483 (C-C Ar); Found (TOF MS 
ASAP+) [M + H]+ 262.1596, C19H20N requires 262.1595; 
Partial separation of the two other isomers was achieved by further column 
chromatograph (eluent: 10:1 to 5:1 petrol 40-60 oC/toluene).  
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(E)-1-Methyl-3-(1-phenylbut-2-en-1-yl)-1H-indole (3.3pc’) 
 
RF 0.36 (5:1 petrol 40-60 oC/toluene); 1H NMR (300 MHz, CDCl3) δ 7.41 (1H, dd, J = 8.0, 
1.0 Hz, indole), 7.35-7.27 (5H, m, Ar-H), 7.28-7.15 (1H, m, indole), 7.03 (1H, ddd, J = 
8.0, 6.9, 1.1 Hz, indole), 6.74 (1H, s, NCH=C), 5.99 (1H, ddq, J = 15.1, 7.5, 1.2 Hz, 
=CHCH), 5.58 (1H, dqd, J = 15.1, 6.5, 1.1 Hz, =CHCH3), 4.92 (1H, d, J = 7.5 Hz,=CHCH), 
3.75 (3H, s, NCH3), 1.75 (3H, d, J = 6.5 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 144.5 (C), 
137.5 (C), 133.7 (CH), 128.42 (CH), 128.39 (CH), 127.4 (C), 127.2 (CH), 126.2 (CH), 125.9 
(CH), 121.6 (CH), 120.1 (CH), 118.8 (CH), 117.9 (C), 109.2 (CH), 46.2 (CH), 32.8 (CH3), 
18.1 (CH3); [𝛼]𝐷
22 ℃ = -7.8 (c = 1.53 in CHCl3); CSP-HPLC (Chiralpak IB, hexane, 1 ml min-
1) (minor)-3.3pc’ 26.8 min and (major)-3.3pc’ 35.3 min. 
 
(E)-1-Methyl-3-(4-phenylbut-3-en-2-yl)-1H-indole (3.3pc) 
 
RF 0.31 (5:1 petrol 40-60 oC/toluene); 1H NMR (300 MHz, CDCl3) δ 7.66 (1H, dt, J = 7.9, 
0.9 Hz, indole), 7.39-7.14 (7H, m, Ar-H + indole), 7.07 (1H, ddd, J = 8.0, 6.9, 1.1 Hz, 
indole), 6.88 (1H, s, NCH=C), 6.52 (1H, d, J = 15.9 Hz, =CHPh), 6.44 (1H, dd, J = 15.9, 5.5 
Hz, =CHCH), 3.93 (1H, app. p, J = 6.4 Hz, CHCH3), 3.76 (3H, s, NCH3), 1.56 (3H, d, J = 7.0 
Hz, CHCH3); 13C NMR (101 MHz, CDCl3) δ 137.8 (C), 137.3 (C), 135.6 (CH), 128.4 (CH), 
128.1 (CH), 127.2 (C), 126.8 (CH), 126.1 (CH), 125.3 (CH), 121.5 (CH), 119.7 (CH), 119.0 
(C), 118.7 (CH), 109.2 (CH), 34.2 (CH), 32.6 (CH3), 20.9 (CH3); CSP-HPLC (Chiralpak IB, 
99.75:0.25 hexane:IPA, 1 ml min-1) (R)-3.3pc 13.4 min and (S)-3.3pc 15.5 min. 
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(E)-3-(1-cyclohexyl-5-phenylpent-2-en-1-yl)-1-methyl-1H-indole (3.3qc) + (E)-3-(1-
cyclohexyl-5-phenylpent-1-en-3-yl)-1-methyl-1H-indole (3.3qc’) 
 
General procedure followed on a reduced scale (0.096 mmol allene 1o) and crude 
product purified by column chromatography (eluent: 20:1 to 5:1 petrol 40-60 
oC/toluene) to yield an inseparable mixture of isomers 3.3qc and 3.3qc’ as a colourless 
oil (9.7 mg, 0.027 mmol, 28%, 1.4:1 3.3qc:3.3qc’).  
 
RF 0.60 (50:1 petrol 40-60 oC/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.64 – 7.58 (1 H + 1 
H’, m, indole major + minor), 7.31 – 7.26 (3 H, m), 7.25 – 7.14 (8 H, m), 7.12 – 7.04 (2 
H, m), 6.83 (1 H’, s, indole minor), 6.74 (1 H, s, indole major), 5.70 (1 H, ddt, J = 15.1, 
9.1, 1.3 Hz, =CHCH major), 5.57 – 5.54 (2 H’, m, 2=CH minor), 5.50 (1 H, dt, J = 15.1, 6.8 
Hz, =CHCH2 major), 3.75 (3 H’, s, NCH3 minor), 3.74 (3 H, s, NCH3 major), 3.52 (1 H’, qm, 
J = 6.8 Hz, =CHCHCH2 minor), 3.26 (1 H, app. t, J = 8.5 Hz, =CHCHCy major), 2.79 – 2.57 
(2 H + 2 H’, m, CH2Ph major + minor), 2.34 (2 H, app. q, J = 6.8 Hz, =CHCH2CH2 major), 
2.27 – 2.13 (1 H’, m, =CHCH2CH2 minor), 2.09 – 1.92 (2 H’, m, CHCH2CH2 minor), 1.86 – 
1.55 (7 H + 6H’, m, Alkyl CHs major + minor), 1.37 – 1.02 (4 H + 4H’, m, Alkyl CHs major 
+ minor). 
 
(R,E)-2-(4-(1H-Indol-3-yl)pent-2-en-1-yl)isoindoline-1,3-dione (3.3ed) 
 
General procedure followed and crude purified by column chromatography (eluent: 
5:1 to 4:1 petrol 40-60 oC/EtOAc) to yield product 3.3ed as a light yellow oil (44.2 mg, 
0.13 mmol, 89%, >20:1 regioselectivity, 95:5 e.r.).  
 
RF 0.21 (4:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3409 (br, N-H) 3017, 2966 (C-H), 1705 
(C=O), 1615, 1456 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.95 (1H, br s, NH), 7.88-7.80 
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(2H, m, Phth), 7.74-7.67 (2H, m, Phth), 7.59 (1H, d, J = 7.9 Hz, indole), 7.33 (1H, d, J = 
8.1 Hz, indole), 7.16 (1H, ddd, J = 8.1, 6.9, 1.1 Hz, indole), 7.05 (1H, ddd, J = 7.9, 6.9, 1.1 
Hz, indole), 6.94 (1H, d, J = 2.3 Hz, NCH=C), 6.04 (1H, ddt, J = 15.4, 6.6, 1.2 Hz, =CHCH), 
5.62 (1H, dtd, J = 15.4, 5.9, 1.3 Hz, =CHCH2), 4.29 (2H, d, J = 5.9 Hz, CH2), 3.79 (1H, m, 
CHCH3), 1.43 (3H, d, J = 7.0 Hz, CH3CH); 13C NMR: (75 MHz, CDCl3) δ 168.2 (C), 139.5 
(CH), 136.7 (C), 134.1 (CH), 132.4 (C), 126.8 (C), 123.4 (CH), 122.1 (CH), 121.9 (CH), 
120.7 (CH), 120.4 (C), 119.7 (CH), 119.4 (CH), 111.3 (CH), 39.8 (CH2), 33.6 (CH), 20.6 
(CH3); Found (FTMS + p NSI) [M + H]+ 331.1447, C21H19N2O2 requires 331.1441; [𝛼]𝐷
25 ℃ 
= -2.2 (c = 3.68 in CHCl3); CSP-HPLC (Chiralpak IB, 12:1 hexane:IPA, 1 ml min-1) (R)-3.3ed 
28.0 min and (S)-3.3ed 30.0 min. 
 
(R,E)-2-(4-(1-Benzyl-1H-indol-3-yl)pent-2-en-1-yl)isoindoline-1,3-dione (3.3ee) 
 
General procedure followed and crude purified by column chromatography (eluent: 
10:1 to 8:1 petrol 40-60 oC/EtOAc) to yield product 3.3ee as a yellow oil (62.8 mg, 0.15 
mmol, 99%, >20:1 regioselectivity, 95:5 e.r.).  
 
RF 0.27 (8:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2965, 2928 (C-H), 1709 (C=O), 1612, 
1467 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.89-7.81 (2H, m, Phth), 7.74-7.66 (2H, m, 
Phth), 7.63 (1H, d, J = 7.9 Hz, indole), 7.35-7.22 (4H, m, indole + Ph), 7.20-7.01 (4H, m, 
indole + Ph), 6.92 (1H, s, NCH=C), 6.07 (1H, dd, J = 15.4, 6.6 Hz, =CHCH), 5.66 (1H, dt, J 
= 15.4, 6.3 Hz, =CHCH2), 5.28 (2H, s, CH2Ph), 4.31 (2H, d, J = 6.3 Hz, CH2HC=), 3.79 (1H, 
m, CHCH3), 1.46 (3H, d, J = 7.0 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 168.2 (C), 139.7 
(CH), 137.9 (C), 137.0 (C), 134.0 (CH), 132.4 (C), 128.9 (CH), 127.7 (CH), 127.5 (C), 126.9 
(CH), 125.0 (CH), 123.4 (CH), 121.9 (2CH), 119.9 (CH), 119.4 (C), 119.0 (CH), 109.9 (CH), 
50.1 (CH2), 39.8 (CH2), 33.6 (CH), 20.7 (CH3); Found (FTMS + p NSI) [M + H]+ 421.1909, 
C28H25N2O2 requires 421.1911; [𝛼]𝐷
24 ℃ = -4.2 (c = 4.30 in CHCl3); CSP-HPLC (Chiralpak 
IC, 98:2 hexane:IPA, 1 ml min-1) (R)-3.3ee 29.3 min and (S)-3.3ee 32.9 min. 
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(R,E)-tert-Butyl 3-(5-(1,3-dioxoisoindolin-2-yl)pent-3-en-2-yl)-1H-indole-1-carboxylate 
(3.3ef) 
 
General procedure followed and crude purified by column chromatography (eluent: 
12:1 to 10:1 petrol 40-60 oC/EtOAc) to yield product 3.3ef as a light yellow oil (20.8 mg, 
0.05 mmol, 32%, 18:1 regioselectivity, 55:45 e.r.).  
 
RF 0.20 (10:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2975, 2931 (C-H), 1711 (C=O), 1613, 
1452 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 8.10 (1H, d, indole), 7.89-7.80 (2H, m, Phth), 
7.76-7.65 (2H, m, Phth), 7.49 (1H, d, J = 7.8 Hz, indole), 7.32 (1H, s, indole), 7.30-7.23 
(1H, m, indole), 7.15 (1H, ddd, J = 7.8, 7.6, 1.0 Hz, indole), 5.99 (1H, ddt, J = 15.4, 6.5, 
1.2 Hz, =CHCH), 5.61 (1H, dtd, J = 15.4, 6.2, 1.3 Hz, =CHCH2), 4.28 (2H, d, J = 6.2 Hz, 
CH2), 3.67 (1H, m, CHCH3), 1.67 (9H, s, 3CH3), 1.42 (3H, d, J = 7.0 Hz, CH3CH); 13C NMR 
(75 MHz, CDCl3) δ 168.1 (C), 150.0 (C), 138.4 (CH), 135.9 (C), 134.1 (CH), 132.4 (C), 
130.0 (C), 124.5 (C), 124.4 (CH), 123.4 (CH), 122.9 (CH), 122.4 (CH), 122.1 (CH), 119.8 
(CH), 115.5 (CH), 83.6 (C), 39.7 (CH2), 33.4 (CH), 28.4 (CH3), 20.0 (CH3); Found (FTMS + p 
NSI) [M + NH4]+ 448.2227, C26H30N3O4 requires 448.2231; [𝛼]𝐷
22 ℃ = -1.5 (c = 1.34 in 
EtOH); CSP-HPLC (Chiralpak IB, 99.5:0.5 hexane:IPA, 1 ml min-1) (R)-3.3ef 18.5 min and 
(S)-3.3ef 23.1 min. 
 
(R,E)-2-(4-(5-Chloro-1H-indol-3-yl)pent-2-en-1-yl)isoindoline-1,3-dione (3.3eg) 
 
General procedure followed and crude purified by column chromatography (eluent: 
5:1 to 3:1 petrol 40-60 oC/EtOAc) to yield product 3.3eg as a light yellow oil (52.6 mg, 
0.14 mmol, 96%, 15:1 regioselectivity, 85:15 e.r.).  
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RF 0.30 (3:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3399 (br, N-H), 3018, 2966, 2930 (C-H), 
1705 (C=O), 1615, 1464 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 8.15 (1H, br s, NH), 7.87-
7.78 (2H, m, Phth), 7.74-7.65 (2H, m, Phth), 7.52 (1H, d, J = 1.9 Hz, indole), 7.22 (1H, d, 
J = 8.6 Hz, indole), 7.07 (1H, dd, J = 8.6, 2.0 Hz, indole), 6.94 (1H, d, J = 2.2 Hz, NCH=C), 
6.00 (1H, ddt, J = 15.4, 6.6, 1.3 Hz, =CHCH), 5.60 (1H, dtd, J = 15.4, 6.3, 1.4 Hz, =CHCH2), 
4.29 (2H, d, J = 6.3 Hz, CH2), 3.66 (1H, app. p, J = 6.8 Hz, CHCH3), 1.40 (2H, d, J = 7.0 Hz, 
CH3); 13C NMR (75 MHz, CDCl3) δ 168.2 (C), 139.2 (CH), 135.0 (C), 134.0 (CH), 132.3 (C), 
127.8 (C), 124.9 (C), 123.4 (CH), 122.2 (CH), 122.1 (CH), 119.9 (C), 119.0 (CH), 112.2 
(CH), 39.7 (CH2), 33.4 (CH), 20.5 (CH3); Found (FTMS + p NSI) [M + H]+ 365.1054, 
C21H18ClN2O2 requires 365.1051; [𝛼]𝐷
21 ℃ = +15.3 (c = 3.65 in CHCl3); CSP-HPLC 
(Chiralpak IB, 90:10 hexane:IPA, 1 ml min-1) (R)-3.3eg 19.0 min and (S)-3.3eg 20.3 min. 
 
(R,E)-4-(5-Methoxy-1H-indol-3-yl)pent-2-en-1-yl benzoate (3.3gi) 
 
General procedure followed and crude purified by column chromatography (eluent: 
12:1 to 6:1 petrol 40-60 oC/EtOAc) to yield product 3.3gi as a light yellow oil (33.7 mg, 
0.10 mmol, 67%, 11:1 regioselectivity, 97:3 e.r.).  
 
RF 0.23 (6:1 hexane/Et2O); νmax/cm-1 3401 (br, N-H), 3008, 2961, 2932 (C-H), 1708 
(C=O), 1483 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 8.01-7.91 (2H, m, Ar-H), 7.92 (1H, br 
s, NH), 7.52-7.40 (1H, m, Ar-H), 7.39-7.28 (2H, m, Ar-H), 7.20-7.09 (2H, m, indole), 6.98 
(1H, d, J = 2.4 Hz, indole), 6.86 (1H, d, J = 2.3 Hz, indole), 6.76 (1H, dd, J = 8.8, 2.4 Hz, 
indole), 6.01 (1H, dd, J = 15.4, 6.7 Hz, =CHCH), 5.72 (1H, dtd, J = 15.4, 6.3, 1.3 Hz, 
CHCH2), 4.73 (2H, d, J = 6.3 Hz, CH2O), 3.72 (3H, s, OCH3), 3.67 (1H, m, CHCH3), 1.40 
(3H, d, J = 7.0 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 166.6 (C), 153.9 (C), 140.6 (CH), 
133.0 (CH), 131.9 (C), 130.5 (C), 129.7 (CH), 128.4 (CH), 127.2 (C), 122.5 (CH), 121.5 
(CH), 119.6 (C), 112.2 (CH), 112.0 (CH), 101.6 (CH), 65.8 (CH2), 56.0 (CH3), 33.8 (CH), 
20.3 (CH3); Found (FTMS + p NSI) [M + H]+ 336.1598, C21H22NO3 requires 336.1594; 
[𝛼]𝐷
24 ℃ = -1.6 (c = 2.43 in CHCl3); CSP-HPLC (Chiralcel OD-H, 20:1 hexane:IPA, 1 ml min-
1) (R)-3.3gi 64.3 min and (S)-3.3gi 69.7 min. 
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 (R,E)-2-(4-(6-Chloro-1H-indol-3-yl)pent-2-en-1-yl)isoindoline-1,3-dione (3.3ek) 
 
General procedure followed and crude purified by column chromatography (eluent: 
5:1 to 4:1 petrol 40-60 oC/EtOAc) to yield product 3.3ek as a light yellow oil (53.8 mg, 
0.15 mmol, 98%, 15:1 regioselectivity, 82:18 e.r.).  
 
RF 0.29 (3:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3370 (br, N-H), 2967, 2930 (C-H), 1704 
(C=O), 1615, 1455 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 8.11 (1H, br s, NH), 7.88-7.78 
(2H, m, Phth), 7.74-7.65 (2H, m, Phth), 7.45 (1H, d, J = 8.4 Hz, indole), 7.29 (1H, d, J = 
1.3 Hz, indole), 6.98 (1H, dd, J = 8.4, 1.8 Hz, indole), 6.91 (1H, d, J = 2.2 Hz, indole), 5.99 
(1H, ddt, J = 15.4, 6.6, 1.2 Hz, =CHCH), 5.60 (1H, dtd, J = 15.4, 6.2, 1.2 Hz, =CHCH2), 4.29 
(2H, d, J = 6.2 Hz, CH2), 3.69 (1H, m, CHCH3), 1.40 (3H, d, J = 7.2 Hz, CHCH3); 13C NMR 
(75 MHz, CDCl3) δ 168.3 (C), 139.2 (CH), 137.0 (C), 134.1 (CH), 132.3 (C), 127.9 (C), 
125.4 (C), 123.4 (CH), 122.2 (CH), 121.4 (CH), 120.5 (CH), 120.4 (C), 120.0 (CH), 111.2 
(CH), 39.7 (CH2), 33.5 (CH), 20.5 (CH3); Found (FTMS + p NSI) [M + H]+ 365.1056, 
C21H18ClN2O2 requires 365.1051; [𝛼]𝐷
23 ℃ = -1.0 (c = 2.06 in CHCl3); CSP-HPLC (Chiralpak 
IB, 10:1 hexane:IPA, 1 ml min-1) (R)-3.3ek 17.1 min and (S)-3.3ek 18.8 min. 
 
(R,E)-2-(4-(1,2-Dimethyl-1H-indol-3-yl)pent-2-en-1-yl)isoindoline-1,3-dione (3.3el) 
 
General procedure followed and crude purified by column chromatography (eluent: 
8:1 to 5:1 petrol 40-60 oC/EtOAc) to yield product 3.3el as a light yellow oil (49.7 mg, 
0.14 mmol, 92%, >20:1 regioselectivity, 98:2 e.r.).  
 
RF 0.30 (5:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3019, 2976, 2927 (C-H), 1708 (C=O), 
1614, 1468 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.91-7.78 (2H, m, Phth), 7.76-7.63 
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(2H, m, Phth), 7.56 (1H, d, J = 8.0 Hz, indole), 7.24 (1H, d, J = 8.1 Hz, indole), 7.13 (1H, 
app. t, J = 7.5 Hz, indole), 7.00 (1H, app. t, J = 7.9 Hz, indole), 6.15 (1H, dd, J = 15.4, 5.1 
Hz, =CHCH), 5.62 (1H, dt, J = 15.4, 6.2 Hz, CHCH2), 4.31 (2H, d, J = 6.2 Hz, CH2N), 3.71-
3.86 (1H, m, CHCH3), 3.63 (3H, s, NCH3), 2.34 (3H, s, CH3), 1.47 (3H, d, J = 7.2 Hz, 
CHCH3); 13C NMR (75 MHz, CDCl3) δ 168.1 (C), 139.4 (CH), 136.7 (C), 133.9 (CH), 132.32 
(C), 132.28 (C), 126.5 (C), 123.3 (CH), 121.5 (CH), 120.4 (CH), 119.2 (CH), 118.6 (CH), 
113.8 (C), 108.7 (CH), 39.7 (CH2), 33.2 (CH), 29.5 (CH3), 20.2 (CH3), 10.6 (CH3); Found 
(FTMS + p NSI) [M + H]+ 359.1757, C23H23N2O2 requires 359.1754; [𝛼]𝐷
24 ℃ = -16.4 (c = 
2.93 in CHCl3); CSP-HPLC (Chiralpak IC, 95:5 hexane:IPA, 1 ml min-1) (R)-3.3el 21.2 min 
and (S)-3.3el 25.6 min. 
 
(R,E)-2-(4-(1,3-Dimethyl-1H-indol-2-yl)pent-2-en-1-yl)isoindoline-1,3-dione (3.3em) 
 
General procedure followed and crude purified by column chromatography (eluent: 
8:1 to 6:1 petrol 40-60 oC/EtOAc) to yield product 3.3em as a light yellow oil (25.5 mg, 
0.07 mmol, 48%, >20:1 regioselectivity , 82:18 e.r.).  
 
RF 0.17 (8:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2969, 2929 (C-H), 1709 (C=O), 1613, 
1469 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.89-7.81 (2H, m, Phth), 7.76-7.67 (2H, m, 
Phth), 7.49 (1H, d, J = 7.7 Hz, indole), 7.22 (1H, d, J = 8.0 Hz, indole), 7.15 (1H, ddd, J = 
8.0, 6.9, 1.2 Hz, indole), 7.06 (1H, ddd, J = 7.7, 6.9, 1.3 Hz, indole), 6.00 (1H, ddt, J = 
15.6, 4.4, 1.5 Hz, =CHCH), 5.56 (1H, dtd, J = 15.6, 5.9, 2.2 Hz, =CHCH2), 4.32 (2H, app. 
dt, J = 5.9, 1.5 Hz, CHCH2), 3.90-3.86 (1H, m, CHCH3), 3.63 (3H, s, NCH3), 2.25 (3H, s, 
CH3), 1.46 (3H, d, J = 7.3 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 168.1 (C), 138.0 (C), 
136.8 (C), 136.5 (CH), 134.1 (CH), 132.3 (C), 128.5 (C), 123.4 (CH), 123.2 (CH), 121.0 
(CH), 118.8 (CH), 118.3 (CH), 108.7 (CH), 106.7 (C), 39.5 (CH2), 32.7 (CH), 30.6 (CH3), 
18.7 (CH3), 9.2 (CH3); Found (FTMS + p NSI) [M + H]+ 359.1756, C23H23N2O2 requires 
359.1754; [𝛼]𝐷
22 ℃ = -3.5 (c = 1.72 in CHCl3); CSP-HPLC (Chiralpak IA, 96:4 hexane:IPA, 1 
ml min-1) (R)-3.3em 13.2 min and (S)-3.3em 14.1 min. 
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(R,E)-2-(4-(1-Methyl-1H-pyrrol-2-yl)pent-2-en-1-yl)isoindoline-1,3-dione (3.3en) + 
(R,E)-2-(4-(1-Methyl-1H-pyrrol-3-yl)pent-2-en-1-yl)isoindoline-1,3-dione (3.3en’’) 
 
General procedure followed and crude purified by column chromatography (eluent: 
6:1 petrol 40-60 oC/EtOAc) to yield a 1:1 mixture of isomers 3.3en and 3.3en’’ as a 
brown oil (25.4 mg, 0.09 mmol, 58%, >20:1 regioselectivity).  
RF 0.58 (5:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2966, 2930 (C-H), 1708 (C=O), 1613, 
1429 (C-C Ar); Found (FTMS + p NSI) [M + H]+ 295.1443, C18H19N2O2 requires 295.1441;  
Partial separation of the two isomers was achieved by 5% AgNO3/silica column 
chromatography (eluent: 3:1 to 1:3 petrol 40-60 oC/EtOAc) for characterisation 
purposes. 
 
(R,E)-2-(4-(1-Methyl-1H-pyrrol-2-yl)pent-2-en-1-yl)isoindoline-1,3-dione (3.3en) 
 
Using 1 M AgNO3 in MeCN dipped TLC plates RF 0.20 (1:1 petrol 40-60 oC/EtOAc); 1H 
NMR (300 MHz, CDCl3) δ 7.92-7.78 (2H, m, Phth), 7.78-7.66 (2H, m, Phth), 6.52 (1H, 
app. t, J = 2.3 Hz, pyrrole), 6.05 (1H, app. t, J = 3.3 Hz, pyrrole), 5.90 (1H, dd, J = 3.6, 1.9, 
Hz, pyrrole), 5.79 (1H, ddt, J = 15.4, 6.9, 1.4 Hz, =CHCH), 5.42 (1H, dtd, J = 15.4, 5.9, 1.2 
Hz, =CHCH2), 4.25 (2H, d, J = 5.9 Hz, NCH2), 3.48 (3H, s, NCH3), 3.50-3.36 (1H, m, 
CHCH3), 1.34 (3H, d, J = 7.0 Hz, CHCH3); 13C NMR (101 MHz, CDCl3) δ 168.1 (C), 138.3 
(CH), 135.6 (C), 134.1 (CH), 132.4 (C), 123.4 (CH), 122.7 (CH), 121.9 (CH), 106.6 (CH), 
105.0 (CH), 39.5 (CH2), 34.2 (CH), 33.9 (CH3), 20.0 (CH3). 
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(R,E)-2-(4-(1-Methyl-1H-pyrrol-3-yl)pent-2-en-1-yl)isoindoline-1,3-dione (3.3en’’) 
 
Using 1 M AgNO3 in MeCN dipped TLC plates RF 0.26 (1:1 petrol 40-60 oC/EtOAc); 1H 
NMR (300 MHz, CDCl3) δ 7.90-7.78 (2H, m, Phth), 7.77-7.66 (2H, m, Phth), 6.50 (1H, 
app. t, J = 2.4 Hz, pyrrole), 6.36 (1H, app. t, J = 1.7 Hz, pyrrole), 5.96 (1H, app. t, J = 2.1 
Hz, pyrrole), 5.87 (1H, ddt, J = 15.3, 7.2, 1.3 Hz, =CHCH), 5.53 (1H, dtd, J = 15.3, 6.6, 1.2 
Hz, =CHCH2), 4.27 (2H, d, J = 6.6 Hz, NCH2), 3.59 (3H, s, NCH3), 3.35 (1H, app. p, J = 7.0 
Hz, CHCH3), 1.26 (3H, d, J = 7.0 Hz, CHCH3); 13C NMR (101 MHz, CDCl3) δ 168.1 (C), 
140.5 (CH), 134.0 (C), 132.5 (C), 128.4 (CH), 123.4 (CH), 121.8 (CH), 121.2 (CH), 118.6 
(CH), 107.3 (CH), 39.8 (CH3), 36.2 (CH2), 34.8 (CH), 21.4 (CH3). 
 
(R,E)-2-(4-(1,2,5-Trimethyl-1H-pyrrol-3-yl)pent-2-en-1-yl)isoindoline-1,3-dione 
(3.3eo) 
 
General procedure followed using 15 mol% catalyst and crude purified by column 
chromatography (eluent: 15:1 to 8:1 petrol 40-60 oC/EtOAc) to yield product 3.3eo as a 
brown oil (23.3% mg, 0.07 mmol, 48%, >20:1 regioselectivity, 98:2 e.r.).  
 
RF 0.40 (5:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2927 (C-H), 1707 (C=O), 1651, 1466 (C-C 
Ar); 1H NMR (300 MHz, CDCl3) δ 7.89-7.78 (2H, m, Phth), 7.78-7.63 (2H, m, Phth), 5.87 
(1H, dd, J = 15.3, 6.7 Hz, =CHCH), 5.67 (1H, s, pyrrole), 5.49 (1H, dtd, J = 15.3, 6.3, 1.3 
Hz, =CHCH2), 4.24 (2H, d, J = 6.3 Hz, =CHCH2), 3.24-3.41 (1H, m, CHCH3), 3.33 (3H, s, 
NCH3), 2.17 (3H, s, CH3), 2.09 (3H, s, CH3), 1.24 (3H, d, J = 7.1 Hz, CHCH3); 13C NMR (75 
MHz, CDCl3) δ 168.2 (C), 140.8 (CH), 133.9 (CH), 132.4 (C), 126.9 (C), 123.32 (CH), 
123.30 (C), 121.6 (C), 120.4 (CH), 103.5 (CH), 39.9 (CH2), 33.8 (CH), 30.2 (CH3), 21.4 
(CH3), 12.6 (CH3), 10.3 (CH3);  Found (FTMS + p NSI) [M + H]+ 323.1757, C20H23N2O2 
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requires 323.1754; [𝛼]𝐷
22 ℃ = -6.9 (c = 0.58 in CHCl3); CSP-HPLC (Chiralpak IC, 95:5 
hexane:IPA, 1 ml min-1) (R)-3.3eo 14.4 min and (S)-3.3eo 16.7 min. 
 
(R,E)-2-(4-(5-Benzyl-1-methyl-1H-pyrrol-2-yl)pent-2-en-1-yl)isoindoline-1,3-dione 
(3.3ep) + (R,E)-2-(4-(5-benzyl-1-methyl-1H-pyrrol-3-yl)pent-2-en-1-yl)isoindoline-1,3-
dione (3.3ep’’) + (R,E)-2-(4-(2-benzyl-1-methyl-1H-pyrrol-3-yl)pent-2-en-1-
yl)isoindoline-1,3-dione (3.3ep’’’) 
   
General procedure followed and crude purified by column chromatography (eluent: 
10:1 to 4:1 petrol 40-60 oC/EtOAc) to yield a 5:1:1 mixture of isomers 3.3ep, 3.3ep’’ 
and 3.3ep’’’ as a brown oil (34.9 mg, 0.09 mmol, 60%) and a complex mixture of 3.3ep’ 
isomers (7.5 mg, 0.02 mmol, 13%, giving 5:1 regioselectivity).  
RF was not measured as the products streaked badly.  
Partial separation of the major isomer from the two other isomers was achieved by 5% 
AgNO3/silica column chromatography (eluent: 3:1 to 2:1 petrol 40-60 oC/EtOAc) for 
characterisation purposes. 
 
(R,E)-2-(4-(5-Benzyl-1-methyl-1H-pyrrol-2-yl)pent-2-en-1-yl)isoindoline-1,3-dione 
(3.3ep) 
 
Using 1 M AgNO3 in MeCN dipped TLC plates RF 0.22 (2:1 petrol 40-60 oC/EtOAc); 
νmax/cm-1 2973, 2929, 2868 (C-H), 1712 (C=O), 1494 (C-C Ar); 1H NMR (300 MHz, CDCl3) 
δ 7.87-7.80 (2H, m, Phth), 7.76-7.68 (2H, m, Phth), 7.25-7.07 (5H, m, Ar-H), 5.85 (1H, d, 
J = 3.4 Hz, pyrrole), 5.79 (1H, app. dt, J = 15.4, 1.3 Hz, =CHCH), 5.78 (1H, d, J = 3.4 Hz, 
pyrrole), 5.39 (1H, dtd, J = 15.4, 6.1, 1.2 Hz, =CHCH2), 4.24 (2H, d, J = 6.1 Hz, CH2N), 
3.90 (2H, s, CH2Ph), 3.41 (1H, app. p, J = 7.4 Hz, CHCH3), 3.23 (3H, s, NCH3), 1.33 (3H, d, 
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J = 7.0 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 168.5 (C), 140.0 (C), 138.8 (CH), 136.0 
(C), 134.5 (CH), 132.7 (C), 131.8 (C), 129.0 (CH), 128.9 (CH), 126.6 (CH), 123.8 (CH), 
123.0 (CH), 106.9 (CH), 103.9 (CH), 39.9 (CH2), 34.9 (CH), 33.8 (CH2), 31.1 (CH3), 20.3 
(CH3); Found (FTMS + p NSI) [M + H]+ 395.1909, C25H25N2O2 requires 395.1911. 
 
(R,E)-2-(4-(2,4,6-Trimethoxyphenyl)pent-2-en-1-yl)isoindoline-1,3-dione (3.3eb) 
 
General procedure followed and crude purified by column chromatography (eluent: 
4:1 petrol 40-60 oC/EtOAc) to yield product 3.3eb as a white crystalline solid (56.0 mg, 
0.15 mmol, 98%, >20:1 regioselectivity, 90:10 e.r.).  
 
RF 0.25 (4:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2937, 2871, 2838 (C-H), 1705 (C=O), 
1606, 1588, 1464 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.88-7.76 (2H, m, Phth), 7.75-
7.62 (2H, m, Phth), 6.15 (1H, ddt, J = 15.4, 6.9, 1.2 Hz, =CHCH2), 6.09 (2H, s, Ar-H), 5.49 
(1H, dtd, J = 15.4, 6.4, 1.4 Hz, =CHCH2), 4.22 (2H, d, J = 6.4 Hz, CH2N), 4.02 (1H, app. p, J 
=  7.1 Hz, CHCH3), 3.77 (3H, s, OCH3), 3.73 (6H, s, 2OCH3), 1.27 (3H, d, J = 7.1 Hz, 
CHCH3); 13C NMR (75 MHz, CDCl3) δ 168.1 (C), 159.4 (C), 158.8 (C), 139.9 (CH), 133.9 
(CH), 132.4 (C), 123.2 (CH), 120.7 (CH), 114.4 (C), 91.3 (CH), 55.8 (CH3), 55.3 (CH3), 39.9 
(CH2), 31.7 (CH), 19.0 (CH3);  Found (FTMS + p NSI) [M + H]+ 382.1648, C22H24NO5 
requires 382.1649; [𝛼]𝐷
17 ℃ = +2.9 (c = 3.44 in CHCl3); CSP-HPLC (Chiralpak IA, 95.5 
hexane:IPA, 1 ml min-1) (R)-3.3eb 13.1 min and (S)-3.3eb 15.2 min; m.p. 127 oC 
(Et2O/hexane).  
 
(R,E)-2-(4-(2,4-Dimethoxyphenyl)pent-2-en-1-yl)isoindoline-1,3-dione (3.3eq) 
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General procedure followed and crude purified by column chromatography (eluent: 
8:1 to 6:1 petrol 40-60 oC/EtOAc) to yield product 3.3eq as a white oily paste (51.1 mg, 
0.15 mmol, 97%, 10:1 regioselectivity, 57:43 e.r.).  
 
RF 0.30 (6:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3012, 2961, 2934, 2836 (C-H), 1709 
(C=O), 1610, 1586, 1504, 1466 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 7.89-7.79 (2H, m, 
Phth), 7.76-7.64 (2H, m, Phth), 7.00 (1H, d, J = 9.0 Hz, Ar-H), 6.48-6.39 (2H, m, Ar-H), 
5.94 (1H, ddt, J = 15.4, 5.7, 1.0 Hz, =CHCH), 5.52 (1H, dtd, J = 15.4, 6.2, 1.6 Hz, =CHCH2), 
4.27 (2H, d, J = 6.2 Hz, CH2N), 3.79 (1H, m, CHCH3), 3.78 (3H, s, OCH3), 3.77 (3H, s, 
OCH3), 1.24 (3H, d, J = 7.0 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 168.1 (C), 159.2 (C), 
157.7 (C), 139.3 (CH), 132.0 (CH), 132.4 (C), 127.9 (CH), 126.3 (C), 123.3 (CH), 121.6 
(CH), 104.2 (CH), 98.7 (CH), 55.5 (CH3), 55.4 (CH3), 39.9 (CH2), 34.1 (CH), 19.9 (CH3); 
Found (FTMS + p NSI) [M + H]+ 352.1546, C21H22NO4 requires 352.1543; CSP-HPLC 
(Chiralpak IB, 99:1 hexane:IPA, 1 ml min-1) (R)-3.3eq 21.3 min and (S)-3.3eq 25.6 min. 
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4.1 Introduction  
4.1.1 Previous developments in gold C-H activation 
The design of greener methods for synthesis has become an important and heavily 
researched area of chemistry.91 This drive towards greener methods has led to 
increased investigation into C-H functionalisation reactions which can greatly improve 
atom economy by removing the requirement for prefunctionalisation of substrates. 
Much of the research in this area focuses on the use of palladium, ruthenium and 
rhodium as the transition metal catalysts for C-H activation.92-98 However, gold has also 
been shown to activate C-H bonds under mild conditions. In addition to the attractive 
mild conditions under which gold can achieve C-H activation, gold also reacts 
regioselectively, removing the need for chelate-assisted directing groups and thus 
further increasing atom efficiency.99-101 These remarkable properties of gold allow for 
regioselective aryl-aryl cross-coupling reactions; a much sought after method for the 
preparation of highly valuable biaryl motifs.102 
 
Gold-catalysed C-H activation for aryl coupling was first demonstrated in a double C-H 
activation homocoupling methodology reported by Tse and co-workers (Scheme 
4.1).103, 104   
 
 
Scheme 4.1: Example of aryl homocoupling through double gold C-H activation103, 104   
 
The mechanism of this reaction is not discussed in detail but the results clearly 
demonstrate that it is possible for gold to catalyse aryl-aryl couplings and shows the 
potential for these couplings to be regioselective. Cross-coupling reactions were also 
attempted by Tse’s group but the selectivity observed was very low.104 Another 
drawback to this seminal work is the use of the oxidant rather than the arene as the 
limiting reagent.  
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Double C-H activation cross-couplings were later achieved by Larrosa under much 
improved conditions (Scheme 4.2).105 The gold-catalysed conditions allowed for the 
selective coupling of very electron-poor arenes with electron-rich heterocycles or 
arenes.  
 
 
Scheme 4.2: Cross-coupling through double gold C-H activation105 
 
Larrosa proposes that both coupling partners undergo C-H functionalization by gold 
catalysis with the selectivity being determined by the difference in preferred reactivity 
of gold(I) and gold(III). Gold(I) is thought to undergo C-H activation through a 
concerted metalation–deprotonation step and so selectively activates the most acidic 
C-H bond available. Conversely, gold(III) has been shown to readily undergo 
electrophilic aromatic substitution and so reacts preferentially with electron-rich 
aryls.106 This difference in reactivity allowed for the design of a catalytic cycle whereby 
the gold(I) reacts first with the electron-poor arene which has the most acidic protons 
and then, after oxidation, the gold(III) will selectively react with the more electron-rich 
coupling partner to give selective cross-couplings.  
 
The selectivity observed in Larrosa’s methodology is dependent on the coupling 
partners being very electron-poor and very electron-rich respectively, which limits the 
scope of the reaction. The temperature required for the reaction is also quite high, 
likely due to the difficult gold(I) C-H activation step required for the mechanism. In 
order to broaden the scope of gold-catalysed C-H functionalisations and also avoid the 
difficult gold(I) C-H activation step, other groups have used functionalised arenes as 
one of the coupling partners. This was pioneered by Lloyd-Jones and Russell who 
reported the first successful gold-catalysed cross-coupling of arylsilanes and arenes 
(Scheme 4.3).102, 107  
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Scheme 4.3: Seminal work on site selective arylation of arylsilanes102, 107 
 
Lloyd-Jones and Russell elegantly demonstrate the selectivity of the gold catalysts to 
preferentially activate one C-H bond, achieving excellent regioselectivity in a range of 
products. They also demonstrated that gold, unlike other transition metals, is tolerant 
of a range of functional groups, including bromo-groups which are unsuited to 
palladium cross-couplings.102, 107 A detailed investigation of the mechanism of this 
reaction shows that the gold(I) catalyst is first oxidised to gold(III) and then adds into 
the more reactive Si-C bond in a chemoselective manner. After ligand exchange, the 
gold catalyst, at this point in the cycle, much prefers to coordinate with the more 
electron-rich coupling partner and so the C-H activation step occurs exclusively with 
the arene, giving excellent selectivity for heterocoupling. The selectivity for 
heterocoupling is therefore dependent on the arene being more electron-rich than the 
arylsilane, limiting slightly, the otherwise broad scope of this reaction. 
 
Despite these impressive advances in gold-catalysed aryl-aryl couplings through C-H 
activation, there are still two main limitations in this field, the first being the restricted 
arene scope. Under mild conditions, gold(III) C-H bond activation is only observed with 
electron-rich or electron neutral arenes and so the arene scope for gold-catalysed C-H 
activations does not extend to electron-poor arenes. The second limitation of the 
previous work in this area is the requirement for stoichiometric amounts of oxidant.14 
Stoichiometric oxidant is essential in these procedures in order to access the 
Au(I)/Au(III) cycle necessary for cross-couplings. Additionally, the oxidant must also be 
relatively strong due to the high redox potential of the Au(I)/Au(III) couple (E0 = 1.41 
V).108 However, it would be much more beneficial to employ a catalytic and mild 
oxidant in place of the stoichiometric oxidant, which would avoid the generation of 
stoichiometric amounts of waste from the stoichiometric oxidant. This is particularly 
pertinent in C-H activation reactions as some of the benefits of not requiring 
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prefunctionalisation are lost by the generation of stoichiometric waste. Additionally, 
the use of stoichiometric oxidant limits the scope of the reaction to oxidant tolerant 
substrates. Employing photoredox catalysis to access the Au(I)/Au(III) cycle required 
for cross-couplings offers an attractive alternative to stoichiometric oxidants and has 
recently been investigated in gold-catalysed couplings. Importantly however, prior to 
this project, gold catalysed C(sp2)-H activation through photoredox catalysis had not 
been achieved. 
 
 4.1.2 Previous developments in dual gold- and photoredox-catalysis 
The use of visible light over conventional energy sources to drive organic 
transformations has been heavily investigated in recent years.109 This surge in research 
activity is partly due to the numerous environmental and economic benefits visible 
light driven reactions have over more conventional methods. Furthermore, the use of 
a photocatalyst, especially in cooperation with transition metal catalysis, has led to a 
wealth of entirely new transformations using visible light. The dual photoredox and 
transition metal catalysed coupling of aryl diazonium salts has been particularly useful 
in the development of new coupling reactions.110, 111 Accessing the Au(I)/Au(III) redox 
cycle of gold catalysts in this way is of particular interest as, due to gold(I)’s reluctance 
to oxidise, photoredox catalysis provides a mild alternative to using harsh 
stoichiometric oxidants.  
 
Dual gold- and photoredox- catalysis was first utilised to expand on established gold-
catalysed transformations by replacing the typical protodeauration step with reductive 
elimination to give a new C-C bonds. This work was initially developed by Glorius 
(2013)112 and Toste (2014)113 and has been recently reviewed.109, 114, 115 Also, 
photoredox-catalysed couplings can be performed without a separate photocatalyst 
using a digold catalyst.115 For the purposes of this introduction however, the focus will 
be on dual gold and photoredox-catalysed cross-couplings114 which are more relevant 
to this work.  
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Scheme 4.4: Dual gold and photoredox-catalysed arylation of terminal alkynes 
reported by Glorius and co-workers116 
 
 
Scheme 4.5: Dual gold and photoredox-catalysed arylation of alkynyltrimethylsilanes 
reported by Toste and co-workers117 
 
The first C-C bond forming reaction to utilise dual gold- and photoredox- catalysis was 
carried out independently by both Glorius (Scheme 4.4)116 and Toste (Scheme 4.5)117 in 
2016. The Sonogashira-type couplings proceed through the same general mechanism 
shown below (Scheme 4.6). Excitation of the ruthenium photocatalyst allows for the 
generation of an aryl radical from the diazonium salt which then adds to the gold(I) 
catalyst 4.I to give intermediate 4.II. The gold(II) complex 4.II is then oxidised to 
gold(III) 4.III through SET to regenerate the ground state ruthenium catalyst. The 
gold(III) catalyst then coordinates to the alkyne (intermediate 4.IV), undergoes C-H or 
C-Si insertion (intermediate 4.V) and then reductive elimination to provide the 
substituted alkyne product 4.6.  
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Scheme 4.6: Proposed mechanism of the dual gold and photoredox-catalysed 
Sonogashira-type couplings116, 117 
 
 
Scheme 4.7: Suzuki-type coupling reported previously in the Lee group118 
 
 
Scheme 4.8: Suzuki-type coupling reported by Fouquet119 
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Suzuki-type couplings are also possible using dual gold- and photoredox- catalysis. The 
coupling of boronic acids and diazonium salts through dual gold- and photoredox- 
catalysis was reported independently by the Lee group118 (Scheme 4.7) and Fouquet119 
(Scheme 4.8). These reactions proceed in a similar manner as the dual gold and 
photoredox-catalysed Sonogashira-type couplings described in Scheme 4.6 with the 
boronic acid taking the place of the alkyne to give sp2-sp2 couplings. Unlike in the 
Sonogashira-type couplings (Scheme 4.6) where the activation of the C-H or C-Si can be 
assumed to be carried out by the gold(III) species, in the Suzuki-type couplings gold(I) 
or gold(III) catalysts could activate the C-B bond. This means that the C-B activation 
could occur before or after the oxidation of the gold(I) species. Further investigation by 
the Lee group led to the proposal of two possible catalytic cycles (Scheme 4.9 and 
4.10). In the first catalytic cycle (Scheme 4.9), the aryl radical, generated by the 
photocatalysed breakdown of the diazonium salt, adds to the gold(I) catalyst 4.I and 
then, after SET oxidation, the gold(III) species 4.III undergoes transmetalation with 
the boronic acid to give intermediate 4.VI. Reductive elimination of 4.VI then 
provides the desired biaryl product 4.3 and regenerates the gold(I) catalyst 4.I. 
Alternatively (Scheme 4.10), the gold(I) catalyst 4.I can first add into the C-B bond120 to 
give intermediate 4.VII and then undergo radical addition followed by SET to provide 
the same gold(III) intermediate 4.VI seen in Scheme 4.9. As in the “oxidation first” 
mechanism (Scheme 4.9) reductive elimination then delivers the product and 
completes the catalytic cycle. 
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Scheme 4.9: “Oxidation first” proposed mechanism116 
 
 
Scheme 4.10: “Transmetalation first” proposed mechanism116 
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Upon further investigation, the Lee group proposed that the mechanism by which the 
reaction proceeds is dependent on the catalyst which is used. When the neutral 
catalyst Ph3PAuCl was used in the reaction the “oxidation first” mechanism (Scheme 
4.9) is thought to be preferred. The “oxidation first” mechanism is suggested in this 
case as side product 4.9 is detected during stoichiometric NMR studies, implying the 
formation of 4.III (Scheme 4.9). When the catalyst is switched to Ph3PAuNTf2, side 
product 4.9 is not detected suggesting the mechanism has changed and is reacting 
through the “transmetalation first” pathway (Scheme 4.10). The transmetallated 
intermediate 4.VII is detected during stoichiometric NMR studies, providing evidence 
for the “transmetallation first” pathway in this case. 
 
The examples discussed in this section show that photoredox can be used to access the 
Au(I)/Au(III) cycle under mild conditions and allows for a range of cross-coupling 
reactions with diazonium salts as one of the coupling partners. Prior to the work 
detailed in this chapter however, C(sp2)-H activation using dual gold- and photoredox- 
catalysis for aryl–aryl cross-couplings had not been reported.  
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4.2 Project aims 
The aim of the project was to develop the first dual gold- and photoredox-catalysed 
aryl–aryl cross-coupling reaction which proceeds through C-H activation and does not 
require a stoichiometric oxidant (Scheme 4.11).  
 
 
Scheme 4.11: Desired aryl-aryl cross-coupling through dual gold and photoredox-
catalysed C-H activation 
  
Given the recent advances in gold-catalysed C-H activations and the development of 
dual gold- and photoredox- catalysis for cross-couplings (Section 4.1), the following 
catalytic cycle was envisaged (Scheme 4.12).  
 
 
Scheme 4.12: Designed mechanism for aryl-aryl cross-coupling through C-H activation 
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Photoredox- catalysis will be employed to access the Au(I)/Au(III) cycle through 
addition of the radical aryl from the diazonium salt 4.2 and subsequent SET. The 
gold(III) species 4.III can then achieve C-H activation of a suitable arene 4.1 followed 
by reductive elimination to provide the biaryl product 4.3 (Scheme 4.12).  
 
The dual gold- and photoredox-catalysed aryl–aryl cross-coupling methodology 
described will be a significant advancement as the mild conditions under which the 
Au(I)/Au(III) cycle is accessed allows oxidant-sensitive substrates to be subjected to the 
conditions and avoids the production of stoichiometric waste from the oxidant. 
Additionally, the use of gold C-H activation removes the need for prefunctionalisation 
of substrates and takes advantage of the regioselectivity seen in gold-catalysed C-H 
activations, removing the need for chelate assisted directing groups.  
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4.3 Results and Discussion 
4.3.1 Optimisation 
The starting point for the optimisation of the dual gold- and photoredox-catalysed C-H 
activation cross-coupling reaction was based on the Suzuki-type cross-coupling 
previously achieved in the group116 (Scheme 4.7). Replacing the boronic acid 4.8 with 
mesitylene 4.1a and removing the water, which was included to improve boronic acid 
solubility and assist transmetalation, gave our initial trial conditions (Scheme 4.13). 
The light source used for this reaction was also changed to the more easily 
standardised blue LEDs.  To our delight, the conditions initially gave a promising yield 
of 31% (Scheme 4.13) and were successfully optimised (Table 4.1). 
 
Scheme 4.13: Initial trial conditionsЯ 
 
 
Entry Equiv. 
4.1a 
Equiv. 
4.2a 
PPh3AuNTf2  
(mol%) 
Ru(bpy)3(PF6)2 
(mol%) 
Solvent NMR 
yield  
(%)[a] 
1Я 1 2 5 2.5 MeCN 31% 
2Я 1 2 5 2.5 THF ND 
3Я 1 2 5 2.5 DMF ND 
4Я 1 2 5 2.5 Toluene ND 
5Я 1 2 5 2.5 DCM 7% 
6Я 1 2 5 2.5 DCE 8% 
7 1 2 5 2.5 MeOH 19% 
8Я 1 1 5 2.5 MeCN 51% 
9 2 1 5 2.5 MeCN 61% 
10 3 1 5 2.5 MeCN 67% 
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11 4 1 5 2.5 MeCN 68% 
12Я 5 1 5 2.5 MeCN 52% 
13 10 1 5 2.5 MeCN 54% 
14Я 3 1 5 5 MeCN 43% 
15Я 3 1 5 1 MeCN 63% 
16 3 1 5 Eosin Y[b] MeCN 62% 
17 3 1 5 Fluorescein[b] MeCN 58% 
18 3 1 10 2.5 MeCN 81% 
19Я[c] 3 1 10 2.5 MeCN 51% 
20Я 1 2 - 2.5 MeCN <13% 
21Я 1 2 5 - MeCN ND 
22Я[d] 1 2 5 2.5 MeCN <9% 
[a] Dimethylsulfone was used as the internal standard. [b] 2.5 mol%. [c] Reaction carried out 
under air. [d] No light.   ND = not detected  
Table 4.1: Optimisation of reaction conditions 
 
A scope of solvents showed that the solvent used in the trial reaction (MeCN, Entry 1, 
Table 4.1) outperformed the other solvents investigated (Entries 2-7, Table 4.1). 
Changing the equivalents so that the arene rather than the diazonium salt was in 
excess was investigated next with much more success (Entries 8-13, Table 4.1). The 
optimum number of equivalents of arene was found to be 3 or 4 (Entries 10 and 11, 
Table 4.1) with the yield dropping off when higher equivalents of arene were used 
(Entries 12 and 13, Table 4.1). The photocatalyst was investigated next with an 
increase in loading giving a decrease in yield (43% Entry 14 vs. 67% Entry 10, Table 4.1). 
With this in mind the loading of Ru(bpy)3(PF6)2 was reduced, however a slight decrease 
in yield was observed (63% Entry 15 vs. 67% Entry 10, Table 4.1). Pleasingly, the 
organic photocatalysts Eosin Y and Fluorescein offer a viable alternative (62% and 58% 
respectively, Entries 16 and 17, Table 4.1) to the more expensive ruthenium catalyst 
Ru(bpy)3(PF6)2 (67%, Entry 10, Table 4.1). Finally, the gold catalyst loading was 
increased to 10 mol% to give an optimised NMR yield of 81% (Entry 18, Table 4.1). As 
expected, the yield of the reaction was found to drop significantly when the reaction 
was not carried out under an inert atmosphere (51%, Entry 19, Table 4.1). Other 
control reactions carried out during the optimisation process showed that omission of 
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the gold or ruthenium catalysts or the light was detrimental to the reaction (Entries 20-
22, Table 4.1). 
 
4.3.2 Diazonium salt scope  
With optimised conditions in hand (Entry 18, Table 4.1) an investigation into the scope 
of the reaction commenced (Table 4.2).  
 
 
Entry Diazonium  
salt 
Cond. Equiv. 
4.1a 
Temp. 
 
Product Yield[a] 
1 
 
A 3 r.t. 
 
73% 
 
2 
 
A 3 r.t. 
 
80% 
 
3 
  
A 3 r.t. 
 
63% 
 
4 
 
A 3 r.t. 
 
73% 
 
5 
 
A 3 r.t. 
 
50% 
 
6 
 
A 
B 
3 
3 
r.t. 
50 oC 
 
57% 
62% 
7 
 
A 3 r.t. 
 
59% 
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8 
 
A 3 r.t. 
 
37% 
 
9 
 
A 
B 
C 
3 
3 
10 
r.t. 
50 oC 
50 oC 
 
48% 
50% 
60% 
10 
 
A 
C 
3 
10 
r.t. 
50 oC 
 
41% 
44% 
11 
 
A 3 r.t. 
 
67% 
 
12 
 
A 3 r.t. 
 
62% 
 
13 
 
A 3 r.t. 
 
48% 
 
14 
 
A 3 r.t. 
 
48% 
 
15 
 
A 3 r.t. 
 
<26%[b] 
 
[a] Isolated yield. [b] Yield of impure product 
Table 4.2: Diazonium salt scope 
 
Under the optimised conditions, mesitylene 4.1a was reacted with a range of aryl 
diazonium salts 4.2. The fluoro-, chloro-, and bromo- substituted aryl diazonium salts 
were subjected to our conditions first and reacted well giving the desired products 
4.3ab-4.3ad in good yields (80%, 63% and 73% respectively, Entries 2-4, Table 4.2). The 
final halogenated diazonium salt investigated, iodo-substituted 4.2e, gave a slightly 
lower yield (4.3ae, 50%, Entry 5, Table 4.2) presumably due to the more labile C-I 
bond. Pleasingly though, para- and meta- nitro substituted substrates 4.2f and 4.2g 
reacted smoothly (4.3af and 4.3ag, 57% (cond. A) and 59%, Entry 6 and 7, Table 4.2) 
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with 4.3af being obtained in a slightly higher yield when reacted at 50 oC (62% (cond. 
B), Entry 6, Table 4.2).  Understandably, moving to the ortho- substituted diazonium 
salt 4.2h gave a drop in yield for the reaction (4.3ah, 37%, Entry 8, Table 4.2) 
presumably due to steric hindrance. Unfortunately, the poorer yield of ortho-
substituted 4.3ah could not be improved by raising the temperature of the reaction. 
Disubstituted and electron-poor 4.2i and 4.2j were targeted next. However, the yields 
under conditions A were initially disappointing (4.3ai and 4.3aj, 48% and 41% (cond. 
A), Entries 9 and 10, Table 4.2) and raising the reaction temperature only resulted in an 
increase in diazonium salt homocoupling (4.3ai, 50% (cond. B), Entry 9, Table 4.2). 
However, to our delight, when the equivalents of mesitylene were also increased 
(Conditions C) the yield of biaryl 4.3ai was raised to 60% (cond. C, Entry 9, Table 4.2). 
Disappointingly, when substrate 4.2j was subjected to conditions C, the increase in 
yield of 4.3aj was much more modest (44%, Entry 10, Table 4.2). Next, slightly 
electron-poor and electroneutral substrates 4.2k and 4.2l were investigated and their 
respective products obtained in good yields (4.3ak and 4.3al, 67% and 62%, Entries 11 
and 12, Table 4.2), however, the yield of the reaction dropped when moving to more 
electron-rich diazonium salts (4.3am and 4.3an, 48% and 48%, Entries 13 and 14, Table 
4.2). Unfortunately, increasing the temperature and equivalents of mesitylene did not 
improve the yield for these substrates (4.2m and 4.2n) and the methoxy-substituted 
diazonium salt 4.2o was found to be much less suited to the reaction, providing impure 
4.3ao in a low yield (<26%, Entry 15, Table 4.2).  
 
4.3.3 Arene scope  
The arene scope of the reaction was investigated next, targeting electron-rich and 
electron neutral arenes. As previously discussed, electron-poor arenes are unsuited to 
the electrophilic aromatic substitution step required for the reaction to proceed (see 
Section 4.1.1). 
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Entry Arene Cond. Equiv. 
4.1a 
Temp. 
 
Major product Yield[a] 
1 
 
A 3 r.t. 
 
73% 
 
2 
 
A 3 r.t. 
 
35% 
 
3 
 
 
A 3 r.t. 
 
<5%[b] 
 
4 
 
A 
C 
3 
10 
r.t. 
50 oC 
 
50%[b] 
82% 
 
5 
 
C 10 50 oC 
 
82% 
 
6 
 
C 10 50 oC 
 
76%[c] 
4.3fa:4.3fa’ 
2.7:1 
56% 4.3fa[d] 
 
7 
 
C 10 50 oC 
 
71%[c] 
4.3ga:4.3ga’ 
5.7:1 
 
8 
 
C 10 50 oC 
 
56% 
 
9 
 
C 10 50 oC 
 
58% 
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10 
 
C 10 50 oC 
 
52% 
 
11 
 
C 10 50 oC 
 
57% 
 
12 
 
C 10 50 oC 
 
37% 
 
13 
 
C 10 50 oC 
 
trace[b] 
4.3ma 
 
 
<50%[e] 
 
14 
 
C 10 50 oC 
 
92%[b] 
(4.3na ND) 
[a] Isolated yield. [b] Determined by 1H NMR. [c] Combined isolated yield of both isomers 
obtained. [d] Isolated yield of major product. [e] Yield of impure product. ND = Not detected. 
Table 4.3: Arene scopeЯ 
 
Although the already fairly sterically hindered mesitylene performed well under our 
conditions, when larger alkyl groups are used in place of the methyl groups of 
mesitylene the yield of the reaction dropped of significantly (4.3ba and 4.3ca, 35% and 
<5%, Entries 2 and 3, Table 4.3). Para-xylene 4.1d was investigated next but 
disappointingly gave a NMR yield of only 50% under conditions A (4.3da, Entry 4, Table 
4.3). To our delight, this could be improved greatly by increasing the temperature to 
50 oC and the equivalents of arene to 10 (Conditions C) (4.3da, 82%, Entry 4, Table 4.3). 
Conditions C were found to be much more general and were applied to the remainder 
of the substrate scope.  
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The regioselectivity conferred by the gold-catalysed C-H activation step was examined 
next and pleasingly showed perfect regioselectivity giving 4.3ea as the only product, in 
excellent yield (82%, Entry 5, Table 4.3). The high yield and selectivity achieved for 
4.3ea is in stark contrast to the photocatalyst-only approach previously reported,121 
showing the importance of the gold catalyst in this methodology (see Section 4.3.4). 
Toluene 4.1f and tert-butylbenzene 4.1g were also subjected to the reaction 
conditions, predictably forming a mixture of para- and ortho- substituted products 
(2.7:1 and 5.7:1 respectively, Entries 6 and 7, Table 4.3). Thankfully, the overall yields 
for the two reactions are good (4.3fa and 4.3ga, 76% and 71%, Entries 6 and 7, Table 
4.3) and the major para-isomer of 4.3fa can be isolated in a 56% yield. To our delight, 
biphenyl 4.1h reacts exclusively at the para-position giving tricyclic 4.3ha in good yield 
(56%, Entry 8, Table 4.3) and benzene 4.1i also reacts smoothly (4.3ia, 58%, Entry 9, 
Table 4.3). Substituted mesitylene substrates 4.1j and 4.1k also reacted well despite 
bearing electron-withdrawing groups (4.3ja and 4.3ka, 52% and 57%, Entries 10 and 
11, Table 4.3). However, as predicted, moving to more strongly electron withdrawing 
substituents does lower the yield of the reaction (4.3la, 37%, Entry 12, Table 4.3). 
Unfortunately, very electron-rich substrates are unsuited to the reaction conditions 
due to the competing azo coupling reaction122, 123 (4.3ma’ and 4.3na’, Entries 13 and 
14, Table 4.3). 
 
 
Scheme 4.14: Intramolecular examplesЯ 
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To our delight, the intramolecular version of the reaction was found to proceed with 
excellent yield (Scheme 4.14) and with no oxidation of the sulfide or benzylic positions 
of the substrates. The reactions’ tolerance of these readily oxidizable moieties is due to 
the use of mild photoredox conditions, rather than harsh stoichiometric oxidants 
previously used in the gold-catalysed C-H activations.  
 
4.3.4 Investigation into regioselectivity 
 
Scheme 4.15: Our optimised dual gold- and photoredox- catalysed conditionsЯ 
 
 
Scheme 4.16: Our optimised conditions without gold catalystЯ 
 
 
Scheme 4.17: Reported photoredox only conditionsЯ 121 
 
One of the main advantages of gold-catalysed C-H activation is the regioselectivity 
conferred in the C-H activation step. This is demonstrated very clearly in the arylation 
of meta-xylene which occurs totally selectively and in high yield under our dual gold- 
and photoredox-catalysed conditions (82%, Scheme 4.15). This is in stark contrast to 
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the same conditions without the gold catalyst which give a much lower yield of an 
inseparable mixture of all three possible isomers (30%, Scheme 4.16). This shows 
conclusively that the reaction developed is a dual gold- and photoredox-catalysed 
reaction and not a photocatalysis-only process. Also, the poor regioselectivity 
observed without the gold catalyst shows that the gold-catalysed C-H activation step is 
crucial to obtaining the excellent regioselectivity observed under our conditions. 
Comparison with a reported photocatalyst-only reaction (Scheme 4.17) shows that 
under more optimised conditions (using a larger excess of arene 4.1e) the yield can be 
improved. However, the combined yield is still substantially lower under the reported 
photocatalyst-only conditions compared to our dual gold- and photoredox-catalysed 
methodology (58% vs. 82%) and crucially the regioselectivity observed is much poorer.     
 
4.3.5 Proposed mechanism 
 
Scheme 4.18: Proposed mechanism 
 
The dual gold- and photoredox- catalytic cycle is thought to begin with the excitation 
of the ruthenium photocatalyst, which can then reduce the diazonium salt 4.2 to 
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generate the aryl radical. The gold(I) catalyst then undergoes radical addition with the 
aryl radical to give gold complex 4.II, which can undergo single electron transfer (SET) 
to regenerate the ruthenium photocatalyst and provide the crucial gold(III) 
intermediate 4.III. Alternatively, the gold complex 4.II could undergo SET to another 
diazonium salt 4.2 to generate another aryl radical. This aryl radical can in turn add to 
another gold(I) catalyst, thereby regenerating the gold complex 4.II and allowing for 
radical chain propagation which does not require the photocatalytic cycle to turn over. 
Quantum yield calculations carried out on the related dual gold- and photoredox- 
catalysed alkyne coupling reaction114 (Scheme 4.4) show that this radical chain 
pathway is possible under similar conditions. The gold(III) intermediate 4.III, which is 
known to be formed in the reaction due to NMR detection of 4.9,111, 116 can then 
undergo the crucial C-H activation step. This step confers regioselectivity to the 
product as it occurs through the Wheland-type intermediate shown (Scheme 4.18). 
Finally reductive elimination provides the biaryl product 4.3 and regenerates the 
gold(I) catalyst 4.I.  
 
Consideration of the proposed mechanism can help to explain some of the trends seen 
in the scope of the reaction. Firstly, as predicted, electron-poor arenes are not suited 
to this reaction (Section 4.3.3) as the crucial C-H activation step occurs through 
electrophilic auration. Also, electron-rich diazonium salts (4.2m-4.2o, Section 4.3.2) do 
not perform as well in the reaction. This could be because the gold(III) intermediate 
4.III will be less electron deficient and so less reactive with an electron-rich aryl 
substituent.  
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4.4 Conclusions 
Dual gold- and photoredox- catalysed aryl–aryl cross-coupling through C–H activation 
has been achieved for the first time. This work also constitutes the first gold-catalysed 
C-H activation of an arene for aryl–aryl cross-coupling which does not require 
stoichiometric oxidant, cited as one of the major limitations in gold-catalysed C–H 
activations.101 The avoidance of stoichiometric oxidant allows the scope to be 
expanded to oxidant sensitive substrates and also avoids the production of 
stoichiometric waste. The other major limitation in the field of gold-catalysed C–H 
activation reactions is the restricted arene scope. This limitation is due to electron-
poor arenes being unsuited to the electrophilic auration step of the catalytic cycle and 
could not be overcome in this project. As a result, the arene scope of the reaction is 
limited to electron-rich and electron neutral substrates, however, it did show good 
functional group tolerance. Unfortunately, competing azo-coupling meant that very 
electron-rich arenes such as trimethoxybenzene were also unsuited to the reaction, 
but pleasingly the intramolecular version of the reaction shows great promise. 
Gratifyingly, the diazonium scope was much broader with electron-poor diazonium 
salts being higher yielding in the reaction.  
 
A short investigation into the regioselectivity observed in the reaction found that, as 
suspected, the gold C-H activation step confers regioselectivity to the product. When 
the gold catalyst was removed from the reaction, the yield dropped and the previously 
excellent regioselectivity was lost. Although the yield could be partially recovered 
under previously reported photocatalyst-only conditions,121 the regioselectivity was 
still very poor. This demonstrates that the methodology developed is indeed a dual 
gold- and photoredox-catalysed process and shows the importance of the gold-
catalysed C-H activation step for conferring regioselectivity in this reaction.  
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4.5 Experimental 
4.5.1 General considerations 
1H NMR spectra was recorded on Bruker AV 300 and AV 400 spectrometers at 300 and 
400 MHz respectively and referenced to residual solvent. 13C NMR spectra were 
recorded using the same spectrometers at 75 and 100 MHz respectively. Chemical shift 
data are quoted in parts per million (ppm) and are referenced to tetramethylsilane 
(TMS) or to residual solvent peaks (CDCl3 at δH 7.26). J values are given in Hz and s, d, 
dd, dt, ddt, dtd, t, td, tt, q, qd, qt, p and m abbreviations correspond to singlet, 
doublet, doublet of doublet, doublet of triplet, doublet of doublet of triplet, doublet of 
triplet of doublet, triplet, triplet of doublet, triplet of triplet, quartet, quartet of 
doublet, quartet of triplet, quintet and multiplet respectively. Mass spectra were 
obtained at the EPSRC National Mass Spectrometry Service Centre in Swansea. 
Infrared spectra were obtained on Perkin-Elmer Spectrum 100 FT-IR Universal ATR 
Sampling Accessory, deposited neat or as a chloroform solution to a diamond/ZnSe 
plate. Flash column chromatography was carried out using silica gel 60 from Fisher 
Chemicals or Silicagel 60A from Fluorochem and TLC was performed using Merck silica 
gel 60 F254 pre-coated sheets and visualised by UV (254 nm) or stained by the use of 
aqueous acidic KMnO4 or aqueous acidic ceric ammonium molybdate as appropriate. 
Chemicals were purchased from Sigma-Aldrich, Acros, Apollo Scientific, Fisher, 
Fluorochem and Manchester Organics chemical companies and used without further 
purification unless otherwise stated. MeCN was dried using an MBRAUN SPS-800 
solvent purification system. 
 
Unless otherwise stated, all dual gold and photoredox reactions were carried out 
under inert atmosphere using Schlenk techniques. Prior to each catalytic run, the 
reaction vessel was wrapped in aluminium foil and the mixture was degassed in the 
dark through three freeze-thaw (1 min)-pump cycles. The foil was then removed, and 
light irradiation was performed using blue LEDs (1.5 Watt/foot). 
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4.5.2 Dual gold- and photoredox- catalysed aryl–aryl cross-couplings 
 
General procedure A: Diazonium salt 4.2 (0.1 mmol), PPh3AuNTf2 (7.8 mg, 0.01 mmol, 
10 mol%) and Ru(bpy)3(PF6)2 (2.2 mg, 2.5x10-3 mmol) were added to a nitrogen or 
argon backfilled Schlenk tube and wrapped in aluminium foil before MeCN (1 ml) was 
added, and the mixture was degassed using 3 freeze-pump-thaw cycles. The mixture 
was allowed to warm to r.t. and arene 4.1 (3 equiv.) was added. The foil was removed 
and the reaction mixture was stirred for 16 h at r.t., under blue LED light irradiation. 
The mixture was then diluted with EtOAc (10 ml) and washed with distilled water. The 
aqueous phase was extracted with EtOAc and the combined organic phases were 
washed with brine, dried over magnesium sulfate and concentrated under vacuum 
before purification by column chromatography to give product 4.3. 
General procedure B: As in general procedure A, but the reaction was heated to 50 °C 
instead of r.t. 
General procedure C: As in general procedure A, but 10 equiv. of arene 1 was used and 
the reaction was heated to 50 °C instead of r.t. 
 
Ethyl 2',4',6'-trimethyl-[1,1'-biphenyl]-4-carboxylate (4.3aa)  
  
 
 
 
General procedure A followed and crude purified by column chromatography (eluent: 
50:1 petrol 40-60 oC/EtOAc) to yield product 4.3aa as a light yellow oil (19.6 mg, 0.073 
mmol, 73%). 
 
RF 0.21 (50:1 petrol 40-60 oC/EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.09 - 8.17 (2H, m, 
Ar-H), 7.23 - 7.29 (2H, m, Ar-H), 6.98 (2H, s, Ar-H), 4.42 (2 H, q, J = 7.3 Hz, CH2), 2.37 
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(3H, s, CH3), 2.02 (6H, s, 2CH3), 1.45 (3 H, t, J = 7.3 Hz, CH3); NMR data matches 
literature values124 and characterisation carried out by Vincent Gauchot 
 
4'-Fluoro-2,4,6-trimethyl-1,1'-biphenyl (4.3ab)  
 
General procedure A followed and crude purified by column chromatography (eluent: 
petrol 40-60 oC) to yield product 4.3ab as a light yellow oil (17.2 mg, 0.080 mmol, 
80%). 
 
RF 0.27 (petrol 40-60 oC); 1H NMR (300 MHz, CDCl3) δ 7.12 – 7.16 (4H, m, Ar-H), 6.98 
(2H, s, Ar-H), 2.37 (3H, s, CH3), 2.04 (6H, s, 2CH3); 13C NMR (75 MHz, CDCl3) δ 161.8 (d, J 
= 244.8 Hz, CF), 138.1 (C), 137.0 (d, J = 3.5 Hz, CCHCHCF), 136.9 (C), 136.3 (2C), 131.0 
(d, J = 7.8 Hz, CHCHCF), 128.3 (2CH), 115.4 (d, J = 21.1 Hz, CHCF), 21.2 (CH3), 20.9 
(2CH3); Found (TOF MS ASAP+) [M]+ 214.1158, C15H15F requires 214.1158; NMR data 
matches literature values.125 
 
4'-Chloro-2,4,6-trimethyl-1,1'-biphenyl (4.3ac) 
 
 
 
General procedure A followed and crude purified by column chromatography (eluent: 
petrol 40-60 oC) to yield product 4.3ac as a light yellow oil (14.6 mg, 0.063 mmol, 63%). 
 
RF 0.27 (petrol 40-60 oC); 1H NMR (300 MHz, CDCl3) δ 7.37 – 7.43 (2H, m, Ar-H), 7.05 – 
7.12 (2H, m, Ar-H), 6.95 (2H, s, Ar-H), 2.34 (3H, s, CH3), 2.00 (6H, s, 2CH3); 13C NMR (75 
MHz, CDCl3) δ 139.5 (C), 137.7 (C), 136.9 (C), 135.9 (2C), 132.5 (C), 130.7 (2CH), 128.7 
(2CH), 128.2 (2CH), 21.0 (CH3), 20.7 (2CH3); Found (TOF MS EI+) [M]+ 230.0862, 
C15H15Cl requires 230.0869; NMR data matches literature values.126 
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4'-Bromo-2,4,6-trimethyl-1,1'-biphenyl (4.3ad)  
 
 
 
General procedure A followed and crude purified by column chromatography (eluent: 
petrol 40-60 oC) to yield product 4.3ad as a light yellow oil (20.1 mg, 0.073 mmol, 
73%). 
 
RF 0.29 (petrol 40-60 oC); 1H NMR (300 MHz, CDCl3) δ 7.54 – 7.64 (2H, m, Ar-H), 7.02 – 
7.13 (2H, m, Ar-H), 6.99 (2H, s, Ar-H), 2.37 (3H, s, CH3), 2.04 (6H, s, 2CH3); 13C NMR (75 
MHz, CDCl3) δ 140.0 (C), 137.9 (C), 137.1 (C), 135.9 (2C), 131.7 (2CH), 131.3 (2CH), 
128.3 (2CH), 120.8 (C), 21.2 (CH3), 20.9 (2CH3); Found (TOF MS EI+) [M]+ 274.0356, 
C15H15Br requires 274.0357; NMR data matches literature values.127 
 
4'-Iodo-2,4,6-trimethyl-1,1'-biphenyl (4.3ae) 
 
 
 
General procedure A followed and crude purified by column chromatography (eluent: 
petrol 40-60 oC) to yield product 4.3ae as a light yellow oil (16.0 mg, 0.050 mmol, 50%). 
 
RF 0.28 (petrol 40-60 oC); νmax/cm-1 2918, 2853 (C-H), 1471 (C-C Ar); 1H NMR (300 MHz, 
CDCl3) δ 7.70 – 7.80 (2H, m, Ar-H), 6.96 (2H, s, Ar-H), 6.84 – 6.93 (2H, m, Ar-H), 2.33 
(3H, s, CH3), 2.00 (6H, s, 2CH3); 13C NMR (75 MHz, CDCl3) δ 140.8 (C), 137.9 (C), 137.7 
(2CH), 137.1 (C), 135.9 (2C), 131.6 (2CH), 128.3 (2CH), 92.3 (C), 21.2 (CH3), 20.9 (2CH3); 
Found (TOF MS EI+) [M]+ 322.0225, C15H15I requires 322.0219. 
 
 2,4,6-Trimethyl-4'-nitro-1,1'-biphenyl (4.3af)  
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General procedure A followed and crude purified by column chromatography (eluent: 
50:1 petrol 40-60 oC/EtOAc) to yield product 4.3af as a light yellow oil (15.0 mg, 0.062 
mmol, 62%). 
 
RF 0.24 (50:1 petrol 40-60 oC/EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.22 – 8.37 (2H, m, 
Ar-H), 7.29 – 7.40 (2H, m, Ar-H), 6.97 (2H, s, Ar-H), 2.35 (3H, s, CH3), 1.99 (6H, s, 2CH3); 
13C NMR (75 MHz, CDCl3) δ 148.7 (C), 147.0 (C), 137.9 (C), 136.9 (C), 135.4 (2C), 130.6 
(2CH), 128.5 (2CH), 123.9 (2CH), 21.2 (CH3), 20.8 (2CH3); Found (TOF MS ASAP+) [M + 
H]+ 242.1181, C15H15NO2 requires 242.1181; NMR data matches literature values.126 
 
2,4,6-Trimethyl-3'-nitro-1,1'-biphenyl (4.3ag) 
 
 
 
General procedure B followed and crude purified by column chromatography (eluent: 
50:1 petrol 40-60 oC/EtOAc) to yield product 4.3ag as a light yellow oil (14.4 mg, 0.059 
mmol, 59%). 
 
RF 0.24 (50:1 petrol 40-60 oC/EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.15 – 8.27 (1H, m, 
Ar-H), 8.02 – 8.07 (1H, m, Ar-H), 7.54 – 7.67 (1H, m, Ar-H), 7.42 – 7.54 (1H, m, Ar-H), 
6.97 (2H, s, Ar-H), 2.35 (3H, s, CH3), 1.99 (6H, s, 2CH3); 13C NMR (75 MHz, CDCl3) δ 148.6 
(C), 143.0 (C), 137.8 (C), 136.6 (C), 136.0 (CH), 135.7 (2C), 129.6 (CH), 128.6 (2CH), 
124.6 (CH), 121.9 (CH), 21.2 (CH3), 20.8 (2CH3); Found (TOF MS ASAP+) [M + H]+ 
242.1179, C15H15NO2 requires 242.1181; NMR data matches literature values.128 
 
2,4,6-Trimethyl-2'-nitro-1,1'-biphenyl (4.3ah)  
 
 
 
General procedure A followed and crude purified by column chromatography (eluent: 
50:1 petrol 40-60 oC/EtOAc) to yield product 4.3ah as a light yellow oil (8.8 mg, 0.037 
mmol, 37%). 
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RF 0.24 (50:1 petrol 40-60 oC/EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.92 – 8.08 (1H, m, 
Ar-H), 7.59 – 7.74 (1H, m, Ar-H), 7.39 – 7.59 (1H, m, Ar-H), 7.17 – 7.30 (1H, m, Ar-H), 
6.91 (2H, s, Ar-H), 2.31 (3H, s, CH3), 1.95 (6H, s, 2CH3); 13C NMR (75 MHz, CDCl3) δ 149.5 
(C), 137.6 (C), 136.0 (C), 135.6 (2C), 134.3 (C), 133.0 (CH), 132.2 (CH), 128.29 (2CH), 
128.28 (CH), 124.3 (CH), 21.2 (CH3), 20.5 (2CH3); Found (TOF MS ASAP+) [M + H]+ 
242.1179, C15H15NO2 requires 242.1181; NMR data matches literature values.129 
 
2,4,6-Trimethyl-3',5'-bis(trifluoromethyl)-1,1'-biphenyl (4.3ai) 
 
 
 
 
General procedure C followed and crude purified by column chromatography (eluent: 
petrol 40-60 oC) to yield product 4.3ai as a light yellow oil (19.8 mg, 0.060 mmol, 60%). 
 
RF 0.32 (petrol 40-60 oC); νmax/cm-1 2924 (C-H), 1616, 1464 (C-C Ar); 1H NMR (300 MHz, 
CDCl3) δ 7.87 (1H, s, Ar-H), 7.63 (2H, s, Ar-H), 6.97 (2H, s, Ar-H), 2.34 (3H, s, CH3), 1.98 
(6H, s, 2CH3); 13C NMR (75 MHz, CDCl3) δ 143.5 (C), 138.2 (C), 136.0 (C), 135.7 (2C), 
131.95 (q, J = 33.2 Hz, 2CCF3), 129.9 (m, CH), 128.7 (2CH), 123.5 (q, J = 272.8 Hz, CF3) 
120.9 (m, CH) 21.03 (CH3), 20.71 (2CH3); Found (TOF MS EI+) [M]+ 332.1001, C17H14F6 
requires 332.1000. 
 
3',5'-Dichloro-2,4,6-trimethyl-1,1'-biphenyl (4.3aj) 
 
 
 
 
General procedure C followed and crude purified by column chromatography (eluent: 
petrol 40-60 oC) to yield product 4.3aj as a light yellow oil (11.6 mg, 0.044 mmol, 44%). 
RF 0.29 (petrol 40-60 oC); νmax/cm-1 2919, 2855 (C-H), 1613, 1586, 1556 (C-C Ar); 1H 
NMR (300 MHz, CDCl3) δ 7.34 (1H, t, J = 1.9 Hz, Ar-H), 7.04 (2H, d, J = 1.9 Hz, Ar-H), 6.93 
(2H, s, Ar-H), 2.32 (3H, s, CH3), 2.01 (6H, s, 2CH3); 13C NMR (75 MHz, CDCl3) δ 144.4 (C), 
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137.6 (C), 136.5 (C), 135.7 (2C), 135.1 (2C), 128.4 (2CH), 128.1 (2CH), 127.0 (CH), 21.2 
(CH3), 20.8 (2CH3); Found (TOF MS EI+) [M]+ 264.0463, C15H14Cl2 requires 264.0472. 
 
5-Mesitylisoindoline-1,3-dione (4.3ak) 
 
 
 
 
General procedure A followed and crude purified by column chromatography (eluent: 
10:1 petrol 40-60 oC/EtOAc) to yield product 4.3ak as a light yellow oil (17.8 mg, 0.067 
mmol, 67%). 
 
RF 0.23 (10:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3196 (N-H), 2919 (C-H), 1765, 1727, 
1699 (C=O), 1616, 1469 (C-C Ar); 1H NMR (300 MHz, CDCl3) δ 8.14 (1H, broad s, N-H), 
7.92 (1H, dd, J = 7.6, 0.5 Hz, Ar-H), 7.67 (1H, dd, J = 1.4, 0.5 Hz, Ar-H), 7.53 (1H, dd, J = 
7.6, 1.4 Hz, Ar-H), 6.97 (2H, s, Ar-H), 2.34 (3H, s, CH3), 1.98 (6H, s, 2CH3); 13C NMR (75 
MHz, CDCl3) δ 168.3 (C), 168.2 (C), 148.6 (C), 137.9 (C), 136.9 (C), 135.7 (CH), 135.4 
(2C), 133.2 (C), 131.1 (C), 128.6 (2CH), 124.9 (CH), 123.9 (CH), 21.2 (CH3), 20.8 (2CH3); 
Found (FTMS p NSI+) [M + H]+ 266.1177, C17H16NO2 requires 266.1176. 
 
2,4,6-Trimethyl-1,1'-biphenyl (4.3al)  
 
 
 
General procedure A followed and crude purified by column chromatography (eluent: 
petrol 40-60 oC) to yield product 4.3al as a light yellow oil (12.3 mg, 0.062 mmol, 62%). 
 
RF 0.26 (petrol 40-60 oC); 1H NMR (300 MHz, CDCl3) δ 7.38 – 7.47 (2H, m, Ar-H), 7.29 – 
7.37 (1H, m, Ar-H), 7.11 – 7.18 (2H, m, Ar-H), 6.96 (2H, s, Ar-H), 2.35 (3H, s, CH3), 2.02 
(6H, s, 2CH3); 13C NMR (75 MHz, CDCl3) δ 141.2 (C), 139.2 (C), 136.7 (C), 136.1 (2C), 
129.4 (CH), 128.5 (2CH), 128.2 (2CH), 126.6 (CH), 21.2 (CH3), 20.9 (2CH3); Found (TOF 
MS EI+) [M]+ 196.1252, C15H16 requires 196.1252; NMR data matches literature 
values.126 
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2,4,4',6-Tetramethyl-1,1'-biphenyl (4.3am)  
 
 
 
General procedure A followed and crude purified by column chromatography (eluent: 
petrol 40-60 oC) to yield product 4.3am as a light yellow oil (12.8 mg, 0.048 mmol, 
48%). 
 
RF 0.28 (petrol 40-60 oC); 1H NMR (300 MHz, CDCl3) δ 7.19 – 7.25 (2H, m, Ar-H), 7.00 – 
7.07 (2H, m, Ar-H), 6.94 (2H, s, Ar-H), 2.41 (3H, s, CH3), 2.34 (3H, s, CH3), 2.02 (6H, s, 
2CH3); 13C NMR (75 MHz, CDCl3) δ 139.2 (C), 138.1 (C), 136.5 (C), 136.3 (2C), 136.1 (C), 
129.3 (2CH), 129.2 (2CH), 128.2 (2CH), 21.4 (CH3), 21.2 (CH3), 20.9 (2CH3); Found (TOF 
MS EI+) [M]+ 210.1411, C16H18 requires 210.1409; NMR data matches literature 
values.130 
 
4'-(Tert-butyl)-2,4,6-trimethyl-1,1'-biphenyl (4.3an) 
 
 
 
General procedure A followed and crude purified by column chromatography (eluent: 
petrol 40-60 oC) to yield product 4.3an as a light yellow oil (15.6 mg, 0.048 mmol, 
48%). 
 
RF 0.30 (petrol 40-60 oC); 1H NMR (300 MHz, CDCl3) δ 7.37 – 7.44 (2H, m, Ar-H), 7.03 – 
7.11 (2H, m, Ar-H), 6.95 (2H, s, Ar-H), 2.34 (3H, s, CH3), 2.03 (6H, s, 2CH3), 1.38 (9H, s, 
3CH3); 13C NMR (75 MHz, CDCl3) δ 149.28 (C), 139.20 (C), 138.00 (C), 136.48 (C), 136.39 
(2C), 129.00 (2CH), 128.12 (2CH), 125.25 (2CH), 34.65 (C), 31.61 (3CH3), 21.16 (CH3), 
20.89 (2CH3); Found (TOF MS EI+) [M]+ 252.1878, C19H24 requires 252.1882; NMR data 
matches literature values.131 
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4'-Methoxy-2,4,6-trimethyl-1,1'-biphenyl (4.3ao) 
 
General procedure C followed and crude purified by column chromatography (eluent: 
50:1 to 20:1 petrol 40-60 oC/EtOAc) to yield product 4.3ao as a light yellow oil (6.9 mg 
(approximately 85% purity), 0.026 mmol, <26%). 
 
RF 0.26 (20:1 petrol 40-60 oC/EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.01 – 7.09 (2H, m, 
Ar-H), 6.94 – 6.99 (2H, m, Ar-H), 6.93 (2H, s, Ar-H), 3.86 (3H, s, OCH3), 2.33 (3H, s, CH3), 
2.01 (6H, s, 2CH3); 13C NMR (75 MHz, CDCl3) δ 139.2 (C), 138.1 (C), 136.5 (C), 136.3 
(2C), 136.1 (C), 129.3 (2CH), 129.2 (2CH), 128.2 (2CH), 21.4 (CH3), 21.2 (CH3), 20.9 
(2CH3); Found (TOF MS EI+) [M]+ 226.1360, C16H18O requires 226.1358; NMR data 
matches literature values.130 
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Chapter 5: Metal-, photocatalyst- and 
light-free, C-H alkylation of 
N-heteroarenes and 1,4-quinones  
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5.1 Introduction  
5.1.1 Introduction to the Minisci reaction  
N-Heteroarenes and 1,4-quinones are very privileged motifs, being present in a large 
portion of natural products, pharmaceuticals and ligand scaffolds132-136 (e.g. Figure 5.1, 
also see Table 5.7). The importance of these motifs has led to a great deal of research 
into their late stage modification and in particular C-H functionalisation.137, 138  
 
Figure 5.1: Pharmaceuticals and natural products containing N-Heteroarenes and 
1,4-quinones motifs133, 136 
 
Since many N-heteroarenes and 1,4-quinones are electron-poor, their functionalisation 
is dominated by Minisci-type chemistry with many examples of late-stage 
modifications being carried out in this way.139 However, the silver-mediated conditions 
originally developed by Minisci for the alkylation of N-heteroarenes140, 141 (Scheme 5.1) 
and those reported later for the alkylation of 1,4-quinones142 (Scheme 5.2) are harsh 
and have a limited scope, with varying yields.  
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Scheme 5.1: Silver-mediated alkylation of N-Heteroarenes reported by Minisci140 
 
 
Scheme 5.2: Silver-mediated alkylation of 1,4-quinones reported by Jacobsen142 
 
 
Scheme 5.3: Proposed mechanism for the generation of the alkyl radical under 
Minisci’s conditions140 
 
The Minisci reaction is thought to proceed through the oxidation of the Ag+ by the 
persulfate oxidant to give Ag2+ which can then oxidise the carboxylic acid, regenerating 
the Ag+ ion and causing decarboxylation of the carboxylic acid to give the alkyl radical 
(Scheme 5.3). The alkyl radical can then undergo addition to the protonated 
N-heteroarene or the 1,4-quinone providing the alkylated product after loss of one 
electron and deprotonation.140  
 
Since, the first publications by Minisci140, 141 and Jacobsen142 there have been many 
reports which have endeavoured to make the Minisci reaction milder and more 
substrate scope tolerant, and thereby more applicable to late-stage C-H 
functionalisations. Many of these reports use alternative coupling partners to the 
cheap and readily available carboxylic acids originally used by Minisci (Scheme 5.1). 
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These alternative radical sources include alkyl halides,143, 144 boronic acids145-148 and 
their derivatives,149, 150 sulfonates,151, 152 peroxides153 and acid chlorides154 and are 
used in conjunction with metal- or photoredox-catalysis. However, the focus of this 
project, and therefore introduction, will be on procedures using carboxylic acids as the 
radical source and methodologies which are metal- and photocatalyst-free. Carboxylic 
acids were chosen as the radical source in this project because as well as being cheap 
and readily available they are also stable, non-toxic, naturally abundant, and release 
only traceless CO2 upon breakdown.155  
 
5.1.2 Minisci-type reactions using carboxylic acids  
In recent years many novel approaches have been developed to make the Minisci-type 
alkylation of N-heteroarenes and 1,4-quinones more mild and so well-suited to late-
stage C-H functionalisations. In 2017, Baxter reported a silver-catalysed Minisci-type 
procedure for the alkylation of N-heteroarenes and 1,4-quinones using selectfluor as 
an oxidant148 (Scheme 5.4). A reasonable range of substrates as well as primary, 
secondary and tertiary carboxylic acids were tolerated in the reaction. However, the 
yields for the alkylation are moderate and the procedure requires silver as a catalyst in 
fairly high loading (Scheme 5.4).  
 
 
Scheme 5.4: Silver-catalysed alkylation using mild oxidant148 
 
The generation of the alkyl radical can instead be achieved through photocatalysis, 
avoiding the use of silver and rendering the reaction milder. Photocatalysed Minisci-
type reactions were first achieved with redox active esters as the radical source156 
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(Scheme 5.5). Reported in 2017, this high yielding procedure is very tolerant of a range 
of N-heteroarenes156 and can also be used for the coupling of peptides under similar 
conditions.157 Additionally, with the addition of a chiral Brønsted acid catalyst, this 
reaction can be made enantioselective.158 Although this reaction has excellent 
applications and is very tolerant and high yielding, the use of a redox active ester 
rather than the carboxylic acid itself is a major drawback. Although the redox active 
esters are easily prepared from the carboxylic acid, the extra step needed to prepare 
the ester is undesirable and makes the reaction very atom inefficient. Dhar recently 
reported a one-pot version of this reaction159 which removes the need for the 
prefunctionalisation step but does not improve the atom-efficiency of the method.  
 
 
Scheme 5.5: Redox active ester and photocatalysis for the alkylation of 
N-heteroarenes156 
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Scheme 5.6: Proposed photocatalytic cycle for the alkylation of N-heteroarenes with 
redox active esters156 
 
The mechanism of this reaction proceeds through a single electron transfer (SET) from 
the IrII catalyst to the redox active ester 5.6 giving the intermediate 5.I which breaks 
down to provide the alkyl radical 5.III. The product 5.3 is then produced through 
deprotonation and SET to the excited state iridium photocatalyst to regenerate the 
active IrII catalyst.  
  
As discussed, the main drawback of using redox active esters 5.6 is the need to 
prefunctionalise the carboxylic acid. This can be avoided by using the carboxylic acid 
directly in a photocatalysed alkylation protocol without the use of a silver catalyst, 
something first achieved by Glorius in 2017.160 Glorius’s mild, tolerant and high 
yielding method (Scheme 5.7) is proposed to operate through hydrogen atom transfer 
(HAT) from the carboxylic acid to the radical sulfate anion (Scheme 5.8).  
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Scheme 5.7: Photocatalytic procedure for the alkylation of N-heteroarenes with 
carboxylic acids160 
 
 
Scheme 5.8: Proposed photocatalytic cycle for the alkylation of N-heteroarenes with 
carboxylic acids160 
 
In the mechanism proposed by Glorius, the radical sulfate anion (SO4.-) is generated by 
the breakdown of the persulfate through SET from the photocatalyst. The radical 
sulfate anion then abstracts a radical H from the carboxylic acid 5.2, causing 
decarboxylation to provide the alkyl radical 5.III. Radical addition of 5.III to the N-
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heteroarene gives the intermediate 5.IV, which is converted to the product 5.3 
through deprotonation and SET to the photocatalyst. 
 
The alkylation of N-heteroarenes using carboxylic acids was also achieved 
independently by the groups of Chen,161 Zhang162 and Frenette163 in 2018. These 
procedures all employ a combination of hypervalent iodine reagents and either 
photocatalysis or light to generate the alkyl radical. Importantly, none of the light 
based procedures described in this section are suited to 1,4-quinones. This is perhaps 
due to 1,4-quinones being light sensitive and so only suited to light- and photocatalyst-
free reactions (see Section 5.3.1).  
 
5.1.3 Metal- light- and photocatalyst-free Minisci-type reactions 
Metal- light- and photocatalyst-free Minisci-type alkylations were achieved by 
Molander164 in 2017, although not with carboxylic acids as the radical source. 
Molander and co-workers employed 1,4-dihydropyridines (DHPs) 5.7 in their 
procedure, achieving good yields for the alkylation of both N-heteroarenes (Scheme 
5.9) and 1,4-quinones (Scheme 5.10). However, the procedure is limited to mainly 
secondary alkyl radicals and requires the preparation of the DHPs 5.7 used as 
substrates.  
 
 
Scheme 5.9: Metal- light- and photocatalyst-free alkylation of N-heteroarenes with 
1,4-dihydropyridines164 
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Scheme 5.10: Metal- light- and photocatalyst-free alkylation of 1,4-quinones with 1,4-
dihydropyridines164 
 
Under the reaction conditions developed by Molander and co-workers, the DHP is 
thought to be readily oxidised to generate the alkyl radical without the need for a 
metal catalyst or light irradiation. Although this allows for a large scope of 
N-heteroarenes and 1,4-quinones, the need to synthesise the alkyl radical source from 
the corresponding aldehydes is a main drawback to this procedure. A methodology 
allowing the direct use of a cheap and commercially available alkyl radical source 
would be much more desirable. Interestingly, the alkylation of N-heteroarenes with 
unactivated ethers has been shown to be possible under metal- light- and 
photocatalyst-free conditions. 
 
The alkylation of N-heteroarenes with unactivated ethers was originally reported by 
MacMillan under photoredox conditions165 but the reaction was later found to be 
possible without the use of a photocatalyst166 and then, later again, under 
photocatalyst- and light-free conditions167 albeit at much higher temperatures 
(Scheme 5.11).  
 
 
Scheme 5.11: Metal- light- and photocatalyst-free alkylation of N-heteroarenes with 
unactivated ethers167 
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Scheme 5.12: Proposed mechanism for the alkylation of N-heteroarenes with 
unactivated ethers167 
 
The metal-, light- and photocatalyst-free alkylation of N-heteroarenes with unactivated 
ethers, reported by Barriault, is thought to proceed through the generation of the alkyl 
radical by hydrogen atom transfer (HAT).167 The radical H is abstracted from the 
unactivated ether 5.8 by the radical sulfate anion which is generated by homolysis of 
the persulfate. The generation of the radical sulfate anion by homolysis of the 
persulfate rather than under photocatalytic conditions is key to this procedure 
(Scheme 5.12). This is particularly interesting if the radical sulfate anion can be 
produced under photocatalyst- and light-free conditions and, as reported by Glorius, 
the radical sulfate anion can produce alkyl radicals through HAT of carboxylic acids, 
then metal-, light- and photocatalyst-free Minisci-type alkylations with carboxylic acids 
may be possible.  
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5.2 Project aims 
The aim of the project was to develop the first mild, metal-, light- and photocatalyst 
free Minisci-type alkylation procedure which uses cheap and readily available 
carboxylic acids and is suitable for the late-stage C-H functionalisation of 
N-heteroarene and 1,4-quinone moieties.  
 
 
Scheme 5.13: Desired metal- light- and photocatalyst-free alkylation of N-
heteroarenes and 1,4-quinones with carboxylic acids 
 
In recent years, there have been many publications describing milder (<50 °C), Minisci-
type alkylation procedures which are better suited to the late-stage C-H alkylation of 
N-heteroarene and 1,4-quinone moieties. Since these moieties are very prevalent in 
nature and present in a large number of medicinally relevant compounds, their mild 
late-stage C-H alkylation is highly sought after.132-136 However, as discussed in section 
5.1, many of the recent publications in this area use metal, light and photocatalysis to 
achieve alkylation with carboxylic acids.148, 156-163 Additionally, reports which are metal-
, light- and photocatalyst-free require the use of an alternative alkylating agent which 
must be prepared prior to the alkylation.164 The development of a procedure which 
uses readily available carboxylic acids without the need for metal, light or 
photocatalysis would be a significant advance in the field because the methodology 
would not require expensive photocatalysts or additives, would use cheap starting 
materials without prefunctionalisation and would also be tolerant to light-sensitive 
substrates which degrade under photocatalytic conditions.    
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5.3 Results and discussion 
5.3.1 Optimisation 
 
Entry Conc.  
(mol/L) 
DMSO: 
H2O 
Ratio* 
Temp. 
(oC) 
Time 
(h) 
Oxidant LEDs SM 
5.4 
(%) 
Ratio 
5.5:5.5’ 
Yield 
5.5 
(%)[a] 
1[b] 1 1:0 r.t 16 (NH4)2S2O8 Blue 7 >20:1 9 
2Ѫ 1 1:0 30 16 (NH4)2S2O8 Blue 22 >20:1 16 
3[c]Ѫ 1 1:0 30 16 (NH4)2S2O8 Blue 28 - - 
4[c]Ѫ 1 1:0 30 72 (NH4)2S2O8 Green 87 - - 
5 1.33 600:1 30 40 (NH4)2S2O8 Green 26 >20:1 53 
6 2 600:1 30 40 (NH4)2S2O8 Green 21 >20:1 59 
7 2 30:1 30 40 (NH4)2S2O8 Green 21 >20:1 60 
8[d] 2 600:1 30 40 (NH4)2S2O8 Green 43 >20:1 31 
9Ѫ 2 600:1 30 40 Na2S2O8 Green 30 >20:1 45 
10Ѫ 2 600:1 30 40 K2S2O8 Green 80 >20:1 9 
11Ѫ 2 600:1 30 40 t-Bu2O2 Green 86 - 0 
12Ѫ 2 600:1 30 40 DDQ Green 85 - 0 
13Ѫ 2 600:1 30 40 - Green 83 - 0 
14 2 600:1 30 66 (NH4)2S2O8 Green 9 8:1 64 
15[e] 2 600:1 30 40 (NH4)2S2O8 Green 15 11:1 56 
16[f] 2 600:1 30 40 (NH4)2S2O8 Green <5 8:1 68 
17 2 600:1 40 40 (NH4)2S2O8 Green <5 1.7:1 54 
18 2 600:1 40 16 (NH4)2S2O8 Green <5 >20:1 70 
19[g] 2 600:1 40 16 (NH4)2S2O8 - <5 >20:1 71 
20[h]Ѫ 2 600:1 40 16 (NH4)2S2O8 - <5 >20:1 54 
21[i]Ѫ 2 600:1 40 16 (NH4)2S2O8 - 16 >20:1 54 
[a]Determined by 1H NMR analysis using 1,3,5-trimethoxybenzene as an internal standard,  [b] 
[Ir(dF(CF3)ppy)dtbbpy)]PF6 (2 mol%), [c] Control - No acid 5.2a added, [d] Reaction carried out 
under air, [e] 20 equiv. CyCO2H 5.2a, [f] 4 equiv. oxidant [g] Reaction carried out in dark: 
Schlenk flask wrapped thoroughly with aluminium foil and reproduced 3 times, [h] 5 equiv. 
CyCO2H 5.2a, [i] 1 equiv. oxidant. *During our studies, yields were found to be approximately 
10% better in "wet" solvent than anhydrous DMSO, so the 600:1 DMSO:H2O ratio was adopted 
to obtain consistency in yields. 
Table 5.1: Optimisation of the monoalkylation of 1,4-naphthoquinone 
 
The initial aim of this project was to develop suitable photoredox conditions to allow 
the alkylation of 1,4-quinones. Inspired by Glorius’s work on the alkylation of 
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N-heteroarenes (Scheme 5.7), we first subjected 1,4-naphthoquinone to Glorius’s 
conditions (Entry 1, Table 5.1). Glorius’s conditions (Entry 1, Table 5.1) gave only traces 
of our desired product despite almost all of the starting material 5.4a being consumed. 
A control reaction without photocatalyst (Entry 2, Table 5.1) showed that the small 
amount of product we were seeing was due to the uncatalysed background reaction 
and the degradation of the starting material 5.4a was still occurring. Further control 
reactions (Entry 3, Table 5.1) showed that the 1,4-naphthoquinone 5.4a is unstable 
under blue LED irradiation, but to our delight, is more stable under green LED 
irradiation (Entry 4, Table 5.1). Inspired by the work of Shah166 we then attempted the 
reaction without any photocatalyst and obtained a pleasing yield of 53% under the 
green LED only conditions (Entry 5, Table 5.1). Increasing the dilution slightly gave a 
cleaner reaction with a marginally better yield (59%, Entry 6, Table 5.1). Increasing the 
equivalents of water had no effect on the yield (60%, Entry 7, Table 5.1) but as 
expected the yield was lower when the reaction was carried out under air (31%, Entry 
8, Table 5.1). We then looked to screen a range of different oxidants only to find that 
our initial choice of oxidant (59%, Entry 6, Table 5.1) outperformed the others trialled 
(45% and 9%, Entries 9 and 10, Table 5.1) and that the persulfate was crucial for the 
reaction to occur (Entries 10-13, Table 5.1). In an attempt to obtain full conversion of 
the starting material and improve the yield, we then increased the reaction time, 
equivalents of carboxylic acid and equivalents of oxidant (Entries 14, 15 and 16 
respectively, Table 5.1). All of these changes to the conditions gave an increase in the 
conversion of starting material. However, increasing the temperature slightly to 40 oC 
(Entry 17, Table 5.1) was deemed the most atom efficient and synthetically useful 
change. Reducing the reaction time to 16 h provided excellent selectivity for the mono-
alkylated product 5.5aa over the dialkylation product 5.5aa’ and provided our 
optimised conditions (70%, Entry 18, Table 5.1). To our surprise, when we conducted a 
control reaction omitting all light from the reaction we obtained exactly the same yield 
(71%, Entry 19, Table 5.1). Unfortunately, attempts to reduce the equivalents of 
oxidant or carboxylic acid had an adverse effect on the yield (Entries 20 and 21, Table 
5.1) but this result (Entry 19, Table 5.1) shows that as well as not requiring a metal or 
photocatalyst our newly optimised conditions also do not require light. Realising the 
potential value of a metal- light- and photocatalyst-free alkylation procedure which 
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was applicable to both 1,4-quinones and N-heteroarenes, we next investigated the 
alkylation of lepidine 5.1a.  
 
 
Entry Conc.  
(mol/L) 
DMSO: 
H2O 
ratio 
Temp. 
(oC) 
Time 
(h) 
Oxidant 
(equiv.) 
[Ir]  
(mol%) 
Equiv.  
5.2a 
SM 
5.1a 
(%) 
Yield 
5.3aa 
(%) 
1[a],[b] 1 - r.t. 1.5 2 0.5 10 NR 94(81) 
2[a] 1 - r.t. 1.5 2 0.5 10 NR 8 
3[c] 1 - r.t. 16 2 0.5 10 89 9 
4[c] 0.5 600:1 40 16 2 - 10 15 69 
5[c] 0.5 600:1 40 16 3 - 10 <5 79(82) 
6[c] 0.5 600:1 40 16 3 0.5 10 20 76 
7[c] 0.5 600:1 40 16 3 - 5 41 54 
8[c],[d] 0.5 600:1 40 16 3 - 5 56 43 
[a] Conditions reported by Glorius and coworkers168, 1H NMR yields (isolated yield). [b] Blue 
LED irradiation. [c] Yields determined by 1H NMR analysis using 1,3,5-trimethoxybenzene as an 
internal standard, [d] TFA (1.5 equiv.) added. [Ir] = [Ir(dF(CF3)ppy)dtbbpy)]PF6, NR – Not 
reported 
Table 5.2: Investigation into the alkylation of lepidine 5.1a 
 
To our delight, the alkylation of lepidine 5.1a under our new conditions gave the 
desired product in good NMR yield (69%, Entry 4, Table 5.2). Since Glorius had 
achieved the alkylation of N-heteroarenes under photocatalytic conditions we looked 
to investigate the difference between the two procedures. Under blue light irradiation 
Glorius reports an excellent yield of 5.3aa in just 1.5 h (81%, Entry 1, Table 5.2) and 
very low NMR yield without irradiation (8%, Entry 2, Table 5.2). Suspecting that under 
longer reaction times the control reaction reported by Glorius (Entry 2, Table 5.2) may 
give a higher yield through a non-photocatalytic pathway, a control reaction under the 
same condition was allowed to react for 16 h (Entry 3, Table 5.2). There was, however, 
no increase in yield due to the longer reaction time (8% vs. 9%, Entry 2 vs. Entry 3, 
Table 5.2) suggesting that the slightly increased temperature and dilution is crucial for 
the non-photocatalytic conditions to be high-yielding. It was later shown that the 
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inclusion of the iridium photocatalyst is slightly detrimental to the non-photocatalytic 
conditions (Entry 6, Table 5.2). Pleasingly, the initial conditions trialled for the 
alkylation of lepidine 5.1a (69%, Entry 4, Table 5.2) could be optimised further for N-
heteroarenes simply by increasing the equivalents of oxidant (82%, Entry 5, Table 5.2). 
Reducing the equivalents of carboxylic acid 5.2a was found to be detrimental to the 
reaction (54%, Entry 7, Table 5.2) and could not be improved with the inclusion of 1.5 
equiv. of TFA to activate the heterocycle (43%, Entry 7, Table 5.2). 
 
A final investigation into the conditions was carried out with the substrate 5.1b (Table 
5.3). This solvent study showed that DMSO was the only solvent which facilitated the 
reaction (Entries 2-7 vs. Entry 1, Table 5.3). It should be noted that no product is 
observed when acetonitrile and/or water, common solvents for the Minisci reaction, is 
employed (Entries 2-4, Table 5.3). Pleasingly, the reaction was found to occur at the 
even milder temperature of 30 oC but complete conversion of the starting material was 
not observed after 16 h (Entry 8, Table 5.3).  
 
 
Entry Conc.  
(mol/L) 
Solvent Solvent 
ratio 
Temp. 
(oC) 
Oxidant 
(equiv.) 
SM 
5.1b 
(%) 
Yield 
5.3ba 
(%)[a] 
1 0.5 DMSO/H2O 600:1 40 3 <5 91(80) 
2 0.5 H2O - 40 3 80 0 
3 0.5 H2O/MeCN 2:1 40 3 90 0 
4 0.5 MeCN - 40 3 90 0 
5 0.5 Acetone - 40 3 94 0 
6 0.5 DMF - 40 3 - 0 
7 0.5 MeOH - 40 3 85 0 
8 0.5 DMSO/H2O 600:1 30 3 19 73 
[a] Yields determined by 1H NMR analysis using 1,3,5-trimethoxybenzene as an internal 
standard (isolated yield) 
Table 5.3: Investigation into the alkylation of quinaldine 5.1b  
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It is thought that DMSO is crucial for the metal-, light- and photocatalyst-free reaction 
as it improves the rate at which homolysis of the persulfate occurs. The rate at which 
persulfate is broken down under thermal conditions is reported to be very solvent 
dependent169 and DMSO can increase the rate of homolysis significantly.170 The 
homolysis of persulfate is proposed to be central to the mechanism (see Section 5.3.7) 
and can only occur under these very mild conditions due to the use of DMSO as a 
solvent. In order to check whether the breakdown of the persulfate could be caused by 
reaction with DMSO, (NH4)2S2O8 was heated to 40 oC in d-DMSO and the solution 
analysed by 1H NMR. No NMR evidence for the formation of DMSO based 
intermediates or products were found under our reaction conditions (Figure 5.2 vs. 
Figure 5.3).  
 
 
Figure 5.2: 1H NMR of (NH4)2S2O8 in d-DMSO under normal conditions 
 
(NH4)2S2O8  
H2O 
d-DMSO 
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Figure 5.3: 1H NMR of (NH4)2S2O8 in d-DMSO after heating at 40 oC for 4 h under N2 
 
5.3.2 N-Heteroarene scope 
 
Entry N-Heteroarene (NH4)2S2O8 
(equiv.) 
Time  
(h) 
Major product Yield[a] 
1 
 
3 16 
 
82% 
 
2 
 
3 16 
 
80% 
 
3 
 
 
3 16 
 
62% 
(NH4)2S2O8  
(splitting with 14N observed) 
H2O 
d-DMSO DMSO 
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4 
 
3 16 
 
68% 
 
5 
 
3 16 
 
91% 
 
6 
 
3 16 
 
80% 
7 
 
3 16 
 
77% 
 
8[b] 
 
6 16 
 
74% 
 
9 
 
4 16 
 
69% 
10 
 
3 16 
 
50% 
 
11 
 
6 24 
 
60% 
 
12 
 
6 40 
 
25% 
 
[a] Isolated yields, [b] A 5 : 1 : 1.9 ratio of 5.3ha’/5.3ha/5.1h was obtained with 3 
equiv. of oxidant. 
Table 5.4: N-Heteroarene scope 
 
The N-heteroarene substrate scope was investigated next and substituted quinolines 
were investigated first with lepidine 5.1a and quinaldine 5.1b giving excellent yields 
under our conditions (5.3aa 82% and 5.3ba 80%, Entries 1 and 2, Table 5.4). Methoxy- 
and fluoro- substituted quinaldine were also successfully alkylated in good yields 
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(5.3ca 62% and 5.3da 68%, Entries 3 and 4, Table 5.4) and 5.3ea and 5.3fa were 
prepared in excellent yields from 3-methylisoquinoline 5.1e and phenanthridine 5.3f 
(91% and 80% respectively, Entries 5 and 6, Table 5.4). Expanding the scope to 
heteroarenes containing two nitrogen atoms, quinazoline 5.1g was subjected to the 
reaction giving 5.3ga in a pleasing 77% yield (Entry 7, Table 5.4). Under our initial 
reaction conditions, phthalazine 5.1h gave a mixture of mono and dialkylated products 
(5 : 1 : 1.9 ratio of 5.3ha’/5.3ha/5.1h). However, to our delight, simply by increasing 
the equivalents of oxidant, the reaction was successfully adapted to give only the 
dialkylated product 5.3ha’ (74%, Entry 8, Table 5.3). 2-Methylquinoxaline, 2,6-lutidine 
and 4(1H)-quinazolinone all performed well under our conditions to give the alkylated 
products 5.3ia, 5.3ja and 5.3ka respectively (69%, 50% and 60%, Entries 9, 10 and 11, 
Table 5.4). However, the alkylation of the less reactive benzothiazole did not proceed 
with as high a yield, giving only 25% of product 5.3la (Entry 12, Table 5.4).  
 
Pleased with our alkylation conditions, we next looked to overcome some of the 
potential limitations of the procedure. Firstly, the reaction was carried out on an 
increased scale to investigate whether further scale up in an industrial setting could be 
possible. To our delight, upon scale up the yield of the reaction remained high (78%, 
Scheme 5.14 vs. 80% on 0.15 mmol scale).  
 
 
Scheme 5.14: Larger 3.5 mmol scale alkylation of quinaldine 5.1bД 
 
Another potential drawback of this procedure is the requirement for 10 equivalents of 
the carboxylic acid. Unfortunately, reducing the equivalents of carboxylic acid resulted 
in a considerable drop in yield (See Tables 5.1 and 5.2), so we looked to recover the 
carboxylic acid after the reaction. Pleasingly, almost all of the carboxylic acid can be 
recovered by aqueous washing, albeit with some minor impurities (98% recovery, 
Method A, Scheme 5.15, Figure 5.4). Alternatively, the carboxylic acid can be 
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recovered using a “catch-and release” protocol by utilising Amberlyst A26 to sequester 
the unreacted carboxylic acid, followed by washing with formic acid/MeOH to release 
the carboxylic acid into solution. This protocol gives very high purity carboxylic acid in a 
slightly lower yield of recovery (73% recovery, Method B, Scheme 5.15, Figure 5.5).  
 
 
Scheme 5.15: Recovery of carboxylic acid 
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Figure 5.4: Carboxylic acid recovered by aqueous washing  
 
 Figure 5.5: Carboxylic acid recovered by “catch-and release” protocol 
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5.3.3 Carboxylic acid scope 
 
Entry Carboxylic acid (NH4)2S2O8 
(equiv.) 
Time  
(h) 
Major product Yield[a] 
1 
 
3 16 
 
80% 
 
2Д 
 
3 16 
 
71% 
 
3Д 
 
 
3 16 
 
71% 
4 
 
3 16 
 
91% 
 
5Д 
 
3 16 
 
74% 
 
6Д 
 
3 16 
 
53% 
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7Д 
 
3 16 
 
67% 
 
8Д 
 
3 16 
 
26% 
 
9Д 
 
3 16 
 
61% 
10Д 
 
4 16 
 
28% 
 
11Д 
 
4 16 
 
37% 
 
12Д 
 
6 72 
 
34% 
 
13 
 
6 16 
 
53% 
 
14Д 
 
3 16 
 
68% 
 
[a] Isolated yields 
Table 5.5: Carboxylic acid scope 
 
In addition to cyclohexanecarboxylic acid 5.2a (80%, Entry 1, Table 5.5) a range of 
other secondary carboxylic acids were tolerated in the reaction with quinaldine 5.1b, 
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including other cyclic carboxylic acids (5.3bb, 71%, Entry 2, Table 5.5) and straight 
chain acids (5.3bc, 71%, Entry 3, Table 5.5). To our delight, protected amino acid 5.2d 
reacted very cleanly to give a yield of 91% (5.3bd, Entry 4, Table 5.5) and the 
fluorinated cyclohexyl carboxylic acid 5.2e also reacted well (5.3be, 74%, Entry 5, Table 
5.5). Oxygen containing carboxylic acids were also tolerated well (5.3bf, 53%, Entry 6, 
Table 5.5) even when the heteroatom is directly adjacent to the site of reaction (5.3bg, 
67%, Entry 7, Table 5.5). Unfortunately, alkenes are not tolerated as well under these 
conditions with product 5.3bh being obtained in only 26% yield (Entry 8, Table 5.5). 
Alkylation with the tertiary carboxylic acid, pivalic acid, did proceed well however 
giving a 61% yield of 5.3bi (Entry 9, Table 5.5). Primary carboxylic acids initially seemed 
less suited to the reaction conditions (5.3bj 28% and 5.3bk 37%, Entries 10 and 11, 
Table 5.5) but later showed good yields when coupled with menadione 5.4b (see Table 
5.6). Pleasingly, the formation of product 5.3bl (34%, Entry 12, Table 5.5) shows that 
the alkyne moiety is tolerated in the reaction and the yield with primary carboxylic 
acids can be greatly improved by using a more electron-rich benzyl carboxylic acid 
(5.3bm, 53%, Entry 13, Table 5.5) or by having an oxygen adjacent to the reaction site 
(5.3bn, 68%, Entry 14, Table 5.5).  
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5.3.4 Alkylation of 1,4-quinone scope 
 
Entry N-Heteroarene Carboxylic acid Major product Yield[a] 
1 
 
 
 
70% 
 
2[b] 
 
 
 
64% 
 
3 
 
 
 
 
72% 
 
4 
 
 
 
55% 
 
5 
 
 
 
78% 
 
6[c] 
 
 
 
64% 
1.3 : 1 
regio. 
 
10% 
5.5ea’ 
7 
 
 
 
27% 
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8 
 
 
 
67% 
 
9 
 
 
 
85% 
 
10 
 
 
 
63% 
 
11 
 
 
 
59% 
 
[a] Isolated yields, [b] 20 equiv. of acid, 4 equiv. oxidant and 3 days, [c] 1.3 : 1 mixture of the 
two regioisomers of 5.5ea as well as 10% disubstitution (5.5ea’). 
Table 5.6: Scope for the alkylation of 1,4-quinones 
 
The C-H alkylation of quinones was investigated next. Optimisation of the reaction 
conditions on 1,4-naphthoquinone 5.4a (Table 5.1) provided the alkylated product in 
good yield (5.5aa, 70%, Entry 1, Table 5.6) and also showed the potential for 
dialkylation of 1,4-naphthoquinone 5.4a. Dialkylation could be achieved by simply 
increasing the reaction time and equivalents of reagents (5.5aa’, 64%, Entry 2, Table 
5.6). Moving to other quinones we found that the provitamin menadione 5.4b and 1,4-
anthraquinone 5.4c also reacted very smoothly under our conditions (5.5ba and 5.5ca, 
72% and 78%, Entry 3 and 4, Table 5.6).  Pleasingly, 2-methoxy-1,4-naphthoquinone 
also reacted reasonably well under our conditions (5.5da, 55%, Entry 5, Table 5.6) and 
the hydroxyl group in the 5-position of juglone was tolerated well, albeit with low 
regioselectivity and some dialkylation being obtained (5.5ea, 64% 1.3:1 regio., + 5.5ea’, 
10%  Entry 6, Table 5.6). Disappointingly, the parent 1,4-benzoquinone was not as well 
suited to our conditions (5.5fa, 27%, Entry 7, Table 5.6) but we were overall very 
pleased with the range of the quinones which could be alkylated, especially given the 
moiety’s prevalence in nature. We next investigated the scope of carboxylic acids 
which could be used for the alkylation of 1,4-quinones by coupling both tertiary and 
primary carboxylic acids with menadione 5.5b. To our surprise, pivalic acid did not 
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react well with menadione 5.5b giving only trace product. Gratifyingly, reaction with 
1,4-naphthoquinone 5.5a proceeded much more smoothly providing 5.5ai in good 
yield (67%, Entry 8, Table 5.6) and suggesting that coupling with menadione 5.5b was 
problematic due to steric hindrance. Pleasingly, primary carboxylic acids reacted well 
under our conditions with the addition of a benzyl group occurring with excellent yield 
(5.5bj, 85%, Entry 9, Table 5.6), propionic acid reacting smoothly (5.5bk, 63%, Entry 10, 
Table 5.6) and the alkyne functionality being tolerated well in the formation of product 
5.5bl (59%, Entry 11, Table 5.6). These yields are a big improvement on the lower 
yields obtained using primary carboxylic acids during our initial carboxylic acid screen 
with N-heteroarene 5.1b (Entries 10-12, Table 5.5), showing that the performance of 
the primary carboxylic acids is substrate dependent.  
 
In order to take full advantage of the potential of 1,4-naphthoquinone 5.4a to be 
dialkylated, we developed conditions to add two different acids without the need for 
isolation of the intermediate 5.5aa. To our delight, after the first alkylation the excess 
carboxylic acid CyCO2H 5.2a can be simply washed out of the crude reaction mixture 
before the addition of a second acid (nPr)2CHCO2H 5.2f to give the dialkylated product 
5.5aaf in 46% yield over the two steps (Scheme 5.15). 
 
 
Scheme 5.15: Rapid dialkylation using different carboxylic acids 
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5.3.5 Late-stage C-H alkylation 
 
 
Entry Substrate Carboxylic 
acid 
(NH4)2S2O8 
(equiv.) 
Major product Yield[a] 
1 
  
3 
 
82% 
 
2[b] 
 
 
4 
 
44% 
 
3[c] 
 
 
 
3 
 
28% 
4 
 
 
4 
 
86% 
 
5 
 
 
2 
 
33% 
 
6 
 
 
2 
 
61% 
[a] Isolated yields, [b] half normal scale, isolated product impure (90% purity), [c] 40 hours. 
Table 5.7: Late-stage C-H alkylation 
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Having shown that our conditions are amenable to a range of N-heteroarenes, 
quinones and carboxylic acids we looked to achieve late-stage C-H functionalisation of 
more complex substrates (Table 5.7). First, neocuproine 5.1m, a commonly used ligand 
in transition metal catalysis, was successfully dialkylated in excellent yield (5.3ma’, 
82%, Entry 1, Table 5.7). The more complex fasudil.HCl 5.1n, a well know rho-kinase 
inhibitor and vasodilator, was functionalised next (5.3na, 44%, Entry 2, Table 5.7) and 
the less reactive caffeine 5.1o was also successfully alkylated, albeit in a lower yield 
(5.3oa, 28%, Entry 3, Table 5.7). To our delight, we were also able to prepare an 
analogue of the antispasmodic drug papaverine under our conditions, coupling 
3-methylisoquinoline 5.1e with homoveratric acid 5.2m in an excellent yield (5.3em, 
86%, Entry 4, Table 5.7). Parvaquone 5.5ga, which is marketed as Clexon® for the 
treatment of cattle, was also successfully prepared by the alkylation of lawsone 5.4g 
with carboxylic acid 5.2a (5.5ga, 33%, Entry 5, Table 5.7). Finally, compound 3bo, 
which is reported to bind and inhibit glutathione reductase, a targeted enzyme in the 
treatment of malaria,171 was also successfully prepared by coupling menadione 5.4b 
and pimelic acid 5.2o (5.5bo, 59%, Entry 6, Table 5.7). The preparation of 5.5bo also 
shows the conditions are tolerant to a second carboxylic acid group, which remains 
intact in the reaction.  
 
5.3.6 Substrates and carboxylic acids unsuited to the reaction 
 
Entry Substrate Carboxylic 
acid 
(NH4)2S2O8 
(equiv.) 
Major product NMR 
Yield[a] 
1 
 
 
4 
 
<30% 
 
2 
 
 
6 
 
5.3qa 
31%  
5.3qa’ 
13%  
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3 
 
  
3 No product - 
4 
 
 
3 No product -
 
5 
 
 
3 No product - 
6 
  
3 
6 
 
<20% 
<20% 
7Д 
 
 
3 
 
 
36% 
8Д 
  
3 
 
15% 
9Д 
 
 
3 No product - 
10Д 
 
 
3 No product - 
11Д 
  
3 No product - 
12Д 
  
3 No product - 
13Ѫ 
 
 
2 No product - 
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14Ѫ 
 
 
2 No product - 
15Ѫ 
 
 
2 No product - 
[a] Determined by 1H NMR analysis using 1,3,5-trimethoxybenzene as an internal standard, 
the NMR signals integrated matched literature signals as the products were not isolated. 
Table 5.8: Substrates and carboxylic acids unsuited to the reaction 
 
Although the alkylation procedure developed was found to be tolerant to a large scope 
of carboxylic acids, N-heteroarenes and 1,4-quinones there were several substrates 
and acids which were found not to be suited to our conditions. 2,4-Dichloropyrimidine 
5.1p and 4-ethylpyridine 5.1q were found to react very sluggishly giving low NMR 
yields of the desired products 5.3pa and 5.3qa (<30% and 31%, Entries 1 and 2, Table 
5.8). Disappointingly, 2,6-dichloropyridine 5.1r, which was expected to react similarly 
to 2,6-lutidine 5.1j (5.3ja, 50%, Entry 10, Table 5.4), preformed worse still, providing no 
product under our conditions (Entry 3, Table 5.8). Hypoxanthine 5.1s was also found to 
be totally unreactive (Entry 4, Table 5.8), as was the common ligand 5.1t (Entry 5, 
Table 5.8) although this may have been caused by 5.1t being insoluble in DMSO.  
 
Some carboxylic acids investigated were also found to be unsuited to the alkylation 
procedure, including the tertiary carboxylic acids 5.2p and 5.2q which gave much 
lower yields (5.3bp and 5.3bq, <20% and 36%, Entries 6 and 7, Table 5.8) when 
compared to pivalic acid 5.2i (5.3bi, 61%, Entry 9, Table 5.5). Acetic acid 5.2r was also 
found to perform poorly (5.3br, 15%, Entry 8, Table 5.8) and N-methylproline 5.2r 
provided no product in the reaction (Entry 9, Table 5.8). 5.2r being unreactive was 
thought to be due to the radical being formed alpha to the nitrogen. However, 
N-benzyl-beta-proline was also totally unreactive under our conditions (Entry 10, Table 
5.8). Interestingly, the unprotected amine containing carboxylic acid 5.2u was not 
tolerated in the reaction (No reaction, Entry 11, Table 5.8) despite the protected amino 
acid 5.2d reacting very cleanly (91%, 5.3bd, Entry 4, Table 5.5). Bromine containing 
carboxylic acid 5.2v was also not tolerated in the reaction presumably due to the 
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reactivity of the bromo-group (Entry 12, Table 5.8). Finally, carboxylic acids 5.2w, 5.2x 
and 5.2y were found to be totally unreactive under our alkylation procedure perhaps 
due to the very different nature of the radicals generated (Entry 12-15, Table 5.8). 
 
5.3.7 Mechanistic studies 
 
Scheme 5.16: Proposed mechanism for the alkylation of N-heteroarenes and 
1,4-quinones 
 
Our proposed mechanism (Scheme 5.16) begins with the homolysis of the persulfate to 
the radical sulfate anion which would usually be slow at the temperatures used in our 
procedure (30-40 °C). However, the rate at which homolysis of S2O82- occurs is 
reported to be dependent on solvent,169 and is known to be much faster in DMSO,170 
also explaining why the use of DMSO as a solvent is crucial to the reaction (Table 5.3). 
The radical sulfate anion is therefore thought to be produced at rate fast enough to 
sustain the reaction without the need for a metal, light or a photocatalyst. Once 
generated, the radical sulfate anion undergoes hydrogen atom transfer (HAT) with the 
carboxylic acid causing decarboxylation and providing the alkyl radical 5.III. Radical 
addition to the substrate 5.4a then gives intermediate V which can be converted to 
196 
 
the product 5.5 by two possible mechanisms. The first of these is single electron 
oxidation using another equivalent of persulfate and deprotonation. Alternatively, the 
product 5.5 could be formed from intermediate V by radical H extraction by a radical 
sulfate anion.  
 
In order to gain evidence for the proposed mechanism we first looked to show that the 
reaction was proceeding through a radical pathway. Addition of radical trap TEMPO 
totally retarded the reaction ((a), Scheme 5.17) and coupling of menadione 5.4b and 
2-cyclopropylacetic acid 5.2z gave the ring opened product 5.5bz ((b), Scheme 5.17) 
suggesting radicals are indeed involved in the mechanism.  
 
 
Scheme 5.17: Experiments suggesting a radical mechanism 
 
Having shown that the reaction proceeds through a radical mechanism, the 
involvement of the radical sulfate anion was investigated next using allyl acetate. Allyl 
acetate is known to sequester radical sulfate anions and so should slow down the 
reaction if radical sulfate anions are involved directly in the mechanism.169, 172 Adding 6 
equivalents of allyl acetate reduced the yield of the alkylation of both 
1,4-naphthoquinone 5.4b (Scheme 5.18) and quinaldine 5.1b (Scheme 5.19). However, 
the drop in yield was deemed to be not substantial enough to prove that allyl acetate 
was having an effect on the reaction and so further investigation was carried out. 
Aliquots of the reaction both with and without allyl acetate were taken at various time 
points, providing the % conversion over time for the alkylation of quinaldine 5.1b 
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(Table 5.10 and Figure 5.6). The data clearly indicates that allyl acetate is having an 
effect on the rate of the reaction and further experiments using a large excess of allyl 
acetate (Scheme 5.20) and investigating the effect of allyl acetate at 30 oC (Scheme 
5.21) also indicate that allyl acetate is having a negative effect on the reaction.  
 
 
Scheme 5.18: Effect of 6 equiv. allyl acetate on the alkylation of 5.4bѪ 
 
 
Scheme 5.19: Effect of 6 equiv. allyl acetate on the alkylation of 5.1b 
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Time  
(h) 
% conv. by NMR 
Normal  
conditions 
6 equiv.  
allyl acetate  
added  
1 16 8 
2 31 21 
3 50 31 
5 73 41 
8 81 64 
Table 5.10: Effect of allyl acetate on the alkylation of 5.1b over time 
 
 
 
Figure 5.6: Effect of allyl acetate on the alkylation of 5.1b over time 
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Scheme 5.20: Effect of 30 equiv. allyl acetate on the alkylation of 5.1b 
 
 
Scheme 5.21: Effect of 6 equiv. allyl acetate on the alkylation of 5.1b at 30 oC 
 
Since the evidence suggests that the addition of allyl acetate slows the alkylation we 
can conclude that the radical sulfate anion is, as proposed (Scheme 5.16), involved in 
the reaction mechanism. The final piece of mechanistic investigation done was the 
study of an alternative pathway for the conversion of intermediate 5.V to the product 
5.5 via intermediate 5.VI (Scheme 5.22).   
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Scheme 5.22: Alternative mechanistic pathway (found to be unlikely) 
 
In addition to the two pathways by which 5.V can be converted to the product 5.5 
previously discussed, there is also the possibility of a third radical chain propagation 
pathway (bold arrows, Scheme 5.22). This pathway (along with the SET with 
persulfate) can be considered a radical chain propagation pathway, as the generation 
of the radical sulfate anion by homolysis is not required for this pathway to propagate. 
In this third proposed pathway which is similar to the mechanism proposed by 
Molander and co-workers in their alkylation procedure using 1,4-dihydropyridines,162 
intermediate 5.V abstracts a radical H from the carboxylic acid 5.2 generating another 
alkyl radical which can go on to react with another equivalent of substrate 5.4a.  
 
In order to investigate the possibility of this alternative pathway (Scheme 5.22), we 
attempted to detect intermediate 5.VI. This was unlikely to be possible using 
1,4-naphthoquinone 5.4b as a substrate as it was thought that intermediate 5.VI 
would be too readily oxidised. However, since the intermediate 5.kVI is easily 
synthesised by other means (see Section 5.5.6) and a similar compound was detected 
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by Molander and co-workers in their alkylation procedure,164 substrate 5.1k could be 
used for this investigation (Scheme 5.23). 
 
 
Scheme 5.23: Alternative mechanistic pathway for 5.1k (found to be unlikely) 
 
Using HPLC as the detection method, the reaction mixture was analysed at various 
time points and using different amounts of oxidant but the intermediate 5.kVI could 
not be detected (Figures 5.7 and 5.8). Since Molander and co-workers previously 
detected a similar intermediate in their alkylation protocol and did so using the same 
method,164 it was concluded that intermediate 5.VI is not forming under our reaction 
conditions. Since intermediate 5.VI is not detectable in our reaction mixture this 
alternative pathway is thought to be unlikely under our conditions.  
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Figure 5.7: HPLC trace of a mixture of starting material 5.1k, intermediate 5.kVI and 
product 5.3ka. 
 
 
HPLC (LUNA 5µ C18(2), 1:1 MeOH:H2O, 1.75 ml min-1) 
Figure 5.8: Example HPLC trace of reaction mixture (1 equiv. of oxidant, 3 h) 
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5.4 Conclusions 
The first metal-, light- and photocatalyst free alkylation procedure using carboxylic 
acids has been developed and has been shown to be suitable for the late-stage C-H 
functionalisation of N-heteroarene and 1,4-quinone moieties. The reaction is 
particularly useful as it does not require expensive photocatalysts or metals, uses 
cheap and readily available carboxylic acids and does not require irradiation. The 
development of light-free conditions was of particular importance as it allowed for the 
alkylation of 1,4-quinones which, during the optimisation of the reaction, were shown 
to degrade under blue light irradiation.   
 
The mild Minisci-type conditions developed allows for the generation of alkyl radicals 
without the previously employed metal, photocatalyst, light or prefunctionalisation. 
This is thought to be thanks to DMSO increasing the rate of persulfate homolysis,170 a 
key step in the proposed mechanism. The thermal homolysis of persulfate is reported 
to occur at higher temperatures (>70 oC)169 but the use of DMSO as a solvent makes 
this possible under much milder conditions, allowing for late-stage C-H alkylation of 
medicinally relevant compounds. As well as medicinally relevant compounds, a range 
of N-heteroarenes and 1,4-quinones were functionalised and primary, secondary and 
tertiary carboxylic acids were all tolerated.  
 
  
204 
 
5.5 Experimental 
5.5.1 General considerations 
1H NMR spectra were recorded on a Bruker AV300 or AV400 spectrometer at 300 MHz 
or 400 MHz respectively. 13C NMR spectra were recorded using the same 
spectrometers at 75 MHz or 100 MHz respectively. Chemical shifts (δ in ppm) were 
referenced to tetramethylsilane (TMS) or to residual solvent peaks (CDCl3 at δH 7.26 
ppm and δC at 77.0 ppm and CD3CN at δH 2.13, 1.94 ppm and δC at 116.3, 1.3 ppm). 19F 
NMR spectra were recorded on a Bruker AV400 spectrometer at 376 MHz. J values are 
given in Hz and br., s, d, t, q, quin, sext, sept, m, are abbreviations corresponding to 
broad, singlet, doublet, triplet, quartet, quintet, sextuplet, septuplet, multiplet 
respectively or a combination of these. Mass spectra were obtained from the EPSRC UK 
National Mass Spectrometry Facility at Swansea University. Infrared spectra were 
obtained on Perkin-Elmer Spectrum 100 FT-IR Universal ATR Sampling Accessory, 
deposited neat to a diamond/ZnSe plate. 
Column chromatography was carried out using Matrix silica gel 60 from Fluorochem or 
neutral alumina Brockmann I 50-200 µm 60 from Acros Organics. TLC performed using 
Merck silica gel 60 F254 or Aluminium oxide 60 F254 neutral pre-coated sheets and 
visualised by UV (254 nm) or stained by the use of aqueous acidic KMnO4. Chemicals 
were purchased from Sigma‐Aldrich, Acros, Apollo Scientific, Fisher, Fluorochem, Alfa 
Aesar, TCI and Manchester Organics chemical companies and either used without 
further purification or purified by recrystallisation (menadione, 1,4-anthraquinone, 2-
hydroxy-1,4-naphthoquinone, quinazoline, phthalazine and 4-hydroxyquinazoline) or 
sublimation (1,4-benzoquinone and 1,4-naphthoquinone). 
High performance liquid chromatography (HPLC) was carried out on a Shimadzu LC-
20AD.  
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5.5.2 General procedure for alkylation reaction 
General procedure A 
To a nitrogen or argon backfilled Schlenk tube substrate 5.1 or 5.4 (0.15 mmol, 1 
equiv.), carboxylic acid 5.2 (1.50 mmol, 10 equiv.) and ammonium persulfate were 
added. After a final backfill, DMSO/water (3mL/5 µL degassed by bubbling with argon 
(2 balloons/15 mins) was added and the reaction was sealed and stirred overnight at 
40 oC. 
The reaction mixture was diluted with DCM (15 mL) and washed with sat. NaHCO3 
solution. The aqueous layer was then extracted with DCM (2 x 15 mL) and the 
combined organic layers were washed with brine (40 mL), dried (Na2SO4) and 
concentrated to give the crude product.  
 
General procedure B 
Heteroarene 5.1 (0.15 mmol, 1 equiv.) was weighed into a small RBF before being 
transferred to a nitrogen or argon backfilled Schlenk tube with DMSO/water (3 mL/5 
µL, degassed by bubbling with argon). After 5 minutes of bubbling with argon, 
carboxylic acid 5.2 (1.50 mmol, 10 equiv.) and ammonium persulfate were added, and 
the reaction was sealed and stirred overnight at 40 oC. 
The reaction mixture was diluted with DCM (15 mL) and washed with sat. NaHCO3 
solution. The aqueous layer was then extracted with DCM (2 x 15 mL) and the 
combined organic layers were washed with brine (40 mL), dried (Na2SO4) and 
concentrated to give the crude product.  
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5.5.3 Procedure for carboxylic acid recovery 
 
Quinaldine 5.1b (21.5 mg, 0.15 mmol, 1 equiv.) was weighed into a small RBF before 
being transferred to a nitrogen or argon backfilled Schlenk tube with DMSO/water (3 
mL/5 µL, degassed by bubbling with argon). After 5 minutes of bubbling with argon, 
cyclohexanecarboxylic acid 5.2a (192 mg, 1.50 mmol, 10 equiv.) and ammonium 
persulfate (103 mg, 0.45 mmol, 3 equiv.) were added and the reaction was sealed and 
stirred overnight at 40 oC. 
Method A: The reaction mixture was diluted with DCM (15 mL) and washed twice with 
sat. NaHCO3 solution. The aqueous layer was then acidified to pH 1 with dilute HCl(aq) 
and extracted with DCM (3 x 20mL) and the combined organic layers were washed 
with brine (40 mL), dried (Na2SO4) and concentrated under reduced pressure. 1,3,5-
Trimethoxybenzene (8.4mg, 0.05 mmol, 0.33 equiv.) was added as an internal standard 
and the 1H NMR yield was taken.  
Method B:173, 174 The reaction mixture was diluted with DCM (40 mL) and washed with 
very dilute HCl(aq) and then brine. The combined aqueous layers were extracted with 
DCM and the combined organic layers were dried (Na2SO4) and concentrated under 
reduced pressure. The crude mixture was redissolved in DCM (15 mL) and stirred for 2 
hours with Amberlyst A26 (1.68 g, 2.25 mmol, 15 equiv.). The Amberlyst A26 was 
filtered off and washed with MeOH to give the crude product 5.3ba. The Amberlyst 
A26 was then washed again with 20% formic acid in MeOH and the filtrate was 
concentrated under reduced pressure. 1,3,5-Trimethoxybenzene (8.4mg, 0.05 mmol, 
0.33 equiv.) was added as an internal standard and the 1H NMR yield was taken.  
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5.5.4 Mechanistic studies – evidence for radical mechanism 
 
Following general procedure A, 1,4-naphthoquinone 5.4a (23.7 mg, 0.15 mmol, 1 
equiv.), cyclohexanecarboxylic acid 5.2a (192 mg, 1.50 mmol, 10 equiv.) and 
ammonium persulfate (68.5 mg, 0.30 mmol, 2 equiv.), with the addition of (2,2,6,6-
tetramethylpiperidin-1-yl)oxyl (46.9 mg, 0.30 mmol, 2 equiv.) were allowed to stir at 
40 °C and after 16 h, the NMR of the crude reaction mixture showed no desired 
product and unreacted starting material 5.4a. 
 
 
General procedure A was followed, reacting menadione and cyclopropylacetic acid to 
give solely the ring opened product 5.5bz. Full characterisation in Section 5.5.7.  
 
5.5.5 Mechanistic studies – allyl acetate 
 
Following general procedure A menadione 5.4b (25.8 mg, 0.15 mmol, 1 equiv.), 
cyclohexanecarboxylic acid 5.2a (192 mg, 1.50 mmol, 10 equiv.) and ammonium 
persulfate (68.5 mg, 0.30 mmol, 2 equiv.) were added to the Schlenk flask. Allyl acetate 
(79 µL, 0.90 mmol, 6 equiv.) was added immediately after DMSO/water was added. 1H 
NMR analysis of the crude reaction mixture with 1,3,5-trimethoxybenzene as an 
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internal standard showed the NMR yield of 5.5ba to be 64%, slightly lower than the 
isolated yield without allyl acetate (72%).  
 
 
Under Schlenk conditions, to quinaldine 5.1b (21.5 mg, 0.15 mmol, 1 equiv.) and allyl 
acetate (97µL, 0.90 mmol, 6 equiv.), in argon bubbled DMSO/water (3mL/5µL), was 
added cyclohexanecarboxylic acid 5.2a (192 mg, 1.50 mmol, 10 equiv.) and ammonium 
persulfate (103 mg, 0.45 mmol, 3 equiv.). The reaction mixture was briefly bubbled 
with argon, sealed and stirred overnight at 40 oC. 1H NMR of the crude reaction 
mixture with 1,3,5-trimethoxybenzene as an internal standard showed the yield of 
5.3ba (70%) to be slightly lower than under the standard conditions without allyl 
acetate (82% isolated yield).  
 
 
Further investigation was carried out by running two experiments in tandem - one with 
allyl acetate and one without. The experiments were set up as detailed above and 
aliquots were taken at the time points shown below. The percentage conversion was 
determined by 1H NMR.  
 
 
209 
 
The reaction was carried out as above with a greater excess of allyl acetate (486 µL, 
4.50 mmol, 30 equiv.) giving 5.3ba in a NMR yield of 44% with 29% starting material 
5.1b remaining. 
 
 
The reaction was also carried out as detailed above but at 30 oC, showing a lower yield 
with allyl acetate at this temperature. 
 
5.5.6 Starting material and intermediate synthesis 
2-Methoxynaphthalene-1,4-dione (5.4c)175 
 
Concentrated sulphuric acid (75 μL) was added to 2-hydroxy-1,4-naphthoquinone (296 
mg, 1.70 mmol) in methanol (15 mL) and refluxed overnight. The reaction mixture was 
neutralised with 2M NaOH(aq), concentrated under vacuum, redissoved in DCM and 
dried (Na2SO4). The crude product was concentrated and purified by column 
chromatography (eluent: 5:1 to 2:1 petrol 40-60 oC/EtOAc) to yield product 5.4c as a 
white solid (258 mg, 1.37 mmol, 81%). 
 
RF 0.29 (2:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3050, 2956, 2853 (C-H), 1680, 1644 
(C=O), 1605, 1591, 1577, 1445 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.18 – 8.04 (2H, m, 
Ar-H), 7.81 – 7.65 (2H, m, Ar-H), 6.18 (1H, s, =CH), 3.91 (3H, s, CH3); 13C NMR (75 MHz, 
CDCl3) δ 185.0 (C), 180.3 (C), 160.6 (C), 134.5 (CH), 133.5 (CH), 132.2 (C), 131.2 (C), 
126.9 (CH), 126.4 (CH), 110.1 (CH), 56.6 (CH3); m.p. = 183 oC (lit.176 182-183 oC). 
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2-Cyclohexyl-2,3-dihydroquinazolin-4(1H)-one (5.kVI)  
 
Following an adapted procedure164 2-aminobenzamide (136 mg, 1.0 mmol) and 
cyclohexanecarbaldehyde (363 µL, 3 mmol) were refluxed in 2,2,2-trifluoroethanol (2.5 
mL) under an argon atmosphere for 45 minutes. The reaction mixture was 
concentrated under reduced pressure and purified by column chromatography 
(eluent: 2:1 to 1:2 petrol 40-60 oC/EtOAc) to yield product 5.kVI as a white solid (210 
mg, 0.98 mmol, 98%). 
 
RF 0.29 (1:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3364, 3166 (N-H), 3055, 2921, 2850 (C-
H), 1642 (C=O), 1609, 1503, 1484 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 7.87 (1H, dd, 
J=7.8, 1.6 Hz, Ar-H), 7.34 – 7.23 (1H, ddd, J=8.2, 7.5, 1.6 Hz, Ar-H), 6.82 (1H, app. td, 
J=7.5, 1.0 Hz, Ar-H), 6.65 (1H, dd, J=8.2, 1.0 Hz, Ar-H), 6.20 (1H, br. S, NH), 4.64 (1H, dd, 
J=5.1, 1.6 Hz, NHCH), 4.26 (1H, br. s, NH), 1.90 – 1.57 (6H, m, alkyl CHs), 1.36 – 1.00 
(5H, m, alkyl CHs); 13C NMR (75 MHz, CDCl3) δ 165.3 (C), 147.6 (C), 133.9 (CH), 128.6 
(CH), 119.1 (CH), 115.8 (C), 114.6 (CH), 69.7 (CH), 42.8 (CH), 27.7 (CH2), 27.6 (CH2), 26.3 
(CH2), 25.91 (CH2), 25.89 (CH2); Found (FTMS + p NSI) [M + H]+ 231.1492, C14H19N2O 
requires 231.1492; m.p. = 175 oC (lit.177 175-176 oC). 
 
5.5.7 Product characterisation 
2-Cyclohexyl-4-methylquinoline (5.3aa) 
 
General procedure B was followed, reacting 4-methylquinoline (21.5 mg, 0.15 mmol), 
cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate (103 mg, 
0.45 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by column 
chromatography (eluent: 80:1 to 30:1 petrol 40-60 oC/EtOAc + 5% toluene) to yield 
product 5.3aa as a yellow oil (27.6 mg, 0.12 mmol, 82%).   
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RF 0.24 (30:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2923, 2851 (C-H), 1603, 1559, 1507, 
1447 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.04 (1H, ddd, J=8.4, 1.3, 0.6 Hz, Ar-H), 7.94 
(1H, dm, J=8.2 Hz, Ar-H), 7.66 (1H, ddd, J=8.4, 6.9, 1.5 Hz, Ar-H), 7.49 (1H, ddd, J=8.2, 
6.9, 1.3 Hz, Ar-H), 7.17 (1H, q, J=0.9 Hz, Ar-H), 2.87 (1H, tt, J=11.9, 3.4 Hz, alkyl CH), 
2.68 (3H, d, J=0.9 Hz, CH3), 2.07 – 1.74 (5H, m, alkyl CHs), 1.66 – 1.23 (5H, m, alkyl CHs); 
13C NMR (75 MHz, CDCl3) δ 166.7 (C), 147.7 (C), 144.4 (C), 129.6 (CH), 129.1 (CH), 127.2 
(C), 125.5 (CH), 123.7 (CH), 120.4 (CH), 47.7 (CH), 33.0 (2CH2), 26.7 (2CH2), 26.3 (CH2), 
19.0 (CH3); NMR data matches literature values.160 
 
4-Cyclohexyl-2-methylquinoline (5.3ba) 
 
General procedure B was followed, reacting 2-methylquinoline (21.5 mg, 0.15 mmol), 
cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate (103 mg, 
0.45 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by column 
chromatography (eluent: neat to 10:1 petrol 40-60 oC/EtOAc) to yield product 5.3ba as 
a colourless oil (27.0 mg, 0.12 mmol, 80%).   
 0.5 g Scale experiment. 
General procedure B was followed reacting 2-methylquinoline (0.47 mL, 3.49 mmol), 
cyclohexanecarboxylic acid (4.48 g, 34.9 mmol) and ammonium persulfate (2.39 g, 10.5 
mmol) in DMSO/water (69.8 mL/116 µL). The crude product was purified by column 
chromatography (eluent: 3:1 hexanes/EtOAc) to yield product 5.3ba as a yellow oil 
(617 mg, 2.72 mmol, 78%). 
 
RF 0.25 (5:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2925, 2851 (C-H), 1600, 1563, 1510, 1447 
(C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.10 – 7.94 (2H, m, Ar-H), 7.65 (1H, ddd, J=8.4, 
6.8, 1.4 Hz, Ar-H), 7.48 (1H, ddd, J=8.3, 6.8, 1.3 Hz, Ar-H), 7.17 (1H, s, Ar-H), 3.39 – 3.20 
(1H, m, alkyl CH), 2.72 (3H, s, CH3), 2.08 – 1.80 (5H, m, alkyl CHs), 1.66 – 1.44 (4H, m, 
alkyl CHs), 1.41 – 1.28 (1H, m, alkyl CH); 13C NMR (75 MHz, CDCl3) δ 159.0 (C), 153.4 
(C), 148.3 (C), 129.7 (CH), 128.9 (CH), 125.4 (CH), 125.3 (C), 123.0 (CH), 118.5 (CH), 38.9 
212 
 
(CH), 33.7 (2CH2), 27.1 (2CH2), 26.5 (CH2), 25.7 (CH3); NMR data matches literature 
values.160 
 
4-Cyclohexyl-6-fluoro-2-methylquinoline (5.3ca) 
 
General procedure A was followed, reacting 6-fluoro-2-methylquinoline (24.2 mg, 0.15 
mmol), cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate 
(103 mg, 0.45 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by 
column chromatography (eluent: 12:1 to 7:1 toluene/EtOAc) to yield product 5.3ca as 
a yellow oil (22.8 mg, 0.09 mmol, 62%).    
 
RF 0.33 (5:1 toluene/EtOAc); νmax/cm-1 2926, 2852 (C-H), 1625, 1604, 1564, 1513, 1465 
(C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.00 (1H, dd, J=9.2, 5.7 Hz, Ar-H), 7.61 (1H, dd, 
J=10.6, 2.8 Hz, Ar-H), 7.41 (1H, ddd, J=9.2, 8.0, 2.8 Hz, Ar-H), 7.17 (1H, s, Ar-H), 3.23 – 
3.02 (1H, m, alkyl CH), 2.70 (3H, s, CH3), 2.03 – 1.79 (5H, m, alkyl CHs), 1.65 – 1.43 (4H, 
m, alkyl CHs), 1.39 – 1.24 (1H, m, alkyl CH); 13C NMR (CDCl3, 75 MHz) δ 160.2 (d, 
J=245.1 Hz, CF), 158.2 (d, J=2.5 Hz, C), 152.9 (d, J=5.5 Hz, C), 145.4 (C), 131.9 (d, J=9.0 
Hz, FCHCHC), 126.0 (d, J=9.0 Hz, FCHCC), 119.1 (CH), 118.8 (d, J=25.4 Hz, FCCH), 106.7 
(d, J=22.5 Hz, FCCH), 39.2 (CH), 33.6 (2CH2), 27.0 (2CH2), 26.4 (CH2), 25.5 (CH3); Found 
(TOF MS ASAP+) [M + H]+ 244.1503, C16H19FN requires 244.1503.  
 
4-Cyclohexyl-6-methoxy-2-methylquinoline (5.3da) 
 
General procedure A was followed, reacting 6-methoxy-2-methylquinoline (26.0 mg, 
0.15 mmol), cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium 
persulfate (103 mg, 0.45 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was 
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purified by column chromatography (eluent: 8:1 to 5:1 petrol 40-60 oC/EtOAc) to yield 
product 5.3da as a yellow oil (26.0 mg, 0.10 mmol, 68%).   
 
RF 0.20 (5:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2924, 2850 (C-H), 1598, 1495, 1468 (C-C 
Ar); 1H NMR (CDCl3, 300 MHz) δ 7.88 (1H, d, J=9.1 Hz, Ar-H), 7.25 (1H, dd, J=9.1, 2.7 Hz, 
Ar-H), 7.20 (1H, d, J=2.7 Hz, Ar-H), 7.05 (1H, s, Ar-H), 3.86 (3H, s, OCH3), 3.20 – 3.01 
(1H, m, alkyl CH), 2.60 (3H, s, CH3), 2.01 – 1.72 (5H, m, alkyl CHs), 1.56 – 1.37 (4H, m, 
alkyl CHs), 1.33 – 1.21 (1H, m, alkyl CH); 13C NMR (75 MHz, CDCl3) δ 157.1 (C), 156.4 
(C), 152.1 (C), 144.1 (C), 131.0 (CH), 126.0 (C), 120.4 (CH), 118.7 (CH), 102.1 (CH), 55.6 
(CH3), 39.1 (CH2), 33.5 (2CH2), 27.0 (2CH2), 26.5 (CH2), 25.3 (CH3); Found (FTMS + p NSI) 
[M + H]+ 256.1696, C17H22NO requires 256.1696.  
 
1-Cyclohexyl-3-methylisoquinoline (5.3ea) 
 
General procedure A was followed, reacting 2-methylisoquinoline (21.5 mg, 0.15 
mmol), cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate 
(103 mg, 0.45 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by 
column chromatography (eluent: 100:1 petrol 40-60 oC/EtOAc) to yield product 5.3ea 
as a colourless oil (30.8 mg, 0.14 mmol, 91%).    
 
RF 0.35 (50:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2923, 2850 (C-H), 1622, 1592, 1563, 
1448 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.17 (1H, d, J=8.3 Hz, Ar-H), 7.70 (1H, d, 
J=8.0 Hz, Ar-H), 7.58 (1H, ddd, J=8.0, 6.8, 1.2 Hz, Ar-H), 7.48 (1H, ddd, J=8.3, 6.8, 1.4 Hz, 
Ar-H), 7.29 (1H, s, Ar-H), 3.53 (1H, tt, J=11.2, 3.4 Hz, alkyl CH), 2.67 (3H, s, CH3), 2.02 – 
1.77 (7H, m, alkyl CH), 1.63 – 1.36 (3H, m, alkyl CH); 13C NMR (75 MHz, CDCl3) δ 165.1 
(C), 150.7 (C), 137.3 (C), 129.4 (CH), 127.1 (CH), 125.8 (CH), 124.8 (CH), 124.5 (C), 116.8 
(CH), 41.8 (CH), 32.6 (2CH2), 27.0 (2CH2), 26.3 (CH2), 24.7 (CH3); NMR data matches 
literature values.178 
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6-Cyclohexylphenanthridine (5.3fa) 
 
General procedure A was followed, reacting phenanthridine (26.9 mg, 0.15 mmol), 
cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate (103 mg, 
0.45 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by column 
chromatography (eluent: 1:1 petrol 40-60 oC/toluene to 10:1 toluene/Et2O) to yield 
product 5.3fa as a colourless oil (31.8 mg, 0.12 mmol, 80%).   
 
RF 0.23 (80:1 petrol 40-60 oC/Et2O); νmax/cm-1 2923, 2849 (C-H), 1610, 1581, 1575, 1485 
(C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.66 (1H, d, J=8.2 Hz, Ar-H), 8.54 (1H, dd, J=8.1, 
1.5 Hz, Ar-H), 8.32 (1H, d, J=8.2 Hz, Ar-H), 8.13 (1H, dd, J=8.1, 1.5 Hz, Ar-H), 7.81 (1H, 
ddd, J=8.3, 7.0, 1.3 Hz, Ar-H), 7.75 – 7.65 (2H, m, Ar-H), 7.60 (1H, ddd, J=8.3, 7.0, 1.5 
Hz, Ar-H), 3.62 (1H, tt, J=11.1, 3.3 Hz, alkyl CH), 2.18 – 1.78 (7H, m, alkyl CHs), 1.64 – 
1.39 (3H, m, alkyl CHs); 13C NMR (75 MHz, CDCl3) δ 165.4 (C), 144.0 (C), 133.2 (C), 
130.09 (CH), 130.05 (CH), 128.5 (CH), 127.2 (CH), 126.3 (CH), 125.8 (CH), 124.9 (C), 
123.5 (C), 122.7 (CH), 122.0 (CH), 42.1 (CH), 32.4 (2CH2), 27.0 (2CH2), 26.5 (CH2); NMR 
data matches literature values.160 
 
4-Cyclohexylquinazoline (5.3ga) 
 
General procedure B was followed, reacting quinazoline (19.5 mg, 0.15 mmol), 
cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate (103 mg, 
0.45 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by column 
chromatography (eluent: 10:1 to 8:1 petrol 40-60 oC/EtOAc) to yield product 5.3ga as a 
colourless oil (24.6 mg, 0.12 mmol, 77%).    
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RF 0.20 (10:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2926, 2852 (C-H), 1615, 1569, 1557, 
1494 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 9.24 (1H, s, Ar-H), 8.17 (1H, d, J=8.4 Hz), 8.03 
(1H, d, J=8.3 Hz, Ar-H), 7.85 (1H, ddd, J=8.4, 6.9, 1.4 Hz, Ar-H), 7.62 (1H, ddd, J=8.3, 6.9, 
1.3 Hz, Ar-H), 3.55 (1H, tt, J=11.5, 3.3 Hz, alkyl CH), 2.00 – 1.72 (7H, m, alkyl CHs), 1.58 
– 1.29 (3H, m, alkyl CHs); 13C NMR (75 MHz, CDCl3) δ 175.2 (C), 154.9 (CH), 150.2 (C), 
133.4 (CH), 129.5 (CH), 127.4 (CH), 124.3 (CH), 123.4 (C), 41.4 (CH), 32.2 (CH2), 26.6 
(CH2), 26.1 (CH2); NMR data matches literature values.160 
 
1,4-Dicyclohexylphthalazine (5.3ha’) 
 
General procedure B was followed, reacting phthalazine (19.5 mg, 0.15 mmol), 
cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate (206 mg, 
0.90 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by column 
chromatography (eluent: neat to 15:1 toluene/EtOAc) to yield product 5.3ha’ as a 
colourless oil (32.5 mg, 0.11 mmol, 74%).   
 
RF 0.25 (15:1 toluene/EtOAc); νmax/cm-1 2924, 2848 (C-H), 1539, 1446 (C-C Ar); 1H NMR 
(CDCl3, 300 MHz) δ 8.21 – 8.08 (2H, m, Ar-H), 7.88 – 7.79 (2H, m, Ar-H), 3.46 (2H, tt, 
J=11.0, 3.9 Hz, alkyl CHs), 2.13 – 1.75 (14H, m, alkyl CHs), 1.61 – 1.30 (6H, m, alkyl CHs); 
13C NMR (75 MHz, CDCl3) δ 161.9 (C), 131.2 (CH), 125.1 (C), 124.3 (CH), 40.6 (CH), 32.5 
(CH2), 27.1 (CH2), 26.4 (CH2); NMR data matches literature values;160 m.p. = 133 oC. 
 
2-Cyclohexyl-3-methylquinoxaline (5.3ia) 
 
General procedure B was followed, reacting 3-methylquinoxaline (21.6 mg, 0.15 
mmol), cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate 
(137 mg, 0.60 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by 
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column chromatography (eluent: 50:1 to 30:1 petrol 40-60 oC/EtOAc) to yield product 
5.3ia as a colourless oil (23.5 mg, 0.10 mmol, 69%).    
 
RF 0.29 (30:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2924, 2851 (C-H), 1565, 1486, 1449 (C-C 
Ar); 1H NMR (CDCl3, 300 MHz) δ 8.06 – 7.90 (2H, m, Ar-H), 7.69 – 7.58 (2H, m, Ar-H), 
3.03 (1H, tt, J=11.5, 3.2 Hz, alkyl CH), 2.78 (3H, s, CH3), 1.97 – 1.71 (7H, m, alkyl CH), 
1.57 – 1.34 (3H, m, alkyl CHs); 13C NMR (75 MHz, CDCl3) δ 160.5 (C), 152.8 (C), 141.5 
(C), 140.7 (C), 128.9 (CH), 128.8 (CH), 128.7 (CH), 128.3 (CH), 42.7 (CH), 31.7 (CH2), 26.8 
(CH2), 26.1 (CH2), 22.8 (CH3); NMR data matches literature values.179  
 
4-Cyclohexyl-2,6-dimethylpyridine (5.3ja) 
 
General procedure B was followed, reacting 2,6-lutidine (16.1 mg, 0.15 mmol), 
cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate (103 mg, 
0.45 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by column 
chromatography (eluent: 1:1 to 1:2 DCM/EtOAc) to yield product 5.3ja as a yellow oil 
(14.1 mg, 0.08 mmol, 50%).    
 
RF 0.26 (1:2 DCM/EtOAc); νmax/cm-1 2924, 2851 (C-H), 1605, 1564, 1447 (C-C Ar); 1H 
NMR (CDCl3, 300 MHz) δ 6.79 (2H, s, Ar-H), 2.48 (6H, s, 2CH3), 2.47 – 2.33 (1H, m, alkyl 
CH), 1.90 – 1.71 (5H, m, alkyl CHs), 1.45 – 1.22 (5H, m, alkyl CHs); 13C NMR (75 MHz, 
CDCl3) δ 157.6 (C), 157.4 (C), 119.1 (CH), 44.0 (CH), 33.7 (CH2), 26.7 (CH2), 26.1 (CH2), 
24.5 (CH3); NMR data matches literature values.160 
 
2-Cyclohexylquinazolin-4(3H)-one (5.3ka) 
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General procedure A was followed, reacting 4-hydroxyquinazoline (21.9 mg, 0.15 
mmol), cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate 
(206 mg, 0.90 mmol) in DMSO/H2O (3 mL/5 µL) for 24 hours. The crude product was 
purified by column chromatography (eluent: 5:1 to 4:1 petrol 40-60 oC/EtOAc) to yield 
product 5.3ka as a colourless oil (19.2 mg, 0.09 mmol, 60%).   
 
RF 0.28 (3:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3166 (N-H), 3026, 2929, 2853 (C-H), 1679 
(C=O), 1603, 1467 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 11.69 (1H, s, NH), 8.28 (1H, dd, 
J=7.9, 0.9 Hz, Ar-H), 7.86 – 7.65 (2H, m, Ar-H), 7.46 (1H, ddd, J=8.1, 6.8, 1.6 Hz, Ar-H), 
2.74 (1H, tt, J=12.0, 3.4 Hz, alkyl CH), 2.10 – 1.69 (7H, m, alkyl CHs), 1.55 – 1.34 (3H, m, 
alkyl CHs); 13C NMR (75 MHz, CDCl3) δ 164.3 (C), 160.34 (C), 149.7 (C), 134.8 (CH), 
127.5 (CH), 126.4 (CH), 126.3 (CH), 120.9 (C), 45.0 (CH), 30.7 (2CH2), 26.2 (2CH2), 25.9 
(CH2); NMR data matches literature values;164 m.p. = 133 oC. 
 
2-Cyclohexylbenzo[d]thiazole (5.3la) 
 
General procedure B was followed, reacting benzothiazole (20.3 mg, 0.15 mmol), 
cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate (206 mg, 
0.90 mmol) in DMSO/H2O (3 mL/5 µL) for 40 hours. The crude product was purified by 
column chromatography (eluent: 80:1 to 60:1 petrol 40-60 oC/EtOAc) to yield product 
5.3la as a colourless oil (8.3 mg, 0.04 mmol, 25%).   
 
RF 0.36 (30:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2924, 2851 (C-H), 1514, 1448 (C-C Ar); 
1H NMR (CDCl3, 300 MHz) δ 7.97 (1H, ddd, J=8.1, 1.2, 0.6 Hz, Ar-H), 7.85 (1H, dm, J=7.9 
Hz, Ar-H), 7.44 (1H, ddd, J=8.3, 7.2, 1.3 Hz, Ar-H), 7.39 – 7.28 (1H, ddd, J=7.6, 6.4, 1.2 
Hz, Ar-H), 3.11 (1H, tt, J=11.6, 3.6 Hz, alkyl CH), 2.26 – 2.15 (2H, m, alkyl CHs), 1.96 – 
1.28 (8H, m, alkyl CHs); 13C NMR (75 MHz, CDCl3) δ 177.8 (C), 153.3 (C), 134.7 (C), 125.9 
(CH), 124.6 (CH), 122.7 (CH), 121.7 (CH), 43.6 (CH), 33.6 (2CH2), 26.2 (2CH2), 25.9 (CH2); 
NMR data matches literature values.160 
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N-(1-(2-methylquinolin-4-yl)ethyl)acetamide (5.3bd) 
 
General procedure B was followed, reacting 2-methylquinoline (21.5 mg, 0.15 mmol), 
acetylalanine (197 mg, 1.50 mmol) and ammonium persulfate (103 mg, 0.45 mmol) in 
DMSO/H2O (3 mL/5 µL). The crude product was purified by column chromatography on 
neutral alumina (eluent: 1:1 petrol 40-60 oC/EtOAc to neat EtOAc to 5% MeOH in 
EtOAc) to yield product 5.3bd as a yellow oil (31.0 mg, 0.14 mmol, 91%). 
 
RF 0.42 (EtOAc, neutral alumina plate); νmax/cm-1 3270 (N-H), 3062, 2979, 2932 (C-H), 
1651 (C=O), 1602, 1542, 1511 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.03 (2H, app. d, 
J=8.9 Hz, Ar-H), 7.68 (1H, ddd, J=8.5, 6.9, 1.3 Hz, Ar-H), 7.52 (1H, ddd, J=8.2, 6.9, 1.3 Hz, 
Ar-H), 7.24 (1H, s, Ar-H), 5.87 (1H, app. p, J=6.9 Hz, NHCHCH3), 5.78 (1H, br. s, NH), 2.73 
(3H, s, CH3), 2.03 (3H, s, CH3), 1.62 (3H, d, J=6.7 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 
169.2 (C), 158.8 (C), 148.4 (C), 148.3 (C), 129.6 (CH), 129.5 (CH), 126.3 (CH), 124.5 (C), 
123.2 (CH), 118.0 (CH), 44.5 (CH), 25.7 (CH3), 23.5 (CH3), 21.0 (CH3); Found (FTMS + p 
NSI) [M + H]+ 229.1334, C14H17N2O requires 229.1335. 
 
4-(3,4-Dimethoxybenzyl)-2-methylquinoline (5.3bm) 
 
General procedure B was followed, reacting 2-methylquinoline (21.5 mg, 0.15 mmol), 
2-(3,4-dimethoxyphenyl)acetic acid (288 mg, 1.50 mmol) and ammonium persulfate 
(206 mg, 0.90 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by 
column chromatography (eluent: 4:1 to 3:1 toluene/EtOAc) and further purified by 
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column chromatography on neutral alumina (eluent: 6:1 to 1:3 petrol 40-60 oC/EtOAc) 
to yield product 5.3bm as a white solid (23.5 mg, 0.08 mmol, 53%).   
 
RF 0.20 (2:1 petrol 40-60 oC/EtOAc)/0.54 (neutral alumina 3:1 petrol 40-60 oC/EtOAc); 
νmax/cm-1 3002, 2934, 2834 (C-H), 1600, 1511, 1463 (C-C Ar); 1H NMR (CDCl3, 300 MHz) 
δ 8.03 (1H, dd, J=8.3, 1.5 Hz, Ar-H), 7.98 (2H, dd, J=8.4, 1.3Hz, Ar-H), 7.66 (1H, ddd, 
J=8.4, 6.9, 1.5 Hz, Ar-H), 7.46 (1H, ddd, J=8.3, 6.9, 1.3 Hz, Ar-H), 7.00 (1H, s, Ar-H), 6.81 
(1H, d, J=8.0 Hz, Ar-H), 6.72 (1H, s, Ar-H), 6.71 (H, d, J=8.0 Hz, Ar-H), 4.35 (2H, s, CH2), 
3.86 (3H, s, OCH3), 3.81 (3H, s, OCH3), 2.68 (3H, s, CH3); 13C NMR (101 MHz, CDCl3) δ 
159.0 (C), 149.4 (C), 148.3 (C), 148.0 (C), 146.9 (C), 131.4 (C), 129.6 (CH), 129.2 (CH), 
126.1 (C), 125.8 (CH), 123.7 (CH), 122.6 (CH), 121.3 (CH), 112.6 (CH), 111.7 (CH), 56.10 
(CH3), 56.08 (CH3), 37.8 (CH2), 25.5 (CH3); Found (FTMS + p NSI) [M + H]+ 294.1487, 
C19H20NO2 requires 294.1489; m.p. = 109 oC. 
 
2-Cyclohexylnaphthalene-1,4-dione (5.5aa) 
 
General procedure A was followed, reacting 1,4-naphthaquinone (23.7 mg, 0.15 
mmol), cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate 
(68.5 mg, 0.30 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by 
column chromatography (eluent: 1:1 to 1:2 petrol 40-60 oC/toluene) to yield product 
5.5aa as a yellow paste (25.1 mg, 0.11 mmol, 70%).  
 
RF 0.41 (30:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2918, 2851 (C-H), 1654, 1656 (C=O), 
1593, 1450 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.14 – 7.87 (2H, m, Ar-H), 7.71 – 7.58 
(2H, m, Ar-H), 6.66 (1H, d, J=1.1 Hz, =CH), 2.92 – 2.74 (1H, m, alkyl CH), 1.82 – 1.73 (4H, 
m, alkyl CHs), 1.46 – 1.29 (2H, m, alkyl CHs), 1.25 – 1.09 (4H, m, alkyl CHs); 13C NMR (75 
MHz, CDCl3) δ 185.7 (C), 184.9 (C), 156.4  (C), 133.71 (CH), 133.68 (CH), 133.2 (CH), 
132.6 (C), 132.1 (C), 126.8 (CH), 126.0 (CH), 36.8 (CH), 32.4 (2CH2), 26.5 (2CH2), 26.2 
(CH2); NMR data matches literature values.180 
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2,3-Dicyclohexylnaphthalene-1,4-dione (5.5aa’) 
 
General procedure A was followed, reacting 1,4-naphthaquinone (23.7 mg, 0.15 
mmol), cyclohexanecarboxylic acid (384 mg, 3.00 mmol) and ammonium persulfate 
(137 mg, 0.60 mmol) in DMSO/H2O (3 mL/5 µL) for 3 days. The crude product was 
purified by column chromatography (eluent: 2:1 petrol 40-60 oC/toluene) to yield 
product 5.5aa’ as a yellow solid (31.1 mg, 0.10 mmol, 64%).  
 
RF 0.46 (50:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2923, 2851 (C-H), 1654 (C=O), 1614, 
1592, 1443 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.03 – 7.94 (2H, m, Ar-H), 7.70 – 7.58 
(2H, m, Ar-H), 3.15 – 2.99 (2H, m, alkyl CHs), 2.13 – 1.19 (4H, m, alkyl CHs)), 1.91 – 1.72 
(6H, m, alkyl CHs)), 1.60 (4H, m, alkyl CHs)), 1.40 – 1.32 (6H, m, alkyl CHs)); 13C NMR (75 
MHz, CDCl3) δ 186.0 (C), 151.0 (C), 133.2 (CH), 132.6 (C), 126.0 (CH), 39.9 (CH), 30.7 
(2CH2), 27.2 (2CH2), 26.1 (CH2); Found (TOF MS ASAP+) [M + H]+ 323.2011, C22H27O2 
requires 323.2011; m.p. = 107 oC.  
 
2-Cyclohexyl-3-methylnaphthalene-1,4-dione (5.5ba) 
 
General procedure A was followed, reacting menadione (25.8 mg, 0.15 mmol), 
cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate (68.5 mg, 
0.30 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by column 
chromatography (eluent: 2:1 to 1:1 petrol 40-60 oC/toluene) to yield product 5.5ba as 
a yellow solid (27.4 mg, 0.11 mmol, 72%).  
 
 RF 0.44 (50:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2933, 2849 (C-H), 1655 (C=O), 1592, 
1454 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.13 – 7.90 (2H, m, Ar-H), 7.73 – 7.57 (2H, 
m, Ar-H), 2.87 (1H, tt, J=12.1, 3.4 Hz, alkyl CH), 2.22 (3H, s, alkyl CHs)), 2.16 – 1.95 (2H, 
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m, alkyl CHs)), 1.94 – 1.68 (3H, m, alkyl CHs)), 1.68 – 1.51 (2H, m, alkyl CHs)), 1.45 – 
1.14 (3H, m, alkyl CHs)); 13C NMR (75 MHz, CDCl3) δ 185.8 (C), 185.3 (C), 150.7 (C), 
143.2 (C), 133.5 (CH), 133.2 (CH), 132.9 (C), 131.9 (C), 126.3 (CH), 126.1 (CH), 40.9 (CH), 
30.0 (2CH2), 27.1 (2CH2), 26.1 (CH2), 12.7 (CH3); NMR data matches literature values;181 
m.p. = 78 oC (lit.181 77.5-79.0 oC). 
 
2-Cyclohexyl-3-methoxynaphthalene-1,4-dione (5.5ca) 
 
General procedure A was followed, reacting 1,4-naphthaquinone (28.2 mg, 0.15 
mmol), cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate 
(68.5 mg, 0.30 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by 
column chromatography (eluent: 2:1 to 1:1 petrol 40-60 oC/toluene) to yield product 
5.5ca as a yellow paste (22.2 mg, 0.08 mmol, 55%).  
 
 RF 0.26 (40:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2924, 2851 (C-H), 1667, 1651 (C=O), 
1594, 1577, 1448 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.09 – 7.97 (2H, m, Ar-H), 7.74 – 
7.61 (2H, m, Ar-H), 4.06 (3H, s, CH3), 3.09 (1H, tt, J=12.1, 3.3 Hz, alkyl CH), 1.99 – 1.67 
(5H, m, alkyl CHs)), 1.65 – 1.53 (2H, m, alkyl CHs)), 1.45 – 1.22 (3H, m, alkyl CHs)); 13C 
NMR (75 MHz, CDCl3) δ 185.7 (C), 182.1 (C), 158.5 (C), 139.9 (C), 133.9 (CH), 133.2 
(CH), 132.4 (C), 131.6 (C), 126.5 (CH), 126.0 (CH), 61.4 (CH3), 36.0 (CH), 30.1 (2CH2), 
27.0 (2CH2), 26.1 (CH2); Found (TOF MS ASAP+) [M + H]+ 271.1339, C17H19O3 requires 
271.1334. 
 
2-Cyclohexylanthracene-1,4-dione (5.5da) 
 
General procedure A was followed, reacting 1,4-anthraquinone (31.2 mg, 0.15 mmol), 
cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate (68.5 mg, 
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0.30 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by column 
chromatography (eluent: 100:1 to 60:1 petrol 40-60 oC/EtOAc) to yield product 5.5da 
as a yellow solid (33.9 mg, 0.12 mmol, 78%).  
 
 RF 0.24 (50:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2957, 2919, 2846 (C-H), 1660 (C=O), 
1615, 1588, 1459 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.58 (1H, s, Ar-H), 8.54 (1H, s, 
Ar-H), 8.06 – 7.98 (2H, m, Ar-H), 7.70 – 7.59 (2H, m, Ar-H), 6.82 (1H, s, =CH), 2.96 (1H, 
td, J=11.8, 2.6 Hz, alkyl CH), 1.95 – 1.73 (5H, m, alkyl CHs)), 1.57 – 1.37 (2H, m, alkyl 
CHs)), 1.35 – 1.15 (3H, m, alkyl CHs)); 13C NMR (75 MHz, CDCl3) δ 185.3 (C), 184.5 (C), 
157.9 (C), 135.0 (C), 134.8 (C), 134.7 (CH), 130.24 (CH), 130.20 (CH), 129.43 (CH), 
129.39 (CH), 129.2 (CH), 129.1 (C), 128.7 (C), 128.2 (CH), 37.0 (CH), 32.4 (2CH2), 26.6 
(2CH2), 26.2 (CH2); Found (FTMS + p NSI) [M + H]+ 291.1388, C20H19O2 requires 
291.1385; m.p. = 185 oC. 
 
2-Cyclohexyl-5-hydroxynaphthalene-1,4-dione + 2-cyclohexyl-8-hydroxynaphthalene-
1,4-dione (5.5ea) + 2,3-Dicyclohexyl-5-hydroxynaphthalene-1,4-dione (5.5ea’)  
 
General procedure A was followed, reacting 5-hydroxy-1,4-naphthalenedione (26.1 
mg, 0.15 mmol), cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium 
persulfate (68.5 mg, 0.30 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was 
purified by column chromatography (eluent: 5:1 to neat petrol 40-60 oC/toluene) to 
yield isomeric products 5.5ea (1.3:1 ratio) and product 5.5ea’ as a yellow solids.  
5.5eamajor (14.0 mg, 0.05 mmol, 36%). 
 
 RF 0.46 (50:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2921, 2854 (C-H), 1633 (C=O) 1654, 
1593, 1579, 1456 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 11.98 (1H, s, OH), 7.71 – 7.50 
(2H, m, Ar-H), 7.23 (1H, dd, J=7.6, 2.0 Hz, Ar-H), 6.69 (1H, d, J=1.0 Hz, =CH), 2.96 – 2.82 
(1H, m, alkyl CH), 1.91 – 1.71 (5H, m, alkyl CHs)), 1.54 – 1.35 (2H, m, alkyl CHs)), 1.31 – 
1.15 (3H, m, alkyl CHs)); 13C NMR (75 MHz, CDCl3) δ 191.0 (C), 184.2 (C), 161.2 (C), 
157.9 (C), 136.2 (CH), 133.0 (CH), 132.6 (C), 124.1 (CH), 119.5 (CH), 115.0 (C), 37.0 (CH), 
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32.5 (2CH2), 26.5 (2CH2), 26.2 (CH2); Found (TOF MS ASAP+) [M + H]+ 257.1179, 
C16H17O3 requires 257.1178; m.p. = 112 oC. 
  
5.5eaminor (10.6 mg, 0.04 mmol, 28%). 
 RF 0.38 (50:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2953, 2927, 2848 (C-H), 1636 (C=O) 
1666, 1603, 1451 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 12.16 (1H, s, OH), 7.64 – 7.56 
(2H, m, Ar-H), 7.28 – 7.19 (1H, m, Ar-H), 6.71 (1H, d, J=1.1 Hz, =CH), 3.03 – 2.76 (1H, m, 
alkyl CH), 1.93 – 1.74 (5H, m, alkyl CHs)), 1.54 – 1.36 (2H, m, alkyl CHs)), 1.32 – 1.18 
(3H, m, alkyl CHs)); 13C NMR (75 MHz, CDCl3) δ 190.4 (C), 185.0 (C), 161.8 (C), 156.3 (C), 
136.4 (CH), 134.1 (CH), 132.1 (C), 124.3 (CH), 118.7 (CH), 115.5 (C), 36.4 (CH), 32.4 
(2CH2), 26.5 (2CH2), 26.1 (CH2); Found (TOF MS ASAP+) [M + H]+ 257.1181, C16H17O3 
requires 257.1178; m.p. = 112 oC. 
 
5.5ea’ (5.1 mg, 0.02 mmol, 10%) 
RF 0.68 (50:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2931, 2915, 2850 (C-H), 1633 (C=O) 
1661, 1608, 1575, 1458 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 12.27 (1H, s, OH), 7.57 – 
7.50 (2H, m, Ar-H), 7.21 – 7.14 (1H, m, Ar-H), 3.19 – 2.94 (2H, m, alkyl CHs), 2.15 – 1.56 
(14H, m, alkyl CHs)), 1.45 – 1.26 (6H, m, alkyl CHs)); 13C NMR (101 MHz, CDCl3) δ 191.5 
(C), 185.4 (C), 161.2 (C), 152.6 (C), 150.7 (C), 135.8 (C), 132.9 (CH), 123.5 (CH), 118.6 
(CH), 115.5 (C), 40.14 (CH), 40.11 (CH), 30.75 (CH2), 30.72 (CH2), 27.3 (CH2), 27.2 (CH2), 
26.12 (CH2), 26.10 (CH2); Found (TOF MS ASAP+) [M + H]+ 339.1954, C22H27O3 requires 
339.1960; m.p. = 153 oC.  
 
[1,1'-bi(cyclohexane)]-3,6-diene-2,5-dione (5.5fa) 
 
General procedure A was followed, reacting 1,4-benzoquinone (16.2 mg, 0.15 mmol), 
cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate (68.5 mg, 
0.30 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by column 
chromatography (eluent: 2:1 to 1:2 petrol 40-60 oC/toluene) to yield product 5.5fa as a 
yellow paste (7.7 mg, 0.04 mmol, 27%).  
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 RF 0.37 (20:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2938, 2851 (C-H), 1645 (C=O), 1593, 
1447 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 6.75 (1H, d, J=10.1 Hz, Ar-H), 6.69 (1H, dd, 
J=10.1, 2.3 Hz, Ar-H), 6.50 (1H, dd, J=2.3, 1.1 Hz, Ar-H), 2.75 – 2.62 (1H, m, alkyl CH), 
1.87 – 1.70 (5H, m, alkyl CHs), 1.47 – 1.31 (2H, m, alkyl CHs), 1.28 – 1.10 (3H, m, alkyl 
CHs); 13C NMR (75 MHz, CDCl3) δ 188.4 (C), 187.3 (C), 154.2 (C), 137.2 (CH), 136.1 (CH), 
130.9 (CH), 36.5 (CH), 32.2 (2CH2), 26.4 (2CH2), 26.1 (CH2); NMR data matches 
literature values.181 
 
2-(tert-Butyl)naphthalene-1,4-dione (5.5ai) 
 
General procedure A was followed, reacting 1,4-naphthaquinone (23.7 mg, 0.15 
mmol), pivalic acid (153 mg, 1.50 mmol) and ammonium persulfate (68.5 mg, 0.30 
mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by column 
chromatography (eluent: 100:1 to 80:1 petrol 40-60 oC/EtOAc) to yield product 5.5ai as 
a yellow solid (21.4 mg, 0.10 mmol, 67%).  
 
 RF 0.21 (60:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2969, 2959, 2872 (C-H), 1664, 1654 
(C=O), 1601, 1592, 1483 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.13 – 7.98 (2H, m, Ar-H), 
7.78 – 7.63 (2H, m, Ar-H), 6.84 (1H, s, =CH), 1.37 (9H, s, 3CH3); 13C NMR (75 MHz, 
CDCl3) δ 186.1 (C), 185.1 (C), 158.5 (C), 134.0 (CH), 133.9 (CH), 133.7 (C), 133.4 (CH), 
131.7 (C), 127.0 (CH), 125.7 (CH), 35.9 (C), 29.5 (3CH3); NMR data matches literature 
values;182 m.p. = 74-76 °C (lit.182 75-76 °C). 
 
2-Benzyl-3-methylnaphthalene-1,4-dione (5.5bj) 
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General procedure A was followed, reacting menadione (25.8 mg, 0.15 mmol), 2-
phenylacetic acid (204 mg, 1.50 mmol) and ammonium persulfate (68.5 mg, 0.30 
mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by column 
chromatography (eluent: 100:1 to 60:1 petrol 40-60 oC/EtOAc) to yield product 5.5bj as 
a yellow solid (33.5 mg, 0.13 mmol, 85%).  
 
 RF 0.21 (60:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3063, 3025, 2963, 2934 (C-H), 1660, 
1652 (C=O), 1619, 1590, 1494 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.14 – 8.05 (2H, m, 
Ar-H), 7.75 – 7.66 (2H, m, Ar-H), 7.37 – 7.07 (5H, m, Ar-H), 4.05 (2H, s, CH2), 2.26 (3H, s, 
CH3); 13C NMR (75 MHz, CDCl3) δ 185.5 (C), 184.8 (C), 145.4 (C), 144.5 (C), 138.2 (C), 
133.60 (CH), 133.56 (CH), 132.23 (C), 132.15 (C), 128.8 (CH), 128.7 (CH), 126.6 (CH), 
126.5 (CH), 126.4 (CH), 32.5 (CH2), 13.4 (CH3); NMR data matches literature values;183 
m.p. = 106 oC (lit.183 106-108 oC). 
 
2-Ethyl-3-methylnaphthalene-1,4-dione (5.5bk) 
 
General procedure A was followed, reacting menadione (25.8 mg, 0.15 mmol), 
propionic acid (112 µL, 1.50 mmol) and ammonium persulfate (68.5 mg, 0.30 mmol) in 
DMSO/H2O (3 mL/5 µL). The crude product was purified by column chromatography 
(eluent: 50:1 petrol 40-60 oC/EtOAc) to yield product 5.5bk as a yellow paste (18.9 mg, 
0.09 mmol, 63%).  
 
RF 0.25 (60:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2968, 2934, 2873 (C-H), 1657, 1652 
(C=O), 1616, 1594, 1582, 1459 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.12 – 8.02 (2H, m, 
Ar-H), 7.72 – 7.63 (2H, m, Ar-H), 2.66 (2H, q, J=7.5 Hz, CH2), 2.19 (3H, s, =CCH3), 1.12 
(3H, t, J=7.5 Hz, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 185.7 (C), 184.7 (C), 148.7 (C), 
143.0 (C), 133.5 (CH), 133.4 (CH), 132.4 (C), 132.3 (C), 126.4 (CH), 126.3 (CH), 20.5, 
13.0, 12.5; NMR data matches literature values;184 m.p. = 66 oC (lit.184 66-68 oC). 
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2-Methyl-3-(pent-4-yn-1-yl)naphthalene-1,4-dione (5.5bl) 
 
General procedure A was followed, reacting menadione (25.8 mg, 0.15 mmol), 5-
hexynoic acid (166 µL, 1.50 mmol) and ammonium persulfate (68.5 mg, 0.30 mmol) in 
DMSO/H2O (3 mL/5 µL). The crude product was purified by column chromatography 
(eluent: 1:1 to neat petrol 40-60 oC/toluene) to yield product 5.5bl as a yellow solid 
(21.0 mg, 0.09 mmol, 59%).  
 
RF 0.26 (30:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3278 (H-C alkyne), 2961, 2937, 2867 (C-
H), 1655 (C=O), 1619, 1594, 1457 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.12 – 8.04 (2H, 
m, Ar-H), 7.73 – 7.65 (2H, m, Ar-H), 2.83 – 2.72 (2H, m, =CCH2), 2.31 (2H, td, J=6.9, 2.6 
Hz, CH2C≡), 2.23 (3H, s, CH3), 2.00 (1H, t, J=2.6 Hz, ≡CH), 1.80 – 1.66 (2H, m, 
CH2CH2CH2); 13C NMR (75 MHz, CDCl3) δ 185.4 (C), 184.8 (C), 146.6 (C), 143.9 (C), 133.6 
(CH), 133.5 (CH), 132.3 (2 overlapping Cs), 126.5 (CH), 126.4 (CH), 83.9 (C), 69.2 (CH), 
27.6 (CH2), 26.3 (CH2), 18.9 (CH2), 12.8 (CH3); Found (FTMS + p NSI) [M + H]+ 239.1077, 
C16H15O2 requires 239.1072; m.p. = 98 oC. 
 
2-Cyclohexyl-3-(heptan-4-yl)naphthalene-1,4-dione (5.5aaf) 
 
To a backfilled Schlenk tube 1,4-naphthoquinone (23.7 mg, 0.15 mmol), 
cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate (68.5 mg, 
0.30 mmol) were added. After a final backfill DMSO/water (3mL/5 µL degassed by 
bubbling with argon (2 balloons/15 mins)) was added and the reaction was sealed and 
stirred overnight at 40 oC. 
The reaction mixture was diluted with DCM (15 mL) and washed twice with sat. 
NaHCO3 solution. The aqueous layer was then extracted with DCM (2 x 15 mL) and the 
combined organic layers were washed with brine (40 mL), dried (Na2SO4) and 
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concentrated before being transferred to a backfilled Schlenk tube with DMSO/water 
(3 mL/5 µL, degassed by bubbling with argon). After 5 minutes of bubbling with argon, 
2-propylpentanoic acid (238 µL, 1.50 mmol) and ammonium persulfate (68.5 mg, 0.30 
mmol) were added, and the reaction was sealed and stirred overnight at 40 oC. 
The reaction mixture was diluted with DCM (15 mL) and washed with sat. NaHCO3 
solution. The aqueous layer was then extracted with DCM (2 x 15 mL) and the 
combined organic layers were washed with brine (40 mL), dried (Na2SO4) and 
concentrated to give the crude product. The crude product was purified by column 
chromatography (eluent: 5:1 to 3:1 petrol 40-60 oC/toluene) to yield product 5.5aaf as 
a yellow paste (23.2 mg, 0.07 mmol, 46%).  
 
RF 0.56 (50:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2956, 2924, 2855 (C-H), 1657 (C=O), 
1594, 1451 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.05 – 7.94 (2H, m, Ar-H), 7.70 – 7.60 
(2H, m, Ar-H), 2.92 (1H, tt, J=12.0, 3.3 Hz, CHCy), 2.24 – 2.07 (2H, m, alkyl CHs), 1.90 – 
1.52 (9H, m, alkyl CHs), 1.47 – 1.08 (8H, m, alkyl CHs), 0.88 (6H, t, J=7.3 Hz, 2CH3); 13C 
NMR (75 MHz, CDCl3) δ 185.8 (C), 185.6 (C), 150.02 (C), 150.00 (C), 133.2 (CH), 133.1 
(CH), 133.0 (C), 126.1 (C), 126.0 (2CH), 41.21 (CH), 41.19 (CH), 37.0 (CH2), 30.7 (CH2), 
27.3 (CH2), 26.1 (CH2), 22.0 (CH2), 14.5 (CH3); Found (TOF MS ASAP+) [M + H]+ 
339.2322, C23H31O2 requires 339.2324. 
 
2-(But-3-en-1-yl)-3-methylnaphthalene-1,4-dione (5.5bz) 
 
General procedure A was followed, reacting menadione (25.8 mg, 0.15 mmol), 
cyclopropylacetic acid (140 µL, 1.50 mmol) and ammonium persulfate (68.5 mg, 0.30 
mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by column 
chromatography (eluent: 1:1 petrol 40-60 oC/toluene) to yield product 5.5bz as a 
yellow paste (9.9 mg, 0.04 mmol, 29%). 
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RF 0.19 (1:1 petrol 40-60 oC/toluene); νmax/cm-1 3074, 3017, 2925 (C-H), 1656 (C=O), 
1617, 1595 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.14 – 7.98 (2H, m, Ar-H), 7.74 – 7.57 
(2H, m, Ar-H), 5.87 (1H, ddt, J=16.9, 10.1, 6.8 Hz, CH2HC=), 5.05 (1H, app. dq, J=16.9, 
1.6 Hz, =CH2), 4.99 (1H, ddt, J=10.1, 2.0, 1.2 Hz, =CH2), 2.74 (1H, t, J=7.1 Hz, CH2CH2), 
2.25 (2H, app. qm, J=7.1 Hz, CH2HC=), 2.19 (3H, s, CH3); 13C NMR (75 MHz, CDCl3) δ 
185.4 (C), 184.7 (C), 146.6 (C), 143.8 (C), 137.4 (CH), 133.52 (CH), 133.48 (CH), 132.3 
(2C), 126.44 (CH), 126.37 (CH), 115.7 (CH2), 32.8 (CH2), 26.8 (CH2), 13.0 (CH3); Found 
(TOF MS ASAP+) [M + H]+ 227.1076, C15H15O2 requires 227.1072. 
 
4,7-Dicyclohexyl-2,9-dimethyl-1,10-phenanthroline (5.3ma’) 
 
General procedure A was followed, reacting neocuproine (32.6 mg, 0.15 mmol), 
cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate (103 mg, 
0.45 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was purified by column 
chromatography (eluent: EtOAc) to yield product 5.3ma’ as a white solid (46.9 mg, 
0.12 mmol, 82%).   
 
RF 0.21 (EtOAc); νmax/cm-1 2926, 2850 (C-H), 1621, 1582, 1549, 1444 (C-C Ar); 1H NMR 
(CDCl3, 300 MHz) δ 7.99 (2H, s, Ar-H), 7.33 (2H, s, Ar-H), 3.41 – 3.23 (2H, m, alkyl CH), 
2.88 (6H, s, alkyl CHs), 2.07 – 1.81 (10H, m, alkyl CHs), 1.64 – 1.47 (8H, m, alkyl CHs), 
1.42 – 1.27 (2H, m, alkyl CHs); 13C NMR (75 MHz, CDCl3) δ 158.9 (C), 153.0 (C), 146.1 
(C), 124.5 (C), 120.3 (CH), 119.8 (CH), 39.2 (CH2), 33.7 (CH2), 27.0 (CH2), 26.4 (CH2), 26.2 
(CH3); Found (FTMS + p NSI) [M + H]+ 373.2637, C26H33N2 requires 373.2638; m.p. = 114 
oC. 
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5-((1,4-Diazepan-1-yl)sulfonyl)-1-cyclohexylisoquinoline (5.3na) 
 
General procedure A was followed, reacting Fasudil.HCl (24.6 mg, 0.08 mmol), 
cyclohexanecarboxylic acid (192 mg, 0.75 mmol) and ammonium persulfate (68.5 mg, 
0.30 mmol) in DMSO/H2O (1.5 mL/3 µL). The crude product was purified by column 
chromatography (eluent: 1 to 10% MeOH/DCM + 0.1% Et3N) and further purified by 
column chromatography on neutral alumina (eluent: 1 to 20% MeOH/DCM) to yield 
impure product 5.3na as a yellow oil (12.3 mg, 0.03 mmol, 44%, 90% purity). 
 
RF 0.14 (5% MeOH/DCM + 0.1% Et3N)/0.38 (neutral alumina 2% MeOH/DCM); νmax/cm-
1 3019, 2929, 2853 (C-H), 1610, 1580, 1558, 1490, 1450 (C-C Ar); 1H NMR (CDCl3, 300 
MHz) δ 8.62 (1H, d, J=6.1 Hz, Ar-H), 8.47 (1H, d, J=8.8 Hz, Ar-H), 8.30 (1H, dd, J=7.4, 1.1 
Hz, Ar-H), 8.25 (1H, dd, J=6.1, 0.8 Hz, Ar-H), 7.64 (1H, dd, J=8.5, 7.4 Hz, Ar-H), 3.56 (1H, 
tt, J=11.4, 3.2 Hz, alkyl CH), 3.54 – 3.42 (4H, m, NCH2), 3.21 (1H, br. s, NH), 3.09 – 2.97 
(4H, m, NCH2), 2.00 – 1.76 (9H, m, NCH2 + alkyl CHs), 1.60 – 1.35 (3H, m, alkyl CHs); 13C 
NMR (101 MHz, CDCl3) δ 166.8 (C), 144.1 (CH), 135.4 (C), 132.5 (C), 132.4 (CH), 130.5 
(CH), 127.1 (C), 125.2 (CH), 115.6 (CH), 50.4 (CH2), 50.3 (CH2), 47.5 (CH2), 47.4 (CH2), 
42.3 (CH), 32.9 (CH2), 30.6 (CH2), 30.0 (CH2), 26.3 (CH2); NMR data matches literature 
values.164 
 
8-Cyclohexyl-1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione (5.3oa) 
 
General procedure A was followed, reacting caffeine (29.1 mg, 0.15 mmol), 
cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium persulfate (103 mg, 
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0.45 mmol) in DMSO/H2O (3 mL/5 µL) for 40h. The crude product was purified by 
column chromatography (eluent: 3:1 to 2:1 petrol 40-60 oC/EtOAc) to yield product 
5.3oa as a white powder (11.6 mg, 0.04 mmol, 28%).   
 
RF 0.30 (2:1 petrol 40-60 oC/EtOAc); νmax/cm-1 2924, 2841 (C-H), 1695, 1663 (C=O), 
1651, 1603, 1541, 1493 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 3.92 (3H, s, CH3), 3.56 
(3H, s, CH3), 3.39 (3H, s, CH3), 2.70 (1H, tt, J=11.5, 3.4 Hz, alkyl CH), 1.93 – 1.61 (7H, m, 
alkyl CHs), 1.47 – 1.27 (3H, m, alkyl CHs); 13C NMR (75 MHz, CDCl3) δ 158.1 (C), 155.6 
(C), 151.9 (C), 148.3 (C), 107.2 (C), 35.9 (CH), 31.5 (CH3), 31.1 (CH2), 29.9 (CH3), 28.0 
(CH3), 26.1 (CH2), 25.7 (CH2); NMR data matches literature values;159 m.p. = 210 oC 
(lit.185 212 oC). 
 
1-(3,4-Dimethoxybenzyl)-3-methylisoquinoline (5.3em) 
 
General procedure A was followed, reacting 3-methylisoquinoline (21.5 mg, 0.15 
mmol), 2-(3,4-dimethoxyphenyl)acetic acid (288 mg, 1.50 mmol) and ammonium 
persulfate (137 mg, 0.45 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was 
purified by column chromatography (eluent: 4:1 to 2:1 petrol 40-60 oC/EtOAc) to yield 
product 5.3em as a yellow oil (38.0 mg, 0.13 mmol, 86%).   
 
RF 0.48 (2:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3013, 2934, 2834 (C-H), 1626, 1590, 
1512, 1463 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.09 (1H, d, J=8.3 Ar-H), 7.69 (1H, d, 
J=8.2 Hz, Ar-H), 7.55 (1H, ddd, J=8.2, 6.8, 1.2 Hz, Ar-H), 7.41 (1H, ddd, J=8.3, 6.8, 1.3 Hz, 
Ar-H), 7.38 (1H, s, Ar-H), 6.86 (1H, d, J=1.8 Hz, Ar-H), 6.76 (1H, dd, J=8.2, 1.8 Hz, Ar-H), 
6.71 (1H, d, J=8.2 Hz, Ar-H), 4.58 (2H, s, CH2), 3.79 (3H, s, OCH3), 3.78 (3H, s, OCH3), 
2.71 (3H, s, CH3); 13C NMR (75 MHz, CDCl3) δ 159.8 (C), 150.5 (C), 148.9 (C), 147.5 (C), 
137.5 (C), 132.3 (C), 129.9 (CH), 126.8 (CH), 126.3 (CH), 125.9 (CH), 125.4 (C), 120.6 
(CH), 118.0 (CH), 112.0 (CH), 111.2 (CH), 55.9 (2CH3), 41.7 (CH2), 24.4 (CH3); Found 
(FTMS + p NSI) [M + H]+ 294.1487, C19H20NO2 requires 294.1489.  
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2-Cyclohexyl-3-hydroxynaphthalene-1,4-dione (5.5ga) 
 
General procedure A was followed, reacting 2-hydroxy-1,4-naphthoquinone (26.1 mg, 
0.15 mmol), cyclohexanecarboxylic acid (192 mg, 1.50 mmol) and ammonium 
persulfate (68.5 mg, 0.30 mmol) in DMSO/H2O (3 mL/5 µL). The crude product was 
purified by column chromatography (eluent: 1:1 to neat petrol 40-60 oC/toluene) to 
yield product 5.5ga as an orange solid (12.5 mg, 0.05 mmol, 33%).  
 
 RF 0.40 (30:1 petrol 40-60 oC/EtOAc); νmax/cm-1 3348 (H-O), 2926, 2918, 2850 (C-H), 
1656, 1646 (C=O), 1633, 1590, 1453 (C-C Ar); 1H NMR (CDCl3, 300 MHz) δ 8.11 (1H, dd, 
J=7.8, 1.1 Hz, Ar-H), 8.05 (1H, dd, J=7.6, 1.3 Hz, Ar-H), 7.74 (1H, td, J=7.6, 1.5 Hz, Ar-H), 
7.66 (1H, td, J=7.5, 1.4 Hz, Ar-H), 7.44 (1H, s, OH), 3.07 (1H, tt, J=12.2, 3.5 Hz, alkyl CH), 
2.06 – 1.89 (2H, m, alkyl CHs)), 1.85 – 1.58 (5H, m, alkyl CHs)), 1.45 – 1.25 (3H, m, alkyl 
CHs)); 13C NMR (75 MHz, CDCl3) δ 184.7 (C), 182.1 (C), 153.0 (C), 135.0 (CH), 133.3 (C), 
133.0 (CH), 129.4 (C), 128.0 (C), 127.1 (CH), 126.1 (CH), 35.3 (CH), 29.4 (2CH2), 27.0 
(2CH2), 26.1 (CH2); NMR data matches literature values;186 m.p. = 133 oC (lit. 186 133-
135o C). 
 
6-(3-Methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)hexanoic acid (5.5bo) 
 
General procedure A was followed, reacting menadione (25.8 mg, 0.15 mmol), pimelic 
acid (192 mg, 1.50 mmol) and ammonium persulfate (68.5 mg, 0.30 mmol) in 
DMSO/H2O (3 mL/5 µL). The crude product was purified by column chromatography 
(eluent: 6:1 to 4:1 petrol 40-60 oC/EtOAc + 0.5% AcOH) to yield product 5.5bo as a 
yellow solid (26.1 mg, 0.09 mmol, 61%).   
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RF 0.23 (4:1 petrol 40-60 oC/EtOAc + 0.5% AcOH); νmax/cm-1 3100 – 2500 (COO-H), 2938, 
2866 (C-H), 1719 (C=O of CO2H), 1693, 1651 (C=O) 1616, 1593 (C-C Ar); 1H NMR (CDCl3, 
400 MHz) δ 8.11 – 8.04 (2H, m, Ar-H), 7.72 – 7.66 (2H, m, Ar-H), 2.64 (2H, t, J=7.4 Hz, 
CCH2CH2), 2.37 (2H, t, J=7.4 Hz, CCH2CH2), 2.19 (3H, s, CH3), 1.70 (2H, p, J=7.5 Hz, 
CH2CH2CH2), 1.55 – 1.42 (4H, m, alkyl CHs); 13C NMR (101 MHz, CDCl3) δ 185.5 (C), 
184.8 (C), 178.4 (C), 147.3 (C), 143.4 (C), 133.49 (CH), 133.46 (CH), 132.4 (C), 126.5 
(CH), 126.4 (CH), 33.8 (CH2), 29.5 (CH2), 28.4 (CH2), 27.0 (CH2), 24.6 (CH2), 12.8 (CH3) 
(one overlapping peak); NMR data matches literature values;187 m.p. = 102 oC (lit.187 
103-105 oC). 
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